<<<<<<< HEAD
ID,Source,Compound,CID,Class,Label,Voted_Label,MW,XLOGP,TPSA,H-Bond ACC,H-Bond Donor,Heavy_Atom_Count,Canonical SMILES,Metabolism,Note
3243,Liew,Bortezomib,387447,positive,1,1,384.2,,124,6,4,28,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,,
1323,LIverTox,Ixazomib,25183872,E*,0,0,361,,98.7,4,4,23,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,"Liver CYP: 3A4 42%, 1A2 26%, 2B6 16% and others",
3473,Liew,Ethinamate,3284,negative,0,0,167.2,1.3,52.3,2,1,12,C#CC1(CCCCC1)OC(=O)N,,
1580,LIverTox,Pralatrexate,148121,E*,0,0,477.5,-0.9,207,11,5,35,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,.,
1631,LIverTox,Rasagiline,3052776,E,0,0,171.24,1.8,12,1,1,13,C#CCNC1CCC2=CC=CC=C12,CYP1A2,
2701,Xu,maleic acid,444266,Positive,1,1,116.07,-0.3,74.6,4,2,8,C(=CC(=O)O)C(=O)O,.,
3583,Liew,Hydroxyurea,3657,positive,1,1,76.055,-1.8,75.4,2,3,5,C(=O)(N)NO,,
1221,LIverTox,Foscarnet,3415,D,1,1,126.01,-2,94.8,5,3,7,C(=O)(O)P(=O)(O)O,.,
211,DILIrank,lanthanum carbonate,168924,vNo-DILI-Concern,0,0,457.84,,190,9,0,14,C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].[La+3].[La+3],.,
3517,Liew,Fluoroacetic acid,5237,positive,0,0,78.04,0.2,37.3,3,1,5,C(C(=O)O)F,,
2797,Xu,Sorbitol,5780,Negative,0,0,182.17,-3.1,121,6,6,12,C(C(C(C(C(CO)O)O)O)O)O,.,
3460,Liew,Erythrityl tetranitrate,5284553,positive,0,0,302.11,1.4,220,12,0,20,C(C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],,
1917,Greene,Ascorbate,54670067,NE,0,0,176.12,-1.6,107,6,4,12,C(C(C1C(=C(C(=O)O1)O)O)O)O,.,
638,DILIrank,nitroglycerin,4510,vNo-DILI-Concern,0,0,227.09,1.6,165,9,0,15,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],	Liver,
2057,Greene,Dimercaprol,3080,HH,1,0,124.23,0.2,22.2,3,3,6,C(C(CS)S)O,,
1001,LIverTox,Chloral hydrate,2707,E,0,0,165.4,1,40.5,2,2,7,C(C(Cl)(Cl)Cl)(O)O,Liver and renal converted to trichloroethanol,
1314,LIverTox,Isoflurane,	3763,B,1,1,184.49,2.1,9.2,6,0,10,C(C(F)(F)F)(OC(F)F)Cl,.,
1083,LIverTox,Desflurane,42113,C,1,1,168.04,2.6,9.2,7,0,10,C(C(F)(F)F)(OC(F)F)F,Not metabolized,
1148,LIverTox,Enflurane,3226,B,1,1,184.49,2.1,9.2,6,0,10,C(C(OC(F)F)(F)F)(F)Cl,.,
1251,LIverTox,Glucosamine,439213,D,1,1,179.17,-2.8,116,6,5,12,C(C1C(C(C(C(O1)O)N)O)O)O,.,
167,DILIrank,dextrose,5793,vNo-DILI-Concern,0,0,180.16,-2.6,110,6,5,12,C(C1C(C(C(C(O1)O)O)O)O)O,.,no cid
3974,Liew,Sucralfate,6398525,positive,0,0,1571.9,,624,55,28,83,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al],"Liver, GI",
2172,Greene,Lactose,6134,NE,0,0,342.3,-4.7,190,11,8,23,C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O,.,
359,DILIrank,lactulose,11333,vNo-DILI-Concern,0,0,342.3,-4.3,190,11,8,23,C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O,	100% in colon by enteric bacteria,
1923,Greene,Aurothioglucose,6104,HH,1,1,392.18,,91.2,6,4,13,C(C1C(C(C(C(O1)[S-])O)O)O)O.[Au+],.,
3176,Liew,Aminolevulinic acid,137,positive,1,1,131.13,-3.8,80.4,4,2,9,C(CC(=O)O)C(=O)CN,,
975,LIverTox,Carglumic Acid,121396,E,0,0,190.15,-2.4,130,5,4,13,C(CC(=O)O)C(C(=O)O)NC(=O)N,Partial,
208,DILIrank,gamma hydroxybutyric acid,3037032,vNo-DILI-Concern,0,0,103.1,0,60.4,3,1,7,C(CC(=O)[O-])CO,"	95%, mainly liver, also in blood and tissues",
738,DILIrank,l-arginine,6322,vNo-DILI-Concern,0,0,174.2,-4.2,128,4,4,12,C(CC(C(=O)O)N)CN=C(N)N,.,
3446,Liew,Eflornithine,3009,negative,0,0,182.17,-2.9,89.3,6,3,12,C(CC(C(F)F)(C(=O)O)N)CN,,
3152,Liew,Alendronate,2088,positive,1,1,249.1,-6.5,161,8,6,14,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,,
3173,Liew,Aminocaproic acid,564,positive,0,0,131.17,-3,63.3,3,2,9,C(CCC(=O)O)CCN,,
3571,Liew,Gusperimus,55362,negative,0,0,387.5,-2,181,6,7,27,C(CCCN=C(N)N)CCC(=O)NC(C(=O)NCCCCNCCCN)O,,
978,LIverTox,Carmustine,2578,E*,0,0,214.05,1.5,61.8,3,1,12,C(CCl)NC(=O)N(CCCl)N=O,.,
357,DILIrank,pentetic acid,3053,vNo-DILI-Concern,0,0,393.35,-8.5,196,13,5,27,C(CN(CC(=O)O)CC(=O)O)N(CCN(CC(=O)O)CC(=O)O)CC(=O)O,.,
3057,Liew,Pamidronate,4674,negative,.,0,235.07,-6.9,161,8,6,13,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,,
431,DILIrank,amifostine,2141,vNo-DILI-Concern,0,0,214.23,-4.5,121,6,4,12,C(CN)CNCCSP(=O)(O)O,.,
2466,Greene,Trientine HCl,5565,HH,1,0,146.23,-2.5,76.1,4,4,10,C(CNCCNCCN)N,,
2942,Liew,Ethanolamine,700,negative,.,0,61.08,-1.3,46.2,2,2,4,C(CO)N,,
3360,Liew,Cysteamine,6058,positive,1,1,77.15,-0.4,27,2,2,4,C(CS)N,,
1973,Greene,carbon tetrachloride (2),5943,HH,1,1,153.8,2.8,0,0,0,5,C(Cl)(Cl)(Cl)Cl,.,
2235,Greene,Myo-inositol,892,NE,0,0,180.16,-3.7,121,6,6,12,C1(C(C(C(C(C1O)O)O)O)O)O,.,
1210,LIverTox,Fluorouracil,3385,A,1,1,130.08,-0.9,58.2,3,2,9,C1=C(C(=O)NC(=O)N1)F,Intracellular and liver CYP-mediated,
2477,Greene,Uracil Mustard,6194,HH,1,1,252.09,0.5,61.4,3,2,15,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl,.,
3499,Liew,Fialuridine,50313,positive,1,1,372.09,-0.9,99.1,6,3,18,C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)F)I,,
435,DILIrank,levothyroxine,5819,vLess-DILI-Concern,1,1,776.87,2.4,92.8,5,3,24,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,"	Mainly in liver, kidneys, brain and muscles",
3642,Liew,Lodoxamide,44564,negative,0,0,311.63,0.5,157,7,4,21,C1=C(C=C(C(=C1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N,,
331,DILIrank,dichlorphenamide,3038,vNo-DILI-Concern,0,0,305.2,0.3,137,6,2,16,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,.,
1948,Greene,Bithionol,2406,HH,1,1,356,5.8,65.8,3,2,19,C1=C(C=C(C(=C1SC2=C(C(=CC(=C2)Cl)Cl)O)O)Cl)Cl,.,
50,DILIrank,famotidine,3325,vLess-DILI-Concern,1,1,337.5,-0.6,238,8,4,20,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,.,
303,DILIrank,histamine diphosphate,65513,vNo-DILI-Concern,0,0,307.14,,210,10,8,18,C1=C(NC=N1)CCN.OP(=O)(O)O.OP(=O)(O)O,.,
3770,Liew,Nitrofurazone,5447130,negative,0,0,198.14,0.2,126,5,2,14,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,,
487,DILIrank,chlorothiazide,2720,vLess-DILI-Concern,1,1,295.7,-0.2,135,6,2,17,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,	Nil,
4056,Liew,Trichlormethiazide,5560,negative,0,0,380.7,0.6,135,7,3,20,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl,,
220,DILIrank,bromfenac,60726,vMost-DILI-Concern,1,1,334.16,3.3,80.4,4,2,20,C1=CC(=C(C(=C1)C(=O)C2=CC=C(C=C2)Br)N)CC(=O)O,	CYP2C9,
3567,Liew,Guanabenz,5702063,positive,0,0,231.08,1.7,76.8,2,2,14,C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,,
1263,LIverTox,Guanfacine,3519,E,0,0,246.09,2,81.5,1,2,15,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl,CYP3A4,
1336,LIverTox,Lamotrigine,3878,A,1,1,256.09,1.4,90.7,5,2,16,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,UGT1A4,
1959,Greene,Butoconazole Nitrate,47472,NE,0,0,411.8,6.4,43.1,2,0,25,C1=CC(=C(C(=C1)Cl)SC(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)Cl,,
1668,LIverTox,Rufinamide,129228,E*,0,0,238.19,0.7,73.8,5,1,17,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F,Carboxylesterase-mediated hydrolysis CYP not involved,
1121,LIverTox,Droxidopa,92974,E,0,0,213.19,-3.2,124,6,5,15,C1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O,Liver,
3774,Liew,Norepinephrine,439260,negative,0,0,169.18,-1.2,86.7,4,4,12,C1=CC(=C(C=C1C(CN)O)O)O,,
1618,LIverTox,Quercetin,5280343,E,0,0,302.23,1.5,127,7,5,22,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,.,
46,DILIrank,diflunisal,3059,vMost-DILI-Concern,1,1,250.2,4.4,57.5,5,2,18,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,Liver,
1352,LIverTox,Levodopa,6047,E,0,0,197.19,-2.7,104,5,4,14,C1=CC(=C(C=C1CC(C(=O)O)N)O)O,Aromatic-l-amino-acid decarboxylase,
2072,Greene,Dopamine,681,NE,0,0,153.18,-1,66.5,3,3,11,C1=CC(=C(C=C1CCN)O)O,"MAO, COMT",
4034,Liew,Tioconazole,5482,negative,0,0,387.7,5.3,55.3,3,0,23,C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl,,
3717,Liew,Miconazole,4189,negative,0,0,416.1,5.3,27,2,0,25,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,,
3796,Liew,Oxiconazole,5361463,negative,0,0,429.1,6.1,39.4,3,0,26,C1=CC(=C(C=C1Cl)Cl)CON=C(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,,
106,DILIrank,fluconazole,3365,vMost-DILI-Concern,1,1,306.27,0.4,81.6,7,1,22,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,liver 11%,
186,DILIrank,mesalazine,4075,vLess-DILI-Concern,1,1,153.14,1.3,83.6,4,3,11,C1=CC(=C(C=C1N)C(=O)O)O,	Rapidly & extensively metabolized intestinal mucosal wall and the liver,
3177,Liew,4-Aminosalicylic acid,4649,positive,1,1,153.14,1.3,83.6,4,3,11,C1=CC(=C(C=C1N)O)C(=O)O,,
3782,Liew,Olsalazine,22419,positive,1,1,302.24,3.1,140,8,4,22,C1=CC(=C(C=C1N=NC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O,,
3004,Liew,Liothyronine,16218759,negative,.,0,690.97,,96.6,6,3,25,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.O.[Na+],,
3760,Liew,Niclosamide,4477,negative,0,0,327.12,4,95.2,4,2,21,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,,
629,DILIrank,mitoxantrone,4212,vLess-DILI-Concern,1,1,444.5,1,163,10,8,32,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,CYP2E1,
3638,Liew,Liarozole,60652,positive,0,0,308.8,3.5,46.5,2,1,22,C1=CC(=CC(=C1)Cl)C(C2=CC3=C(C=C2)N=CN3)N4C=CN=C4,,
1870,Greene,"1,3 dinitrobenzene",7452,HH,1,1,168.11,1.5,91.6,4,0,12,C1=CC(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-],.,
3629,Liew,Letrozole,3902,positive,1,1,285.3,2.7,78.3,4,0,22,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,,
3885,Liew,Progabide,5361323,positive,0,0,334.8,3.1,72.2,4,2,23,C1=CC(=CC=C1C(=C2C=C(C=CC2=O)F)NCCCC(=O)N)Cl,Liver,
70,DILIrank,pentamidine,4735,vLess-DILI-Concern,1,1,340.4,2.6,118,4,4,25,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N,.,
3529,Liew,Folic acid,6037,negative,0,0,441.4,-1.1,209,9,6,32,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,,
3175,Liew,Aminohippuric acid,2148,negative,0,0,194.19,-0.9,92.4,4,3,14,C1=CC(=CC=C1C(=O)NCC(=O)O)N,,
3218,Liew,Balsalazide,5362070,negative,0,0,357.32,1.2,145,8,4,26,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O,,
480,DILIrank,chloramphenicol,5959,vNo-DILI-Concern,0,1,323.13,1.1,115,5,3,20,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],Liver,
3217,Liew,Baclofen,2284,positive,1,1,213.66,-1,63.3,3,2,14,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,,
691,DILIrank,fenclozic acid,28858,vMost-DILI-Concern,1,1,253.71,2.7,78.4,4,1,16,C1=CC(=CC=C1C2=NC(=CS2)CC(=O)O)Cl,.,
459,DILIrank,ezetimibe,150311,vLess-DILI-Concern,1,1,409.4,4,60.8,5,2,30,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,"Intestinal wall, liver",
1639,LIverTox,Resveratrol,445154,E,0,0,228.24,3.1,60.7,3,3,17,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,.,
3668,Liew,Melphalan,460612,positive,1,1,305.2,-0.5,66.6,4,2,19,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,,
3062,Liew,Pemetrexed,135410875,positive,.,1,427.4,0.2,187,7,6,31,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O,,
150,DILIrank,chlorambucil,2708,vLess-DILI-Concern,1,1,304.2,1.7,40.5,3,1,19,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,Liver,
3199,Liew,Arbutamine,60789,negative,0,0,317.4,0.9,93,5,5,23,C1=CC(=CC=C1CCCCNCC(C2=CC(=C(C=C2)O)O)O)O,,
771,DILIrank,tyramine,5610,vNo-DILI-Concern,0,0,137.18,1.1,46.2,2,2,10,C1=CC(=CC=C1CCN)O,"	CYP2D6, flavin-containing monooxygenase 3, monoamine oxidase A, monoamine oxidase B, phenylethanolamine N-methyltransferase, DBH, others",
3655,Liew,Mafenide,3998,negative,0,0,186.23,-0.7,94.6,4,2,12,C1=CC(=CC=C1CN)S(=O)(=O)N,,
3444,Liew,Econazole,3198,negative,0,0,381.7,5.3,27,2,0,24,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,,
2428,Greene,Sulconazole Nitrate,5318,NE,0,0,397.7,6.1,43.1,2,0,24,C1=CC(=CC=C1CSC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,,
3303,Liew,Chlorbenside,7639,positive,0,0,269.2,5.2,25.3,1,0,16,C1=CC(=CC=C1CSC2=CC=C(C=C2)Cl)Cl,,
2034,Greene,Dapsone,2955,HH,1,1,248.3,1,94.6,4,2,17,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,CYP2E1,
2431,Greene,Sulfanilamide,5333,HH,1,1,172.21,-0.6,94.6,4,2,11,C1=CC(=CC=C1N)S(=O)(=O)N,.,
258,DILIrank,sulfathiazole,5340,vMost-DILI-Concern,1,1,255.3,0.1,122,6,2,16,C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2,.,
3311,Liew,Chlorphenesin,2724,negative,0,0,245.66,1.2,81.8,4,2,16,C1=CC(=CC=C1OCC(COC(=O)N)O)Cl,,
692,DILIrank,ebrotidine,65869,vMost-DILI-Concern,1,1,477.4,1.5,198,7,3,26,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br,.,
399,DILIrank,tiludronate,60937,vNo-DILI-Concern,0,0,318.61,-0.3,140,7,4,17,C1=CC(=CC=C1SC(P(=O)(O)O)P(=O)(O)O)Cl,.,
3759,Liew,Niacinamide,936,positive,1,1,122.12,-0.4,56,2,1,9,C1=CC(=CN=C1)C(=O)N,,
3758,Liew,Niacin,938,positive,1,1,123.11,0.4,50.2,3,1,9,C1=CC(=CN=C1)C(=O)O,,
1551,LIverTox,Pexidartinib,25151352,B,1,1,417.8,4.5,66.5,7,2,29,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,.,
3626,Liew,Lazabemide,71307,positive,0,0,199.64,0.2,68,3,2,13,C1=CC(=NC=C1Cl)C(=O)NCCN,,
1610,LIverTox,Psoralen,6199,C,1,1,186.16,2.3,39.4,3,0,14,C1=CC(=O)OC2=CC3=C(C=CO3)C=C21,.,
3310,Liew,Chloroxine,2722,negative,0,0,214.04,3.5,33.1,2,1,13,C1=CC2=C(C(=C(C=C2Cl)Cl)O)N=C1,,
3954,Liew,Sertaconazole,65863,positive,0,0,437.8,6.3,55.3,3,0,27,C1=CC2=C(C(=C1)Cl)SC=C2COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl,,
3317,Liew,Chlorzoxazone,2733,positive,1,1,169.56,1.8,38.3,2,1,11,C1=CC2=C(C=C1Cl)NC(=O)O2,,
672,DILIrank,riluzole,5070,vMost-DILI-Concern,1,1,234.2,3.6,76.4,7,1,15,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,CYP1A2,
2111,Greene,Flufenamic Acid (Flufenamate),3371,WE,1,1,281.23,5.2,49.3,6,2,20,C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F,"	Hydroxylation, glucuronidation",
3949,Liew,Salsalate,5161,positive,1,1,258.23,3,83.8,5,2,19,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O,,
746,DILIrank,glafenine,3474,vMost-DILI-Concern,1,1,372.8,3.5,91.7,6,3,26,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC(=CC3=NC=C2)Cl,.,
1430,LIverTox,Mitotane,4211,E*,0,0,320,6.2,0,0,0,18,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,.,
3648,Liew,Lorazepam,3958,positive,1,1,321.2,2.4,61.7,3,2,21,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,,
233,DILIrank,deferasirox,214348,vMost-DILI-Concern,1,1,373.4,3.8,109,6,3,28,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O,Liver glucuronidation,
2048,Greene,"diclofenac (BMS, reactive metabolite)",3033,HH,1,1,296.1,4.4,49.3,3,2,19,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,,
693,DILIrank,aceclofenac,71771,vLess-DILI-Concern,1,1,354.2,4.3,75.6,5,2,23,C1=CC=C(C(=C1)CC(=O)OCC(=O)O)NC2=C(C=CC=C2Cl)Cl,.,
1952,Greene,Bromobenzene,7961,HH,1,1,157.01,3,0,0,0,7,C1=CC=C(C=C1)Br,.,
3755,Liew,Nepafenac,151075,negative,0,0,254.28,1.9,86.2,3,2,19,C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N,,
2574,Xu,Clotrimazole,2812,Negative,0,1,344.8,5,17.8,1,0,25,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,Liver,
3728,Liew,Modafinil,4236,positive,1,1,273.4,1.7,79.4,3,1,19,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,,
1427,LIverTox,Mirabegron,9865528,E*,0,0,396.5,2.1,129,6,4,28,C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,"Liver via direct glucuronidation, amide hydrolysis, and minimal oxidative metabolism in vivo by CYP2D6 and CYP3A4. Some involvement of butylcholinesterase",
1189,LIverTox,Felbamate,3331,B,1,1,238.24,0.6,105,4,2,17,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,Liver,
1224,LIverTox,Fosphenytoin,56339,A,1,1,362.27,0.6,116,6,3,25,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3,Liver,
2762,Xu,phenytoin,1775,Positive,1,1,252.27,2.5,58.2,2,2,19,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,Liver,
1512,LIverTox,Oxaprozin,4614,C,1,1,293.3,4.2,63.3,4,1,22,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,Liver?65% oxidation and 35% glucuronic acid conjugation. 5% are active phenolic metabolites.,
3491,Liew,Fenbufen,3335,positive,0,0,254.28,3.2,54.4,3,1,19,C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)CCC(=O)O,,
3497,Liew,Fentiazac,28871,positive,0,0,329.8,5.2,78.4,4,1,22,C1=CC=C(C=C1)C2=NC(=C(S2)CC(=O)O)C3=CC=C(C=C3)Cl,,
3794,Liew,Oxazepam,4616,positive,0,0,286.71,2.2,61.7,3,2,20,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,Liver,
1803,LIverTox,Triamterene,5546,D,1,1,253.26,1,130,7,3,19,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,hydroxylation to para-hydroxytriamterene,
494,DILIrank,cinchophen,8593,vMost-DILI-Concern,1,1,249.26,3.4,50.2,3,1,19,C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2)C(=O)O,.,
3838,Liew,Phenindione,4760,positive,1,1,222.24,2.9,34.1,2,0,17,C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O,,
133,DILIrank,pemoline,4723,vMost-DILI-Concern,1,1,176.17,0.9,64.7,2,1,13,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,	Liver,
3835,Liew,Phenacemide,4753,positive,0,0,178.19,0.9,72.2,2,2,13,C1=CC=C(C=C1)CC(=O)NC(=O)N,,
3222,Liew,Bendroflumethiazide,2315,positive,1,1,421.4,1.2,135,10,3,27,C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2,,
1558,LIverTox,Phenylbutyrate,5258,E,0,0,186.18,,40.1,2,0,13,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+],Liver and kidney to phenylacetic acid,
3868,Liew,Pranlukast,4887,positive,0,0,481.5,4.2,119,7,2,36,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5,CYP3A4,
3948,Liew,Salmeterol,5152,negative,0,0,415.6,3.9,82,5,4,30,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,CYP3A4,
2757,Xu,phenelzine,3675,Negative,0,1,136.19,1.2,38,2,2,10,C1=CC=C(C=C1)CCNN,Liver,
446,DILIrank,bendazac,2313,vMost-DILI-Concern,1,1,282.29,3.1,64.4,4,1,21,C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)OCC(=O)O,.,
635,DILIrank,nialamide,4472,vMost-DILI-Concern,1,1,298.34,0.9,83.1,4,3,22,C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2,.,
914,LIverTox,Benznidazole,31593,D,1,1,260.25,0.9,92.7,4,1,19,C1=CC=C(C=C1)CNC(=O)CN2C=CN=C2[N+](=O)[O-],Liver,
3231,Liew,Benzthiazide,2343,negative,0,0,431.9,1.7,161,7,2,26,C1=CC=C(C=C1)CSCC2=NS(=O)(=O)C3=CC(=C(C=C3N2)Cl)S(=O)(=O)N,,
1546,LIverTox,Perampanel,9924495,E,0,0,349.4,3.4,57,3,0,27,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,"Liver, mostly via CYP3A4 and/or CYP3A5",
1851,LIverTox,Vorinostat,5311,E,0,0,264.32,1.9,78.4,3,3,19,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,"Liver glucuronidation and ??-oxidation
CYP system not involved",
908,LIverTox,Belinostat,6918638,D,1,1,318.3,1.7,104,5,3,22,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO,UGT1A1,
3645,Liew,Lonidamine,39562,positive,0,0,321.2,4.3,55.1,3,1,21,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,,
3409,Liew,Dihydralazine,10230,positive,0,0,190.21,0.2,102,6,4,14,C1=CC=C2C(=C1)C(=NN=C2NN)NN,,
96,DILIrank,zonisamide,5734,vLess-DILI-Concern,1,1,212.23,0.2,94.6,5,1,14,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,Liver throug CYP3A4,
3516,Liew,Fluorescein,16850,negative,0,0,332.3,3.4,76,5,2,25,C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O,,
1947,Greene,Bismuth Subsalicylate,16682734,NE,0,0,363.1,,36.5,4,1,12,C1=CC=C2C(=C1)C(=O)O[Bi]O2.O,.,
3804,Liew,Oxyphenisatin,31315,positive,1,1,317.3,3.2,69.6,3,3,24,C1=CC=C2C(=C1)C(C(=O)N2)(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O,,
1969,Greene,carbamazepine,2554,HH,1,1,236.27,2.5,46.3,1,1,18,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,CYP3A4,
1280,LIverTox,Hydralazine,3637,A,1,1,160.18,0.7,63.8,4,2,12,C1=CC=C2C(=C1)C=NN=C2NN,Liver,
1762,LIverTox,Thiabendazole,5430,ND,.,1,201.25,2.5,69.8,3,1,14,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,GI tract,
2365,Greene,phenothiazine,7108,HH,1,1,199.27,4.2,37.3,2,1,14,C1=CC=C2C(=C1)NC3=CC=CC=C3S2,.,
3981,Liew,Sulfapyridine,5336,positive,0,0,249.29,0,93.5,5,2,17,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N,,
2801,Xu,Sulfasalazine,5339,Positive,1,1,398.4,-0.7,150,9,3,28,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,.,
3469,Liew,Etanidazole,3276,positive,0,0,214.18,-1.3,113,5,2,15,C1=CN(C(=N1)[N+](=O)[O-])CC(=O)NCCO,,
588,DILIrank,gemcitabine,60750,vMost-DILI-Concern,1,1,263.2,-1.5,108,6,3,18,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,.,
3361,Liew,Cytarabine,6253,positive,1,1,243.22,-2.1,129,5,4,17,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,,
1010,LIverTox,Cidofovir,60613,E,0,0,279.19,-3.6,146,6,4,18,C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O,.,
439,DILIrank,zoledronate,68740,vLess-DILI-Concern,1,1,272.09,-4.3,153,8,5,16,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,	Nil,
3901,Liew,Pyrazinamide,1046,positive,1,1,123.11,-0.6,68.9,3,1,9,C1=CN=C(C=N1)C(=O)N,Liver,
84,DILIrank,sulfadiazine,5215,vLess-DILI-Concern,1,1,250.28,-0.1,106,6,2,17,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,Liver acetylation,
3959,Liew,Silver sulfadiazine,441244,negative,0,0,357.14,,95.3,6,1,18,C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Ag+],,
823,LIverTox,Amifampridine,5918,E,0,0,109.13,-0.5,64.9,3,2,8,C1=CN=CC(=C1N)N,Acetylation to 3-N-acetyl??amifampridine,
2159,Greene,isoniazid,3767,HH,1,1,137.14,-0.7,68,3,2,10,C1=CN=CC=C1C(=O)NN,"liver; CYP450: 2C19, 3A4 inhibitor",
1912,Greene,Amrinone,3698,HH,1,1,187.2,-0.2,68,3,2,14,C1=CN=CC=C1C2=CNC(=O)C(=C2)N,Liver,
1063,LIverTox,Dalfampridine,	1727,E*,0,0,94.11,0.3,38.9,2,1,7,C1=CN=CC=C1N,.,
2663,Xu,Furosemide,3440,Positive,1,1,330.74,2,131,7,3,21,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,	liver and kidney glucuronidation,
261,DILIrank,ticrynafen,38409,vMost-DILI-Concern,1,1,331.2,4.1,91.8,5,1,20,C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)OCC(=O)O)Cl)Cl,Liver,
4004,Liew,Tenidap,60712,positive,1,1,320.8,3.8,114,4,2,21,C1=CSC(=C1)C(=O)C2=C(N(C3=C2C=C(C=C3)Cl)C(=O)N)O,,
2832,Xu,Vidarabine,21704,Negative,0,0,267.24,-1.1,140,8,4,19,C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N,"Liver: CYP2C9, 2C19, 2C8, 2C18, 1A2,3A4",
461,DILIrank,adefovir,60172,vLess-DILI-Concern,1,0,273.19,-2,136,8,3,18,C1=NC(=C2C(=N1)N(C=N2)CCOCP(=O)(O)O)N,.,
1925,Greene,Azacytidine,9444,HH,1,0,244.2,-2.2,141,5,4,17,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,.,
2410,Greene,Ribavirin,37542,E*,0,0,244.2,-1.8,144,7,4,17,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,liver and intracellularly,
1207,LIverTox,Flucytosine,3366,D,1,1,129.09,-0.9,67.5,3,2,9,C1=NC(=O)NC(=C1F)N,"minimal, in the GI tract",
2813,Xu,Thioguanine,2723601,Positive,1,1,167.19,-0.1,111,2,3,11,C1=NC2=C(N1)C(=S)N=C(N2)N,	Intracellular,
3676,Liew,Mercaptopurine,667490,positive,1,1,152.18,0,85.2,2,2,10,C1=NC2=C(N1)C(=S)N=CN2,,
3819,Liew,Penciclovir,135398748,negative,0,1,253.26,-1.9,126,5,4,18,C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N,"CYP3A4(major), CYP2C9(minor)",
3144,Liew,Acyclovir,2022,positive,1,1,225.2,-1.6,115,4,3,16,C1=NC2=C(N1COCCO)NC(=NC2=O)N,,
3335,Liew,Clofarabine,119182,positive,1,1,303.68,0.9,119,8,3,20,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,,
574,DILIrank,fludarabine,657237,vNo-DILI-Concern,0,0,285.23,-0.6,140,9,4,20,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,.,
21,DILIrank,allopurinol,135401907,vMost-DILI-Concern,1,1,136.11,-0.7,70.1,3,2,10,C1=NNC2=C1C(=O)NC=N2,"	liver 80% oxipurinol, 10% allopurinol ribosides",
3274,Liew,Cefaclor,51039,positive,1,1,367.8,-1.8,138,6,3,24,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,,
464,DILIrank,cefaclor,51038,vLess-DILI-Concern,1,1,385.8,,139,7,4,25,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl.O,15% to 40%,
3283,Liew,Cefonicid,43594,positive,0,0,542.6,-1.9,264,13,4,35,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)O)C(=O)O)CSC4=NN=NN4CS(=O)(=O)O,,
3290,Liew,Cefsulodin,5284530,positive,0,0,532.6,0.2,225,9,3,36,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)S(=O)(=O)O)C(=O)[O-])C[N+]4=CC=C(C=C4)C(=O)N,,
3285,Liew,Ceforanide,43507,positive,0,0,519.6,-3.2,244,12,4,35,C1C(=C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3CN)C(=O)O)CSC4=NN=NN4CC(=O)O,,
3572,Liew,Halazepam,31640,negative,0,0,352.7,4,32.7,5,0,24,C1C(=O)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3)CC(F)(F)F,,
2613,Xu,Dantrolene Sodium,2952,Positive,1,1,314.25,1.7,121,6,1,23,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-],	Liver,
67,DILIrank,nitrofurantoin,6604200,vMost-DILI-Concern,1,1,238.16,-0.5,121,6,1,17,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],Liver 75%,
1026,LIverTox,Clonazepam,2802,D,1,1,315.71,2.4,87.3,4,1,22,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,CYP3A,
3904,Liew,Quazepam,4999,negative,0,0,386.8,4,47.7,6,0,25,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,Liver,
4097,Liew,Voglibose,444020,positive,0,0,267.28,-4.1,154,8,8,18,C1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO,,
250,DILIrank,neomycin,8378,vNo-DILI-Concern,0,0,614.6,-9,353,19,13,42,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N,,
2685,Xu,Kanamycin Sulfate,6032,Negative,0,0,484.5,-6.9,283,15,11,33,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N,	Unknown,
4039,Liew,Tobramycin,36294,positive,1,1,467.5,-6.2,268,14,10,32,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,,
3812,Liew,Paromomycin,441375,negative,1,1,713.7,,430,23,15,47,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O,,
3171,Liew,Amikacin,37768,positive,0,0,585.6,-7.9,332,17,13,40,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N,,
1418,LIverTox,Migalastat,176077,E,0,0,163.17,-2.3,93,5,5,11,C1C(C(C(C(N1)CO)O)O)O,.,
1419,LIverTox,Miglitol,441314,E,0,0,207.22,-2.6,104,6,5,14,C1C(C(C(C(N1CCO)CO)O)O)O,Nil,
4060,Liew,Trifluridine,6256,negative,0,0,296.2,-0.5,99.1,8,3,20,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,Thymidine phosphorylase,
3505,Liew,Floxuridine,5790,positive,1,1,246.19,-1.2,99.1,6,3,17,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,,
2678,Xu,Idoxuridine,5905,Positive,1,1,354.1,-1,99.1,5,3,17,C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O,.,
1072,LIverTox,Decitabine,451668,E*,0,0,228.21,-1.2,121,4,3,16,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,.,
2010,Greene,Cladribine,20279,NE,0,0,285.69,0.8,119,7,3,19,C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O,"Mostly via intracellular kinases; 15-18% is excreted unchanged.Intravenous and subcutaneous bolus injection: 15-18% is excreted unchangedAfter oral administration, 25% ??21% of dose is excreted unchanged in urine and 3.8% as a metabolite.",
653,DILIrank,pentostatin,439693,vMost-DILI-Concern,1,1,268.27,-2.1,112,6,4,19,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,"Liver, minor",
686,DILIrank,tranylcypromine,19493,vLess-DILI-Concern,1,1,133.19,1.5,26,1,1,10,C1C(C1N)C2=CC=CC=C2,Liver,
2162,Greene,Isosorbide dinitrate,6883,NE,0,0,236.14,1.3,129,8,0,16,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],	Liver,
1078,LIverTox,Delafloxacin,487101,E*,0,0,440.8,2.7,120,11,3,30,C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O,.,
1527,LIverTox,Pasireotide,9941444,E*,0,0,1047.2,4.7,281,11,9,77,C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,.,
1588,LIverTox,Pretomanid,456199,D,1,1,359.26,2.8,91.3,9,0,25,C1C(COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F,.,
2177,Greene,Leucovorin Calcium,6006,NE,0,0,473.4,-1.2,216,9,7,34,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,.,
1037,LIverTox,Colestipol,62816,E,0,0,281.83,,101,6,5,18,C1C(O1)CCl.C(CNCCNCCNCCN)N,.,
1887,Greene,acivicin,294641,NE,0,0,178.57,-2.7,84.9,5,2,11,C1C(ON=C1Cl)C(C(=O)O)N,.,
3190,Liew,Anagrelide,135409400,negative,0,1,256.08,1.6,44.7,2,1,16,C1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3,,
426,DILIrank,oxcarbazepine,34312,vLess-DILI-Concern,1,1,252.27,1.7,63.4,2,1,19,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,Liver cytosolic enzymes and glucuronic acid,
545,DILIrank,estazolam,3261,vNo-DILI-Concern,0,0,294.74,1.7,43.1,3,0,21,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,Liver,
2537,Xu,Biotin,171548,Negative,0,0,244.31,0.3,104,4,3,16,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,.,
3454,Liew,Epinastine,3241,negative,0,0,249.31,3.5,41.6,1,1,19,C1C2C3=CC=CC=C3CC4=CC=CC=C4N2C(=N1)N,,
3151,Liew,Aldrin,2087,positive,0,0,364.9,4.5,0,0,0,18,C1C2C=CC1C3C2C4(C(=C(C3(C4(Cl)Cl)Cl)Cl)Cl)Cl,,
3357,Liew,Cyclothiazide,2910,negative,0,0,389.9,2,135,7,3,24,C1C2CC(C1C=C2)C3NC4=CC(=C(C=C4S(=O)(=O)N3)S(=O)(=O)N)Cl,,
1677,LIverTox,Saxagliptin,11243969,E*,0,0,315.4,0.7,90.4,4,2,23,C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N,"CYP3A4, CYP3A5",
3425,Liew,Dolasetron,60654,positive,0,0,324.4,3.4,62.4,4,1,24,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,,
3165,Liew,Amantadine,2130,positive,0,0,151.25,2.4,26,1,1,11,C1C2CC3CC1CC(C2)(C3)N,,
2507,Xu,Amantadine HCl,64150,Negative,0,0,187.71,,26,1,2,12,C1C2CC3CC1CC(C2)(C3)N.Cl,	Minimal mostly to acetyl metabolites,
4088,Liew,Varenicline,5310966,negative,1,1,211.26,0.8,37.8,3,1,16,C1C2CNCC1C3=CC4=NC=CN=C4C=C23,,
3416,Liew,Diphenidol,9175,negative,0,0,280.4,4,0,0,0,22,C1C=C2C=C3C=CC=CC3=CC2=C4C1C=C5C=CC=CC5=C4,,
3647,Liew,Loracarbef,5284584,positive,0,0,367.78,,114,6,4,25,C1CC(=C(N2C1C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl.O,,
3767,Liew,Nitisinone,115355,negative,0,0,329.23,2.3,97,8,0,23,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],,
1321,LIverTox,Ivosidenib,71657455,E*,0,0,583,3.4,119,9,1,41,C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,.,
1577,LIverTox,Pomalidomide,134780,D,1,1,273.24,0.2,110,5,2,20,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,Liver mostly CYP1A2- and CYP3A4-mediated; some minor contributions by CYP2C19 and CYP2D6,
197,DILIrank,thalidomide,5426,vLess-DILI-Concern,1,1,258.23,0.3,83.6,4,1,19,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,Liver minimally via CYP2C19-mediated 5-hydroxylation; mostly via non-enzymatic hydrolysis at the four amide sites,
3628,Liew,Lenalidomide,216326,positive,1,1,259.26,-0.5,92.5,4,2,19,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,,
3201,Liew,Aripiprazole,60795,negative,1,1,448.4,4.6,44.8,4,1,30,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,Liver mostly via CYP3A4 and 2D6,
34,DILIrank,carboplatin,498142,vLess-DILI-Concern,1,1,371.25,,76.6,6,4,13,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt],.,
633,DILIrank,nalbuphine,5311304,vNo-DILI-Concern,0,0,357.4,0.2,73.2,5,3,26,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,	Liver glucuronidation,
4017,Liew,Tetrahydrozoline,5419,negative,0,0,200.28,1.8,24.4,1,1,15,C1CC(C2=CC=CC=C2C1)C3=NCCN3,,
3547,Liew,Gadofosveset,158440,positive,0,0,975.9,,270,18,1,56,C1CC(CCC1OP(=O)([O-])OCC(CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-])(C2=CC=CC=C2)C3=CC=CC=C3.O.[Na+].[Na+].[Na+].[Gd+3],,
1475,LIverTox,Niraparib,24958200,E*,0,0,320.4,2.2,72.9,3,2,24,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,Carboxylesterases,
171,DILIrank,protirelin,638678,vNo-DILI-Concern,0,0,362.38,-2.5,150,5,4,26,C1CC(N(C1)C(=O)C(CC2=CN=CN2)NC(=O)C3CCC(=O)N3)C(=O)N,.,
1359,LIverTox,Lisinopril,5362119,B,1,1,405.5,-2.9,133,7,4,29,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,,
768,DILIrank,Argipressin,644077,vNo-DILI-Concern,0,0,1084.2,-4.8,515,16,14,75,C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N,	Predominantly in the liver and kidneys,
1341,LIverTox,Larotrectinib,46188928,E*,0,0,428.4,1.7,86,7,2,31,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,.,
2490,Greene,Zalcitabine,24066,NE,0,0,211.22,-1.3,88.2,3,2,15,C1CC(OC1CO)N2C=CC(=NC2=O)N,Liver,
2050,Greene,Didanosine,135398739,HH,1,1,236.23,-1.2,88.7,5,2,17,C1CC(OC1CO)N2C=NC3=C2N=CNC3=O,.,
1134,LIverTox,Efavirenz,64139,A,1,1,315.67,4,38.3,5,1,21,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,"CYP2A6,CYP2B6",
1495,LIverTox,Olaparib,23725625,E,0,0,434.5,1.9,82.1,5,1,32,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,.,
1346,LIverTox,Lesinurad,56928182,E,0,0,426.3,,96.1,5,0,25,C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)[O-].[Na+],CYP2C9,
1571,LIverTox,Pitavastatin,	5282452,D,1,1,421.5,3.5,90.6,6,3,31,C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)O)O)O)C4=CC=C(C=C4)F,"Liver CYP2C9, minimally",
3870,Liew,Prazepam,4890,negative,0,0,324.8,3.6,32.7,2,0,23,C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4,Liver,
1660,LIverTox,Roflumilast,449193,E,0,0,403.2,4.6,60.4,6,1,26,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,"CYP1A2, CYP3A4",
2013,Greene,clinafloxacin,60062,WE,1,1,402.2,,86.9,7,3,26,C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)Cl)N4CCC(C4)N)F)C(=O)O.Cl,.,
2561,Xu,Ciprofloxacin HCl,2764,Positive,1,1,331.34,-1.1,72.9,7,2,24,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,	Liver incl. CYP1A2,
783,LIverTox,Abacavir,441300,C,1,1,286.33,0.9,102,6,3,21,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,Liver,
438,DILIrank,desloratadine,124087,vLess-DILI-Concern,1,1,310.8,4.5,24.9,2,1,22,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,"UGT2B10, CYP2C8",
1458,LIverTox,Nebivolol,71301,E,0,0,405.4,3,71,7,3,29,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O,CYP2D6,
1900,Greene,Amineptine HCl,34870,HH,1,1,337.5,2.1,49.3,3,2,25,C1CC2=CC=CC=C2C(C3=CC=CC=C31)NCCCCCCC(=O)O,.,
400,DILIrank,eptifibatide,123610,vNo-DILI-Concern,0,0,832,-2.4,377,12,10,57,C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N,.,
4064,Liew,Trimethaphan,23576,negative,0,0,365.5,3.6,24.6,1,0,26,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5,,
927,LIverTox,Bictegravir,90311989,E*,0,0,449.4,2.7,99.2,9,2,32,C1CC2CC1N3C(O2)CN4C=C(C(=O)C(=C4C3=O)O)C(=O)NCC5=C(C=C(C=C5F)F)F,.,
3807,Liew,Palonosetron,148211,positive,0,0,296.4,2.8,23.6,2,0,22,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5,"CYP2D6, CYP3A4, CYP1A2",
1376,LIverTox,Lurasidone,213046,E,0,0,492.7,5.4,85,6,0,35,C1CCC(C(C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)C6C7CCC(C7)C6C5=O,CYP3A4,
1511,LIverTox,Oxaliplatin,77994,A,1,1,397.29,,132,6,2,15,C1CCC(C(C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+2],.,
1669,LIverTox,Ruxolitinib,25126798,C,1,1,306.4,2.1,83.2,4,1,23,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,CYP3A4,
1553,LIverTox,Phencyclidine,6468,C[HD],1,1,243.4,3.6,3.2,1,0,18,C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3,"Oxidative hydroxylation in liver by CYP450 enzymes, glucuronidation",
157,DILIrank,gabapentin,3446,vLess-DILI-Concern,1,1,171.24,-1.1,63.3,3,2,12,C1CCC(CC1)(CC(=O)O)CN,Not significantly metabolized,
2278,Greene,perhexiline,4746,HH,1,1,277.5,6.8,12,1,1,20,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,	Saturable Liver,
762,DILIrank,procyclidine,207841,vNo-DILI-Concern,0,0,323.9,,23.5,2,2,22,C1CCC(CC1)C(CCN2CCCC2)(C3=CC=CC=C3)O.Cl,.,
4061,Liew,Trihexyphenidyl,5572,negative,0,0,301.5,4.5,23.5,2,1,22,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O,,
1011,LIverTox,Cilostazol,2754,E,0,0,369.5,3.1,81.9,5,1,27,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,"CYP3A4 ,CYP2C19",
3644,Liew,Lomustine,3950,negative,1,1,233.69,2.8,61.8,3,1,15,C1CCC(CC1)NC(=O)N(CCCl)N=O,,
1957,Greene,buspirone,2477,NE,0,0,385.5,2.6,69.6,6,0,28,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,CYP3A4,
956,LIverTox,Butorphanol,5361092,ND,.,0,327.5,3.8,43.7,3,2,24,C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,hydroxylated & glucuronidated,
3568,Liew,Guanadrel,38521,negative,0,0,213.28,0,82.9,3,2,15,C1CCC2(CC1)OCC(O2)CN=C(N)N,,
3225,Liew,Bentazepam,34592,positive,1,1,296.4,3.1,66.8,3,1,21,C1CCC2=C(C1)C3=C(NCC(=O)N=C3S2)C4=CC=CC=C4,,
1733,LIverTox,Tacrine,1935,A,1,1,198.26,2.7,38.9,2,1,15,C1CCC2=NC3=CC=CC=C3C(=C2C1)N,CYP1A2,
3569,Liew,Guanethidine,3518,negative,0,0,198.31,0.5,67.6,2,2,14,C1CCCN(CCC1)CCN=C(N)N,,
3858,Liew,Piretanide,4849,positive,0,0,362.4,2.2,118,7,2,25,C1CCN(C1)C2=C(C(=CC(=C2)C(=O)O)S(=O)(=O)N)OC3=CC=CC=C3,,
3723,Liew,Minoxidil,4201,positive,0,0,209.25,1.2,88.9,3,3,15,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,,
3418,Liew,Dipyridamole,3108,negative,0,0,504.6,0.7,145,12,4,36,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,,
3945,Liew,Roxatidine,91276,positive,0,0,306.4,1.5,61.8,4,2,22,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)CO,Liver,
3240,Liew,Biperiden,2381,negative,0,0,311.5,4.3,23.5,2,1,23,C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O,,
3912,Liew,Raloxifene,5035,positive,0,0,473.6,6.1,98.2,6,2,34,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,Liver,
614,DILIrank,mefloquine,40692,vLess-DILI-Concern,1,1,378.31,3.6,45.2,9,2,26,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,Extensive liver; main metabolite is inactive,
1032,LIverTox,Cobimetinib,16222096,D,1,1,531.3,3.9,64.6,7,3,30,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,Intestinal and low Liver clearance mostly CYP3A4 oxidation and UGT2B7 glucuronidation,
570,DILIrank,flecainide,3356,vLess-DILI-Concern,1,1,414.34,3.8,59.6,10,2,28,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,CYP2D6,
1816,LIverTox,Trospium,107979,E,0,0,428,,46.5,4,1,30,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-],.,
476,DILIrank,darifenacin,444031,vNo-DILI-Concern,0,0,426.5,4.6,55.6,3,1,32,C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5,"CYP2D6,CYP3A4",
2816,Xu,Ticlopidine,5472,Positive,1,1,263.8,3.6,31.5,2,0,17,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,Liver,
3437,Liew,Droperidol,3168,negative,0,0,379.4,3.5,52.6,4,1,28,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,,
3820,Liew,Penfluridol,33630,negative,0,0,524,7.3,23.5,7,1,36,C1CN(CCC1(C2=CC(=C(C=C2)Cl)C(F)(F)F)O)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,,
185,DILIrank,haloperidol,3559,vLess-DILI-Concern,1,1,375.9,3.2,40.5,4,1,26,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,Liver-mediated,
2117,Greene,Fluspirilene,3396,HH,1,1,475.6,5.6,35.6,5,1,35,C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,,
296,DILIrank,pipamazine,6761,vMost-DILI-Concern,1,1,402,4.4,74.9,4,1,27,C1CN(CCC1C(=O)N)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,.,
657,DILIrank,pimozide,16362,vNo-DILI-Concern,0,0,461.5,6.3,35.6,4,1,34,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,"CYP3A4, CYP1A2,CYP2D6",
1362,LIverTox,Lomitapide,9853053,C,1,1,693.7,8.6,61.4,9,2,50,C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F,.,
3831,Liew,Periciazine,4747,positive,0,0,365.5,3.5,75.8,5,1,26,C1CN(CCC1O)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C#N,Liver,
831,LIverTox,Amoxapine,2170,E,0,0,313.8,2.6,36.9,3,1,22,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,Liver cytochrome P450 system,
3854,Liew,Pipobroman,4842,negative,0,0,356.05,0.4,40.6,2,0,16,C1CN(CCN1C(=O)CCBr)C(=O)CCBr,,
567,DILIrank,fipexide,3351,vMost-DILI-Concern,1,1,388.8,3.2,51.2,5,0,27,C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C(=O)COC4=CC=C(C=C4)Cl,.,
3859,Liew,Piribedil,4850,positive,0,0,298.34,1.8,50.7,6,0,22,C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C4=NC=CC=N4,Liver,
3512,Liew,Flunarizine,941361,negative,0,0,404.5,6,6.5,4,0,30,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,,
406,DILIrank,ziprasidone,60854,vLess-DILI-Concern,1,1,412.9,4,76.7,5,1,28,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,Liver aldehyde reductase,
1839,LIverTox,Vilazodone,6918314,E*,0,0,441.5,4,102,5,2,33,C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N,CYP3A4,
944,LIverTox,Brexpiprazole,11978813,E,0,0,433.6,4.7,73,5,1,31,C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4,Liver mainly mediated by CYP3A4 and CYP2D6,
687,DILIrank,trazodone,5533,vLess-DILI-Concern,1,1,371.9,2.8,42.4,4,0,26,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,"CYP3A4, CYP2D6, CYP1A2",
3785,Liew,Opipramol,9417,positive,1,1,363.5,3.6,30,4,1,27,C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO,CYP2D6,
3793,Liew,Oxatomide,4615,positive,0,0,426.6,4.1,38.8,3,1,32,C1CN(CCN1CCCN2C3=CC=CC=C3NC2=O)C(C4=CC=CC=C4)C5=CC=CC=C5,,
3521,Liew,Fluphenazine,3372,positive,1,1,437.5,4.4,55.2,8,1,30,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,,
654,DILIrank,perphenazine,4748,vLess-DILI-Concern,1,1,404,4.2,55.2,5,1,27,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,Liver,
1204,LIverTox,Flibanserin,6918248,E*,0,0,390.4,3.3,38.8,6,1,28,C1CN(CCN1CCN2C3=CC=CC=C3NC2=O)C4=CC=CC(=C4)C(F)(F)F,Extensive by liver mainly by CYP3A4 and CYP2C19,
3299,Liew,Cetirizine,2678,positive,1,1,388.9,1.7,53,5,1,27,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,,
598,DILIrank,hydroxyzine,3658,vNo-DILI-Concern,0,0,374.9,3.7,35.9,4,1,26,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Liver,
145,DILIrank,quetiapine,5002,vLess-DILI-Concern,1,1,383.5,2.1,73.6,5,1,27,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,Liver via CYP3A4-catalysed sulfoxidation to its active metabolite norquetiapine N-desalkylquetiapine,
232,DILIrank,ifosfamide,3690,vLess-DILI-Concern,1,1,261.08,0.9,41.6,4,1,14,C1CN(P(=O)(OC1)NCCCl)CCCl,Liver,
1767,LIverTox,Thiotepa,5453,D,1,1,189.22,0.5,41.1,4,0,11,C1CN1P(=S)(N2CC2)N3CC3,"CYP2B6, CYP3A",
3617,Liew,Ketorolac,3826,positive,1,1,255.27,1.9,59.3,3,1,19,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,,
3660,Liew,Mazindol,4020,negative,0,0,284.74,2.2,35.8,2,1,20,C1CN2C(=N1)C3=CC=CC=C3C2(C4=CC=C(C=C4)Cl)O,,
510,DILIrank,sitagliptin,4369359,vLess-DILI-Concern,1,1,407.31,0.7,77,10,1,28,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N,"CYP3A4,CYP2C8",
1708,LIverTox,Solifenacin,154059,D,1,1,362.5,4,32.8,3,0,27,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5,CYP3A4,
3746,Liew,Naphazoline,4436,negative,0,0,210.27,2.1,24.4,1,1,16,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32,,
4041,Liew,Tolazoline,5504,positive,0,0,160.22,2.6,24.4,1,1,12,C1CN=C(N1)CC2=CC=CC=C2,,
3246,Liew,Brimonidine,2435,negative,0,0,292.13,0.6,62.2,3,2,17,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,,
3196,Liew,Apraclonidine,2216,negative,0,0,245.11,1.3,62.4,2,3,15,C1CN=C(N1)NC2=C(C=C(C=C2Cl)N)Cl,,
1782,LIverTox,Tizanidine,5487,C,1,1,253.71,1.1,90.4,4,2,16,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,"Liver CYP1A2, 95%",
2750,Xu,Paroxetine,43815,Negative,0,1,329.4,3.5,39.7,5,1,24,C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,"Extensive, liver mostly CYP2D6-mediated",
379,DILIrank,fenoldopam,3341,vNo-DILI-Concern,0,0,305.75,2.4,72.7,4,4,21,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,	Liver CYP not involved,
770,DILIrank,plerixafor,65015,vNo-DILI-Concern,0,0,502.8,0,78.7,8,6,36,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,,
6,DILIrank,cyclophosphamide,2907,vLess-DILI-Concern,1,1,261.08,0.6,41.6,4,1,14,C1CNP(=O)(OC1)N(CCCl)CCCl,Liver,
2662,Xu,Furazolidone,3435,Positive,1,1,225.16,-0.1,101,6,0,16,C1COC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],.,
1657,LIverTox,Rivaroxaban,6433119,A,1,1,435.9,2.5,116,6,1,29,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,"CYP3A4, CYP2J2",
3733,Liew,Morniflumate,72106,negative,0,0,395.4,3.7,63.7,9,1,28,C1COCCN1CCOC(=O)C2=C(N=CC=C2)NC3=CC=CC(=C3)C(F)(F)F,,
3631,Liew,Levamisole,26879,positive,0,0,204.29,1.8,40.9,2,0,14,C1CSC2=NC(CN21)C3=CC=CC=C3,,
794,LIverTox,Aclidinium,11519741,E,0,0,564.6,,112,7,1,34,C1C[N+]2(CCC1C(C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5.[Br-],Ester hydrolysis,
2144,Greene,Hydrochlorothiazide,3639,HH,1,1,297.7,-0.1,135,7,3,17,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,	Not significant,
1451,LIverTox,Nalmefene,5284594,E,0,0,339.4,2.7,52.9,4,2,25,C=C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O,Liver,
1861,LIverTox,Zanubrutinib,135565884,E*,0,0,471.5,3.5,103,5,2,35,C=CC(=O)N1CCC(CC1)C2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N,.,
1290,LIverTox,Ibrutinib,24821094,D,1,1,440.5,3.6,99.2,6,1,33,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,"CYP3A,CYP2D6",
4094,Liew,Vigabatrin,5665,positive,1,1,129.16,-2.2,63.3,3,2,9,C=CC(CCC(=O)O)N,,
3278,Liew,Cefdinir,6915944,positive,1,1,395.4,0,212,10,4,26,C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O,,
417,DILIrank,sevelamer,3085017,vNo-DILI-Concern,0,0,149.62,,38.6,2,1,9,C=CCN.C1C(O1)CCl,.,polymer
3744,Liew,Naloxone,5284596,negative,0,0,327.4,2.1,70,5,2,24,C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,,
3157,Liew,Almitrine,33887,positive,0,0,477.6,5.6,69.2,9,2,35,C=CCNC1=NC(=NC(=N1)N2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)NCC=C,,
1895,Greene,Allyl alcohol,7858,HH,1,1,58.08,0.2,20.2,1,1,4,C=CCO,,
291,DILIrank,alclofenac,30951,vMost-DILI-Concern,1,1,226.65,2.5,46.5,3,1,15,C=CCOC1=C(C=C(C=C1)CC(=O)O)Cl,.,
787,LIverTox,Acalabrutinib,71226662,D,1,1,465.5,3,119,6,2,35,CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5,.,
3590,Liew,Iloprost,5311181,positive,0,0,360.5,2.8,77.8,4,3,26,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,,
1356,LIverTox,Linagliptin,10096344,D,1,1,472.5,1.9,114,7,1,35,CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,Minimal ~10% metabolized,
1755,LIverTox,Teriflunomide,54684141,D,1,1,270.21,3.3,73.1,6,2,19,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,.,
3453,Liew,Epalrestat,1549120,positive,1,1,319.4,3.8,115,5,1,21,CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)O,,
1051,LIverTox,Cyproterone,5284537,B,1,1,374.9,3.1,54.4,3,1,26,CC(=O)C1(CCC2C1(CCC3C2C=C(C4=CC(=O)C5CC5C34C)Cl)C)O,.,
1294,LIverTox,Iloperidone,71360,E,0,0,426.5,4.1,64.8,7,0,31,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,Liver CYP2D6-mediated hydroxylation and CYP3A4-mediated O-demethylation,
3141,Liew,Acetophenazine,17676,positive,0,0,411.6,2.6,72.3,6,1,29,CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)CCO,,
1883,Greene,Acetohexamide,1989,HH,1,1,324.4,2.4,101,4,2,22,CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2,.,
115,DILIrank,progesterone,5994,vLess-DILI-Concern,1,1,314.5,3.9,34.1,2,0,23,CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,"	Liver CYP2C19, CYP3A4, CYP2C9, 5??-reductase, 3??-HSDTooltip 3??-hydroxysteroid dehydrogenase, 17??-hydroxylase, 21-hydroxylase, 20??-HSDTooltip 20??-hydroxysteroid dehydrogenase",
943,LIverTox,Brexanolone,92786,E,0,0,318.5,4.9,37.3,2,1,23,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,"Non-CYP450 keto-reduction via aldo-keto reductases AKR, glucuronidation via glucuronosyltransferases UGT, sulfation via sulfotransferases SULT",
1880,Greene,Acenocoumarol,9052,HH,1,1,353.3,2.5,109,6,1,26,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,Liver,
2833,Xu,Warfarin,54678486,Negative,0,1,308.3,2.7,63.6,4,1,23,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,"Liver: CYP2C9, 2C19, 2C8, 2C18, 1A2,3A4",
1447,LIverTox,Nabumetone,4409,E*,0,0,228.29,3.1,26.3,2,0,17,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,"Liver, to active metabolite 6-methoxy-2-naphthylacetic acid; 6-MNA",
3827,Liew,Pentoxifylline,4740,positive,1,1,278.31,0.3,75.5,4,0,20,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,Liver,
1075,LIverTox,Deferoxamine,2973,E,0,1,560.7,-2.1,206,9,6,39,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O,.,
3615,Liew,Ketoconazole,3823,positive,1,1,531.4,4.3,69.1,6,0,36,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,,
619,DILIrank,methazolamide,4100,vLess-DILI-Concern,1,1,236.3,0.1,139,6,1,14,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C,.,
1334,LIverTox,Lacosamide,219078,D,1,1,250.29,0.3,67.4,3,2,18,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,.,
2236,Greene,N-acetyl cysteine,12035,NE,0,0,163.2,0.4,67.4,4,3,10,CC(=O)NC(CS)C(=O)O,Liver,
3395,Liew,Diatrizoate,2140,negative,0,0,613.91,1.8,95.5,4,3,20,CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I,,
1873,Greene,2-acetylaminofluorene (2-AAF),5897,HH,1,1,223.27,3.3,29.1,1,1,17,CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2,.,
3179,Liew,Amithiozone,9568512,positive,0,0,236.3,1,112,3,3,16,CC(=O)NC1=CC=C(C=C1)C=NNC(=S)N,,
3139,Liew,Acetaminophen,1983,positive,1,1,151.16,0.5,49.3,2,2,11,CC(=O)NC1=CC=C(C=C1)O,,
2498,Xu,Acetazolamide,1986,Positive,1,1,222.3,-0.3,152,7,2,13,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,	None,
383,DILIrank,enoxaparin,772,vLess-DILI-Concern,1,1,1134.9,-10.8,652,38,15,70,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,.,
3977,Liew,Sulfacetamide,5320,negative,0,0,214.24,-1,97.6,4,2,14,CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N,,
765,DILIrank,norethindrone acetate,5832,vNo-DILI-Concern,0,0,340.5,3.5,43.4,3,0,25,CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C,.,
278,DILIrank,prasugrel hydrochloride,6918456,vLess-DILI-Concern,1,1,373.4,3.6,74.8,6,0,26,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,.,
509,DILIrank,cyclofenil,2898,vMost-DILI-Concern,1,1,364.4,5.5,52.6,4,0,27,CC(=O)OC1=CC=C(C=C1)C(=C2CCCCC2)C3=CC=C(C=C3)OC(=O)C,.,
932,LIverTox,Bisacodyl,2391,E,0,0,361.4,3.8,65.5,5,0,27,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3,CYP450,
3394,Liew,Diacerein,26248,positive,1,1,368.3,1.9,124,8,1,27,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C2=O)C=C(C=C3OC(=O)C)C(=O)O,,
3766,Liew,Nitazoxanide,41684,positive,0,0,307.28,2,142,7,1,21,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],Liver,
2511,Xu,Aminosalicylic Acid,2244,Positive,1,1,180.16,1.2,63.6,4,1,13,CC(=O)OC1=CC=CC=C1C(=O)O,"	Liver CYP2C19 and possibly CYP3A, some is also hydrolysed to salicylate in the gut wall.",
3938,Liew,Rocuronium,441351,negative,0,0,609.7,,59,6,1,39,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-],,
3411,Liew,Diltiazem,39186,positive,1,1,414.5,3.1,84.4,6,0,29,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,,
1274,LIverTox,Heroin,5462328,"E,E",1,1,369.4,1.5,65.1,6,0,27,CC(=O)OC1C=CC2C3CC4=C5C2(C1OC5=C(C=C4)OC(=O)C)CCN3C,Liver,
1166,LIverTox,Eslicarbazepine,179344,D,1,1,296.32,2,72.6,3,1,22,CC(=O)OC1CC2=CC=CC=C2N(C3=CC=CC=C13)C(=O)N,UGT ,
367,DILIrank,vecuronium,39764,vNo-DILI-Concern,0,0,637.7,,55.8,6,0,41,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-],	liver 30%,
3852,Liew,Pipecuronium,65332,negative,0,0,762.7,,59.1,8,0,45,CC(=O)OC1CC2CCC3C(C2(CC1N4CC[N+](CC4)(C)C)C)CCC5(C3CC(C5OC(=O)C)N6CC[N+](CC6)(C)C)C.[Br-].[Br-],,
352,DILIrank,pancuronium,441289,vNo-DILI-Concern,0,0,572.9,6.6,52.6,4,0,41,CC(=O)OC1CC2CCC3C(C2(CC1[N+]4(CCCCC4)C)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C,Liver,
786,LIverTox,Abiraterone,9821849,C,1,1,391.5,5.2,39.2,3,0,29,CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C,"Esterases, CYP3A4, SULT2A1",
2642,Xu,Ethynodiol Diacetate,9270,Positive,1,1,384.5,3.9,52.6,4,0,28,CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C,.,
311,DILIrank,cortisone acetate,5745,vNo-DILI-Concern,0,0,402.5,2.1,97.7,6,1,29,CC(=O)OCC(=O)C1(CCC2C1(CC(=O)C3C2CCC4=CC(=O)CCC34C)C)O,.,
3515,Liew,Fluocinonide,9642,negative,0,0,494.5,3.2,99.1,9,1,35,CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C,,
3168,Liew,Amcinonide,443958,negative,0,0,502.6,3.6,99.1,8,1,36,CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CCC5=CC(=O)C=CC54C)F)O)C)OC6(O2)CCCC6,,
3487,Liew,Famciclovir,3324,positive,0,0,321.33,0,122,8,1,23,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,,
1987,Greene,Cephapirin Sodium,30699,NE,0,0,423.5,-1.1,177,9,2,28,CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)O,,
2500,Xu,Acetylcholine Chloride,187,Negative,0,0,146.21,0.2,26.3,2,0,10,CC(=O)OCC[N+](C)(C)C,ACH,
1712,LIverTox,Spironolactone,5833,D,1,1,416.6,2.9,85.7,5,0,29,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,"Liver, others: Deacetylation via CESTooltip carboxylesterase  S-Oxygenation via FOMTooltip flavin-containing monooxygenase S-Methylation via TMTTooltip thiol S-methyltransferase Dethioacetylation Hydroxylation via CYP3A4  Lactone hydrolysis via PON3",
380,DILIrank,calcium acetate,6116,vNo-DILI-Concern,0,0,158.17,,80.3,4,0,9,CC(=O)[O-].CC(=O)[O-].[Ca+2],.,
766,DILIrank,exametazime,9552069,vNo-DILI-Concern,0,0,742.6,,179,12,8,40,CC(C(=NO)C)NCC(C)(C)CNC(C)C(=NO)C.CC(C(=NO)C)NCC(C)(C)CNC(C)C(=NO)C.[Tc].[Tc],.,
31,DILIrank,bupropion,444,vLess-DILI-Concern,1,1,239.74,3.2,29.1,2,1,16,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,"Liver, intestines",
1670,LIverTox,Safinamide,131682,E,0,0,302.34,2.2,64.4,4,2,22,CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F,"Amidases, glucuronidation",
1248,LIverTox,Glatiramer Acetate,3081884,B,1,1,623.7,,374,18,12,43,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N,.,
758,DILIrank,alaproclate,2081,vMost-DILI-Concern,1,1,255.74,2.8,52.3,3,1,17,CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N,.,
168,DILIrank,sodium lactate,6286,vNo-DILI-Concern,0,0,112.06,,60.4,3,1,7,CC(C(=O)[O-])O.[Na+],.,
2764,Xu,Pinacidil,4826,Negative,0,0,245.32,2.7,73.1,3,2,18,CC(C(C)(C)C)N=C(NC#N)NC1=CC=NC=C1,.,
2716,Xu,Methoxamine HCl,6082,Negative,0,0,211.26,0.5,64.7,4,2,15,CC(C(C1=C(C=CC(=C1)OC)OC)O)N,.,
3680,Liew,Metaraminol,5906,negative,0,0,167.2,-0.4,66.5,3,3,12,CC(C(C1=CC(=CC=C1)O)O)N,,
3934,Liew,Ritodrine,33572,positive,0,0,287.35,2.3,72.7,4,4,21,CC(C(C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O,Liver,
2370,Greene,Phenylpropanolamine HCl,10297,NE,0,0,151.21,0.8,46.2,2,2,11,CC(C(C1=CC=CC=C1)O)N,CYP2D6,
75,DILIrank,pseudoephedrine,7028,vNo-DILI-Concern,0,0,165.23,0.9,32.3,2,2,12,CC(C(C1=CC=CC=C1)O)NC,	10?30% liver,
3950,Liew,Sapropterin,135398654,negative,0,0,241.25,-1.9,132,6,6,17,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,,
3191,Liew,Anastrozole,2187,positive,1,1,293.4,2.1,78.3,4,0,22,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,,
2901,Liew,Ciprofibrate,2763,positive,.,1,289.15,3.4,46.5,3,1,18,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl,,
1944,Greene,Bezafibrate,39042,NE,0,0,361.8,3.8,75.6,4,2,25,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,.,
1983,Greene,Ceftazidime,5481173,WE,1,1,546.6,0.4,245,12,3,37,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],	negligible,
1534,LIverTox,Penicillamine,5852,A,1,1,149.21,-1.8,64.3,4,3,9,CC(C)(C(C(=O)O)N)S,Liver,
259,DILIrank,terbinafine,1549008,vMost-DILI-Concern,1,1,291.4,5.6,3.2,1,0,22,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,liver,
3417,Liew,Dipivefrin,3105,negative,0,0,351.4,2.9,84.9,6,2,25,CC(C)(C)C(=O)OC1=C(C=C(C=C1)C(CNC)O)OC(=O)C(C)(C)C,,
482,DILIrank,atazanavir,148192,vLess-DILI-Concern,1,1,704.9,5.6,171,9,5,51,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,CYP3A4,
951,LIverTox,Buprenorphine,644073,B[HD],1,1,467.6,5,62.2,5,2,34,CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,"CYP3A4, CYP2C8",
1717,LIverTox,Stiripentol,5311454,E,0,0,234.29,3.6,38.7,3,1,17,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O,.,
3879,Liew,Probucol,4912,positive,0,0,516.8,11.3,91.1,4,2,35,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,,
2443,Greene,terfenadine,5405,NE,0,0,471.7,6.6,43.7,3,2,35,CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O,CYP3A4,
3257,Liew,Butenafine,2484,negative,0,0,317.5,6.3,3.2,1,0,24,CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32,,
3250,Liew,Buclizine,6729,negative,0,0,433,7.1,6.5,2,0,31,CC(C)(C)C1=CC=C(C=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,
454,DILIrank,bosentan,104865,vMost-DILI-Concern,1,1,551.6,3.8,154,11,2,39,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,Liver,
1057,LIverTox,Dabrafenib,44462760,E*,0,0,519.6,4.8,148,11,2,35,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,.,
1499,LIverTox,Omadacycline,54697325,E*,0,0,556.6,3,177,10,6,40,CC(C)(C)CNCC1=CC(=C2CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C,.,
3951,Liew,Saquinavir,441243,positive,1,1,670.8,4.2,167,7,5,49,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,CYP3A4,
1299,LIverTox,Indinavir,5362440,C,1,1,613.8,2.8,118,7,4,45,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,CYP3A4,
3149,Liew,Albuterol,2083,negative,0,0,239.31,0.3,72.7,4,4,17,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,
355,DILIrank,terbutaline,5403,vLess-DILI-Concern,1,1,225.28,0.9,72.7,4,4,16,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O,"	GI tract oral, liver; CYP450: unknown",
2528,Xu,Bambuterol,54766,Negative,0,0,367.4,1.2,91.3,6,2,26,CC(C)(C)NCC(C1=CC(=CC(=C1)OC(=O)N(C)C)OC(=O)N(C)C)O,Extensive Liver.Further metabolized to terbutaline by plasma cholinesterase,
3857,Liew,Pirbuterol,4845,negative,0,0,240.3,-0.1,85.6,5,4,17,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O,,
3990,Liew,Talinolol,68770,positive,0,0,363.5,2.6,82.6,4,4,26,CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O,,
2238,Greene,Nadolol,39147,NE,0,0,309.4,0.7,82,5,4,22,CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O,Not metabolised,
3271,Liew,Carteolol,2583,negative,0,0,292.37,1,70.6,4,3,21,CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O,,
3633,Liew,Levobunolol,39468,negative,0,0,291.4,2.4,58.6,4,2,21,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O,,
4012,Liew,Tertatolol,36920,negative,0,0,295.4,2.7,66.8,4,2,20,CC(C)(C)NCC(COC1=CC=CC2=C1SCCC2)O,,
649,DILIrank,penbutolol,37464,vNo-DILI-Concern,0,0,291.4,4.2,41.5,3,2,21,CC(C)(C)NCC(COC1=CC=CC=C1C2CCCC2)O,.,
353,DILIrank,pentagastrin,9853654,vNo-DILI-Concern,0,0,767.9,1.5,276,10,8,54,CC(C)(C)OC(=O)NCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N,.,
2103,Greene,Fexofenadine,3348,NE,0,0,501.7,3,81,5,3,37,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Liver ???5% of dose,
2726,Xu,montelukast,5281040,Negative,0,1,586.2,7.7,95.7,5,2,41,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,"CYP2C8, CYP3A4, CYP2C9",
345,DILIrank,metyrapone,4174,vNo-DILI-Concern,0,0,226.27,2,42.8,3,0,17,CC(C)(C1=CN=CC=C1)C(=O)C2=CN=CC=C2,.,
1450,LIverTox,Naldemedine,54732242,E,0,0,570.6,3.2,141,9,4,42,CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C(C4C56CCN(C(C5(C3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O,primarily CYP3A4,
1556,LIverTox,Phentermine,4771,E,0,0,149.23,1.9,26,1,1,11,CC(C)(CC1=CC=CC=C1)N,Liver,
1498,LIverTox,Omacetaxine,285033,E,0,0,545.6,0.8,124,10,2,39,CC(C)(CCCC(CC(=O)OC)(C(=O)OC1C2C3=CC4=C(C=C3CCN5C2(CCC5)C=C1OC)OCO4)O)O,Mostly via plasma esterases,
1145,LIverTox,Enasidenib,89683805,E*,0,0,473.4,3.5,109,14,3,33,CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O,.,
2545,Xu,Calcium Pantothenate,988,Negative,0,0,219.23,-1.1,107,5,4,15,CC(C)(CO)C(C(=O)NCCC(=O)O)O,.,
712,DILIrank,dexpanthenol,4678,vNo-DILI-Concern,0,0,205.25,-0.9,89.8,4,4,14,CC(C)(CO)C(C(=O)NCCCO)O,.,
728,DILIrank,pamabrom,11806,vNo-DILI-Concern,0,0,348.2,,116,5,3,20,CC(C)(CO)N.CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Br,.,
1215,LIverTox,Flutamide,3397,A,1,1,276.21,3.3,74.9,6,1,19,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,CYP1A2,
1229,LIverTox,Gabapentin Enacarbil,9883933,E*,0,0,329.39,3.1,102,6,2,23,CC(C)C(=O)OC(C)OC(=O)NCC1(CCCCC1)CC(=O)O,.,
3498,Liew,Fesoterodine,6918558,negative,0,0,411.6,5.5,49.8,4,1,30,CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,,
3318,Liew,Ciclesonide,6918155,negative,0,0,540.7,5.3,99.1,7,1,39,CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6,,
1059,LIverTox,Daclatasvir,25154714,C,1,1,738.9,5.1,175,8,4,54,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,CYP3A,
1862,LIverTox,Zepatier,91669168,C,1,1,1648.9,,388,21,6,119,CC(C)C(C(=O)N1CCCC1C2N=CC(=N2)C3=CC4=C(C=C3)C5=CC6=C(N5C(O4)C7=CC=CC=C7)C=CC(=C6)C8=CN=C(N8)C9CCCN9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC.CC(C)(C)C1C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCCC7CC7OC(=O)N1,.,
3125,Liew,Valganciclovir,135413535,negative,.,1,354.36,-1.5,167,8,4,25,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N,,
1823,LIverTox,Valacyclovir,135398742,D,1,1,324.34,-0.9,147,7,3,23,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,Liver to aciclovir,
116,DILIrank,ergocalciferol,5280793,vNo-DILI-Concern,0,0,396.6,7.4,20.2,1,1,29,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,.,
808,LIverTox,Aliskiren,5493444,C,1,1,551.8,3.5,146,7,4,39,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,CYP3A4,
169,DILIrank,verapamil,2520,vLess-DILI-Concern,1,1,454.6,3.8,64,6,0,33,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,liver,
1139,LIverTox,Elvitegravir,5277135,E*,0,0,447.9,5.3,87.1,7,2,31,CC(C)C(CO)N1C=C(C(=O)C2=C1C=C(C(=C2)CC3=C(C(=CC=C3)Cl)F)OC)C(=O)O,CYP3A,
137,DILIrank,atorvastatin,60823,vMost-DILI-Concern,1,1,558.6,5,112,6,4,41,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,CYP3A4,
3893,Liew,Propofol,4943,positive,1,1,178.27,3.8,20.2,1,1,13,CC(C)C1=C(C(=CC=C1)C(C)C)O,Liver,
3538,Liew,Fospropofol,3038498,negative,1,1,288.28,2.5,76,5,2,19,CC(C)C1=C(C(=CC=C1)C(C)C)OCOP(=O)(O)O,,
1076,LIverTox,Defibrotide,135565962,E,0,0,444.4,1.8,137,7,4,31,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O,.,
3181,Liew,Amlexanox,2161,negative,0,0,298.29,3.1,103,6,2,22,CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N,,
674,DILIrank,ritonavir,392622,vMost-DILI-Concern,1,1,720.9,6,202,9,4,50,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,Liver,
707,DILIrank,rosuvastatin,446157,vLess-DILI-Concern,1,1,481.5,1.6,149,10,3,33,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,Liver: CYP2C9 major and CYP2C19-mediated; ~10% metabolized,
1338,LIverTox,Lanreotide,71349,E*,0,0,1096.3,2.5,406,14,13,77,CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N,In GI tract,
3715,Liew,Mibefradil,60662,negative,0,0,568.5,,67.4,6,3,38,CC(C)C1C2=C(CCC1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F.Cl.Cl,,
3748,Liew,Nateglinide,60026,positive,0,0,317.4,3.2,66.4,3,2,23,CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O,,
1967,Greene,Capsaicin,1548943,NE,0,0,305.4,3.6,58.6,3,2,22,CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,.,
1921,Greene,atractyloside,442005,HH,1,1,726.8,1.2,267,16,5,48,CC(C)CC(=O)OC1C(C(C(OC1OC2CC(C3CCC45CC(CCC4C3(C2)C)C(=C)C5O)C(=O)O)CO)OS(=O)(=O)O)OS(=O)(=O)O,.,
974,LIverTox,Carfilzomib,11556711,D,1,1,719.9,4.7,159,8,4,52,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,Extensive; CYP plays a minor role,
349,DILIrank,cosyntropin,16132265,vNo-DILI-Concern,0,0,4541,-19.7,1860,68,63,322,CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C6CCCN6C(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(C(C)C)NC(=O)C7CCCN7C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC1=CN=CN1)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CO)N,.,peptide
1077,LIverTox,Degarelix,16136245,E,0,0,1632.3,3.5,513,18,17,117,CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C,Subject to common peptidic degradation during passage through the hepato-biliary system; not a substrate for the human CYP450 system,
3740,Liew,Nafarelin,25077649,negative,0,0,1322.5,0.8,475,15,16,96,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,,
201,DILIrank,triptorelin pamoate,25074470,vLess-DILI-Concern,1,0,1311.4,-0.3,490,15,17,95,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,.,oligopeptide
3562,Liew,Gonadorelin,638793,negative,0,0,1182.3,-2.4,475,15,16,85,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,
3563,Liew,Goserelin,5311128,negative,1,1,1269.4,-1.5,496,16,17,91,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,
3659,Liew,Marimastat,119031,positive,0,0,331.41,0.5,128,5,5,23,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C,,
395,DILIrank,sibutramine,5210,vLess-DILI-Concern,1,1,279.8,5.4,3.2,1,0,19,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C,CYP3A4,
460,DILIrank,pregabalin,5486971,vLess-DILI-Concern,1,1,159.23,-1.6,63.3,3,2,11,CC(C)CC(CC(=O)O)CN,.,
117,DILIrank,ibuprofen,3672,vLess-DILI-Concern,1,1,206.28,3.5,37.3,2,1,15,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,	CYP2C9,
3248,Liew,Bromocriptine,31101,negative,1,1,654.6,3.8,118,6,3,43,CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,,
356,DILIrank,calcitonin salmon,16133812,vNo-DILI-Concern,0,0,3431.9,-16.6,1560,55,52,239,CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CNC=N2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO,.,
4015,Liew,Tetrabenazine,6018,negative,0,0,317.4,2.9,38.8,4,0,23,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC,CYP2D6,
505,DILIrank,darunavir,213039,vMost-DILI-Concern,1,1,547.7,2.9,149,9,3,38,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,CYP3A4,
3594,Liew,Imiquimod,57469,positive,0,0,240.3,2.6,56.7,3,1,18,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,,
1563,LIverTox,Pimavanserin,10071196,E,0,0,427.6,4.5,44.8,4,1,31,CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C,"CYP3A4, CYP3A5, CYP2J2",
3232,Liew,Bepridil,2351,positive,0,1,366.5,5.3,15.7,3,0,27,CC(C)COCC(CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3,,
1103,LIverTox,Disopyramide,3114,B,1,1,339.5,3.2,59.2,3,1,25,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C,CYP3A4,
1685,LIverTox,Selexipag,9913767,E,0,0,496.6,3.8,110,7,1,35,CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3,"Activation by carboxylesterases, inactivation by CYP2C8 and others",
2659,Xu,Fluvastatin,446155,Negative,0,1,411.5,3.5,82.7,5,3,30,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,"	Liver: CYP2C9 75%, CYP3A4 20%, CYP2C8 5%",
1146,LIverTox,Encorafenib,50922675,E*,0,0,540,2.7,149,10,3,36,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,.,
4011,Liew,Terconazole,441383,negative,0,0,532.5,4.8,64.9,7,0,36,CC(C)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl,,
1596,LIverTox,Proguanil,4923,E*,0,0,253.73,1.5,88.8,1,3,17,CC(C)N=C(N)N=C(N)NC1=CC=C(C=C1)Cl,CYP2C19,
1022,LIverTox,Clofazimine,2794,E,0,0,473.4,7.1,40,4,1,33,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl,.,
2387,Greene,Procarbazine HCl,4915,HH,1,1,221.3,0.1,53.2,3,3,16,CC(C)NC(=O)C1=CC=C(C=C1)CNNC,"Liver, Kidney",
3375,Liew,Delavirdine,5625,positive,0,0,456.6,2.4,119,7,3,32,CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C,,
295,DILIrank,isaxonine,71169,vMost-DILI-Concern,1,1,137.18,1.3,37.8,3,1,10,CC(C)NC1=NC=CC=N1,.,
118,DILIrank,isoproterenol,3779,vNo-DILI-Concern,0,0,211.26,-0.6,72.7,4,4,15,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,.,
1711,LIverTox,Sotalol,5253,E,0,0,272.37,0.2,86.8,5,3,18,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,Not metabolized,
3204,Liew,Atenolol,2249,negative,1,1,266.34,0.2,84.6,4,3,19,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,,
544,DILIrank,esmolol,59768,vNo-DILI-Concern,0,0,295.37,1.9,67.8,5,2,21,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O,Red blood cell erythrocytic,
3709,Liew,Metoprolol,4171,positive,1,1,267.36,1.9,50.7,4,2,19,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,,
921,LIverTox,Betaxolol,2369,E,0,0,307.4,2.8,50.7,4,2,22,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O,Liver,
3241,Liew,Bisoprolol,2405,positive,0,0,325.4,1.9,60,5,2,23,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,,
658,DILIrank,pindolol,4828,vNo-DILI-Concern,0,0,248.32,1.8,57.3,3,3,18,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O,Liver,
2394,Greene,Propranolol,4946,NE,0,0,259.34,3,41.5,3,2,19,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,"	Liver extensive 1A2, 2D6; minor: 2C19, 3A4",
3797,Liew,Oxprenolol,4631,negative,0,0,265.35,2.1,50.7,4,2,19,CC(C)NCC(COC1=CC=CC=C1OCC=C)O,Liver,
3790,Liew,Oxamniquine,4612,positive,1,1,279.33,2.2,90.1,5,3,20,CC(C)NCC1CCC2=CC(=C(C=C2N1)[N+](=O)[O-])CO,Liver,
3597,Liew,Iproniazid,3748,positive,1,1,179.22,0.4,54,3,2,13,CC(C)NNC(=O)C1=CC=NC=C1,,
2647,Xu,Fenofibrate,3339,Positive,1,1,360.8,5.2,52.6,4,0,25,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,	glucuronidation,
1707,LIverTox,Sofosbuvir,45375808,A,1,1,529.5,1,153,11,3,36,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,"Quickly activated to triphosphate CatA/CES1, HIST1, phosphorylation",
4052,Liew,Travoprost,5282226,negative,0,0,500.5,4.1,96.2,9,3,35,CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O,,
3625,Liew,Latanoprost,5311221,negative,0,0,432.6,4.3,87,5,3,31,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,,
764,DILIrank,tenofovir,5481350,vLess-DILI-Concern,1,1,519.4,1.6,185,14,1,35,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C,Ester hydrolysis,
3604,Liew,Isopropamide,3775,negative,0,0,353.5,4.3,43.1,1,1,26,CC(C)[N+](C)(CCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)N)C(C)C,,
3890,Liew,Propantheline,9279,negative,0,0,448.4,,35.5,4,0,28,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C.[Br-],,
1652,LIverTox,Rimantadine,5071,E,0,0,179.3,2.6,26,1,1,13,CC(C12CC3CC(C1)CC(C3)C2)N,Liver hydroxylation and glucuronidation,
1043,LIverTox,Crizotinib,11626560,C,1,1,450.3,3.7,78,6,2,30,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,"CYP3A4, CYP3A5",
2657,Xu,Flurbiprofen,3394,Positive,1,1,244.26,4.2,37.3,3,1,18,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,	CYP2C9,
3861,Liew,Pirprofen,35935,positive,1,1,251.71,2.9,40.5,3,1,17,CC(C1=CC(=C(C=C1)N2CC=CC2)Cl)C(=O)O,,
3533,Liew,Fosaprepitant,219090,positive,0,0,614.4,1,124,14,3,41,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)N(N3)P(=O)(O)O)C4=CC=C(C=C4)F,,
3197,Liew,Aprepitant,6918365,positive,0,0,534.4,4.2,75.2,11,2,37,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F,,
1661,LIverTox,Rolapitant,10311306,E,0,0,500.5,4.4,50.4,9,2,35,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OCC2(CCC3(CCC(=O)N3)CN2)C4=CC=CC=C4,CYP3A4,
12,DILIrank,ketoprofen,3825,vLess-DILI-Concern,1,1,254.28,3.1,54.4,3,1,19,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,.,
2648,Xu,Fenoprofen Sodium,3342,Positive,1,1,242.27,3.3,46.5,3,1,18,CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)O,,
1127,LIverTox,Duvelisib,50905713,E*,0,0,416.9,4.1,86.8,5,2,30,CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,mainly metabolized by CYP3A4,
3270,Liew,Carprofen,2581,positive,1,1,273.71,4,53.1,2,2,19,CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O,,
2243,Greene,naproxen,156391,WE,1,1,230.26,3.3,46.5,3,1,17,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,	Liver to 6-desmethylnaproxen,
218,DILIrank,benoxaprofen,39941,vMost-DILI-Concern,1,1,301.72,4.1,63.3,4,1,21,CC(C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)Cl)C(=O)O,.,
2113,Greene,flunoxaprofen,68869,WE,1,1,285.27,3.6,63.3,5,1,21,CC(C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)F)C(=O)O,.,
1864,LIverTox,Zileuton,60490,D,1,1,236.29,1.6,94.8,3,2,16,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,"CYP1A2, CYP2C9, CYP3A4",
3988,Liew,Suprofen,5359,positive,0,0,260.31,3.3,82.6,4,1,18,CC(C1=CC=C(C=C1)C(=O)C2=CC=CS2)C(=O)O,,
488,DILIrank,cinacalcet,156419,vNo-DILI-Concern,0,0,357.4,6.1,12,4,1,26,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,"CYP3A4,CYP2D6,CYP1A2",
1018,LIverTox,Clemastine,26987,E,0,0,343.9,5,12.5,2,0,24,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C,Liver,
308,DILIrank,doxylamine,3162,vNo-DILI-Concern,0,0,270.37,2.5,25.4,3,0,20,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C,"CYP2D6,CYP1A2,CYP2C9",
613,DILIrank,mebanazine,6179,vMost-DILI-Concern,1,1,136.19,0.9,38,2,2,10,CC(C1=CC=CC=C1)NN,.,
440,DILIrank,voriconazole,71616,vMost-DILI-Concern,1,1,349.31,1.5,76.7,8,1,25,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,"Liver: CYP2C19 significant involvement, also CYP2C9, CYP3A4",
642,DILIrank,octreotide,448601,vLess-DILI-Concern,1,1,1019.2,1,383,14,13,71,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,Liver,
3737,Liew,Mupirocin,446596,negative,0,0,500.6,3,146,9,4,35,CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,,
1296,LIverTox,Imipenem-Cilastatin,11954222,D,1,1,675.8,,298,14,8,45,CC(C1C2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O.CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)O)C.O,.,
2131,Greene,Gentamycin,3467,NE,0,0,477.6,-4.1,200,12,8,33,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,.,
65,DILIrank,methyldopa,38853,vMost-DILI-Concern,1,1,211.21,-1.9,104,5,4,15,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,Liver,
2549,Xu,Carbidopa,34359,Negative,0,0,226.23,-2.2,116,6,5,16,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,"	7 metabolites known, not metabolized extensively",
3958,Liew,Silodosin,5312125,positive,0,0,495.5,3.6,97,9,3,35,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,,
362,DILIrank,metyrosine,441350,vNo-DILI-Concern,0,0,195.21,-1.6,83.6,4,3,14,CC(CC1=CC=C(C=C1)O)(C(=O)O)N,.,
3532,Liew,Formoterol,3083544,negative,0,0,344.4,1.8,90.8,5,4,25,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,,
2042,Greene,Dextroamphetamine Sulfate,5826,HH,1,0,135.21,1.8,26,1,1,10,CC(CC1=CC=CC=C1)N,"CYP2D6,DBH,FMO3",
676,DILIrank,selegiline,26757,vNo-DILI-Concern,0,0,187.28,2.8,3.2,1,0,14,CC(CC1=CC=CC=C1)N(C)CC#C,Intestines and liver,
343,DILIrank,benzphetamine,5311017,vNo-DILI-Concern,0,0,239.35,4.1,3.2,1,0,18,CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2,.,
3684,Liew,Methamphetamine,1206,negative,0,0,149.23,2.1,12,1,1,11,CC(CC1=CC=CC=C1)NC,,
1009,LIverTox,Cholic Acid,221493,D[HD],1,1,408.6,3.6,98,5,4,29,CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C,.,
1990,Greene,Chenodiol,10133,HH,1,1,392.6,4.9,77.8,4,3,28,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,.,
530,DILIrank,dobutamine,36811,vNo-DILI-Concern,0,0,301.4,3.4,72.7,4,4,22,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,.,
60,DILIrank,labetalol,3869,vMost-DILI-Concern,1,1,328.4,3.1,95.6,4,4,24,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,"Liver pass metabolism,",
255,DILIrank,primaquine,4908,vNo-DILI-Concern,0,0,259.35,2.2,60.2,4,2,19,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2,Liver,
4068,Liew,Trimipramine,5584,positive,1,1,294.4,5.8,6.5,2,0,22,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,Liver,
3693,Liew,Methotrimeprazine,72287,negative,0,0,328.5,4.7,41,4,0,23,CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CN(C)C,,
4063,Liew,Trimeprazine,5574,positive,0,0,298.4,4.7,31.8,3,0,21,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)CN(C)C,Liver,
3888,Liew,Promethazine,4927,positive,1,0,284.4,4.8,31.8,3,0,20,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Liver,
4006,Liew,Tenofovir disoproxil fumarate,464205,positive,1,1,287.21,-1.6,136,8,3,19,CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O,,
3841,Liew,Phenoxybenzamine,4768,negative,0,0,303.8,4.4,12.5,2,0,21,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,,
2684,Xu,Isoxsuprine HCl,3783,Negative,0,0,301.4,2.8,61.7,4,3,22,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O,.,
302,DILIrank,phenoxypropazine,71467,vMost-DILI-Concern,1,1,166.22,1.1,47.3,3,2,12,CC(COC1=CC=CC=C1)NN,.,
3238,Liew,Bicalutamide,2375,positive,1,1,430.4,2.3,116,9,2,29,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,,
3262,Liew,Captopril,44093,positive,1,1,217.29,0.3,58.6,4,2,14,CC(CS)C(=O)N1CCCC1C(=O)O,,
3147,Liew,Alacepril,71992,positive,0,0,406.5,2.1,129,6,2,28,CC(CSC(=O)C)C(=O)N1CCCC1C(=O)NC(CC2=CC=CC=C2)C(=O)O,,
4110,Liew,Zofenopril,92400,positive,0,0,429.6,4.4,125,6,1,29,CC(CSC(=O)C1=CC=CC=C1)C(=O)N2CC(CC2C(=O)O)SC3=CC=CC=C3,,
3683,Liew,Methacholine,6114,negative,0,0,195.69,,26.3,3,0,12,CC(C[N+](C)(C)C)OC(=O)C.[Cl-],,
3234,Liew,Bethanechol,2370,negative,0,0,161.22,0,52.3,2,1,11,CC(C[N+](C)(C)C)OC(=O)N,,
557,DILIrank,etidronic acid,3305,vNo-DILI-Concern,0,0,206.03,-3.7,135,7,5,11,CC(O)(P(=O)(O)O)P(=O)(O)O,	Nil,
636,DILIrank,nilutamide,4493,vMost-DILI-Concern,1,1,317.22,2,95.2,7,1,22,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C,"Liver CYP2C19, FMOTooltip flavin-containing monooxygenase",
2822,Xu,Trimethadione,5576,Positive,1,1,143.14,0.3,46.6,3,0,10,CC1(C(=O)N(C(=O)O1)C)C,	Demethylated to dimethadione,
1152,LIverTox,Enzalutamide,15951529,E,0,0,464.4,3.6,109,8,1,32,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,"CYP2C8,CYP3A4",
1225,LIverTox,Fostamatinib,11671467,E*,0,0,580.5,1.6,187,15,4,40,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,"Gut ALP to tamatinib Liver tamatinib metabolite by CYP3A4, UGT1A9",
3410,Liew,Dihydroergotamine,10531,negative,0,0,583.7,2.4,118,6,3,43,CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C,,
2082,Greene,Ergotamine l-Tartrate,8223,NE,0,0,581.7,2,118,6,3,43,CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C,,
79,DILIrank,indocyanine green,5282412,vNo-DILI-Concern,0,0,775,,137,7,0,54,CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CCCCS(=O)(=O)[O-])C=CC=CC=CC=C4C(C5=C(N4CCCCS(=O)(=O)[O-])C=CC6=CC=CC=C65)(C)C)C.[Na+],.,
3833,Liew,Permethrin,40326,negative,0,0,391.3,6.5,35.5,3,0,26,CC1(C(C1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,,
4001,Liew,Temocillin,171758,negative,0,0,414.5,1.1,187,9,3,27,CC1(C(N2C(S1)C(C2=O)(NC(=O)C(C3=CSC=C3)C(=O)O)OC)C(=O)O)C,,
3169,Liew,Amdinocillin,36273,positive,0,0,325.4,2.1,98.5,5,1,22,CC1(C(N2C(S1)C(C2=O)N=CN3CCCCCC3)C(=O)O)C,,
1910,Greene,Amoxicillin,33613,WE,1,1,365.4,-2,158,7,4,25,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,less than 30% biotransformed in liver,
833,LIverTox,Amoxicillin-Clavulanate,6435924,A,1,1,564.6,,245,12,6,39,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C.C1C2N(C1=O)C(C(=CCO)O2)C(=O)O,.,
836,LIverTox,Ampicillin,6249,C,1,1,349.4,-1.1,138,6,3,24,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C,12 to 50%,
837,LIverTox,Ampicillin-Sulbactam,656676,C,1,1,626.6,,244,11,2,41,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C.CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)[O-])C.[Na+].[Na+],.,
1930,Greene,Azlocillin Sodium,6479523,NE,0,0,461.5,0.1,173,7,4,32,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C,.,
1773,LIverTox,Ticarcillin,36921,D,1,1,384.4,0.8,178,8,3,25,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CSC=C3)C(=O)O)C(=O)O)C,.,
3350,Liew,Cyclacillin,19003,negative,0,0,341.4,1.3,138,6,3,23,CC1(C(N2C(S1)C(C2=O)NC(=O)C3(CCCCC3)N)C(=O)O)C,,
3689,Liew,Methicillin,6087,negative,0,1,380.4,1.2,131,7,2,26,CC1(C(N2C(S1)C(C2=O)NC(=O)C3=C(C=CC=C3OC)OC)C(=O)O)C,,
3822,Liew,Penicillin g benzathine,15232,positive,0,0,909.1,,248,12,6,64,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C.CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C.C1=CC=C(C=C1)CNCCNCC2=CC=CC=C2,,
3823,Liew,Penicillin v,6869,positive,0,0,350.4,2.1,121,6,2,24,CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C,,
938,LIverTox,Boceprevir,10324367,B,1,1,519.7,3.1,151,5,4,37,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,.,
1997,Greene,Chlortetracycline HCl,54675777,HH,1,1,478.9,-1.3,182,9,6,33,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)N)N(C)C)O,.,
18,DILIrank,tetracycline,54685734,vLess-DILI-Concern,1,1,444.4,-2,182,9,6,32,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,Not metabolized,
323,DILIrank,mecamylamine,4032,vNo-DILI-Concern,0,0,167.29,2.6,12,1,1,12,CC1(C2CCC(C2)C1(C)NC)C,.,
1407,LIverTox,Methsuximide,6476,E*,0,0,203.24,1.2,37.4,2,0,15,CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2,Liver (demethylation and glucuronidation),
2153,Greene,indacrinone,42266,HH,1,1,365.2,4.5,63.6,4,1,24,CC1(CC2=CC(=C(C(=C2C1=O)Cl)Cl)OCC(=O)O)C3=CC=CC=C3,.,
1833,LIverTox,Venetoclax,49846579,E,0,0,868.4,8.2,183,11,3,61,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,"CYP3A4, CYP3A5",
3600,Liew,Isepamicin,3037209,positive,0,0,569.6,-6.9,298,16,12,39,CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(C(C(C(O3)CN)O)O)O)N)NC(=O)C(CN)O)O,,
1573,LIverTox,Plazomicin,42613186,E,0,0,592.7,-6.2,269,15,11,41,CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CNCCO)N)N)NC(=O)C(CCN)O)O,.,
3513,Liew,Flunisolide,82153,negative,0,0,434.5,2.5,93.1,7,2,31,CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,,
3522,Liew,Flurandrenolide,15209,negative,0,0,436.5,1.4,93.1,7,2,31,CC1(OC2CC3C4CC(C5=CC(=O)CCC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,,
3382,Liew,Desonide,12536,negative,0,0,416.5,2.7,93.1,6,2,30,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C,,
3573,Liew,Halcinonide,443943,negative,0,0,455,3.6,72.8,6,1,31,CC1(OC2CC3C4CCC5=CC(=O)CCC5(C4(C(CC3(C2(O1)C(=O)CCl)C)O)F)C)C,,
4045,Liew,Topiramate,5284627,positive,1,1,339.36,-0.8,124,9,1,22,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,Liver,
1557,LIverTox,Phentermine-Topiramate,56842108,E*,0,0,488.6,,150,10,2,33,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C.CC(C)(CC1=CC=CC=C1)N,.,
1416,LIverTox,Midostaurin,9829523,E*,0,0,570.6,4.8,77.7,4,1,43,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,.,
107,DILIrank,prednisone,5865,vLess-DILI-Concern,1,1,358.4,1.5,91.7,5,2,26,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,prednisolone liver,
3514,Liew,Fluocinolone,91488,negative,0,0,412.4,1.1,115,8,4,29,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CC(C4=CC(=O)C=CC43C)F)F)O,,
254,DILIrank,prednisolone,5755,vLess-DILI-Concern,1,1,360.4,1.6,94.8,5,3,26,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,.,
3669,Liew,Memantine,4054,positive,1,1,179.3,3.3,26,1,1,13,CC12CC3CC(C1)(CC(C3)(C2)N)C,,
3531,Liew,Formestane,11273,negative,0,0,302.4,2.6,54.4,3,1,22,CC12CCC(=O)C(=C1CCC3C2CCC4(C3CCC4=O)C)O,,
1155,LIverTox,Eplerenone,5282131,E*,0,0,414.5,1.4,82.2,6,0,30,CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC,CYP3A4,
2654,Xu,Fludrocortisone Acetate,31378,Negative,0,0,380.4,1.7,94.8,6,3,27,CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CCC4(C(=O)CO)O)C)O)F,	Liver,
2675,Xu,Hydrocortisone,5754,Negative,0,0,362.5,1.6,94.8,5,3,26,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,"	11??-HSDsTooltip 11??-Hydroxysteroid dehydrogenases, others",
3704,Liew,Methyltestosterone,6010,positive,1,1,302.5,3.4,37.3,2,1,22,CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C,,
4013,Liew,Testolactone,13769,negative,0,0,300.4,3,43.4,3,0,22,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,Liver,
2090,Greene,ethinyl estradiol,5991,HH,1,1,296.4,3.7,40.5,2,2,22,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,	Liver primarily CYP3A4,
2202,Greene,Mestranol,6291,HH,1,1,310.4,4,29.5,2,1,23,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,	Ethinylestradiol,
3908,Liew,Quinestrol,9046,positive,0,0,364.5,5.3,29.5,2,1,27,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC5CCCC5,,
2740,Xu,Norethindrone,6230,Positive,1,1,298.4,3,37.3,2,1,22,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,"	Mainly CYP3A4 liver; also 5??-/5??-reductase, 3??-Tooltip 3??-hydroxysteroid dehydrogenase/3??-HSDTooltip 3??-hydroxysteroid dehydrogenase, and aromatase",
224,DILIrank,danazol,28417,vMost-DILI-Concern,1,1,337.5,3.8,46.3,3,1,25,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5,CYP3A4,
130,DILIrank,oxymetholone,5281034,vMost-DILI-Concern,1,1,332.5,4.4,57.5,3,2,24,CC12CCC3C(C1CCC2(C)O)CCC4C3(CC(=CO)C(=O)C4)C,	Liver,
3969,Liew,Stanozolol,25249,positive,1,1,328.5,4.5,48.9,2,2,24,CC12CCC3C(C1CCC2(C)O)CCC4C3(CC5=C(C4)NN=C5)C,Liver,
3791,Liew,Oxandrolone,5878,positive,1,1,306.4,3.7,46.5,3,1,22,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,Kidney,
181,DILIrank,exemestane,60198,vMost-DILI-Concern,1,1,296.4,3.1,34.1,2,0,22,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,"Liver CYP3A4, aldo-keto reductase",
2088,Greene,Estrone,5870,HH,1,1,270.4,3.1,37.3,2,1,20,CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O,.,
443,DILIrank,dutasteride,6918296,vNo-DILI-Concern,0,0,528.5,5.4,58.2,8,2,37,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,CYP3A4,
3541,Liew,Fulvestrant,104741,negative,0,0,606.8,9.2,76.7,9,2,41,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,,
4062,Liew,Trilostane,656583,negative,0,0,329.4,2.9,76.8,4,2,24,CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C,Liver,
2639,Xu,estradiol,5757,Negative,0,1,272.4,4,40.5,2,2,20,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,"	Liver via hydroxylation, sulfation, glucuronidation",
548,DILIrank,estramustine,259331,vMost-DILI-Concern,1,1,440.4,4,49.8,3,1,29,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl,.,
3745,Liew,Nandrolone,9904,positive,0,0,274.4,2.6,37.3,2,1,20,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34,,
126,DILIrank,testosterone,6013,vMost-DILI-Concern,1,1,288.4,3.3,37.3,2,1,21,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,	Liver mainly reduction and conjugation,
3393,Liew,Dezocine,3033053,negative,0,0,245.36,3.7,46.2,2,2,18,CC12CCCCCC(C1N)CC3=C2C=C(C=C3)O,,
2638,Xu,Eserine,5983,Negative,0,0,275.35,0.7,44.8,4,1,20,CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC)C)C,	Major metabolite: Eseroline,
2704,Xu,Meclofenamate Sodium,4037,Positive,1,1,296.1,5.2,49.3,3,2,19,CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)O)Cl,.,
3917,Liew,Ranolazine,56959,negative,1,1,427.5,2.7,74.3,6,2,31,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,"CYP3A, CYP2D6",
1366,LIverTox,Lopinavir,92727,D,1,1,628.8,5.9,120,5,4,46,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,Liver,
1414,LIverTox,Mexiletine,4178,C,1,1,179.26,2.1,35.2,2,1,13,CC1=C(C(=CC=C1)C)OCC(C)N,"CYP2D6, CYP1A2",
3370,Liew,Dasatinib,3062316,positive,1,1,488,3.6,135,9,3,33,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,,
62,DILIrank,mefenamic acid,4044,vMost-DILI-Concern,1,1,241.28,5.1,49.3,3,2,18,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,CYP2C9,
727,DILIrank,dicloxacillin,18381,vLess-DILI-Concern,1,1,470.3,2.9,138,7,2,30,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,Liver,
3504,Liew,Floxacillin,21319,positive,1,1,453.9,2.6,138,8,2,30,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,,
646,DILIrank,oxacillin,6196,vLess-DILI-Concern,1,1,401.4,2.4,138,7,2,28,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,.,
711,DILIrank,valdecoxib,119607,vLess-DILI-Concern,1,1,314.4,2.6,94.6,5,1,22,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,"CYP3A4,2C9",
500,DILIrank,cloxacillin,6098,vLess-DILI-Concern,1,1,435.9,2.4,138,7,2,29,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,.,
3953,Liew,Seratrodast,2449,positive,1,1,354.4,4.4,71.4,4,1,26,CC1=C(C(=O)C(=C(C1=O)C)C(CCCCCC(=O)O)C2=CC=CC=C2)C,,
3847,Liew,Phytonadione,5284607,positive,0,0,450.7,10.9,34.1,2,0,33,CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C,,
3373,Liew,Deferiprone,2972,positive,0,0,139.15,0.5,40.5,3,1,10,CC1=C(C(=O)C=CN1C)O,,
1135,LIverTox,Elagolix,11250647,E,0,0,631.6,2.6,99.2,11,2,45,CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F,CYP3A,
1520,LIverTox,Palbociclib,5330286,C,1,1,447.5,1.8,103,8,2,33,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,"Liver CYP3A, SULT2A1, glucuronidation",
511,DILIrank,paliperidone,115237,vNo-DILI-Concern,0,0,426.5,2.2,82.2,7,1,31,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,.,
2414,Greene,Risperidone,5073,HH,1,1,410.5,2.7,61.9,6,0,30,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,Liver CYP2D6 mediated to 9-hydroxyrisperidone,
3764,Liew,Nilvadipine,4494,positive,0,0,385.4,2.9,134,8,1,28,CC1=C(C(C(=C(N1)C#N)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC(C)C,,
602,DILIrank,isradipine,3784,vLess-DILI-Concern,1,1,371.4,4.3,104,8,1,27,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,100% Liver,
164,DILIrank,nifedipine,4485,vLess-DILI-Concern,1,1,346.3,2.2,110,7,1,25,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,"Gastrointestinal, Liver",
3047,Liew,Nisoldipine,4499,negative,.,0,388.4,3.3,110,7,1,28,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,CYP3A4,
3321,Liew,Cilnidipine,5282138,positive,0,0,492.5,4.4,120,8,1,36,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC,,
3495,Liew,Fenretinide,5288209,positive,0,0,391.5,7.3,49.3,2,2,29,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C,,
2464,Greene,Tretinoin,444795,HH,1,1,300.4,6.3,37.3,2,1,22,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,.,
1842,LIverTox,Vitamin A,1071,A[HD],1,1,286.5,5.7,20.2,1,1,21,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,.,
3485,Liew,Exisulind,5472495,positive,0,0,372.4,3.5,79.8,5,1,26,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)(=O)C)C=CC(=C2)F)CC(=O)O,,
86,DILIrank,sulindac,1548887,vMost-DILI-Concern,1,1,356.4,3.4,73.6,5,1,25,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,.,
3773,Liew,Nolatrexed,108189,positive,0,0,284.34,1.6,106,3,2,20,CC1=C(C2=C(C=C1)NC(=NC2=O)N)SC3=CC=NC=C3,,
2823,Xu,troglitazone,5591,Positive,1,1,441.5,5.1,110,6,2,31,CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C,.,
1300,LIverTox,Indomethacin,3715,C,1,1,357.8,4.3,68.5,4,1,25,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Liver,
3138,Liew,Acemetacin,1981,positive,0,0,415.8,4.2,94.8,6,1,29,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O,,
497,DILIrank,clometacin,33176,vMost-DILI-Concern,1,1,357.8,4,68.5,4,1,25,CC1=C(C2=C(N1CC(=O)O)C=C(C=C2)OC)C(=O)C3=CC=C(C=C3)Cl,.,
388,DILIrank,porfimer,57166,vNo-DILI-Concern,0,0,1179.4,5.2,314,15,10,87,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)OC(C)C6=C(C7=CC8=C(C(=C(N8)C=C9C(=C(C(=N9)C=C1C(=C(C(=N1)C=C6N7)C)CCC(=O)O)CCC(=O)O)C)C)C(C)O)C)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C(C)O,.,no small molecule
1523,LIverTox,Panobinostat,6918837,E,0,0,349.4,3,77.2,3,4,26,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO,"CYP3A 40%, CYP2D6, CYP2C19",
1578,LIverTox,Ponatinib,24826799,E*,0,0,532.6,4.1,65.8,8,1,39,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,"CYP3A4, 2C8, 2D6, 3A5",
1470,LIverTox,Nilotinib,644241,D,1,1,529.5,4.9,97.6,9,2,39,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,CYP3A4,
276,DILIrank,eltrombopag olamine,9846180,vMost-DILI-Concern,1,1,442.5,4.5,111,7,3,33,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)NN=C3C=CC=C(C3=O)C4=CC(=CC=C4)C(=O)O)C,	extensive liver through CYP1A2 and CYP2C8,
56,DILIrank,imatinib,5291,vMost-DILI-Concern,1,1,493.6,3.5,86.3,7,2,37,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,CYP3A4,
1529,LIverTox,Pazopanib,11525740,C,1,1,474,,127,8,3,32,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl,"Liver: CYP3A4 (major), 1A2 and 2C8 (minor)",
4067,Liew,Trimetrexate,5583,positive,0,0,369.4,2.5,118,8,3,27,CC1=C(C=CC2=C1C(=NC(=N2)N)N)CNC3=CC(=C(C(=C3)OC)OC)OC,,
1699,LIverTox,Simeprevir,24873435,B,1,1,749.9,4.8,194,10,2,52,CC1=C(C=CC2=C1N=C(C=C2OC3CC4C(C3)C(=O)N(CCCCC=CC5CC5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC,"CYP3A, CYP2C8, CYP2C19",
2743,Xu,Novobiocin,9346,Positive,1,1,612.6,3.4,196,11,5,44,CC1=C(C=CC2=C1OC(=C(C2=O)NC(=O)C3=CC(=C(C=C3)O)CC=C(C)C)O)OC4C(C(C(C(O4)(C)C)OC)OC(=O)N)O,	excreted unchanged,
3753,Liew,Nelfinavir,64143,positive,1,1,567.8,5.7,127,6,4,40,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,,
3387,Liew,Dexlansoprazole,9578005,positive,1,1,369.4,2.8,87.1,8,1,25,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,,
142,DILIrank,rabeprazole,5029,vLess-DILI-Concern,1,1,359.4,1.9,96.3,6,1,25,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,"CYP2C19,CYP3A4",
2175,Greene,Leflunomide,3899,HH,1,1,270.21,2.5,55.1,6,1,19,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,GI mucosa and liver,
2494,Greene,Zomepirac,5733,NE,0,0,291.73,2.8,59.3,3,1,20,CC1=C(N(C(=C1)CC(=O)O)C)C(=O)C2=CC=C(C=C2)Cl,.,
3275,Liew,Cefadroxil,47965,positive,0,0,363.4,-2.1,158,7,4,25,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,,
465,DILIrank,cefadroxil,47964,vLess-DILI-Concern,1,1,381.4,,159,8,5,26,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O.O,	unknown,
936,LIverTox,Bleomycin,5460769,D,1,1,1415.6,-7.5,685,31,20,96,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,.,
3323,Liew,Cimetidine,2756,positive,1,1,252.34,0.4,114,4,3,17,CC1=C(N=CN1)CSCCNC(=NC)NC#N,,
3451,Liew,Enoximone,53708,positive,0,0,248.3,1.6,83.5,3,2,17,CC1=C(NC(=O)N1)C(=O)C2=CC=C(C=C2)SC,,
3500,Liew,Flavoxate,3354,negative,0,0,391.5,4.3,55.8,5,0,29,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4,,
3984,Liew,Sulfisoxazole,5344,positive,0,0,267.31,1,107,6,2,18,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,,
228,DILIrank,febuxostat,134018,vMost-DILI-Concern,1,1,316.4,3.9,111,6,1,22,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,"via CYP1A1, 1A2, 2C8, 2C9, UGT1A1, 1A8, 1A9",
3282,Liew,Cefodizime,5361871,positive,0,0,584.7,0.2,305,15,4,37,CC1=C(SC(=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O)CC(=O)O,,
1797,LIverTox,Trametinib,11707110,E*,0,0,615.4,3.4,102,6,2,37,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,.,
139,DILIrank,nevirapine,4463,vMost-DILI-Concern,1,1,266.3,2,58.1,4,1,20,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,Liver,
2267,Greene,Paclitaxel,36314,HH,1,1,853.9,2.5,221,14,4,62,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,"	CYP2C8,CYP3A4",
1106,LIverTox,Docetaxel,148124,C,1,1,807.9,1.6,224,14,5,58,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Liver,
958,LIverTox,Cabazitaxel,9854073,E*,0,0,835.9,2.7,202,14,3,60,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,.,
288,DILIrank,tasosartan,60919,vMost-DILI-Concern,1,1,411.5,3,101,6,1,31,CC1=C2CCC(=O)N(C2=NC(=N1)C)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,.,
1876,Greene,3-Methylcholanthrene,1674,HH,1,1,268.4,6.4,0,0,0,21,CC1=C2CCC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1,.,
3037,Liew,Mycophenolic acid,446541,positive,.,1,320.3,3.2,93.1,6,2,23,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,,
1886,Greene,Acitretin,5284513,HH,1,1,326.4,6.1,46.5,3,1,24,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,Liver,
3800,Liew,Oxymetazoline,4636,negative,0,0,260.37,2.9,44.6,2,2,19,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C,Kidney,
3706,Liew,Metipranolol,31477,negative,0,0,309.4,2.7,67.8,5,2,22,CC1=CC(=C(C(=C1OC(=O)C)C)C)OCC(CNC(C)C)O,,
290,DILIrank,tilbroquinol,65592,vMost-DILI-Concern,1,1,238.08,3.1,33.1,2,1,13,CC1=CC(=C(C2=C1C=CC=N2)O)Br,.,
3555,Liew,Gemfibrozil,3463,positive,1,1,250.33,3.8,46.5,3,1,18,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,,
287,DILIrank,lumiracoxib,151166,vMost-DILI-Concern,1,1,293.72,4.2,49.3,4,2,20,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O,	Predominantly in the liver via oxidation and hydroxylation CYP2C9,
1852,LIverTox,Vortioxetine,9966051,E*,0,0,298.4,4.2,40.6,3,1,21,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,"Liver, primarily CYP2D6-mediated oxidation",
990,LIverTox,Ceritinib,57379345,D,1,1,558.1,6.4,114,8,3,38,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,CYP3A,
630,DILIrank,moxisylyte,4260,vMost-DILI-Concern,1,1,279.37,3.2,38.8,4,0,20,CC1=CC(=C(C=C1OC(=O)C)C(C)C)OCCN(C)C,.,
3903,Liew,Pyrvinium,5281035,negative,0,0,382.5,5.9,12,1,0,29,CC1=CC(=C(N1C2=CC=CC=C2)C)C=CC3=[N+](C4=C(C=C3)C=C(C=C4)N(C)C)C,,
1138,LIverTox,Eluxadoline,11250029,C,1,1,569.6,0.9,165,7,4,42,CC1=CC(=CC(=C1CC(C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)C(C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N,.,
1650,LIverTox,Rilpivirine,6451164,D,1,1,366.4,4.5,97.4,6,2,28,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,CYP3A4,
272,DILIrank,etravirine,193962,vMost-DILI-Concern,1,1,435.3,4.5,121,7,2,28,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,"CYP3A4,CYP2C9,CYP2C19",
327,DILIrank,meclizine,4034,vNo-DILI-Concern,0,0,390.9,5.8,6.5,2,0,28,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,Liver,
1736,LIverTox,Tafenoquine,115358,E,0,0,463.5,5.4,78.6,9,2,33,CC1=CC(=NC2=C1C(=C(C=C2NC(C)CCCN)OC)OC3=CC=CC(=C3)C(F)(F)F)OC,.,
3601,Liew,Isocarboxazid,3759,positive,0,0,231.25,1.5,67.2,4,2,17,CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2,,
2164,Greene,Isoxicam,54677972,NE,0,0,335.34,3,121,7,2,23,CC1=CC(=NO1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,.,
3688,Liew,Methenolone,3037705,positive,1,1,302.5,3.9,37.3,2,1,22,CC1=CC(=O)CC2C1(C3CCC4(C(C3CC2)CCC4O)C)C,,
1999,Greene,Ciclopirox,2749,NE,0,0,207.27,2,40.5,2,1,15,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,.,
4069,Liew,Trioxsalen,5585,negative,0,0,228.24,3,39.4,3,0,17,CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C,,
1794,LIverTox,Trabectedin,108150,C[HD],1,1,761.8,3.4,194,15,4,54,CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O,CYP3A4,
429,DILIrank,bexarotene,82146,vMost-DILI-Concern,1,1,348.5,7.6,37.3,2,1,26,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,CYP3A4,
604,DILIrank,riboflavin,493570,vNo-DILI-Concern,0,0,376.4,-1.5,155,7,5,27,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O,.,
716,DILIrank,cyanocobalamin,16212801,vNo-DILI-Concern,0,0,1355.4,,476,21,9,93,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],.,
779,DILIrank,sitaxsentan,216235,vMost-DILI-Concern,1,1,454.9,3.7,144,9,1,29,CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2,"CYP2C9,CYP3A4",
138,DILIrank,olanzapine,4585,vLess-DILI-Concern,1,1,312.4,2.8,56.2,5,1,22,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Liver (direct glucuronidation and CYP1A2 mediated oxidation),
795,LIverTox,Acrivastine,5284514,E,0,0,348.4,1.6,53.4,4,1,26,CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC(=N3)C=CC(=O)O,.,
4071,Liew,Triprolidine,5282443,negative,0,0,278.4,3.9,16.1,2,0,21,CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3,CYP2D6,
1786,LIverTox,Tolcapone,4659569,C,1,1,273.24,3.3,103,5,2,20,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],Liver mainly glucuronidation,
1787,LIverTox,Tolmetin,5509,D,1,1,257.28,2.8,59.3,3,1,19,CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)O,.,
3242,Liew,Bitolterol,35330,negative,0,0,461.5,5.2,84.9,6,2,34,CC1=CC=C(C=C1)C(=O)OC2=C(C=C(C=C2)C(CNC(C)(C)C)O)OC(=O)C3=CC=C(C=C3)C,,
3294,Liew,Celecoxib,2662,positive,1,1,381.4,3.4,86.4,7,1,26,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,,
3558,Liew,Gliclazide,3475,positive,1,1,323.4,1.5,86.9,4,2,22,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,,
2457,Greene,Tolazamide,5503,HH,1,1,311.4,1.5,86.9,4,2,21,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2,	metabolized in the liver to active metabolites,
275,DILIrank,tolvaptan,216237,vMost-DILI-Concern,1,1,448.9,4.8,69.6,3,2,32,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,CYP3A4,
2261,Greene,Orphenadrine Citrate,4601,NE,0,0,269.4,3.8,12.5,2,0,20,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,	Liver demethylation,
3366,Liew,Dapiprazole,3033538,negative,0,0,325.5,2.4,37.2,4,0,24,CC1=CC=CC=C1N2CCN(CC2)CCC3=NN=C4N3CCCC4,,
453,DILIrank,atomoxetine,54841,vMost-DILI-Concern,1,1,255.35,3.7,21.3,2,1,19,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2,CYP2D6,
4103,Liew,Zafirlukast,5717,positive,1,1,575.7,5.5,124,6,2,41,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,CYP2C9,
3816,Liew,Pemirolast,57697,positive,0,0,228.21,-0.3,87.1,5,1,17,CC1=CC=CN2C1=NC=C(C2=O)C3=NNN=N3,,
1569,LIverTox,Pirfenidone,40632,D,1,1,185.22,1.9,20.3,1,0,14,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,"Liver 70?80% CYP1A2-mediated; minor contributions from CYP2C9, CYP2C19, CYP2D6 and CYP2E1",
1716,LIverTox,Stavudine,18283,A,1,1,224.21,-0.8,78.9,4,2,16,CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,Kidney elimination ~40%,
1863,LIverTox,Zidovudine,35370,B,1,1,267.24,0,93.2,6,2,19,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],Liver,
1745,LIverTox,Telbivudine,159269,E,0,0,242.23,-1.2,99.1,5,3,17,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,Nil,
634,DILIrank,esomeprazole Sodium,9579578,vLess-DILI-Concern,1,1,345.4,2.2,96.3,6,1,24,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,"	Liver CYP2C19, CYP3A4",
132,DILIrank,glipizide,3478,vLess-DILI-Concern,1,1,445.5,1.9,139,6,3,31,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,Liver hydroxylation,
63,DILIrank,meloxicam,54677470,vLess-DILI-Concern,1,1,351.4,3,136,7,2,23,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,"CYP2C9,3A4",
3913,Liew,Raltitrexed,104758,positive,0,0,458.5,1.4,177,8,4,32,CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O,,
489,DILIrank,conivaptan,151171,vNo-DILI-Concern,0,0,498.6,5.7,78.1,3,2,38,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6,.,
714,DILIrank,pyridoxine,1054,vNo-DILI-Concern,0,0,169.18,-0.8,73.6,4,3,12,CC1=NC=C(C(=C1O)CO)CO,.,
1680,LIverTox,Secnidazole,71815,E,0,0,185.18,0.2,83.9,4,1,13,CC1=NC=C(N1CC(C)O)[N+](=O)[O-],.,
1413,LIverTox,Metronidazole,4173,C,1,1,171.15,0,83.9,4,1,12,CC1=NC=C(N1CCO)[N+](=O)[O-],Liver,
625,DILIrank,midazolam,4192,vNo-DILI-Concern,0,0,325.8,2.5,30.2,3,0,23,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,"Liver 3A3, 3A4, 3A5",
3784,Liew,Ondansetron,4595,positive,1,1,293.4,2.3,39.8,2,0,22,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,"CYP3A4, CYP1A2, CYP2D6",
1131,LIverTox,Edaravone,4021,E,0,0,174.2,1.3,32.7,2,0,13,CC1=NN(C(=O)C1)C2=CC=CC=C2,.,
263,DILIrank,maraviroc,3002977,vMost-DILI-Concern,1,1,513.7,5.1,63,6,1,37,CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,"Liver CYP, predominantly CYP3A",
3980,Liew,Sulfamethizole,5328,positive,1,1,270.3,0.5,135,7,2,17,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,,
466,DILIrank,cefazolin,33255,vLess-DILI-Concern,1,1,454.5,-0.4,235,12,2,29,CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O,.,
817,LIverTox,Alprazolam,2118,D,1,1,308.8,2.1,43.1,3,0,22,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,"Liver, via cytochrome P450 3A4",
1804,LIverTox,Triazolam,5556,D,1,1,343.2,2.4,43.1,3,0,23,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,Liver,
966,LIverTox,Capreomycin,3000502,E,0,0,1321.4,,737,23,27,93,CC1C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)NC(C(=O)NCC(C(=O)N1)N)C2CCN=C(N2)N)CNC(=O)CC(CCCN)N.C1CN=C(NC1C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CNC(=O)CC(CCCN)N)CO)N)N,.,
1574,LIverTox,Plecanatide,70693500,E,0,0,1681.9,-8.2,819,31,23,113,CC1C(=O)NC2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC(C)C)C(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C(C)C)CC(=O)N)C(C)C)CC(C)C)CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(=O)N)N,.,
1355,LIverTox,Linaclotide,16158208,E,0,0,1526.8,-6.8,726,28,19,101,CC1C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)O)C(=O)NC(CSSCC(C(=O)N3)N)C(=O)NC(C(=O)N5CCCC5C(=O)N1)CC(=O)N)CC6=CC=C(C=C6)O)CCC(=O)O,.,
2725,Xu,Monocrotaline,9415,Positive,1,1,325.36,-0.7,96.3,7,2,23,CC1C(=O)OC2CCN3C2C(=CC3)COC(=O)C(C1(C)O)(C)O,.,
3215,Liew,Aztreonam,5742832,positive,0,0,435.4,0.3,238,12,4,28,CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N,,
3363,Liew,Dactinomycin,2019,positive,1,1,1255.4,3.8,356,18,5,90,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,,
789,LIverTox,Acarbose,444254,B,1,1,645.6,-8.5,321,19,14,44,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,Gastrointestinal tractglucosidasemaltogenic alpha-amylase and cyclomaltodextrinase from gut microbiome,
83,DILIrank,streptomycin,19649,vNo-DILI-Concern,0,0,581.6,-8,336,15,12,40,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O,.,
4086,Liew,Vancomycin,14969,negative,1,1,1449.2,-2.6,531,26,19,101,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,,
2625,Xu,Digoxin,2724385,Negative,0,0,780.9,1.3,203,14,6,55,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Liver 16%,
3407,Liew,Digitoxin,441207,negative,0,0,764.9,2.3,183,13,5,54,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)O,,
1071,LIverTox,Daunorubicin,30323,E*,0,0,527.5,1.8,186,11,5,38,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,Liver,
2073,Greene,Doxorubicin HCl,443939,HH,1,1,580,,206,12,7,40,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl,Liver,
3856,Liew,Pirarubicin,3033521,positive,0,0,627.6,2.7,204,13,5,45,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)OC6CCCCO6,,
2677,Xu,Idarubicin HCl,42890,Negative,0,0,497.5,1.9,177,10,5,36,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,,
1576,LIverTox,Plicamycin,5284610,A[HD],1,1,1085.1,0.6,358,24,11,76,CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O,.,
3380,Liew,Deslanoside,28620,negative,0,0,943.1,-0.3,282,19,9,66,CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CC(C5(C4(CCC5C6=CC(=O)OC6)O)C)O)C)O)OC7CC(C(C(O7)C)OC8CC(C(C(O8)C)OC9C(C(C(C(O9)CO)O)O)O)O)O,,
3535,Liew,Fosfomycin,446987,positive,1,1,138.06,-1.4,70.1,4,2,8,CC1C(O1)P(=O)(O)O,,
3839,Liew,Phenmetrazine,4762,negative,1,1,177.24,1.4,21.3,2,1,13,CC1C(OCCN1)C2=CC=CC=C2,,
3836,Liew,Phendimetrazine,12460,negative,0,0,191.27,1.9,12.5,2,0,14,CC1C(OCCN1C)C2=CC=CC=C2,Liver,
1370,LIverTox,Lorlatinib,71731823,E*,0,0,406.4,1.5,110,7,1,30,CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,Mainly CYP3A4 and UGT1A4,
1399,LIverTox,Meropenem,441130,D,1,1,383.5,-2.4,136,7,3,26,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O,.,
3459,Liew,Ertapenem,150610,positive,0,0,475.5,-1.5,182,9,5,33,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)C(C)O,,
3427,Liew,Doripenem,73303,positive,0,0,420.5,-3.4,196,10,5,27,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O,,
3434,Liew,Doxycycline,54671203,positive,1,1,444.4,-0.7,182,9,6,32,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,,
3825,Liew,Pentazocine,441278,negative,0,0,285.4,3.3,23.5,2,1,21,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,Liver,
3929,Liew,Rifapentine,135403821,positive,1,1,877,6.7,220,15,6,63,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C6CCCC6)C,,
3928,Liew,Rifampin,5381226,positive,1,1,822.9,4,217,15,6,59,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C,Liver,
1648,LIverTox,Rifaximin,6436173,E,0,0,785.9,6.9,198,12,5,57,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,Liver,
77,DILIrank,rifabutin,6323490,vLess-DILI-Concern,1,1,847,6.3,206,14,5,61,CC1C=CC=C(C(=O)NC2=C3C(=NC4(N3)CCN(CC4)CC(C)C)C5=C(C2=O)C(=C(C6=C5C(=O)C(O6)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)C,liver,
1646,LIverTox,Rifamycin,6324616,E,0,0,697.8,4.9,201,12,6,50,CC1C=CC=C(C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C,.,
25,DILIrank,amphotericin b,14956,vLess-DILI-Concern,1,1,924.1,0,320,18,12,65,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,kidney,
252,DILIrank,nystatin,14960,vNo-DILI-Concern,0,0,926.1,-0.2,320,18,12,65,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,None not extensively absorbed,
1262,LIverTox,Griseofulvin,441140,C,1,1,352.8,2.2,71.1,6,0,24,CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC,Liver demethylation and glucuronidation,
2473,Greene,Troleandomycin,5284630,HH,1,1,814,4.3,184,16,0,57,CC1CC(C(C(O1)OC2C(CC3(CO3)C(=O)C(C(C(C(OC(=O)C(C(C2C)OC4CC(C(C(O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C,.,
1734,LIverTox,Tacrolimus,445643,C,1,1,804,2.7,178,12,3,57,CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,"CYP3A4, CYP3A5",
1246,LIverTox,Givosiran,119058042,E*,0,0,1711,-5.9,597,30,20,119,CC1CC(CN1C(=O)CCCCCCCCCCC(=O)NC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)CO)O)O)NC(=O)C)COCCC(=O)NCCCNC(=O)CCCCOC4C(C(C(C(O4)CO)O)O)NC(=O)C)O,.,
4027,Liew,Tibolone,444008,negative,1,1,312.4,2.4,37.3,2,1,23,CC1CC2=C(CCC(=O)C2)C3C1C4CCC(C4(CC3)C)(C#C)O,"Liver, Intestine",
3150,Liew,Alclometasone,5311000,negative,0,0,408.9,2.2,94.8,5,3,28,CC1CC2C3C(CC4=CC(=O)C=CC4(C3C(CC2(C1(C(=O)CO)O)C)O)C)Cl,,
3574,Liew,Halobetasol,5311167,negative,0,0,428.9,2.7,74.6,6,2,29,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C)F,,
3511,Liew,Flumethasone,16490,negative,0,0,410.5,1.9,94.8,7,3,29,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C)F,,
3526,Liew,Fluticasone,5311101,negative,0,0,444.5,3.2,99.9,8,2,30,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,,
3334,Liew,Clocortolone Pivalate,5282493,negative,0,0,495,4.5,80.7,6,1,34,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)COC(=O)C(C)(C)C)C)O)Cl)C)F,,
3518,Liew,Fluorometholone,9878,negative,0,0,376.5,2,74.6,5,2,27,CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O,,
3703,Liew,Methylprednisolone,6741,positive,1,1,374.5,1.9,94.8,5,3,27,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,,
3664,Liew,Medrysone,247839,negative,0,0,344.5,2.7,54.4,3,1,25,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)CC4)C)O)C)C(=O)C,,
3731,Liew,Mometasone,441335,negative,0,0,427.4,2.7,74.6,4,2,28,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,,
3333,Liew,Clobetasol,5311051,negative,0,0,410.9,2.5,74.6,5,2,28,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,,
2534,Xu,Betamethasone,9782,Negative,0,0,392.5,1.9,94.8,6,3,28,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,CYP3A4,
3383,Liew,Desoximetasone,5311067,negative,0,0,376.5,2.3,74.6,5,2,27,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)CO)C)O)F)C,,
4036,Liew,Tirilazad,104903,positive,0,0,624.9,5.9,72.9,8,0,46,CC1CC2C3CCC4=CC(=O)C=CC4(C3=CCC2(C1C(=O)CN5CCN(CC5)C6=NC(=NC(=C6)N7CCCC7)N8CCCC8)C)C,,
1160,LIverTox,Eribulin,11354606,E*,0,0,729.9,1.1,146,12,2,52,CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O,.,
3612,Liew,Josamycin,5282165,positive,0,0,828,2.9,206,16,3,58,CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)OC(=O)C)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O,,
3925,Liew,Retapamulin,6918462,negative,0,0,517.8,6.1,92.1,6,1,36,CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CC5CCC(C4)N5C)C,CYP3A4,
1343,LIverTox,Lefamulin,25185057,E,0,0,507.7,4.3,135,7,3,35,CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CCC(CC4O)N)C,.,
3510,Liew,Flumequine,3374,positive,1,1,261.25,2.9,57.6,5,1,19,CC1CCC2=C3N1C=C(C(=O)C3=CC(=C2)F)C(=O)O,,
878,LIverTox,Artemisinin,68827,D,1,1,282.33,2.8,54,5,0,20,CC1CCC2C(C(=O)OC3C24C1CCC(O3)(OO4)C)C,.,
195,DILIrank,sirolimus,5284616,vLess-DILI-Concern,1,1,914.2,6,195,13,3,65,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,Liver,
513,DILIrank,temsirolimus,6918289,vNo-DILI-Concern,0,0,1030.3,5.6,242,16,4,73,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,Liver,
1180,LIverTox,Everolimus,6442177,E*,0,0,958.2,5.9,205,14,3,68,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,.,
1322,LIverTox,Ixabepilone,6445540,E*,0,0,506.7,3.6,140,7,3,35,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,CYP3A4,
3200,Liew,Argatroban,440542,positive,0,0,508.6,1.3,189,8,5,35,CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,,
1785,LIverTox,Tofacitinib,9926791,E*,0,0,312.37,1.5,88.9,5,1,23,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,"CYP3A4, CYP2C19",
1732,LIverTox,Suvorexant,24965990,E,0,0,450.9,4.9,80.3,6,0,32,CC1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl,"Liver CYP3A major, CYP2C19 minor",
1109,LIverTox,Dolutegravir,54726191,D,1,1,419.4,2.4,99.2,8,2,30,CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,"UGT1A1, CYP3A",
3967,Liew,Sparfloxacin,60464,positive,0,0,392.4,0.1,98.9,9,3,28,CC1CN(CC(N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F,Liver,
1709,LIverTox,Sonidegib,24775005,E*,0,0,485.5,5.8,63.7,8,1,35,CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,CYP3A,
3164,Liew,Alvimopan,5488548,positive,0,0,424.5,1.7,89.9,5,3,31,CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(=O)O,,
3634,Liew,Levocabastine,54385,negative,0,0,420.5,2.5,64.3,5,1,31,CC1CN(CCC1(C2=CC=CC=C2)C(=O)O)C3CCC(CC3)(C#N)C4=CC=C(C=C4)F,,
3564,Liew,Grepafloxacin,72474,positive,0,0,359.4,-0.2,72.9,7,2,26,CC1CN(CCN1)C2=C(C(=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)C)F,,
2441,Greene,Temafloxacin,60021,HH,1,1,417.4,0.6,72.9,9,2,30,CC1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=C(C=C(C=C4)F)F)F,.,
3552,Liew,Gatifloxacin,5379,positive,0,0,375.4,-0.7,82.1,8,2,27,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,,
1369,LIverTox,Lorcaserin,11658860,E,0,0,195.69,2.7,12,1,1,13,CC1CNCCC2=C1C=C(C=C2)Cl,extensive,
1353,LIverTox,Levofloxacin,149096,A,1,1,361.4,-0.4,73.3,8,1,26,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,<5% desmethyl and N-oxide metabolites,
3022,Liew,Metolazone,4170,positive,.,1,365.8,4.1,101,5,2,24,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,,
3481,Liew,Etoposide,36462,positive,1,1,588.6,0.6,161,13,3,42,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,,
3400,Liew,Dienestrol,667476,negative,0,0,266.3,5.4,40.5,2,2,20,CC=C(C1=CC=C(C=C1)O)C(=CC)C2=CC=C(C=C2)O,,
1662,LIverTox,Romidepsin,	5352062,C,1,1,540.7,2.2,193,8,4,36,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,CYP3A4,
471,DILIrank,cefprozil,9887643,vLess-DILI-Concern,1,1,407.4,,159,8,5,28,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O.O,.,
3436,Liew,Droloxifene,3033767,positive,0,0,387.5,6.8,32.7,3,1,29,CCC(=C(C1=CC=C(C=C1)OCCN(C)C)C2=CC(=CC=C2)O)C3=CC=CC=C3,,
2436,Greene,tamoxifen,2733526,HH,1,1,371.5,7.1,12.5,2,0,28,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,"CYP3A4, CYP2C9, CYP2D6",
3403,Liew,Diethylstilbestrol,448537,positive,0,0,268.3,5.1,40.5,2,2,20,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,,
3470,Liew,Ethacrynic acid,3278,positive,1,1,303.13,3.8,63.6,4,1,19,CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl,,
3932,Liew,Rimexolone,5311412,negative,0,0,370.5,3.5,54.4,3,1,27,CCC(=O)C1(C(CC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C)C,,
3892,Liew,Propiomazine,4940,negative,0,0,340.5,4.8,48.8,4,0,24,CCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CC(C)N(C)C,,
394,DILIrank,remifentanil,60815,vLess-DILI-Concern,1,1,376.4,1.9,76.2,6,0,27,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,	cleaved by non-specific plasma and tissue esterases,
3975,Liew,Sufentanil,41693,negative,0,0,386.6,4,61,4,0,27,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,,
3153,Liew,Alfentanil,51263,negative,0,0,416.5,2.2,81,6,0,30,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,,
3496,Liew,Fentanyl,3345,negative,0,0,336.5,4,23.6,2,0,25,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,,
1741,LIverTox,Tasimelteon,10220503,E,0,0,245.32,2.2,38.3,2,1,18,CCC(=O)NCC1CC1C2=C3CCOC3=CC=C2,"extensive liver, primarily CYP1A2,CYP3A4",
492,DILIrank,ramelteon,208902,vNo-DILI-Concern,0,0,259.34,2.7,38.3,2,1,19,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,"Liver CYP1A2 major, CYP2C,CYP3A4 minor",
583,DILIrank,fosinopril,55891,vLess-DILI-Concern,1,1,563.7,6.2,110,7,1,39,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)O)C3CCCCC3,"liver, GIT mucosa to fosinoprilat",
3894,Liew,Propoxyphene,10100,positive,1,1,339.5,4.2,29.5,3,0,25,CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C,CYP3A4,
3918,Liew,Rapacuronium,5311398,negative,0,0,677.8,,55.8,6,0,44,CCC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)OC(=O)C)N5CCCCC5)C)C)[N+]6(CCCCC6)CC=C.[Br-],,
1936,Greene,Beclomethasone Dipropionate,21700,NE,0,0,521,3,107,7,1,36,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC,	By esterase enzymes found in most tissues,
3873,Liew,Prednicarbate,6714002,negative,0,0,488.6,4.2,116,8,1,35,CCC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)OC(=O)OCC,,
427,DILIrank,levetiracetam,5284583,vLess-DILI-Concern,1,1,170.21,-0.3,63.4,2,1,12,CCC(C(=O)N)N1CCCC1=O,Enzymatic hydrolysis of acetamide group,
1579,LIverTox,Posaconazole,147912,E*,0,0,700.8,4.6,112,11,1,51,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,Liver glucuronidation,
3602,Liew,Isoetharine,3762,negative,0,0,239.31,1.7,72.7,4,4,17,CCC(C(C1=CC(=C(C=C1)O)O)O)NC(C)C,,
1700,LIverTox,Simvastatin,54454,A,1,1,418.6,4.7,72.8,5,1,30,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,.,
112,DILIrank,pravastatin,54687,vLess-DILI-Concern,1,1,424.5,1.6,124,7,4,30,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Liver minimal,
1372,LIverTox,Lovastatin,53232,B,1,1,404.5,4.3,72.8,5,1,29,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Liver CYP3A and CYP2C8 substrate,
193,DILIrank,corticorelin ovine triflutate,16186200,vNo-DILI-Concern,0,0,4757,-14.3,2050,72,67,333,CCC(C)C(C(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CC1=CNC=N1)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC=N2)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)CC)NC(=O)C4CCCN4C(=O)C5CCCN5C(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)N,.,polypeptide
410,DILIrank,bivalirudin,16129704,vNo-DILI-Concern,0,0,2180.3,-7.1,902,35,28,155,CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)C4CCCN4C(=O)C(CCCNC(=N)N)NC(=O)C5CCCN5C(=O)C(CC6=CC=CC=C6)N,	Angiomax is cleared from plasma by a combination of renal mechanisms and proteolytic cleavage,
1686,LIverTox,Semaglutide,56843331,E,0,0,4114,-5.8,1650,63,57,291,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N,Proteolysis,
210,DILIrank,pramlintide,16132446,vNo-DILI-Concern,0,0,3951,-16.7,1690,59,58,277,CCC(C)C(C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC6=CN=CN6)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CS)NC(=O)C(CCCCN)N,Renal,
3101,Liew,Teriparatide,16132393,negative,.,0,4118,-18.7,1800,62,60,289,CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC2=CN=CN2)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC5=CN=CN5)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CO)N,,
1361,LIverTox,Lixisenatide,90472060,E,0,0,4858,-30.8,2090,77,70,342,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC8=CNC=N8)N,.,
1149,LIverTox,Enfuvirtide,16130199,E,0,0,4492,-14.7,1900,67,63,319,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(=O)N)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CC7=CC=CC=C7)C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CC8=CN=CN8)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C,Liver,
204,DILIrank,nesiritide,16134381,vNo-DILI-Concern,0,0,3464,-17.2,1610,55,55,239,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCCN)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C3CCCN3C(=O)C(CO)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC4C=NC=N4)C(=O)O)CC(C)C)CO)CO)CO)CO,.,peptide
1933,Greene,Bacitracin,439542,NE,0,0,1422.7,-4.3,556,21,17,100,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CN=C(S2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,.,
341,DILIrank,oxytocin,439302,vNo-DILI-Concern,0,0,1007.2,-2.6,450,15,12,69,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,Liver and other oxytocinases,
285,DILIrank,ecallantide,118984459,vNo-DILI-Concern,0,0,7054,-27.9,3120,110,100,492,CCC(C)C1C(=O)NC(C(=O)NCC(=O)NCC(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N5CCCC5C(=O)N3)CC(=O)O)CC(=O)O)C)CCCCN)CC6=CC=CC=C6)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CO)NC(=O)C(CC8=CN=CN8)NC(=O)C(CCSC)NC(=O)C(C)NC(=O)C(CCC(=O)O)N)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)O)CCSC)CCCCN)CCCCN)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCC(=O)O)CC(=O)N)CCC(=O)N)CC(=O)N)CCCNC(=N)N)CC9=CC=CC=C9)CCC(=O)O)CO)CC(C)C)CCC(=O)O)CCC(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC1=CC=CC=C1)CCC(=O)O)CCC(=O)O)CCC(=O)N)CCCNC(=N)N)C(C)O)CC1=CC=CC=C1)C(C)CC)CC(=O)N)CC1=CC=CC=C1)CC1=CC=CC=C1)CC1=CNC2=CC=CC=C21)CCCNC(=N)N)CC1=CN=CN1)C)C)CCCNC(=N)N)CC1=CC=C(C=C1)O,.,protein
1320,LIverTox,Ivermectin,6321424,D,1,1,875.1,4.1,170,14,3,62,CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C,CYP450,
3273,Liew,Caspofungin,468682,positive,1,1,1093.3,0.3,412,18,16,77,CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O,,
518,DILIrank,colistimethate,5311054,vNo-DILI-Concern,0,0,1155.4,-3.3,491,18,18,81,CCC(C)CCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)C(C)O,.,
523,DILIrank,polymyxin b sulfate,5702105,vNo-DILI-Concern,0,0,1301.6,,574,22,20,90,CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O,.,
3609,Liew,Itraconazole,55283,positive,1,1,705.6,5.7,101,9,0,49,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,,
277,DILIrank,tapentadol,9838022,vNo-DILI-Concern,0,0,221.34,3.5,23.5,2,1,16,CCC(C1=CC(=CC=C1)O)C(C)CN(C)C,"	Liver mostly via glucuronidation but also by CYP2C9, CYP2C19, CYP2D6",
3842,Liew,Phenprocoumon,9908,negative,0,0,280.3,3.6,46.5,3,1,21,CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,"CYP2C9, CYP3A4",
1292,LIverTox,Idelalisib,11625818,D,1,1,415.4,3.7,99.2,7,2,31,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,"Aldehyde oxidase ~70%, CYP3A4 ~30%; UGT1A4 minor",
3472,Liew,Ethchlorvynol,5281077,positive,0,0,144.6,1.5,20.2,1,1,9,CCC(C=CCl)(C#C)O,,
1545,LIverTox,Peramivir,151164,E,0,0,328.41,0,151,5,5,23,CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C,.,
3788,Liew,Oseltamivir,65028,positive,1,1,312.4,1.1,90.6,5,2,22,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,Liver,
2718,Xu,Methysergide Maleate,9681,Negative,0,0,353.5,2.3,57.5,3,2,26,CCC(CO)NC(=O)C1CN(C2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C,.,
3700,Liew,Methylergonovine,8226,negative,0,0,339.4,2.3,68.4,3,3,25,CCC(CO)NC(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C,,
3471,Liew,Ethambutol,14052,positive,1,1,204.31,-0.1,64.5,4,4,14,CCC(CO)NCCNC(CC)CO,,
3811,Liew,Paramethadione,8280,positive,0,0,157.17,0.8,46.6,3,0,11,CCC1(C(=O)N(C(=O)O1)C)C,,
3673,Liew,Mephobarbital,8271,positive,0,0,246.26,1.8,66.5,3,1,18,CCC1(C(=O)NC(=O)N(C1=O)C)C2=CC=CC=C2,,
1555,LIverTox,Phenobarbital,4763,B,1,1,232.23,1.5,75.3,3,2,17,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,CYP2C19,
140,DILIrank,primidone,4909,vNo-DILI-Concern,0,0,218.25,0.9,58.2,2,2,16,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,Liver,
684,DILIrank,topotecan,60700,vNo-DILI-Concern,0,0,421.4,0.5,103,7,2,31,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O,	Liver,
3475,Liew,Ethosuximide,3291,negative,0,0,141.17,0.4,46.2,2,1,10,CCC1(CC(=O)NC1=O)C,,
1888,Greene,Aclarubicin HCl,42474,WE,1,1,811.9,3.8,217,16,4,58,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O)N(C)C)O,,
2485,Greene,Vinblastine Sulfate,241903,NE,0,0,811,3.7,154,12,3,59,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,CYP3A4,
2486,Greene,Vincristine Sulfate,5978,HH,1,1,825,2.8,171,12,3,60,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,"Liver, mostly via CYP3A4 and CYP3A5",
2510,Xu,Aminoglutethimide,2145,Negative,0,0,232.28,1.2,72.2,3,2,17,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N,	Liver minimal; acetylation,
3559,Liew,Glutethimide,3487,negative,0,0,217.26,1.9,46.2,2,1,16,CCC1(CCC(=O)NC1=O)C2=CC=CC=C2,,
3480,Liew,Etonogestrel,21729469,positive,0,0,324.5,3.3,37.3,2,1,24,CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,,
2741,Xu,Norgestrel,16051930,Positive,1,1,312.4,3.3,37.3,2,1,23,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,.,
2400,Greene,Pyrimethamine,4993,HH,1,1,248.71,2.7,77.8,4,2,17,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,Liver,
147,DILIrank,benzbromarone,2333,vMost-DILI-Concern,1,1,424.1,5.7,50.4,3,1,22,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,.,
448,DILIrank,benziodarone,6237,vMost-DILI-Concern,1,1,518.08,5.6,50.4,3,1,22,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)O)I,.,
3226,Liew,Benzarone,255968,positive,1,1,266.29,4.3,50.4,3,1,20,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC=C(C=C3)O,,
1701,LIverTox,Siponimod,44599207,E*,0,0,516.6,4.8,62.1,8,1,37,CCC1=C(C=CC(=C1)C(=NOCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)C)CN4CC(C4)C(=O)O,.,
1243,LIverTox,Gilteritinib,49803313,E*,0,0,552.7,3.5,121,10,3,40,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,.,
1435,LIverTox,Molindone,23897,D,1,1,276.37,1.7,45.3,3,1,20,CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C,Liver,
1176,LIverTox,Etodolac,3308,C,1,1,287.35,2.8,62.3,3,2,21,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,liver,
600,DILIrank,irinotecan,60838,vLess-DILI-Concern,1,1,586.7,3,113,8,1,43,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,Liver glucuronidation,
803,LIverTox,Alectinib,49806720,D,1,1,482.6,5.2,72.4,5,1,36,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,CYP3A4,
3343,Liew,Clotiazepam,2811,positive,0,0,318.8,3.5,60.9,3,0,21,CCC1=CC2=C(S1)N(C(=O)CN=C2C3=CC=CC=C3Cl)C,,
73,DILIrank,pioglitazone,4829,vLess-DILI-Concern,1,1,356.4,3.8,93.6,5,1,25,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,CYP2C8,
3474,Liew,Ethionamide,2761171,positive,1,1,166.25,1.1,71,2,1,11,CCC1=NC=CC(=C1)C(=S)N,,
2731,Xu,Nefazodone,4449,Positive,1,1,470,4.3,51.6,5,0,33,CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl,"CYP3A4, CYP2D6",
3356,Liew,Cyclosporine,5284373,positive,1,1,1202.6,7.5,279,12,5,85,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,,
1623,LIverTox,Quinupristin-Dalfopristin,23724510,E*,0,0,1713.1,,441,25,6,121,CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CC(C(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CSC6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C.CCN(CC)CCS(=O)(=O)C1CCN2C1C(=O)OC(C(C=CC(=O)NCC=CC(=CC(CC(=O)CC3=NC(=CO3)C2=O)O)C)C)C(C)C,.,
3946,Liew,Roxithromycin,6915744,positive,0,0,837,3.1,217,17,5,58,CCC1C(C(C(C(=NOCOCCOC)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,Liver,
2084,Greene,Erythromycin estolate (1),12560,HH,1,1,733.9,2.7,194,14,5,51,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,.,
3328,Liew,Clarithromycin,84029,positive,1,1,748,3.2,183,14,4,52,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,,
1929,Greene,Azithromycin,55185,WE,1,1,749,4,180,14,5,52,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,LIver,
3419,Liew,Dirithromycin,6917067,positive,0,0,835.1,4.2,196,16,5,58,CCC1C(C2C(C(C(CC(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)C)O)(C)O)C)NC(O2)COCCOC)C)(C)O,,
709,DILIrank,telithromycin,5462516,vMost-DILI-Concern,1,1,812,4.2,172,13,1,58,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,Liver 50% CYP3A4,
1489,LIverTox,Obeticholic Acid,447715,B,1,1,420.6,5.7,77.8,4,3,30,CCC1C2CC(CCC2(C3CCC4(C(C3C1O)CCC4C(C)CCC(=O)O)C)C)O,.,
1198,LIverTox,Fidaxomicin,10034073,E,0,0,1058,6.4,267,18,7,72,CCC1C=C(C(CC=CC=C(C(=O)OC(CC=C(C=C(C1OC2C(C(C(C(O2)(C)C)OC(=O)C(C)C)O)O)C)C)C(C)O)COC3C(C(C(C(O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)C,.,
3848,Liew,Pimecrolimus,16051947,negative,0,0,810.4,3.8,158,11,2,56,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,CYP3A5,
3909,Liew,Quinethazone,6307,positive,0,0,289.74,1.2,110,5,3,18,CCC1NC2=CC(=C(C=C2C(=O)N1)S(=O)(=O)N)Cl,,
1757,LIverTox,Tesamorelin,16137828,E,0,0,5136,-23.3,2360,76,83,361,CCC=CCC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)NC(C(C)CC)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)N,Proteolysis,
415,DILIrank,acebutolol,1978,vLess-DILI-Concern,1,1,336.4,1.7,87.7,5,3,24,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C,LIver,
3406,Liew,Difluprednate,32037,negative,0,0,508.5,3.4,107,9,1,36,CCCC(=O)OC1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C(=O)COC(=O)C,,
265,DILIrank,clevidipine,153994,vNo-DILI-Concern,0,0,456.3,4.3,90.9,7,1,30,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Blood and tissue esterases,
1744,LIverTox,Telaprevir,3010818,B,1,1,679.8,4.2,180,8,4,49,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5,extensive Liver,
3832,Liew,Perindopril,107807,negative,0,0,368.5,0.9,95.9,6,2,26,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Kidney,
617,DILIrank,meprobamate,4064,vNo-DILI-Concern,0,0,218.25,0.7,105,4,2,15,CCCC(C)(COC(=O)N)COC(=O)N,Liver,
3268,Liew,Carisoprodol,2576,negative,0,0,260.33,1.9,90.6,4,2,18,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,,
4024,Liew,Thiopental,3000714,positive,0,0,264.32,,96.6,3,1,17,CCCC(C)C1(C(=O)NC(=S)N=C1[O-])CC.[Na+],Liver,
2066,Greene,Divalproex Sodium,3121,HH,1,1,144.21,2.8,37.3,2,1,10,CCCC(CCC)C(=O)O,"	Liver-glucuronide conjugation 30?50%, mitochondrial ??-oxidation over 40%",
3194,Liew,Anisotropine,6647,negative,0,0,362.3,,26.3,3,0,21,CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[Br-],,
3750,Liew,Nedocromil,50294,negative,0,0,371.3,2.2,121,8,2,27,CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)O)C(=O)C=C(N2CC)C(=O)O,,
1602,LIverTox,Propylthiouracil,657298,A,1,1,170.23,0.8,73.2,2,2,11,CCCC1=CC(=O)NC(=S)N1,.,
1497,LIverTox,Olmesartan,130881,D,1,1,558.6,3.8,154,10,2,41,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,Liver (cannot be removed by hemodialysis),
4087,Liew,Vardenafil,110634,positive,0,0,488.6,2.5,118,7,1,34,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,CYP3A4,
732,DILIrank,telmisartan,65999,vLess-DILI-Concern,1,1,514.6,6.9,72.9,4,1,39,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,Minimal liver glucuronidation,
413,DILIrank,sildenafil,135398744,vLess-DILI-Concern,1,1,474.6,1.5,118,8,1,33,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,"Liver: CYP3A4 major route, CYP2C9 minor route",
946,LIverTox,Brivaracetam,9837243,E,0,0,212.29,1,63.4,2,1,15,CCCC1CC(=O)N(C1)C(CC)C(=O)N,"Hydrolysis by amidase, CYP2C19-mediated hydroxylation",
2014,Greene,Clindamycin HCl,446598,HH,1,1,425,2.2,128,7,4,27,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,Liver,
456,DILIrank,budesonide,40000,vNo-DILI-Concern,0,0,430.5,2.5,93.1,6,2,31,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,CYP3A4,
1826,LIverTox,Valsartan,60846,D,1,1,435.5,4.4,112,6,2,32,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,.,
4084,Liew,Valrubicin,454216,negative,0,0,723.6,4,215,16,5,51,CCCCC(=O)OCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O,,
1375,LIverTox,Lubiprostone,157920,E,0,0,390.5,4,83.8,7,2,27,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,"Extensive, CYP not involved",
2260,Greene,Octyl Methoxycinnamate,5355130,HH,1,1,290.4,5.3,35.5,3,0,21,CCCCC(CC)COC(=O)C=CC1=CC=C(C=C1)OC,.,
1107,LIverTox,Docusate,11339,E,0,0,422.6,5.1,115,7,1,28,CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)O,.,
1119,LIverTox,Dronedarone,208898,C,1,1,556.8,7.2,97.2,7,1,39,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC,Extensive Liver mainly by CYP3A,
1905,Greene,amiodarone,2157,HH,1,1,645.3,7.6,42.7,4,0,31,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,Liver,
2188,Greene,losartan,3961,HH,1,1,422.9,4.3,92.5,5,2,30,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,"	CYP2C9, CYP3A4",
1309,LIverTox,Irbesartan,3749,C,1,1,428.5,4.1,87.1,5,1,32,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,CYP2C9,
1156,LIverTox,Eprosartan,5281037,E*,0,0,424.5,4.5,121,6,2,30,CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O,not metabolized,
2760,Xu,Phenylbutazone,4781,Positive,1,1,308.4,3.2,40.6,2,0,23,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,,
3266,Liew,Carboprost,5281075,negative,0,0,368.5,2.9,98,5,4,26,CCCCCC(C)(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O,,
3414,Liew,Dinoprostone,5280360,positive,0,0,352.5,2.8,94.8,5,3,25,CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,,
3162,Liew,Alprostadil,5280723,positive,0,0,354.5,3.2,94.8,5,3,25,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,,
3413,Liew,Dinoprost,5280363,negative,0,0,354.5,2.7,98,5,4,25,CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O,,
4054,Liew,Treprostinil,6918140,negative,0,0,390.5,4.5,87,5,3,28,CCCCCC(CCC1C(CC2C1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O,Liver,
964,LIverTox,Cannabidiol,644019,E*,0,0,314.5,6.5,40.5,2,2,23,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,.,
1446,LIverTox,Nabilone,5284592,E,0,0,372.5,6.4,46.5,3,1,27,CCCCCCC(C)(C)C1=CC(=C2C3CC(=O)CCC3C(OC2=C1)(C)C)O,.,
4080,Liew,Unoprostone,5311236,negative,0,0,382.5,3.7,94.8,5,3,27,CCCCCCCC(=O)CCC1C(CC(C1CC=CCCCC(=O)O)O)O,,
1136,LIverTox,Eliglustat,23652731,E,0,0,404.5,3.7,71,5,2,29,CCCCCCCC(=O)NC(CN1CCCC1)C(C2=CC3=C(C=C2)OCCO3)O,.,
1200,LIverTox,Fingolimod,107970,C,1,1,307.5,4.2,66.5,3,3,22,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,.,
3368,Liew,Daptomycin,16129629,positive,1,1,1620.7,-5.1,702,28,22,115,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,,
751,DILIrank,nandrolone decanoate,9677,vMost-DILI-Concern,1,1,428.6,7.3,43.4,3,0,31,CCCCCCCCCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C,"	Blood hydrolysis, liver reduction",
759,DILIrank,orlistat,3034010,vMost-DILI-Concern,1,1,495.7,10,81.7,5,1,35,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,In the GI tract,
1036,LIverTox,Colesevelam,160051,E,0,0,618.2,,62.6,5,4,39,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-],Colesevelam is not absorbed and not metabolised.,
681,DILIrank,sulcotidil,5354,vMost-DILI-Concern,1,1,337.6,5.8,57.6,3,2,23,CCCCCCCCNC(C)C(C1=CC=C(C=C1)SC(C)C)O,.,
3587,Liew,Ibutilide,60753,negative,0,0,384.6,4,78,5,2,26,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,,
4101,Liew,Xanomeline,60809,positive,0,0,281.42,3.3,66.5,5,0,19,CCCCCCOC1=NSN=C1C2=CCCN(C2)C,,
3585,Liew,Ibandronate,60852,positive,0,0,319.23,-4.1,139,8,5,19,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,,
3996,Liew,Tegaserod,5362436,positive,0,0,301.39,2.1,84,4,3,22,CCCCCN=C(N)NNC=C1C=NC2=C1C=C(C=C2)OC,"Gastric, Liver",
965,LIverTox,Capecitabine,60953,E*,0,0,359.35,0.6,121,7,3,25,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,"liver, to 5'-DFCR, 5'-DFUR inactive; neoplastic tissue, 5'-DFUR to active fluorouracil",
475,DILIrank,micafungin,477468,vMost-DILI-Concern,1,1,1270.3,-1.6,519,24,16,89,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)C(CC(=O)N)O)C)O)O)O,	Via catechol-O-methyltransferase pathway,
3575,Liew,Halofantrine,37393,positive,0,0,500.4,8.6,23.5,5,1,33,CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O,,
292,DILIrank,aplaviroc,3001322,vMost-DILI-Concern,1,1,577.7,3.1,119,7,3,42,CCCCN1C(=O)C(NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)C(C5CCCCC5)O,.,
3721,Liew,Miglustat,51634,negative,0,0,219.28,-0.6,84.2,5,4,15,CCCCN1CC(C(C(C1CO)O)O)O,,
2540,Xu,Bupivacaine,2474,Negative,0,0,288.4,3.4,32.3,2,1,21,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,	Liver,
3267,Liew,Carbutamide,9564,positive,0,0,271.34,1,110,4,3,18,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)N,,
2539,Xu,Bumetanide,2471,Positive,1,1,364.4,2.8,127,7,3,25,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,	Liver,
329,DILIrank,benzonatate,7699,vLess-DILI-Concern,1,1,603.7,2.4,121,12,1,42,CCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC,.,
3224,Liew,Benoxinate,4633,negative,0,0,308.4,3.1,64.8,5,1,22,CCCCOC1=C(C=CC(=C1)C(=O)OCCN(CC)CC)N,,
3440,Liew,Dyclonine,3180,negative,0,0,289.4,3.6,29.5,3,0,21,CCCCOC1=CC=C(C=C1)C(=O)CCN2CCCCC2,,
3396,Liew,Dibucaine,3025,negative,0,0,343.5,4.4,54.5,4,1,25,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,,
4037,Liew,Tirofiban,60947,negative,0,0,440.6,1.4,113,7,3,30,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O,,
3476,Liew,Etidocaine,37497,negative,0,0,276.4,3.7,32.3,2,1,20,CCCN(CC)C(CC)C(=O)NC1=C(C=CC=C1C)C,,
428,DILIrank,alpidem,54897,vMost-DILI-Concern,1,1,404.3,4.8,37.6,2,0,27,CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl,"	Extensive hydroxylation, dealkylation, conjugation",
3940,Liew,Ropinirole,5095,negative,1,1,260.37,2.7,32.3,2,1,19,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,CYP1A2,
3878,Liew,Probenecid,4911,positive,1,1,285.36,3.2,83.1,5,1,19,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,,
1666,LIverTox,Rotigotine,57537,E,0,0,315.5,4.9,51.7,3,1,22,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O,CYP450,
1547,LIverTox,Pergolide,47811,E*,0,0,314.5,4.2,44.3,2,1,22,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC,Extensively Liver,
3941,Liew,Ropivacaine,175805,negative,0,0,274.4,2.9,32.3,2,1,20,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,CYP1A2,
3314,Liew,Chlorpropamide,2727,positive,1,1,276.74,2.3,83.6,3,2,17,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl,,
3875,Liew,Prilocaine,4906,negative,0,0,220.31,2.1,41.1,2,2,16,CCCNC(C)C(=O)NC1=CC=CC=C1C,"Liver, Kidney",
1581,LIverTox,Pramipexole,119570,E,0,0,211.33,1.9,79.2,4,2,14,CCCNC1CCC2=C(C1)SC(=N2)N,.,
1598,LIverTox,Propafenone,4932,B,1,1,341.4,3.3,58.6,4,2,25,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,.,
1378,LIverTox,Macitentan,16004692,E*,0,0,588.3,3.7,137,10,2,32,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,"Hydrolysis, oxidation CYP3A4",
3896,Liew,Propyliodone,4949,negative,0,0,447.01,2.4,46.6,4,0,16,CCCOC(=O)CN1C=C(C(=O)C(=C1)I)I,,
3891,Liew,Proparacaine,4935,negative,0,0,294.39,2.7,64.8,5,1,21,CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N,,
1832,LIverTox,Vemurafenib,42611257,E*,0,0,489.9,5,100,7,2,33,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,.,
213,DILIrank,albendazole,2082,vMost-DILI-Concern,1,1,265.33,2.9,92.3,4,2,18,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,Liver,
1772,LIverTox,Ticagrelor,9871419,D,1,1,522.6,2,164,12,4,36,CCCSC1=NC(=C2C(=N1)N(N=N2)C3CC(C(C3O)O)OCCO)NC4CC4C5=CC(=C(C=C5)F)F,CYP3A4,
3867,Liew,Prajmaline,37042,positive,0,0,369.5,2.7,43.7,3,2,27,CCC[N+]12C3CC(C(C1O)CC)C4C2CC5(C3N(C6=CC=CC=C65)C)C4O,,
3936,Liew,Rivastigmine,77991,negative,1,1,250.34,2.3,32.8,3,0,18,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,Liver,
269,DILIrank,zaleplon,5719,vNo-DILI-Concern,0,0,305.33,1,74.3,4,0,23,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,"Liver aldehyde oxidase (91%), CYP3A4 (9%)",
3349,Liew,Crotamiton,688020,negative,0,0,203.28,2.8,20.3,1,0,15,CCN(C1=CC=CC=C1C)C(=O)C=CC,,
1150,LIverTox,Entacapone,5281081,D,1,1,305.29,2.1,130,6,2,22,CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N,Liver,
515,DILIrank,milnacipran,65833,vMost-DILI-Concern,1,1,246.35,1.4,46.3,2,1,18,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2,Liver,
3230,Liew,Benzquinamide,2342,negative,0,0,404.5,2.1,68.3,6,0,29,CCN(CC)C(=O)C1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C)OC)OC,,
3401,Liew,Diethylcarbamazine,3052,negative,0,1,199.29,0.3,26.8,2,0,14,CCN(CC)C(=O)N1CCN(CC1)C,,
3421,Liew,Disulfiram,3117,positive,1,1,296.5,3.9,121,4,0,16,CCN(CC)C(=S)SSC(=S)N(CC)CC,,
3402,Liew,Diethylpropion,7029,negative,0,0,205.3,2.8,20.3,2,0,15,CCN(CC)C(C)C(=O)C1=CC=CC=C1,,
741,DILIrank,oxybutynin,4634,vNo-DILI-Concern,0,0,357.5,4.2,49.8,4,1,26,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,.,
2180,Greene,Lidocaine,3676,NE,0,0,234.34,2.3,32.3,2,1,17,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,"	Liver, 90% CYP3A4",
830,LIverTox,Amodiaquine,2165,A,1,1,355.9,2.6,48.4,4,2,25,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O,.,
3906,Liew,Quinacrine,237,positive,0,0,400,6,37.4,4,1,28,CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC,,
3308,Liew,Chloroquine,2719,negative,1,1,319.9,4.6,28.2,3,1,22,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,,
3198,Liew,Aprindine,2218,positive,0,0,322.5,5.2,6.5,2,0,24,CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C3=CC=CC=C3,,
581,DILIrank,flurazepam,3393,vLess-DILI-Concern,1,1,387.9,3,35.9,4,0,27,CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F,Liver,
234,DILIrank,sunitinib,5329102,vMost-DILI-Concern,1,1,398.5,2.6,77.2,4,3,29,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,CYP3A4,
3707,Liew,Metoclopramide,4168,negative,1,1,299.79,2.6,67.6,4,2,20,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,,
3880,Liew,Procainamide,4913,positive,1,1,235.33,0.9,58.4,3,2,17,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N,CYP2D6,
2142,Greene,Hycanthone,3634,HH,1,1,356.5,2.7,77.9,5,2,25,CCN(CC)CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O,,
1090,LIverTox,Dicyclomine,3042,ND,.,0,309.5,5.5,29.5,3,0,22,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,.,
3307,Liew,Chloroprocaine,8612,negative,0,0,270.75,2.9,55.6,4,1,18,CCN(CC)CCOC(=O)C1=C(C=C(C=C1)N)Cl,,
3881,Liew,Procaine,4914,negative,0,0,236.31,1.9,55.6,4,1,17,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N,,
2571,Xu,Clomiphene Citrate,2800,Positive,1,1,406,7.2,12.5,2,0,29,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,"	4-Hydroxyclomiphene 4-OH-CLO, 4-Hydroxy-N-desethylclomiphene 4-OH-DE-CLO",
4075,Liew,Tropicamide,5593,negative,0,0,284.35,1.5,53.4,3,1,21,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2,,
3582,Liew,Hydroxychloroquine,3652,negative,1,1,335.9,3.6,48.4,4,2,23,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,,
3325,Liew,Cinoxacin,2762,positive,0,0,262.22,2.1,88.4,7,1,19,CCN1C2=CC3=C(C=C2C(=O)C(=N1)C(=O)O)OCO3,,
2240,Greene,Nalidixic Acid,4421,HH,1,1,232.23,1.4,70.5,5,1,17,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,	Partially Liver,
3006,Liew,Lomefloxacin,3948,negative,.,1,351.35,-0.8,72.9,8,2,25,CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O,,
3815,Liew,Pefloxacin,51081,positive,0,0,333.36,0.3,64.1,7,1,24,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,Liver,
640,DILIrank,norfloxacin,4539,vLess-DILI-Concern,1,1,319.33,-1,72.9,7,2,23,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,Liver,
3450,Liew,Enoxacin,3229,positive,0,0,320.32,-0.2,85.8,8,2,23,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,,
3978,Liew,Sulfacytine,5322,positive,0,0,294.33,0.1,113,4,2,20,CCN1C=CC(=NC1=O)NS(=O)(=O)C2=CC=C(C=C2)N,,
227,DILIrank,doxapram,3156,vNo-DILI-Concern,0,0,378.5,3.3,32.8,3,0,28,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4,.,
3986,Liew,Sulpiride,5355,positive,0,0,341.4,0.6,110,6,2,23,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,,
1567,LIverTox,Piperacillin,43672,B,1,1,517.6,0.5,182,8,3,36,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,Largely not metabolized,
1568,LIverTox,Piperacillin-Tazobactam,9918881,B,1,1,817.9,,313,15,4,56,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O.CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,.,
785,LIverTox,Abemaciclib,46220502,E*,0,0,506.6,3.8,75,9,1,37,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,.,
205,DILIrank,ganirelix acetate,16186319,vNo-DILI-Concern,0,0,1570.3,5.4,452,16,16,112,CCNC(=NCCCCC(C(=O)NC(CC(C)C)C(=O)NC(CCCCN=C(NCC)NCC)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC=CC6=CC=CC=C65)NC(=O)C)NCC,.,
3577,Liew,Histrelin,25077993,negative,0,0,1323.5,0.7,449,15,15,96,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CN(C=N2)CC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,,
3239,Liew,Bimatoprost,5311027,positive,0,0,415.6,2.8,89.8,4,4,30,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,,
458,DILIrank,cabergoline,54746,vNo-DILI-Concern,0,0,451.6,3.4,71.7,4,2,33,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C,"	Liver, predominately via hydrolysis of the acylurea bond or the urea moiety",
3385,Liew,Dexfenfluramine,66265,positive,0,0,231.26,3.4,12,4,1,16,CCNC(C)CC1=CC(=CC=C1)C(F)(F)F,,
3756,Liew,Netilmicin,41859,positive,0,0,475.6,-4.2,200,12,8,33,CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N,,
3428,Liew,Dorzolamide,5284549,negative,0,0,324.4,0.4,151,7,2,19,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,,
1342,LIverTox,Lavender,	702,E,0,0,46.07,-0.1,20.2,1,1,3,CCO,.,
3337,Liew,Clofibrate,2796,positive,1,1,242.7,3.3,35.5,3,0,16,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,,
1748,LIverTox,Telotristat,25181577,E,0,0,575,5.1,131,11,2,40,CCOC(=O)C(CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)OC(C3=C(C=C(C=C3)Cl)N4C=CC(=N4)C)C(F)(F)F)N,Hydrolysis via carboxylesterases,
3374,Liew,Delapril,5362116,positive,0,0,452.5,1.7,95.9,6,2,33,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N(CC(=O)O)C2CC3=CC=CC=C3C2,,
3592,Liew,Imidapril,5464343,positive,1,1,405.4,-0.7,116,7,2,29,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C(CN(C2=O)C)C(=O)O,,
3915,Liew,Ramipril,5362129,positive,1,1,416.5,1.4,95.9,6,2,30,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Liver,
4049,Liew,Trandolapril,5484727,negative,1,1,430.5,2,95.9,6,2,31,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O,Liver,
1433,LIverTox,Moexipril,91270,E*,0,0,498.6,1.2,114,8,2,36,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC,"active metabolite, moexiprilat",
668,DILIrank,quinapril,54892,vLess-DILI-Concern,1,1,438.5,1.2,95.9,6,2,32,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O,.,
156,DILIrank,enalapril,5388962,vLess-DILI-Concern,1,1,376.4,-0.1,95.9,6,2,27,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Liver to enalaprilat,
2530,Xu,Benazepril,5362124,Negative,0,1,424.5,1.3,95.9,6,2,31,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,Liver glucuronidation,
1395,LIverTox,Meperidine,4058,ND,.,0,247.33,2.5,29.5,3,0,18,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,Liver,
1101,LIverTox,Diphenoxylate,13505,ND,.,0,452.6,5.7,53.3,4,0,34,CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4,.,
1190,LIverTox,Felodipine,3333,E,0,1,384.2,3.9,64.6,5,1,25,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Liver,
3768,Liew,Nitrendipine,4507,positive,0,0,360.4,2.9,110,7,1,26,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,Liver,
3620,Liew,Lacidipine,5311217,positive,0,0,455.5,4.5,90.9,7,1,33,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C,,
829,LIverTox,Amlodipine,2162,C,1,1,408.9,3,99.9,7,2,28,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Liver,
2655,Xu,Flumazenil,3373,Negative,0,0,303.29,1,64.4,5,0,22,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,Liver,
3545,Liew,Gabexate,3447,positive,0,0,321.37,1.4,117,5,2,23,CCOC(=O)C1=CC=C(C=C1)OC(=O)CCCCCN=C(N)N,,
3995,Liew,Tazarotene,5381,negative,0,0,351.5,4.9,64.5,4,0,25,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,,
559,DILIrank,etomidate,36339,vNo-DILI-Concern,0,0,244.29,3,44.1,3,0,18,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2,	Ester hydrolysis in plasma and liver,
3483,Liew,Etretinate,5282375,positive,0,0,354.5,6.8,35.5,3,0,26,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C(=C(C=C1C)OC)C)C,,
3656,Liew,Malathion,4004,negative,0,0,330.4,2.4,128,8,0,19,CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC,,
724,DILIrank,ximelagatran,9574101,vMost-DILI-Concern,1,1,473.6,2.2,146,7,4,34,CCOC(=O)CNC(C1CCCCC1)C(=O)N2CCC2C(=O)NCC3=CC=C(C=C3)C(=NO)N,	to melagatran,
3265,Liew,Carbimazole,31072,positive,1,1,186.23,0.7,64.9,3,0,12,CCOC(=O)N1C=CN(C1=S)C,,
1367,LIverTox,Loratadine,3957,E*,0,0,382.9,5.2,42.4,3,0,27,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,"CYP2D6, CYP3A4",
1185,LIverTox,Ezogabine,121892,E,0,0,303.33,2.8,76.4,5,3,22,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N,Liver glucuronidation and acetylation. CYP not involved,
2233,Greene,Moricizine HCl,34633,HH,1,1,427.5,3,96.4,6,1,30,CCOC(=O)NC1=CC2=C(C=C1)SC3=CC=CC=C3N2C(=O)CCN4CCOCC4,.,
1849,LIverTox,Vorapaxar,10077130,E,0,0,492.6,5.3,77.5,6,1,36,CCOC(=O)NC1CCC2C(C1)CC3C(C2C=CC4=NC=C(C=C4)C5=CC(=CC=C5)F)C(OC3=O)C,"CYP3A4, CYP2J2",
3216,Liew,Bacampicillin,39849,negative,0,0,465.5,2.7,163,9,2,32,CCOC(=O)OC(C)OC(=O)C1C(SC2N1C(=O)C2NC(=O)C(C3=CC=CC=C3)N)(C)C,,
3650,Liew,Loteprednol,444025,negative,0,0,466.9,3.9,99.1,7,1,32,CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl,,
632,DILIrank,nafcillin,8982,vLess-DILI-Concern,1,1,414.5,2.9,121,6,2,29,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,<30% Liver,
1464,LIverTox,Neratinib,9915743,E*,0,0,557,4.9,112,8,2,40,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,.,
873,LIverTox,Apremilast,11561674,E,0,0,460.5,1.8,128,7,1,32,CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,"CYP3A4, with minor contributions from CYP2A6, CYP1A2",
3922,Liew,Repaglinide,65981,negative,1,1,452.6,5.2,78.9,5,2,33,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,CYP3A4,
2755,Xu,Phenacetin,4754,Positive,1,1,179.22,1.6,38.3,2,1,13,CCOC1=CC=C(C=C1)NC(=O)C,,
393,DILIrank,tamsulosin,129211,vLess-DILI-Concern,1,1,408.5,2.7,108,7,2,28,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,Liver,
407,DILIrank,candesartan,2541,vLess-DILI-Concern,1,1,440.5,4.1,119,7,2,33,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Candesartan cilexetil: intestinal wall; candesartan: Hepatic CYP2C9,
897,LIverTox,Azilsartan,135415867,E*,0,1,456.4,4.4,115,7,2,34,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O,CYP2C9,
3539,Liew,Fotemustine,104799,positive,0,0,315.69,0.9,97.3,6,1,19,CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC,,
3443,Liew,Echothiophate,10547,negative,0,0,383.23,,60.8,5,0,16,CCOP(=O)(OCC)SCC[N+](C)(C)C.[I-],,
904,LIverTox,Baricitinib,44205240,E*,0,0,371.4,-0.5,129,7,1,26,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,CYP3A4 <10%,
4022,Liew,Thiethylperazine,5440,positive,0,0,399.6,5.4,60.3,5,0,27,CCSC1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)C,,
2091,Greene,ethionine,6205,HH,1,1,163.24,-1.5,88.6,4,2,10,CCSCCC(C(=O)O)N,.,
3445,Liew,Edrophonium,3202,negative,0,0,166.24,1.8,20.2,1,1,12,CC[N+](C)(C)C1=CC(=CC=C1)O,,
2076,Greene,Edrophonium Chloride,8307,NE,0,0,201.69,,20.2,2,1,13,CC[N+](C)(C)C1=CC(=CC=C1)O.[Cl-],.,
3245,Liew,Bretylium,2431,negative,0,0,243.16,2.8,0,0,0,13,CC[N+](C)(C)CC1=CC=CC=C1Br,,
3685,Liew,Methantheline,4097,negative,0,0,340.4,3.3,35.5,3,0,25,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13,,
4057,Liew,Tridihexethyl chloride,20299,negative,0,0,318.5,4.8,20.2,1,1,23,CC[N+](CC)(CC)CCC(C1CCCCC1)(C2=CC=CC=C2)O,,
2665,Xu,Gallamine Triethiodide,6172,Negative,0,0,891.5,,27.7,6,0,39,CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-],.,
3166,Liew,Ambenonium,2131,negative,0,0,537.6,5.1,58.2,2,2,36,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC2=CC=CC=C2Cl,,
647,DILIrank,ambenonium,8288,vNo-DILI-Concern,0,0,608.5,,58.2,4,2,38,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC2=CC=CC=C2Cl.[Cl-].[Cl-],.,
1922,Greene,Auranofin,6333901,HH,1,1,679.5,,115,10,0,32,CC[PH+](CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+],	Plasma membrane of the cell removes the acetyl groups of the glucose moiety.,
1719,LIverTox,Streptozocin,29327,D,1,1,265.22,-1.4,152,8,5,18,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,"Liver, Kidney",
922,LIverTox,Betrixaban,10275777,E*,0,0,451.9,3.6,107,5,3,32,CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl,.,
1402,LIverTox,Metformin,4091,B,1,1,129.16,-1.3,91.5,1,3,9,CN(C)C(=N)N=C(N)N,Not by liver,
2186,Greene,Loperamide HCl,3955,NE,0,0,477,5,43.8,3,1,34,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,	Liver extensive,
1643,LIverTox,Ribociclib,44631912,C,1,1,434.5,2.2,91.2,7,2,32,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,CYP3A4,
976,LIverTox,Cariprazine,11154555,E*,0,0,427.4,4.3,38.8,3,1,28,CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl,Liver via CYP3A4 and to a lesser extent CYP2D6,
818,LIverTox,Altretamine,2123,E*,0,0,210.28,2.7,48.4,6,0,15,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,Extensive liver,
1157,LIverTox,Eravacycline,54726192,E*,0,0,558.6,1,194,11,6,40,CN(C)C1C2CC3CC4=C(C=C(C(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)NC(=O)CN5CCCC5)F,.,
1674,LIverTox,Sarecycline,54681908,E*,0,0,487.5,1.1,174,10,5,35,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)CN(C)OC,.,
2226,Greene,Minocycline HCl,54675783,HH,1,1,457.5,-0.6,165,9,5,33,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C,.,
3384,Liew,Desvenlafaxine,125017,negative,1,1,263.37,2.6,43.7,3,2,19,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,,
102,DILIrank,venlafaxine,5656,vLess-DILI-Concern,1,1,277.4,2.9,32.7,3,1,20,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,"	Extensively metabolised by the liver, primarily via CYP2D6",
637,DILIrank,niperotidine,3033952,vMost-DILI-Concern,1,1,434.5,2.9,130,9,2,30,CN(C)CC1=CC=C(O1)CSCCNC(=C[N+](=O)[O-])NCC2=CC3=C(C=C2)OCO3,.,
1796,LIverTox,Tramadol,33741,E*,0,0,263.37,2.6,32.7,3,1,19,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,Liver-mediated demethylation and glucuronidation via CYP2D6 & CYP3A4,
702,DILIrank,zimelidine,5365247,vMost-DILI-Concern,1,1,317.22,3.9,16.1,2,0,19,CN(C)CC=C(C1=CC=C(C=C1)Br)C2=CN=CC=C2,.,
799,LIverTox,Afatinib,10184653,D,1,1,485.9,3.6,88.6,8,2,34,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,CYP not involved,
2538,Xu,Brompheniramine Maleate,6834,Negative,0,0,319.24,3.5,16.1,2,0,19,CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2,	Liver,
284,DILIrank,dexchlorpheniramine,33036,vNo-DILI-Concern,0,0,274.79,3.4,16.1,2,0,19,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,.,
906,LIverTox,Bedaquiline,5388906,E*,0,0,555.5,7.2,45.6,4,1,37,CN(C)CCC(C1=CC=CC2=CC=CC=C21)(C(C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O,CYP3A4,
409,DILIrank,rizatriptan,5078,vNo-DILI-Concern,0,0,269.34,1.7,49.7,3,1,20,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,	By monoamine oxidase,
424,DILIrank,almotriptan,123606,vNo-DILI-Concern,0,0,335.5,1.6,64.8,4,1,23,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3,	Liver,
1046,LIverTox,Cyclobenzaprine,2895,E*,0,0,275.4,5.2,3.2,1,0,21,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,"major: CYP3A4, CYP1A2; minor: CYP2D6, N-demethylation",
3180,Liew,Amitriptyline ,2160,positive,1,1,277.4,5,3.2,1,0,21,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,,
3781,Liew,Olopatadine,5281071,negative,0,0,337.4,1.5,49.8,4,1,25,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,,
3432,Liew,Doxepin,3158,positive,1,1,279.4,4.3,12.5,2,0,21,CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31,,
3315,Liew,Chlorprothixene,667467,positive,1,1,315.9,5.2,28.5,2,0,21,CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,,
1015,LIverTox,Citalopram,2771,C,1,1,324.4,3.2,36.3,4,0,24,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,"CYP3A4,CYP2C19",
293,DILIrank,clomacran,21382,vMost-DILI-Concern,1,1,300.8,4.6,15.3,2,1,21,CN(C)CCCC1C2=CC=CC=C2NC3=C1C=C(C=C3)Cl,.,
3339,Liew,Clomipramine,2801,positive,1,1,314.9,5.2,6.5,2,0,22,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,,
2679,Xu,Imipramine HCl,3696,Positive,1,1,280.4,4.8,6.5,2,0,21,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,"CYP1A2, CYP2C19, CYP2D6",
4059,Liew,Triflupromazine,5568,positive,0,0,352.4,5.2,31.8,6,0,24,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F,,
2555,Xu,chlorpromazine,2726,Positive,1,1,318.9,5.2,31.8,3,0,21,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,CYP2D6,
3887,Liew,Promazine,4926,positive,0,0,284.4,4.5,31.8,3,0,20,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31,,
4070,Liew,Tripelennamine,5587,negative,0,0,255.36,3.3,19.4,3,0,19,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2,Liver,
2206,Greene,Methapyrilene,4098,HH,1,1,261.39,2.6,47.6,4,0,18,CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2,,
3287,Liew,Cefotiam,43708,positive,1,1,525.6,-2.4,251,13,3,34,CN(C)CCN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)CC4=CSC(=N4)N)SC2)C(=O)O,,
3183,Liew,Amonafide,50515,positive,0,0,283.32,1.5,66.6,4,1,21,CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)N,,
3354,Liew,Cyclopentolate,2905,negative,0,0,291.4,2.7,49.8,4,1,21,CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O,,
2883,Liew,Carbinoxamine,2564,negative,.,0,290.79,2.9,25.4,3,0,20,CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,,
2627,Xu,Diphenhydramine HCl,3100,Negative,0,0,255.35,3.3,12.5,2,0,19,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,"	CYP2D6, others",
4047,Liew,Toremifene,3005573,positive,1,1,406,7.2,12.5,2,0,29,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,
4065,Liew,Trimethobenzamide,5577,positive,1,1,388.5,2.3,69.3,6,1,28,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC,,
1559,LIverTox,Phenyltoloxamine,7077,E,0,0,255.35,3.9,12.5,2,0,19,CN(C)CCOC1=CC=CC=C1CC2=CC=CC=C2,.,
152,DILIrank,dacarbazine,2942,vMost-DILI-Concern,1,1,182.18,-0.6,99.7,5,2,13,CN(C)N=NC1=C(NC=N1)C(=O)N,Extensive,
3855,Liew,Pipotiazine,62867,positive,0,0,475.7,3.5,97.8,7,1,32,CN(C)S(=O)(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCC(CC4)CCO,,
2270,Greene,Pargyline,4688,NE,0,0,159.23,2.1,3.2,1,0,12,CN(CC#C)CC1=CC=CC=C1,.,
4044,Liew,Tolrestat,53359,positive,1,1,357.3,3.7,81.9,7,1,24,CN(CC(=O)O)C(=S)C1=CC=CC2=C1C=CC(=C2C(F)(F)F)OC,,
2209,Greene,Methotrexate,126941,HH,1,1,454.4,-1.8,211,12,5,33,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,	Liver and intracellular,
3742,Liew,Naftifine,47641,negative,0,0,287.4,5.1,3.2,1,0,22,CN(CC=CC1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32,,
3424,Liew,Dofetilide,71329,negative,0,0,441.6,1.8,122,8,2,29,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,,
3376,Liew,Demecarium,5966,negative,0,0,556.8,6.6,59.1,4,0,40,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC2=CC=CC(=C2)[N+](C)(C)C,,
2038,Greene,Demecarium Bromide,5965,HH,1,1,716.6,,59.1,6,0,42,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC2=CC=CC(=C2)[N+](C)(C)C.[Br-].[Br-],,
3643,Liew,Lofepramine,3947,positive,1,1,419,6.8,23.6,3,0,30,CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl,,
1319,LIverTox,Ivabradine,132999,E,0,0,468.6,2.4,60.5,6,0,34,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC,"Liver first-pass >50%, CYP3A4",
806,LIverTox,Alfuzosin,2092,C,1,1,389.4,1.7,112,8,2,28,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,CYP3A4,
1641,LIverTox,Revefenacin,11753673,E,0,0,597.7,4.1,108,6,2,44,CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(C=C4)CN5CCC(CC5)C(=O)N,.,
2416,Greene,Rosiglitazone,77999,WE,1,1,357.4,3.1,96.8,6,1,25,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,CYP2C8,
3860,Liew,Piroxicam,54676228,positive,1,1,331.3,3.1,108,6,2,23,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,Liver,
4007,Liew,Tenoxicam,5282194,positive,0,0,337.4,2.2,136,8,2,22,CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=C(S1(=O)=O)C=CS3,,
473,DILIrank,ceftriaxone,5479530,vLess-DILI-Concern,1,1,554.6,-1.3,288,13,4,36,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,Negligible,
3734,Liew,Moxalactam,47499,positive,0,0,520.5,-0.6,232,13,4,36,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C(C4=CC=C(C=C4)O)C(=O)O)OC)OC2)C(=O)O,,
3281,Liew,Cefmetazole,42008,positive,0,0,471.5,-0.6,239,12,2,30,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O,,
3280,Liew,Cefmenoxime,9570757,positive,0,0,511.6,0,270,14,3,33,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,,
3276,Liew,Cefamandole,456255,positive,0,0,462.5,-0.9,201,10,3,31,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(C4=CC=CC=C4)O)SC2)C(=O)O,,
2916,Liew,Diazepam,3016,positive,1,1,284.74,3,32.7,2,0,20,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,,
1750,LIverTox,Temozolomide,5394,B,1,1,194.15,-1.1,106,5,1,14,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,hydrolysis,
778,DILIrank,levomefolate calcium,444412,vNo-DILI-Concern,0,0,459.5,-0.5,199,9,7,33,CN1C(CNC2=C1C(=O)N=C(N2)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,.,
3306,Liew,Chlormezanone,2717,positive,1,1,273.74,1.1,62.8,3,0,17,CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl,,
314,DILIrank,dyphylline,3182,vNo-DILI-Concern,0,0,254.24,-1.8,98.9,5,2,18,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O,.,
226,DILIrank,dimenhydrinate,10660,vNo-DILI-Concern,0,0,470,,81.8,5,1,33,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,Liver,
4019,Liew,Theophylline,2153,negative,0,0,180.16,0,69.3,3,1,13,CN1C2=C(C(=O)N(C1=O)C)NC=N2,hepatic,
304,DILIrank,aminophylline,9433,vNo-DILI-Concern,0,0,420.43,,191,8,4,30,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,.,
537,DILIrank,droxicam,65679,vMost-DILI-Concern,1,1,357.3,1.2,105,7,0,25,CN1C2=C(C3=CC=CC=C3S1(=O)=O)OC(=O)N(C2=O)C4=CC=CC=N4,.,
1056,LIverTox,Dabigatran,216210,D,1,1,471.5,1.7,150,7,4,35,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,.,
1749,LIverTox,Temazepam,5391,E,0,0,300.74,2.2,52.9,3,1,21,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Liver,
3221,Liew,Bendamustine,65628,negative,0,0,358.3,2.9,58.4,4,1,23,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,,
2452,Greene,tianeptine,68870,HH,1,1,437,1.2,95.1,6,2,29,CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O,Liver by ??-oxidation,
1033,LIverTox,Cocaine,446220,A[HD],1,1,303.35,2.3,55.8,5,0,22,CN1C2CCC1C(C(C2)OC(=O)C3=CC=CC=C3)C(=O)OC,CYP3A4,
3578,Liew,Homatropine,6321423,negative,0,0,275.34,1.9,49.8,4,1,20,CN1C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O,,
217,DILIrank,atropine,174174,vNo-DILI-Concern,0,0,289.4,1.8,49.8,4,1,21,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,???50% hydrolysed to tropine and tropic acid,
4076,Liew,Tropisetron,72165,positive,0,0,284.35,3.8,45.3,3,1,21,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43,"CYP3A4, CYP1A2, CYP2D6",
449,DILIrank,benztropine,1201549,vNo-DILI-Concern,0,0,307.4,4.5,12.5,2,0,23,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4,Liver,
1509,LIverTox,Osimertinib,71496458,E*,0,0,499.6,3.7,87.6,7,2,37,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,Oxidation CYP3A,
242,DILIrank,methimazole,1349907,vMost-DILI-Concern,1,1,114.17,-0.3,47.4,1,1,7,CN1C=CNC1=S,Liver,
1928,Greene,Azathioprine,2265,HH,1,1,277.27,0.1,143,7,1,19,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],"	Activated non-enzymatically, deactivated mainly by xanthine oxidase",
703,DILIrank,caffeine,2519,vNo-DILI-Concern,0,0,194.19,-0.1,58.4,3,0,14,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,"	Primary: CYP1A2 inor: CYP2E1,CYP3A4,
CYP2C8,CYP2C9",
1735,LIverTox,Tadalafil,110635,D,1,1,389.4,2.3,74.9,4,1,29,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,Liver predominantly CYP3A4,
2739,Xu,nomifensine,4528,Positive,1,1,238.33,2.6,29.3,2,1,18,CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3,.,
3681,Liew,Metergoline,28693,positive,0,0,403.5,3.8,46.5,3,1,30,CN1CC(CC2C1CC3=CN(C4=CC=CC2=C34)C)CNC(=O)OCC5=CC=CC=C5,,
879,LIverTox,Asenapine,163091,D,1,1,285.8,3.8,12.5,2,0,20,CN1CC2C(C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24,Liver glucurinodation by UGT1A4 and oxidative metabolism by CYP1A2,
2687,Xu,Ketotifen,3827,Negative,0,0,309.4,3.2,48.6,3,0,22,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,Liver,
1050,LIverTox,Cyproheptadine,2913,C,1,1,287.4,4.7,3.2,1,0,22,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,CYP3A4,
3210,Liew,Azatadine,19861,negative,0,0,290.4,3.6,16.1,2,0,22,CN1CCC(=C2C3=CC=CC=C3CCC4=C2N=CC=C4)CC1,,
3687,Liew,Methdilazine,14677,positive,0,0,296.4,5.2,31.8,3,0,21,CN1CCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42,,
1828,LIverTox,Vandetanib,3081361,E*,0,0,475.4,4.9,59.5,7,1,30,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,"CYP3A4, FMO1, FMO3",
1247,LIverTox,Glasdegib,25166913,E*,0,0,374.4,2.4,96.8,4,3,28,CN1CCC(CC1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,.,
3802,Liew,Oxymorphone,5284604,negative,0,0,301.34,0.8,70,5,2,22,CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,CYP3A4,
1518,LIverTox,Oxycodone,5284603,E,0,0,315.4,1.2,59,5,1,23,CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O,"Liver: mainly CYP3A, and, to a much lesser extent, CYP2D6 ~5%; 95% metabolized i.e., 5% excreted unchanged",
3036,Liew,Morphine,5288826,positive,.,0,285.34,0.8,52.9,4,2,21,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,,
1034,LIverTox,Codeine,5284371,E,0,0,299.4,1.1,41.9,4,1,22,CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O,"Liver: CYP2D6 to morphine, CYP3A4 to norcodeine, UGT2B7 to 3- and 6-glucuronides of codeine, norcodeine, and morphine",
1230,LIverTox,Galantamine,9651,E,0,0,287.35,1.8,41.9,4,1,21,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,Liver partially CYP450:CYP2D6/3A4,
3637,Liew,Levorphanol,5359272,negative,0,0,257.37,3.1,23.5,2,1,19,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O,,
2619,Xu,Dextromethorphan HBr,5360696,Negative,0,0,271.4,3.4,12.5,2,0,20,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC,"	Liver enzymes: major CYP2D6, minor CYP3A4, and minor CYP3A5",
1132,LIverTox,Edoxaban,10280735,D,1,1,548.1,1.4,165,8,3,37,CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,"minimal CES1, CYP3A4/5, hydrolysis, glucuronidation",
760,DILIrank,apomorphine,6005,vNo-DILI-Concern,0,0,267.32,2.3,43.7,3,2,20,CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O,"Liver, phase II",
4079,Liew,Tubocurarine,6000,negative,0,0,609.7,6,80.6,7,2,45,CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)O)O3)[N+](CCC6=CC(=C5O)OC)(C)C)OC,,
750,DILIrank,mepazine,6075,vMost-DILI-Concern,1,1,310.5,5.6,31.8,3,0,22,CN1CCCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42,.,
3212,Liew,Azelastine,2267,negative,0,0,381.9,4.4,35.9,3,0,27,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,,
3761,Liew,Nicotine,89594,negative,0,0,162.23,1.2,16.1,2,0,12,CN1CCCC1C2=CN=CC=C2,,
2201,Greene,Mesoridazine Besylate,4078,HH,1,1,386.6,4.5,68.1,5,0,26,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)C,	Liver/renal,
4025,Liew,Thioridazine,5452,positive,1,1,370.6,5.9,57.1,4,0,25,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC,CYP2D6,
1614,LIverTox,Pyrantel,708857,E,0,0,206.31,1.6,43.8,2,0,14,CN1CCCN=C1C=CC2=CC=CS2,.,
3803,Liew,Oxyphencyclimine,4642,negative,0,0,344.4,2.9,62.1,4,1,25,CN1CCCN=C1COC(=O)C(C2CCCCC2)(C3=CC=CC=C3)O,,
3468,Liew,Eszopiclone,969472,negative,0,0,388.8,0.5,91.8,7,0,27,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,,
36,DILIrank,chlorcyclizine,2710,vLess-DILI-Concern,1,1,300.8,4.5,6.5,2,0,21,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,.,
1045,LIverTox,Cyclizine,6726,E,0,0,266.4,3.6,6.5,2,0,20,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3,N-demethylated to inactive norcyclizine,
3502,Liew,Fleroxacin,3357,positive,0,0,369.34,-0.1,64.1,9,1,26,CN1CCN(CC1)C2=C(C=C3C(=C2F)N(C=C(C3=O)C(=O)O)CCF)F,,
2021,Greene,Clozapine,2818,HH,1,1,326.8,3.2,30.9,4,1,23,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,"	Liver, by several CYP isozymes",
1374,LIverTox,Loxapine,3964,D,1,1,327.8,3.1,28.1,3,0,23,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,"Extensive Liver; active metabolites include amoxapine and 8-hydroxyloxapine. Inhibits P-gp and is a substrate of CYP1A2, CYP3A4 and CYP2D6",
945,LIverTox,Brigatinib,68165256,E*,0,0,584.1,4.6,85.9,9,2,40,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,.,
1474,LIverTox,Nintedanib,9809715,E*,0,0,539.6,3.3,94.2,7,2,40,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)NC(=C3C4=C(C=C(C=C4)C(=O)OC)NC3=O)C5=CC=CC=C5,"Esterases, glucuronidation",
4058,Liew,Trifluoperazine,5566,positive,1,1,407.5,5,35,7,0,28,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F,Liver,
3883,Liew,Prochlorperazine,4917,positive,1,1,373.9,4.9,35,4,0,25,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,"CYP2D6, CYP3A4",
3828,Liew,Perazine,4744,positive,0,0,339.5,4.1,35,4,0,24,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=CC=CC=C42,,
941,LIverTox,Bosutinib,5328940,D,1,1,530.4,5.4,82.9,8,1,36,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,"By CYP3A4, to inactive metabolites",
1428,LIverTox,Mirtazapine,4205,C,1,1,265.35,3.3,19.4,3,0,20,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,"CYP1A2, CYP2D6, CYP3A4",
2222,Greene,mianserin,4184,HH,1,1,264.4,3.4,6.5,2,0,20,CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42,"	Liver CYP2D6; via aromatic hydroxylation, N-oxidation, N-demethylation",
1743,LIverTox,Tedizolid,11234049,E*,0,0,370.3,1.4,106,8,1,27,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)CO)F,.,
481,DILIrank,chlordiazepoxide,2712,vLess-DILI-Concern,1,1,299.75,2.4,48.2,3,1,21,CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O,Liver,
76,DILIrank,ranitidine,3001055,vLess-DILI-Concern,1,1,314.41,0.3,112,7,2,21,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,"Liver: FMOs, including FMO3; other enzymes",
1482,LIverTox,Nizatidine,3033637,D,1,1,331.5,1.6,140,8,2,21,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,Liver,
3235,Liew,Bethanidine,2368,negative,0,0,177.25,0.9,36.4,1,2,13,CNC(=NC)NCC1=CC=CC=C1,,
869,LIverTox,Apalutamide,24872560,E,0,0,477.4,3,121,9,1,33,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F,"CYP2C8, CYP3A4",
894,LIverTox,Axitinib,6450551,E*,0,0,386.5,4.2,96,4,2,28,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,"Liver mostly CYP3A4/CYP3A5-mediated but with some contributions from CYP1A2, CYP2C19, UGT1A1",
267,DILIrank,regadenoson,219024,vNo-DILI-Concern,0,0,390.35,-1.5,187,10,5,28,CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N,.,
1635,LIverTox,Regorafenib,11167602,B,1,1,482.8,4.2,92.4,8,3,33,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,Hepatic UGT1A9-mediated,
1710,LIverTox,Sorafenib,216239,B,1,1,464.8,4.1,92.4,7,3,32,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,Liver oxidation and glucuronidation CYP3A4 & UGT1A9-mediated,
3546,Liew,Gadodiamide,153921,negative,0,0,573.7,,188,11,2,30,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],,
1327,LIverTox,Ketamine,3821,B,1,1,237.72,2.2,29.1,2,1,16,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,"Liver, intestine oral:",
3955,Liew,Sertraline,68617,positive,1,1,306.2,4.8,12,1,1,20,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,"CYP2B6(major), CYP2C19",
425,DILIrank,frovatriptan,77992,vNo-DILI-Concern,0,0,243.3,1.2,70.9,2,3,18,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N,	Liver,
1667,LIverTox,Rucaparib,9931954,E*,0,0,323.4,2.5,56.9,3,3,24,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,Liver primarily CYP2D6; 1A2 and 3A4 to a lesser extent,
1211,LIverTox,Fluoxetine,3386,C,1,1,309.33,4,21.3,5,1,22,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CYP2D6,
1123,LIverTox,Duloxetine,60835,B,1,1,297.4,4.3,49.5,3,1,21,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,"Liver, two P450 isozymes, CYP2D6 and CYP1A2",
2742,Xu,Nortriptyline HCl,4543,Positive,1,1,263.4,4.5,12,1,1,20,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,Liver,
2190,Greene,Maprotiline,4011,WE,1,1,277.4,4.6,12,1,1,21,CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24,Liver,
1608,LIverTox,Protriptyline,4976,E*,0,0,263.4,4.4,12,1,1,20,CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13,Liver,
3379,Liew,Desipramine,2995,positive,1,1,266.4,4.9,15.3,2,1,20,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,,
3098,Liew,Sumatriptan,5358,negative,.,0,295.4,0.9,73.6,4,2,20,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,MAO,
1028,LIverTox,Clopidogrel,60606,B,1,1,321.8,3.8,57.8,4,0,21,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Liver,
1409,LIverTox,Methylphenidate,4158,C[H],1,1,233.31,0.2,38.3,3,1,17,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Liver 80% mostly CES1A1-mediated,
1857,LIverTox,Yohimbine,8969,E,0,0,354.4,2.9,65.6,4,2,26,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O,.,
1097,LIverTox,Dimethyl Fumarate,637568,"C,E*,E*",1,1,144.12,0.7,52.6,4,0,10,COC(=O)C=CC(=O)OC,.,
1384,LIverTox,Mebendazole,4030,D,1,1,295.29,2.8,84.1,4,2,22,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,Extensive liver,
2253,Greene,Nocodazole,4122,NE,0,0,301.32,2.8,112,5,2,21,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CS3,.,
902,LIverTox,Baloxavir,124081896,E,0,0,571.6,3.8,123,12,0,40,COC(=O)OCOC1=C2C(=O)N3CCOCC3N(N2C=CC1=O)C4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F,.,
3696,Liew,Methoxyflurane,4116,positive,1,1,164.96,2.2,9.2,3,0,8,COC(C(Cl)Cl)(F)F,,
3503,Liew,Flomoxef,65864,positive,0,0,496.5,-1.3,220,14,3,32,COC1(C2N(C1=O)C(=C(CO2)CSC3=NN=NN3CCO)C(=O)O)NC(=O)CSC(F)F,,
3809,Liew,Pantoprazole,4679,positive,1,1,383.4,2.4,106,9,1,26,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,"CYP2C19, CYP3A4",
4092,Liew,Vesnarinone,5663,positive,0,0,395.5,2.1,71.1,5,1,29,COC1=C(C=C(C=C1)C(=O)N2CCN(CC2)C3=CC4=C(C=C3)NC(=O)CC4)OC,,
1347,LIverTox,Letermovir,45138674,E,0,0,572.5,4.6,77.8,10,1,41,COC1=C(C=C(C=C1)C(F)(F)F)N2C(C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O,glucuronidation UGT1A1/1A3 to a minor extent,
3145,Liew,Adapalene,60164,negative,0,0,412.5,7.7,46.5,3,1,31,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,,
4050,Liew,Tranilast,5282230,positive,1,1,327.3,3.2,84.9,5,2,24,COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC,,
3810,Liew,Papaverine,4680,positive,1,1,339.4,3.9,49.8,5,0,25,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC,Liver,
892,LIverTox,Avanafil,9869929,E*,0,0,483.9,2.6,125,9,3,34,COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCCC4CO)Cl,.,
158,DILIrank,glibenclamide,3488,vLess-DILI-Concern,1,1,494,4.8,122,5,3,33,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,	Liver hydroxylation CYP2C9,
3872,Liew,Prazosin,4893,positive,0,0,383.4,2,107,8,1,28,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,,
679,DILIrank,terazosin,5401,vNo-DILI-Concern,0,0,387.4,1.4,103,8,1,28,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,.,
1113,LIverTox,Doxazosin,3157,E*,0,0,451.5,2.5,112,9,1,33,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Liver,
2630,Xu,Donepezil,3152,Negative,0,1,379.5,4.3,38.8,4,0,28,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,"	CYP2D6, CYP3A4, and glucuronidation.Four major metabolites, two of which are active.",
1061,LIverTox,Dacomitinib,11511120,E*,0,0,469.9,4.4,79.4,7,2,33,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,"CYP2D6, CYP3A4",
3553,Liew,Gefitinib,123631,positive,1,1,446.9,4.1,68.7,8,1,31,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,,
2517,Xu,Amsacrine HCl,2179,Positive,1,1,393.5,4,88.7,6,2,28,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,
1040,LIverTox,Copanlisib,24989044,E*,0,0,480.5,-0.3,140,10,2,35,COC1=C(C=CC2=C1N=C(N3C2=NCC3)NC(=O)C4=CN=C(N=C4)N)OCCCN5CCOCC5,"CYP3A4/5 (?90%), CYP1A1 (?10%)",
3735,Liew,Moxifloxacin,152946,positive,1,1,401.4,0.6,82.1,8,2,29,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,,
3695,Liew,Methoxsalen,4114,positive,1,1,216.19,1.9,48.7,4,0,16,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,,
1891,Greene,aflatoxin B1,14403,HH,1,1,312.27,1.6,71.1,6,0,23,COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4C5C=COC5OC4=C1,.,
690,DILIrank,trimethoprim,5578,vLess-DILI-Concern,1,1,290.32,0.9,106,7,2,21,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,Liver,
1622,LIverTox,Quinine,8549,B,1,1,324.4,2.9,45.6,4,1,24,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,"CYP3A4, CYP2C19",
959,LIverTox,Cabozantinib,25102847,E*,0,0,501.5,5.4,98.8,7,2,37,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,CYP3A4,
1345,LIverTox,Lenvatinib,9823820,D,1,1,426.9,2.8,116,5,3,30,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,"CYP3A4, aldehyde oxidase, non-enzymatic",
3309,Liew,Chlorotrianisene,11289,negative,0,0,380.9,6.4,27.7,3,0,27,COC1=CC=C(C=C1)C(=C(C2=CC=C(C=C2)OC)Cl)C3=CC=C(C=C3)OC,,
3192,Liew,Aniracetam,2196,negative,0,0,219.24,1.6,46.6,3,0,16,COC1=CC=C(C=C1)C(=O)N2CCCC2=O,,
3193,Liew,Anisindione,2197,negative,0,0,252.26,2.9,43.4,3,0,19,COC1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O,,
1918,Greene,Astemizole,2247,NE,0,0,458.6,6,42.3,5,1,34,COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F,CYP3A4,
870,LIverTox,Apixaban,10182969,B,1,1,459.5,2.2,111,5,1,34,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,"CYP3A4, CYP3A5, CYP1A2 and others",
441,DILIrank,guaifenesin,3516,vNo-DILI-Concern,0,0,198.22,1.4,58.9,4,2,14,COC1=CC=CC=C1OCC(CO)O,	Kidney,
1405,LIverTox,Methocarbamol,4107,E,0,0,241.24,0.6,91,5,2,17,COC1=CC=CC=C1OCC(COC(=O)N)O,Liver,
3272,Liew,Carvedilol,2585,positive,1,1,406.5,4.2,75.7,5,3,30,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,,
499,DILIrank,nelarabine,3011155,vLess-DILI-Concern,1,1,297.27,-0.7,149,9,4,21,COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N,"By adenosine deaminase, to 9-??-D-arabinofuranosylguanine",
1219,LIverTox,Fondaparinux,636380,E,0,1,1728.1,,901,52,9,101,COC1C(C(C(C(O1)COS(=O)(=O)[O-])OC2C(C(C(C(O2)C(=O)[O-])OC3C(C(C(C(O3)COS(=O)(=O)[O-])OC4C(C(C(C(O4)C(=O)[O-])OC5C(C(C(C(O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],renally excreted unchanged,
1637,LIverTox,Reserpine,5770,E,0,0,608.7,4,118,10,1,44,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,"Liver, Gut",
3923,Liew,Rescinnamine,5280954,negative,0,0,634.7,4.5,118,10,1,46,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C=CC6=CC(=C(C(=C6)OC)OC)OC,,
3378,Liew,Deserpidine,8550,negative,0,0,578.7,4.1,109,9,1,42,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=CC=CC=C45)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,,
2563,Xu,Cisapride,2769,Negative,0,0,465.9,3.4,86,7,2,32,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F,"	liver CYP3A4, intestinal",
2119,Greene,fluvoxamine,5324346,HH,1,1,318.33,2.6,56.8,7,1,22,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,Liver primarily O-demethylation Major: CYP1A2 Minor: CYP3A4 Minor: CYP2C19,
3345,Liew,Clovoxamine,6335903,positive,0,0,284.78,2.4,56.8,4,1,19,COCCCCC(=NOCCN)C1=CC=C(C=C1)Cl,,
1609,LIverTox,Prucalopride,3052762,E,0,0,367.9,2,76.8,5,2,25,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,.,
3458,Liew,Erlotinib,176870,positive,1,1,393.4,3.3,74.7,7,1,29,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,,
1452,LIverTox,Naloxegol,56959087,E,0,0,651.8,-1,127,12,2,46,COCCOCCOCCOCCOCCOCCOCCOC1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC=C)O,CYP3A,
3288,Liew,Cefpirome,6917674,positive,0,0,514.6,0.9,208,10,2,35,CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC5=C4CCC5)C(=O)[O-],,
437,DILIrank,gemifloxacin,9571107,vLess-DILI-Concern,1,1,389.4,-0.7,121,10,2,28,CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F,Limited metabolism by the liver to minor metabolites,
753,DILIrank,simethicone,6433516,vNo-DILI-Concern,0,0,238.46,,52.6,4,0,13,CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O,	Not metabolized,
1841,LIverTox,Vismodegib,24776445,C,1,1,421.3,3.8,84.5,4,1,27,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,"<2% metabolised by CYP2C9, CYP3A4, CYP3A5",
3939,Liew,Rofecoxib,5090,positive,1,1,314.4,2.3,68.8,4,0,22,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Liver,
3624,Liew,Lapatinib,208908,positive,1,1,581.1,5.1,115,9,2,40,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,,
3765,Liew,Nimesulide,4495,positive,1,1,308.31,2.6,110,6,1,21,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,Liver,
149,DILIrank,busulfan,2478,vMost-DILI-Concern,1,1,246.3,-0.5,104,6,0,14,CS(=O)(=O)OCCCCOS(=O)(=O)C,Liver,
172,DILIrank,sincalide,32800,vNo-DILI-Concern,0,0,1143.3,-2.6,486,19,13,78,CSCCC(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CC(=O)O)N,.,
601,DILIrank,l-methionine,6137,vNo-DILI-Concern,0,0,149.21,-1.9,88.6,4,2,9,CSCCC(C(=O)O)N,.,
963,LIverTox,Cangrelor,9854012,E,0,0,776.4,-1,307,21,7,44,CSCCNC1=C2C(=NC(=N1)SCCC(F)(F)F)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O,Rapid deactivation in the circulation independent of CYP system,
1942,Greene,Betaine HCl,247,NE,0,0,117.15,0.5,40.1,2,0,8,C[N+](C)(C)CC(=O)[O-],,
606,DILIrank,l-carnitine,288,vNo-DILI-Concern,0,0,161.2,-0.2,60.4,3,1,11,C[N+](C)(C)CC(CC(=O)[O-])O,slightly,
3973,Liew,Succinylcholine,22475,negative,0,0,361.3,,52.6,6,0,22,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-],,
3263,Liew,Carbachol,5831,negative,0,0,182.65,,52.3,3,1,11,C[N+](C)(C)CCOC(=O)N.[Cl-],,
2009,Greene,Citicoline,11583971,NE,0,0,488.32,-4,214,11,4,31,C[N+](C)(C)CCOP(=O)(O)OP(=O)([O-])OCC1C(C(C(O1)N2C=CC(=NC2=O)N)O)O,.,
3576,Liew,Hexafluorenium,9434,negative,0,0,662.5,,0,2,0,40,C[N+](C)(CCCCCC[N+](C)(C)C1C2=CC=CC=C2C3=CC=CC=C13)C4C5=CC=CC=C5C6=CC=CC=C46.[Br-].[Br-],,
4035,Liew,Tiotropium,5487427,negative,0,0,392.5,2.3,116,6,1,26,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,"CYP2D6, CYP3A4",
3697,Liew,Methscopolamine,441342,negative,0,0,398.3,,59.1,5,1,24,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C.[Br-],,
344,DILIrank,glycopyrrolate,3494,vNo-DILI-Concern,0,0,318.4,3.1,46.5,3,1,23,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C,.,
237,DILIrank,methylnaltrexone bromide,5361918,vNo-DILI-Concern,0,0,356.4,1.6,66.8,4,2,26,C[N+]1(CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6,	Liver,
3429,Liew,Doxacurium,60169,negative,0,0,1035.2,7.4,163,16,0,74,C[N+]1(CCC2=CC(=C(C(=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)OC)CCCOC(=O)CCC(=O)OCCC[N+]4(CCC5=CC(=C(C(=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)OC)C,,
3727,Liew,Mivacurium,71316,negative,0,0,1029.3,8.7,145,14,0,74,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C,,
368,DILIrank,atracurium,47320,vNo-DILI-Concern,0,0,1243.5,,258,18,0,87,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],	Hofmann elimination retro-Michael addition and ester hydrolysis by nonspecific esterases,
3708,Liew,Metocurine,21233,negative,0,0,652.8,6.7,55.4,6,0,48,C[N+]1(CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)OC)O3)[N+](CCC6=CC(=C5OC)OC)(C)C)OC)C,,
3670,Liew,Mepenzolate,4057,negative,0,0,340.4,3.2,46.5,3,1,25,C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C,,
3279,Liew,Cefepime,5479537,positive,1,1,480.6,-0.1,204,10,2,32,C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],,
3331,Liew,Clidinium,2784,negative,0,0,352.4,3.3,46.5,3,1,26,C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O,,
739,DILIrank,pyridostigmine,4991,vNo-DILI-Concern,0,0,181.21,0.7,33.4,2,0,13,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,.,
175,DILIrank,cupric chloride,24014,vNo-DILI-Concern,0,0,134.45,,0,0,0,3,Cl[Cu]Cl,.,
1916,Greene,Arsenic Trioxide,261004,HH,1,1,197.841,,43.4,3,0,5,O=[As]O[As]=O,.,
358,DILIrank,nitroprusside,11953895,vNo-DILI-Concern,0,0,297.95,,139,14,2,17,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.O.O.[Na+].[Na+].[Fe+4],,complex
373,DILIrank,rubidium chloride rb-82,71357,vNo-DILI-Concern,0,0,117.37,,0,1,0,2,[Cl-].[Rb+],.,
452,DILIrank,gadobenate dimeglumine,105124,vNo-DILI-Concern,0,0,667.7,,220,14,2,37,[H+].[H+].C1=CC=C(C=C1)COCC(C(=O)[O-])N(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],.,
1014,LIverTox,Cisplatin,2767,C,1,1,298.03,,2,2,2,5,[NH2-].[NH2-].Cl[Pt+2]Cl,.,
1907,Greene,ammonium chloride,25517,NE,0,0,53.49,,1,1,1,2,[NH4+].[Cl-],.,
2237,Greene,NaCl,5234,NE,0,0,58.44,,0,1,0,2,[Na+].[Cl-],.,
194,DILIrank,sodium thiosulfate,24477,vNo-DILI-Concern,0,0,158.11,,104,4,0,7,[O-]S(=O)(=S)[O-].[Na+].[Na+],.,
=======
ID,Source,Compound,CID,Class,Label,Voted_Label,MW,XLOGP,TPSA,H-Bond ACC,H-Bond Donor,Heavy_Atom_Count,Canonical SMILES,Metabolism,Note
3243,Liew,Bortezomib,387447,positive,1,1,384.2,,124,6,4,28,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,,
1323,LIverTox,Ixazomib,25183872,E*,0,0,361,,98.7,4,4,23,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,"Liver CYP: 3A4 42%, 1A2 26%, 2B6 16% and others",
3473,Liew,Ethinamate,3284,negative,0,0,167.2,1.3,52.3,2,1,12,C#CC1(CCCCC1)OC(=O)N,,
1580,LIverTox,Pralatrexate,148121,E*,0,0,477.5,-0.9,207,11,5,35,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,.,
1631,LIverTox,Rasagiline,3052776,E,0,0,171.24,1.8,12,1,1,13,C#CCNC1CCC2=CC=CC=C12,CYP1A2,
2701,Xu,maleic acid,444266,Positive,1,1,116.07,-0.3,74.6,4,2,8,C(=CC(=O)O)C(=O)O,.,
3583,Liew,Hydroxyurea,3657,positive,1,1,76.055,-1.8,75.4,2,3,5,C(=O)(N)NO,,
1221,LIverTox,Foscarnet,3415,D,1,1,126.01,-2,94.8,5,3,7,C(=O)(O)P(=O)(O)O,.,
211,DILIrank,lanthanum carbonate,168924,vNo-DILI-Concern,0,0,457.84,,190,9,0,14,C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].[La+3].[La+3],.,
3517,Liew,Fluoroacetic acid,5237,positive,0,0,78.04,0.2,37.3,3,1,5,C(C(=O)O)F,,
2797,Xu,Sorbitol,5780,Negative,0,0,182.17,-3.1,121,6,6,12,C(C(C(C(C(CO)O)O)O)O)O,.,
3460,Liew,Erythrityl tetranitrate,5284553,positive,0,0,302.11,1.4,220,12,0,20,C(C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],,
1917,Greene,Ascorbate,54670067,NE,0,0,176.12,-1.6,107,6,4,12,C(C(C1C(=C(C(=O)O1)O)O)O)O,.,
638,DILIrank,nitroglycerin,4510,vNo-DILI-Concern,0,0,227.09,1.6,165,9,0,15,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],	Liver,
2057,Greene,Dimercaprol,3080,HH,1,0,124.23,0.2,22.2,3,3,6,C(C(CS)S)O,,
1001,LIverTox,Chloral hydrate,2707,E,0,0,165.4,1,40.5,2,2,7,C(C(Cl)(Cl)Cl)(O)O,Liver and renal converted to trichloroethanol,
1314,LIverTox,Isoflurane,	3763,B,1,1,184.49,2.1,9.2,6,0,10,C(C(F)(F)F)(OC(F)F)Cl,.,
1083,LIverTox,Desflurane,42113,C,1,1,168.04,2.6,9.2,7,0,10,C(C(F)(F)F)(OC(F)F)F,Not metabolized,
1148,LIverTox,Enflurane,3226,B,1,1,184.49,2.1,9.2,6,0,10,C(C(OC(F)F)(F)F)(F)Cl,.,
1251,LIverTox,Glucosamine,439213,D,1,1,179.17,-2.8,116,6,5,12,C(C1C(C(C(C(O1)O)N)O)O)O,.,
167,DILIrank,dextrose,5793,vNo-DILI-Concern,0,0,180.16,-2.6,110,6,5,12,C(C1C(C(C(C(O1)O)O)O)O)O,.,no cid
3974,Liew,Sucralfate,6398525,positive,0,0,1571.9,,624,55,28,83,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al],"Liver, GI",
2172,Greene,Lactose,6134,NE,0,0,342.3,-4.7,190,11,8,23,C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O,.,
359,DILIrank,lactulose,11333,vNo-DILI-Concern,0,0,342.3,-4.3,190,11,8,23,C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O,	100% in colon by enteric bacteria,
1923,Greene,Aurothioglucose,6104,HH,1,1,392.18,,91.2,6,4,13,C(C1C(C(C(C(O1)[S-])O)O)O)O.[Au+],.,
3176,Liew,Aminolevulinic acid,137,positive,1,1,131.13,-3.8,80.4,4,2,9,C(CC(=O)O)C(=O)CN,,
975,LIverTox,Carglumic Acid,121396,E,0,0,190.15,-2.4,130,5,4,13,C(CC(=O)O)C(C(=O)O)NC(=O)N,Partial,
208,DILIrank,gamma hydroxybutyric acid,3037032,vNo-DILI-Concern,0,0,103.1,0,60.4,3,1,7,C(CC(=O)[O-])CO,"	95%, mainly liver, also in blood and tissues",
738,DILIrank,l-arginine,6322,vNo-DILI-Concern,0,0,174.2,-4.2,128,4,4,12,C(CC(C(=O)O)N)CN=C(N)N,.,
3446,Liew,Eflornithine,3009,negative,0,0,182.17,-2.9,89.3,6,3,12,C(CC(C(F)F)(C(=O)O)N)CN,,
3152,Liew,Alendronate,2088,positive,1,1,249.1,-6.5,161,8,6,14,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,,
3173,Liew,Aminocaproic acid,564,positive,0,0,131.17,-3,63.3,3,2,9,C(CCC(=O)O)CCN,,
3571,Liew,Gusperimus,55362,negative,0,0,387.5,-2,181,6,7,27,C(CCCN=C(N)N)CCC(=O)NC(C(=O)NCCCCNCCCN)O,,
978,LIverTox,Carmustine,2578,E*,0,0,214.05,1.5,61.8,3,1,12,C(CCl)NC(=O)N(CCCl)N=O,.,
357,DILIrank,pentetic acid,3053,vNo-DILI-Concern,0,0,393.35,-8.5,196,13,5,27,C(CN(CC(=O)O)CC(=O)O)N(CCN(CC(=O)O)CC(=O)O)CC(=O)O,.,
3057,Liew,Pamidronate,4674,negative,.,0,235.07,-6.9,161,8,6,13,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,,
431,DILIrank,amifostine,2141,vNo-DILI-Concern,0,0,214.23,-4.5,121,6,4,12,C(CN)CNCCSP(=O)(O)O,.,
2466,Greene,Trientine HCl,5565,HH,1,0,146.23,-2.5,76.1,4,4,10,C(CNCCNCCN)N,,
2942,Liew,Ethanolamine,700,negative,.,0,61.08,-1.3,46.2,2,2,4,C(CO)N,,
3360,Liew,Cysteamine,6058,positive,1,1,77.15,-0.4,27,2,2,4,C(CS)N,,
1973,Greene,carbon tetrachloride (2),5943,HH,1,1,153.8,2.8,0,0,0,5,C(Cl)(Cl)(Cl)Cl,.,
2235,Greene,Myo-inositol,892,NE,0,0,180.16,-3.7,121,6,6,12,C1(C(C(C(C(C1O)O)O)O)O)O,.,
1210,LIverTox,Fluorouracil,3385,A,1,1,130.08,-0.9,58.2,3,2,9,C1=C(C(=O)NC(=O)N1)F,Intracellular and liver CYP-mediated,
2477,Greene,Uracil Mustard,6194,HH,1,1,252.09,0.5,61.4,3,2,15,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl,.,
3499,Liew,Fialuridine,50313,positive,1,1,372.09,-0.9,99.1,6,3,18,C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)F)I,,
435,DILIrank,levothyroxine,5819,vLess-DILI-Concern,1,1,776.87,2.4,92.8,5,3,24,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,"	Mainly in liver, kidneys, brain and muscles",
3642,Liew,Lodoxamide,44564,negative,0,0,311.63,0.5,157,7,4,21,C1=C(C=C(C(=C1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N,,
331,DILIrank,dichlorphenamide,3038,vNo-DILI-Concern,0,0,305.2,0.3,137,6,2,16,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,.,
1948,Greene,Bithionol,2406,HH,1,1,356,5.8,65.8,3,2,19,C1=C(C=C(C(=C1SC2=C(C(=CC(=C2)Cl)Cl)O)O)Cl)Cl,.,
50,DILIrank,famotidine,3325,vLess-DILI-Concern,1,1,337.5,-0.6,238,8,4,20,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,.,
303,DILIrank,histamine diphosphate,65513,vNo-DILI-Concern,0,0,307.14,,210,10,8,18,C1=C(NC=N1)CCN.OP(=O)(O)O.OP(=O)(O)O,.,
3770,Liew,Nitrofurazone,5447130,negative,0,0,198.14,0.2,126,5,2,14,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,,
487,DILIrank,chlorothiazide,2720,vLess-DILI-Concern,1,1,295.7,-0.2,135,6,2,17,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,	Nil,
4056,Liew,Trichlormethiazide,5560,negative,0,0,380.7,0.6,135,7,3,20,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl,,
220,DILIrank,bromfenac,60726,vMost-DILI-Concern,1,1,334.16,3.3,80.4,4,2,20,C1=CC(=C(C(=C1)C(=O)C2=CC=C(C=C2)Br)N)CC(=O)O,	CYP2C9,
3567,Liew,Guanabenz,5702063,positive,0,0,231.08,1.7,76.8,2,2,14,C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,,
1263,LIverTox,Guanfacine,3519,E,0,0,246.09,2,81.5,1,2,15,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl,CYP3A4,
1336,LIverTox,Lamotrigine,3878,A,1,1,256.09,1.4,90.7,5,2,16,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,UGT1A4,
1959,Greene,Butoconazole Nitrate,47472,NE,0,0,411.8,6.4,43.1,2,0,25,C1=CC(=C(C(=C1)Cl)SC(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)Cl,,
1668,LIverTox,Rufinamide,129228,E*,0,0,238.19,0.7,73.8,5,1,17,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F,Carboxylesterase-mediated hydrolysis CYP not involved,
1121,LIverTox,Droxidopa,92974,E,0,0,213.19,-3.2,124,6,5,15,C1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O,Liver,
3774,Liew,Norepinephrine,439260,negative,0,0,169.18,-1.2,86.7,4,4,12,C1=CC(=C(C=C1C(CN)O)O)O,,
1618,LIverTox,Quercetin,5280343,E,0,0,302.23,1.5,127,7,5,22,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,.,
46,DILIrank,diflunisal,3059,vMost-DILI-Concern,1,1,250.2,4.4,57.5,5,2,18,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,Liver,
1352,LIverTox,Levodopa,6047,E,0,0,197.19,-2.7,104,5,4,14,C1=CC(=C(C=C1CC(C(=O)O)N)O)O,Aromatic-l-amino-acid decarboxylase,
2072,Greene,Dopamine,681,NE,0,0,153.18,-1,66.5,3,3,11,C1=CC(=C(C=C1CCN)O)O,"MAO, COMT",
4034,Liew,Tioconazole,5482,negative,0,0,387.7,5.3,55.3,3,0,23,C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl,,
3717,Liew,Miconazole,4189,negative,0,0,416.1,5.3,27,2,0,25,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,,
3796,Liew,Oxiconazole,5361463,negative,0,0,429.1,6.1,39.4,3,0,26,C1=CC(=C(C=C1Cl)Cl)CON=C(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,,
106,DILIrank,fluconazole,3365,vMost-DILI-Concern,1,1,306.27,0.4,81.6,7,1,22,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,liver 11%,
186,DILIrank,mesalazine,4075,vLess-DILI-Concern,1,1,153.14,1.3,83.6,4,3,11,C1=CC(=C(C=C1N)C(=O)O)O,	Rapidly & extensively metabolized intestinal mucosal wall and the liver,
3177,Liew,4-Aminosalicylic acid,4649,positive,1,1,153.14,1.3,83.6,4,3,11,C1=CC(=C(C=C1N)O)C(=O)O,,
3782,Liew,Olsalazine,22419,positive,1,1,302.24,3.1,140,8,4,22,C1=CC(=C(C=C1N=NC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O,,
3004,Liew,Liothyronine,16218759,negative,.,0,690.97,,96.6,6,3,25,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.O.[Na+],,
3760,Liew,Niclosamide,4477,negative,0,0,327.12,4,95.2,4,2,21,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,,
629,DILIrank,mitoxantrone,4212,vLess-DILI-Concern,1,1,444.5,1,163,10,8,32,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,CYP2E1,
3638,Liew,Liarozole,60652,positive,0,0,308.8,3.5,46.5,2,1,22,C1=CC(=CC(=C1)Cl)C(C2=CC3=C(C=C2)N=CN3)N4C=CN=C4,,
1870,Greene,"1,3 dinitrobenzene",7452,HH,1,1,168.11,1.5,91.6,4,0,12,C1=CC(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-],.,
3629,Liew,Letrozole,3902,positive,1,1,285.3,2.7,78.3,4,0,22,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,,
3885,Liew,Progabide,5361323,positive,0,0,334.8,3.1,72.2,4,2,23,C1=CC(=CC=C1C(=C2C=C(C=CC2=O)F)NCCCC(=O)N)Cl,Liver,
70,DILIrank,pentamidine,4735,vLess-DILI-Concern,1,1,340.4,2.6,118,4,4,25,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N,.,
3529,Liew,Folic acid,6037,negative,0,0,441.4,-1.1,209,9,6,32,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,,
3175,Liew,Aminohippuric acid,2148,negative,0,0,194.19,-0.9,92.4,4,3,14,C1=CC(=CC=C1C(=O)NCC(=O)O)N,,
3218,Liew,Balsalazide,5362070,negative,0,0,357.32,1.2,145,8,4,26,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O,,
480,DILIrank,chloramphenicol,5959,vNo-DILI-Concern,0,1,323.13,1.1,115,5,3,20,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],Liver,
3217,Liew,Baclofen,2284,positive,1,1,213.66,-1,63.3,3,2,14,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,,
691,DILIrank,fenclozic acid,28858,vMost-DILI-Concern,1,1,253.71,2.7,78.4,4,1,16,C1=CC(=CC=C1C2=NC(=CS2)CC(=O)O)Cl,.,
459,DILIrank,ezetimibe,150311,vLess-DILI-Concern,1,1,409.4,4,60.8,5,2,30,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,"Intestinal wall, liver",
1639,LIverTox,Resveratrol,445154,E,0,0,228.24,3.1,60.7,3,3,17,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,.,
3668,Liew,Melphalan,460612,positive,1,1,305.2,-0.5,66.6,4,2,19,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,,
3062,Liew,Pemetrexed,135410875,positive,.,1,427.4,0.2,187,7,6,31,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O,,
150,DILIrank,chlorambucil,2708,vLess-DILI-Concern,1,1,304.2,1.7,40.5,3,1,19,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,Liver,
3199,Liew,Arbutamine,60789,negative,0,0,317.4,0.9,93,5,5,23,C1=CC(=CC=C1CCCCNCC(C2=CC(=C(C=C2)O)O)O)O,,
771,DILIrank,tyramine,5610,vNo-DILI-Concern,0,0,137.18,1.1,46.2,2,2,10,C1=CC(=CC=C1CCN)O,"	CYP2D6, flavin-containing monooxygenase 3, monoamine oxidase A, monoamine oxidase B, phenylethanolamine N-methyltransferase, DBH, others",
3655,Liew,Mafenide,3998,negative,0,0,186.23,-0.7,94.6,4,2,12,C1=CC(=CC=C1CN)S(=O)(=O)N,,
3444,Liew,Econazole,3198,negative,0,0,381.7,5.3,27,2,0,24,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,,
2428,Greene,Sulconazole Nitrate,5318,NE,0,0,397.7,6.1,43.1,2,0,24,C1=CC(=CC=C1CSC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,,
3303,Liew,Chlorbenside,7639,positive,0,0,269.2,5.2,25.3,1,0,16,C1=CC(=CC=C1CSC2=CC=C(C=C2)Cl)Cl,,
2034,Greene,Dapsone,2955,HH,1,1,248.3,1,94.6,4,2,17,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,CYP2E1,
2431,Greene,Sulfanilamide,5333,HH,1,1,172.21,-0.6,94.6,4,2,11,C1=CC(=CC=C1N)S(=O)(=O)N,.,
258,DILIrank,sulfathiazole,5340,vMost-DILI-Concern,1,1,255.3,0.1,122,6,2,16,C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2,.,
3311,Liew,Chlorphenesin,2724,negative,0,0,245.66,1.2,81.8,4,2,16,C1=CC(=CC=C1OCC(COC(=O)N)O)Cl,,
692,DILIrank,ebrotidine,65869,vMost-DILI-Concern,1,1,477.4,1.5,198,7,3,26,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br,.,
399,DILIrank,tiludronate,60937,vNo-DILI-Concern,0,0,318.61,-0.3,140,7,4,17,C1=CC(=CC=C1SC(P(=O)(O)O)P(=O)(O)O)Cl,.,
3759,Liew,Niacinamide,936,positive,1,1,122.12,-0.4,56,2,1,9,C1=CC(=CN=C1)C(=O)N,,
3758,Liew,Niacin,938,positive,1,1,123.11,0.4,50.2,3,1,9,C1=CC(=CN=C1)C(=O)O,,
1551,LIverTox,Pexidartinib,25151352,B,1,1,417.8,4.5,66.5,7,2,29,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,.,
3626,Liew,Lazabemide,71307,positive,0,0,199.64,0.2,68,3,2,13,C1=CC(=NC=C1Cl)C(=O)NCCN,,
1610,LIverTox,Psoralen,6199,C,1,1,186.16,2.3,39.4,3,0,14,C1=CC(=O)OC2=CC3=C(C=CO3)C=C21,.,
3310,Liew,Chloroxine,2722,negative,0,0,214.04,3.5,33.1,2,1,13,C1=CC2=C(C(=C(C=C2Cl)Cl)O)N=C1,,
3954,Liew,Sertaconazole,65863,positive,0,0,437.8,6.3,55.3,3,0,27,C1=CC2=C(C(=C1)Cl)SC=C2COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl,,
3317,Liew,Chlorzoxazone,2733,positive,1,1,169.56,1.8,38.3,2,1,11,C1=CC2=C(C=C1Cl)NC(=O)O2,,
672,DILIrank,riluzole,5070,vMost-DILI-Concern,1,1,234.2,3.6,76.4,7,1,15,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,CYP1A2,
2111,Greene,Flufenamic Acid (Flufenamate),3371,WE,1,1,281.23,5.2,49.3,6,2,20,C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F,"	Hydroxylation, glucuronidation",
3949,Liew,Salsalate,5161,positive,1,1,258.23,3,83.8,5,2,19,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O,,
746,DILIrank,glafenine,3474,vMost-DILI-Concern,1,1,372.8,3.5,91.7,6,3,26,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC(=CC3=NC=C2)Cl,.,
1430,LIverTox,Mitotane,4211,E*,0,0,320,6.2,0,0,0,18,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,.,
3648,Liew,Lorazepam,3958,positive,1,1,321.2,2.4,61.7,3,2,21,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,,
233,DILIrank,deferasirox,214348,vMost-DILI-Concern,1,1,373.4,3.8,109,6,3,28,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O,Liver glucuronidation,
2048,Greene,"diclofenac (BMS, reactive metabolite)",3033,HH,1,1,296.1,4.4,49.3,3,2,19,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,,
693,DILIrank,aceclofenac,71771,vLess-DILI-Concern,1,1,354.2,4.3,75.6,5,2,23,C1=CC=C(C(=C1)CC(=O)OCC(=O)O)NC2=C(C=CC=C2Cl)Cl,.,
1952,Greene,Bromobenzene,7961,HH,1,1,157.01,3,0,0,0,7,C1=CC=C(C=C1)Br,.,
3755,Liew,Nepafenac,151075,negative,0,0,254.28,1.9,86.2,3,2,19,C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N,,
2574,Xu,Clotrimazole,2812,Negative,0,1,344.8,5,17.8,1,0,25,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,Liver,
3728,Liew,Modafinil,4236,positive,1,1,273.4,1.7,79.4,3,1,19,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,,
1427,LIverTox,Mirabegron,9865528,E*,0,0,396.5,2.1,129,6,4,28,C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,"Liver via direct glucuronidation, amide hydrolysis, and minimal oxidative metabolism in vivo by CYP2D6 and CYP3A4. Some involvement of butylcholinesterase",
1189,LIverTox,Felbamate,3331,B,1,1,238.24,0.6,105,4,2,17,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,Liver,
1224,LIverTox,Fosphenytoin,56339,A,1,1,362.27,0.6,116,6,3,25,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3,Liver,
2762,Xu,phenytoin,1775,Positive,1,1,252.27,2.5,58.2,2,2,19,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,Liver,
1512,LIverTox,Oxaprozin,4614,C,1,1,293.3,4.2,63.3,4,1,22,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,Liver?65% oxidation and 35% glucuronic acid conjugation. 5% are active phenolic metabolites.,
3491,Liew,Fenbufen,3335,positive,0,0,254.28,3.2,54.4,3,1,19,C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)CCC(=O)O,,
3497,Liew,Fentiazac,28871,positive,0,0,329.8,5.2,78.4,4,1,22,C1=CC=C(C=C1)C2=NC(=C(S2)CC(=O)O)C3=CC=C(C=C3)Cl,,
3794,Liew,Oxazepam,4616,positive,0,0,286.71,2.2,61.7,3,2,20,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,Liver,
1803,LIverTox,Triamterene,5546,D,1,1,253.26,1,130,7,3,19,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,hydroxylation to para-hydroxytriamterene,
494,DILIrank,cinchophen,8593,vMost-DILI-Concern,1,1,249.26,3.4,50.2,3,1,19,C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2)C(=O)O,.,
3838,Liew,Phenindione,4760,positive,1,1,222.24,2.9,34.1,2,0,17,C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O,,
133,DILIrank,pemoline,4723,vMost-DILI-Concern,1,1,176.17,0.9,64.7,2,1,13,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,	Liver,
3835,Liew,Phenacemide,4753,positive,0,0,178.19,0.9,72.2,2,2,13,C1=CC=C(C=C1)CC(=O)NC(=O)N,,
3222,Liew,Bendroflumethiazide,2315,positive,1,1,421.4,1.2,135,10,3,27,C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2,,
1558,LIverTox,Phenylbutyrate,5258,E,0,0,186.18,,40.1,2,0,13,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+],Liver and kidney to phenylacetic acid,
3868,Liew,Pranlukast,4887,positive,0,0,481.5,4.2,119,7,2,36,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5,CYP3A4,
3948,Liew,Salmeterol,5152,negative,0,0,415.6,3.9,82,5,4,30,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,CYP3A4,
2757,Xu,phenelzine,3675,Negative,0,1,136.19,1.2,38,2,2,10,C1=CC=C(C=C1)CCNN,Liver,
446,DILIrank,bendazac,2313,vMost-DILI-Concern,1,1,282.29,3.1,64.4,4,1,21,C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)OCC(=O)O,.,
635,DILIrank,nialamide,4472,vMost-DILI-Concern,1,1,298.34,0.9,83.1,4,3,22,C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2,.,
914,LIverTox,Benznidazole,31593,D,1,1,260.25,0.9,92.7,4,1,19,C1=CC=C(C=C1)CNC(=O)CN2C=CN=C2[N+](=O)[O-],Liver,
3231,Liew,Benzthiazide,2343,negative,0,0,431.9,1.7,161,7,2,26,C1=CC=C(C=C1)CSCC2=NS(=O)(=O)C3=CC(=C(C=C3N2)Cl)S(=O)(=O)N,,
1546,LIverTox,Perampanel,9924495,E,0,0,349.4,3.4,57,3,0,27,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,"Liver, mostly via CYP3A4 and/or CYP3A5",
1851,LIverTox,Vorinostat,5311,E,0,0,264.32,1.9,78.4,3,3,19,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,"Liver glucuronidation and ??-oxidation
CYP system not involved",
908,LIverTox,Belinostat,6918638,D,1,1,318.3,1.7,104,5,3,22,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO,UGT1A1,
3645,Liew,Lonidamine,39562,positive,0,0,321.2,4.3,55.1,3,1,21,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,,
3409,Liew,Dihydralazine,10230,positive,0,0,190.21,0.2,102,6,4,14,C1=CC=C2C(=C1)C(=NN=C2NN)NN,,
96,DILIrank,zonisamide,5734,vLess-DILI-Concern,1,1,212.23,0.2,94.6,5,1,14,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,Liver throug CYP3A4,
3516,Liew,Fluorescein,16850,negative,0,0,332.3,3.4,76,5,2,25,C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O,,
1947,Greene,Bismuth Subsalicylate,16682734,NE,0,0,363.1,,36.5,4,1,12,C1=CC=C2C(=C1)C(=O)O[Bi]O2.O,.,
3804,Liew,Oxyphenisatin,31315,positive,1,1,317.3,3.2,69.6,3,3,24,C1=CC=C2C(=C1)C(C(=O)N2)(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O,,
1969,Greene,carbamazepine,2554,HH,1,1,236.27,2.5,46.3,1,1,18,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,CYP3A4,
1280,LIverTox,Hydralazine,3637,A,1,1,160.18,0.7,63.8,4,2,12,C1=CC=C2C(=C1)C=NN=C2NN,Liver,
1762,LIverTox,Thiabendazole,5430,ND,.,1,201.25,2.5,69.8,3,1,14,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,GI tract,
2365,Greene,phenothiazine,7108,HH,1,1,199.27,4.2,37.3,2,1,14,C1=CC=C2C(=C1)NC3=CC=CC=C3S2,.,
3981,Liew,Sulfapyridine,5336,positive,0,0,249.29,0,93.5,5,2,17,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N,,
2801,Xu,Sulfasalazine,5339,Positive,1,1,398.4,-0.7,150,9,3,28,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,.,
3469,Liew,Etanidazole,3276,positive,0,0,214.18,-1.3,113,5,2,15,C1=CN(C(=N1)[N+](=O)[O-])CC(=O)NCCO,,
588,DILIrank,gemcitabine,60750,vMost-DILI-Concern,1,1,263.2,-1.5,108,6,3,18,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,.,
3361,Liew,Cytarabine,6253,positive,1,1,243.22,-2.1,129,5,4,17,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,,
1010,LIverTox,Cidofovir,60613,E,0,0,279.19,-3.6,146,6,4,18,C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O,.,
439,DILIrank,zoledronate,68740,vLess-DILI-Concern,1,1,272.09,-4.3,153,8,5,16,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,	Nil,
3901,Liew,Pyrazinamide,1046,positive,1,1,123.11,-0.6,68.9,3,1,9,C1=CN=C(C=N1)C(=O)N,Liver,
84,DILIrank,sulfadiazine,5215,vLess-DILI-Concern,1,1,250.28,-0.1,106,6,2,17,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,Liver acetylation,
3959,Liew,Silver sulfadiazine,441244,negative,0,0,357.14,,95.3,6,1,18,C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Ag+],,
823,LIverTox,Amifampridine,5918,E,0,0,109.13,-0.5,64.9,3,2,8,C1=CN=CC(=C1N)N,Acetylation to 3-N-acetyl??amifampridine,
2159,Greene,isoniazid,3767,HH,1,1,137.14,-0.7,68,3,2,10,C1=CN=CC=C1C(=O)NN,"liver; CYP450: 2C19, 3A4 inhibitor",
1912,Greene,Amrinone,3698,HH,1,1,187.2,-0.2,68,3,2,14,C1=CN=CC=C1C2=CNC(=O)C(=C2)N,Liver,
1063,LIverTox,Dalfampridine,	1727,E*,0,0,94.11,0.3,38.9,2,1,7,C1=CN=CC=C1N,.,
2663,Xu,Furosemide,3440,Positive,1,1,330.74,2,131,7,3,21,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,	liver and kidney glucuronidation,
261,DILIrank,ticrynafen,38409,vMost-DILI-Concern,1,1,331.2,4.1,91.8,5,1,20,C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)OCC(=O)O)Cl)Cl,Liver,
4004,Liew,Tenidap,60712,positive,1,1,320.8,3.8,114,4,2,21,C1=CSC(=C1)C(=O)C2=C(N(C3=C2C=C(C=C3)Cl)C(=O)N)O,,
2832,Xu,Vidarabine,21704,Negative,0,0,267.24,-1.1,140,8,4,19,C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N,"Liver: CYP2C9, 2C19, 2C8, 2C18, 1A2,3A4",
461,DILIrank,adefovir,60172,vLess-DILI-Concern,1,0,273.19,-2,136,8,3,18,C1=NC(=C2C(=N1)N(C=N2)CCOCP(=O)(O)O)N,.,
1925,Greene,Azacytidine,9444,HH,1,0,244.2,-2.2,141,5,4,17,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,.,
2410,Greene,Ribavirin,37542,E*,0,0,244.2,-1.8,144,7,4,17,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,liver and intracellularly,
1207,LIverTox,Flucytosine,3366,D,1,1,129.09,-0.9,67.5,3,2,9,C1=NC(=O)NC(=C1F)N,"minimal, in the GI tract",
2813,Xu,Thioguanine,2723601,Positive,1,1,167.19,-0.1,111,2,3,11,C1=NC2=C(N1)C(=S)N=C(N2)N,	Intracellular,
3676,Liew,Mercaptopurine,667490,positive,1,1,152.18,0,85.2,2,2,10,C1=NC2=C(N1)C(=S)N=CN2,,
3819,Liew,Penciclovir,135398748,negative,0,1,253.26,-1.9,126,5,4,18,C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N,"CYP3A4(major), CYP2C9(minor)",
3144,Liew,Acyclovir,2022,positive,1,1,225.2,-1.6,115,4,3,16,C1=NC2=C(N1COCCO)NC(=NC2=O)N,,
3335,Liew,Clofarabine,119182,positive,1,1,303.68,0.9,119,8,3,20,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,,
574,DILIrank,fludarabine,657237,vNo-DILI-Concern,0,0,285.23,-0.6,140,9,4,20,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,.,
21,DILIrank,allopurinol,135401907,vMost-DILI-Concern,1,1,136.11,-0.7,70.1,3,2,10,C1=NNC2=C1C(=O)NC=N2,"	liver 80% oxipurinol, 10% allopurinol ribosides",
3274,Liew,Cefaclor,51039,positive,1,1,367.8,-1.8,138,6,3,24,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,,
464,DILIrank,cefaclor,51038,vLess-DILI-Concern,1,1,385.8,,139,7,4,25,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl.O,15% to 40%,
3283,Liew,Cefonicid,43594,positive,0,0,542.6,-1.9,264,13,4,35,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)O)C(=O)O)CSC4=NN=NN4CS(=O)(=O)O,,
3290,Liew,Cefsulodin,5284530,positive,0,0,532.6,0.2,225,9,3,36,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)S(=O)(=O)O)C(=O)[O-])C[N+]4=CC=C(C=C4)C(=O)N,,
3285,Liew,Ceforanide,43507,positive,0,0,519.6,-3.2,244,12,4,35,C1C(=C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3CN)C(=O)O)CSC4=NN=NN4CC(=O)O,,
3572,Liew,Halazepam,31640,negative,0,0,352.7,4,32.7,5,0,24,C1C(=O)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3)CC(F)(F)F,,
2613,Xu,Dantrolene Sodium,2952,Positive,1,1,314.25,1.7,121,6,1,23,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-],	Liver,
67,DILIrank,nitrofurantoin,6604200,vMost-DILI-Concern,1,1,238.16,-0.5,121,6,1,17,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],Liver 75%,
1026,LIverTox,Clonazepam,2802,D,1,1,315.71,2.4,87.3,4,1,22,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,CYP3A,
3904,Liew,Quazepam,4999,negative,0,0,386.8,4,47.7,6,0,25,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,Liver,
4097,Liew,Voglibose,444020,positive,0,0,267.28,-4.1,154,8,8,18,C1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO,,
250,DILIrank,neomycin,8378,vNo-DILI-Concern,0,0,614.6,-9,353,19,13,42,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N,,
2685,Xu,Kanamycin Sulfate,6032,Negative,0,0,484.5,-6.9,283,15,11,33,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N,	Unknown,
4039,Liew,Tobramycin,36294,positive,1,1,467.5,-6.2,268,14,10,32,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,,
3812,Liew,Paromomycin,441375,negative,1,1,713.7,,430,23,15,47,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O,,
3171,Liew,Amikacin,37768,positive,0,0,585.6,-7.9,332,17,13,40,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N,,
1418,LIverTox,Migalastat,176077,E,0,0,163.17,-2.3,93,5,5,11,C1C(C(C(C(N1)CO)O)O)O,.,
1419,LIverTox,Miglitol,441314,E,0,0,207.22,-2.6,104,6,5,14,C1C(C(C(C(N1CCO)CO)O)O)O,Nil,
4060,Liew,Trifluridine,6256,negative,0,0,296.2,-0.5,99.1,8,3,20,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,Thymidine phosphorylase,
3505,Liew,Floxuridine,5790,positive,1,1,246.19,-1.2,99.1,6,3,17,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,,
2678,Xu,Idoxuridine,5905,Positive,1,1,354.1,-1,99.1,5,3,17,C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O,.,
1072,LIverTox,Decitabine,451668,E*,0,0,228.21,-1.2,121,4,3,16,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,.,
2010,Greene,Cladribine,20279,NE,0,0,285.69,0.8,119,7,3,19,C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O,"Mostly via intracellular kinases; 15-18% is excreted unchanged.Intravenous and subcutaneous bolus injection: 15-18% is excreted unchangedAfter oral administration, 25% ??21% of dose is excreted unchanged in urine and 3.8% as a metabolite.",
653,DILIrank,pentostatin,439693,vMost-DILI-Concern,1,1,268.27,-2.1,112,6,4,19,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,"Liver, minor",
686,DILIrank,tranylcypromine,19493,vLess-DILI-Concern,1,1,133.19,1.5,26,1,1,10,C1C(C1N)C2=CC=CC=C2,Liver,
2162,Greene,Isosorbide dinitrate,6883,NE,0,0,236.14,1.3,129,8,0,16,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],	Liver,
1078,LIverTox,Delafloxacin,487101,E*,0,0,440.8,2.7,120,11,3,30,C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O,.,
1527,LIverTox,Pasireotide,9941444,E*,0,0,1047.2,4.7,281,11,9,77,C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,.,
1588,LIverTox,Pretomanid,456199,D,1,1,359.26,2.8,91.3,9,0,25,C1C(COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F,.,
2177,Greene,Leucovorin Calcium,6006,NE,0,0,473.4,-1.2,216,9,7,34,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,.,
1037,LIverTox,Colestipol,62816,E,0,0,281.83,,101,6,5,18,C1C(O1)CCl.C(CNCCNCCNCCN)N,.,
1887,Greene,acivicin,294641,NE,0,0,178.57,-2.7,84.9,5,2,11,C1C(ON=C1Cl)C(C(=O)O)N,.,
3190,Liew,Anagrelide,135409400,negative,0,1,256.08,1.6,44.7,2,1,16,C1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3,,
426,DILIrank,oxcarbazepine,34312,vLess-DILI-Concern,1,1,252.27,1.7,63.4,2,1,19,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,Liver cytosolic enzymes and glucuronic acid,
545,DILIrank,estazolam,3261,vNo-DILI-Concern,0,0,294.74,1.7,43.1,3,0,21,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,Liver,
2537,Xu,Biotin,171548,Negative,0,0,244.31,0.3,104,4,3,16,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,.,
3454,Liew,Epinastine,3241,negative,0,0,249.31,3.5,41.6,1,1,19,C1C2C3=CC=CC=C3CC4=CC=CC=C4N2C(=N1)N,,
3151,Liew,Aldrin,2087,positive,0,0,364.9,4.5,0,0,0,18,C1C2C=CC1C3C2C4(C(=C(C3(C4(Cl)Cl)Cl)Cl)Cl)Cl,,
3357,Liew,Cyclothiazide,2910,negative,0,0,389.9,2,135,7,3,24,C1C2CC(C1C=C2)C3NC4=CC(=C(C=C4S(=O)(=O)N3)S(=O)(=O)N)Cl,,
1677,LIverTox,Saxagliptin,11243969,E*,0,0,315.4,0.7,90.4,4,2,23,C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N,"CYP3A4, CYP3A5",
3425,Liew,Dolasetron,60654,positive,0,0,324.4,3.4,62.4,4,1,24,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,,
3165,Liew,Amantadine,2130,positive,0,0,151.25,2.4,26,1,1,11,C1C2CC3CC1CC(C2)(C3)N,,
2507,Xu,Amantadine HCl,64150,Negative,0,0,187.71,,26,1,2,12,C1C2CC3CC1CC(C2)(C3)N.Cl,	Minimal mostly to acetyl metabolites,
4088,Liew,Varenicline,5310966,negative,1,1,211.26,0.8,37.8,3,1,16,C1C2CNCC1C3=CC4=NC=CN=C4C=C23,,
3416,Liew,Diphenidol,9175,negative,0,0,280.4,4,0,0,0,22,C1C=C2C=C3C=CC=CC3=CC2=C4C1C=C5C=CC=CC5=C4,,
3647,Liew,Loracarbef,5284584,positive,0,0,367.78,,114,6,4,25,C1CC(=C(N2C1C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl.O,,
3767,Liew,Nitisinone,115355,negative,0,0,329.23,2.3,97,8,0,23,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],,
1321,LIverTox,Ivosidenib,71657455,E*,0,0,583,3.4,119,9,1,41,C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,.,
1577,LIverTox,Pomalidomide,134780,D,1,1,273.24,0.2,110,5,2,20,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,Liver mostly CYP1A2- and CYP3A4-mediated; some minor contributions by CYP2C19 and CYP2D6,
197,DILIrank,thalidomide,5426,vLess-DILI-Concern,1,1,258.23,0.3,83.6,4,1,19,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,Liver minimally via CYP2C19-mediated 5-hydroxylation; mostly via non-enzymatic hydrolysis at the four amide sites,
3628,Liew,Lenalidomide,216326,positive,1,1,259.26,-0.5,92.5,4,2,19,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,,
3201,Liew,Aripiprazole,60795,negative,1,1,448.4,4.6,44.8,4,1,30,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,Liver mostly via CYP3A4 and 2D6,
34,DILIrank,carboplatin,498142,vLess-DILI-Concern,1,1,371.25,,76.6,6,4,13,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt],.,
633,DILIrank,nalbuphine,5311304,vNo-DILI-Concern,0,0,357.4,0.2,73.2,5,3,26,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,	Liver glucuronidation,
4017,Liew,Tetrahydrozoline,5419,negative,0,0,200.28,1.8,24.4,1,1,15,C1CC(C2=CC=CC=C2C1)C3=NCCN3,,
3547,Liew,Gadofosveset,158440,positive,0,0,975.9,,270,18,1,56,C1CC(CCC1OP(=O)([O-])OCC(CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-])(C2=CC=CC=C2)C3=CC=CC=C3.O.[Na+].[Na+].[Na+].[Gd+3],,
1475,LIverTox,Niraparib,24958200,E*,0,0,320.4,2.2,72.9,3,2,24,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,Carboxylesterases,
171,DILIrank,protirelin,638678,vNo-DILI-Concern,0,0,362.38,-2.5,150,5,4,26,C1CC(N(C1)C(=O)C(CC2=CN=CN2)NC(=O)C3CCC(=O)N3)C(=O)N,.,
1359,LIverTox,Lisinopril,5362119,B,1,1,405.5,-2.9,133,7,4,29,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,,
768,DILIrank,Argipressin,644077,vNo-DILI-Concern,0,0,1084.2,-4.8,515,16,14,75,C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N,	Predominantly in the liver and kidneys,
1341,LIverTox,Larotrectinib,46188928,E*,0,0,428.4,1.7,86,7,2,31,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,.,
2490,Greene,Zalcitabine,24066,NE,0,0,211.22,-1.3,88.2,3,2,15,C1CC(OC1CO)N2C=CC(=NC2=O)N,Liver,
2050,Greene,Didanosine,135398739,HH,1,1,236.23,-1.2,88.7,5,2,17,C1CC(OC1CO)N2C=NC3=C2N=CNC3=O,.,
1134,LIverTox,Efavirenz,64139,A,1,1,315.67,4,38.3,5,1,21,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,"CYP2A6,CYP2B6",
1495,LIverTox,Olaparib,23725625,E,0,0,434.5,1.9,82.1,5,1,32,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,.,
1346,LIverTox,Lesinurad,56928182,E,0,0,426.3,,96.1,5,0,25,C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)[O-].[Na+],CYP2C9,
1571,LIverTox,Pitavastatin,	5282452,D,1,1,421.5,3.5,90.6,6,3,31,C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)O)O)O)C4=CC=C(C=C4)F,"Liver CYP2C9, minimally",
3870,Liew,Prazepam,4890,negative,0,0,324.8,3.6,32.7,2,0,23,C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4,Liver,
1660,LIverTox,Roflumilast,449193,E,0,0,403.2,4.6,60.4,6,1,26,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,"CYP1A2, CYP3A4",
2013,Greene,clinafloxacin,60062,WE,1,1,402.2,,86.9,7,3,26,C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)Cl)N4CCC(C4)N)F)C(=O)O.Cl,.,
2561,Xu,Ciprofloxacin HCl,2764,Positive,1,1,331.34,-1.1,72.9,7,2,24,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,	Liver incl. CYP1A2,
783,LIverTox,Abacavir,441300,C,1,1,286.33,0.9,102,6,3,21,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,Liver,
438,DILIrank,desloratadine,124087,vLess-DILI-Concern,1,1,310.8,4.5,24.9,2,1,22,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,"UGT2B10, CYP2C8",
1458,LIverTox,Nebivolol,71301,E,0,0,405.4,3,71,7,3,29,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O,CYP2D6,
1900,Greene,Amineptine HCl,34870,HH,1,1,337.5,2.1,49.3,3,2,25,C1CC2=CC=CC=C2C(C3=CC=CC=C31)NCCCCCCC(=O)O,.,
400,DILIrank,eptifibatide,123610,vNo-DILI-Concern,0,0,832,-2.4,377,12,10,57,C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N,.,
4064,Liew,Trimethaphan,23576,negative,0,0,365.5,3.6,24.6,1,0,26,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5,,
927,LIverTox,Bictegravir,90311989,E*,0,0,449.4,2.7,99.2,9,2,32,C1CC2CC1N3C(O2)CN4C=C(C(=O)C(=C4C3=O)O)C(=O)NCC5=C(C=C(C=C5F)F)F,.,
3807,Liew,Palonosetron,148211,positive,0,0,296.4,2.8,23.6,2,0,22,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5,"CYP2D6, CYP3A4, CYP1A2",
1376,LIverTox,Lurasidone,213046,E,0,0,492.7,5.4,85,6,0,35,C1CCC(C(C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)C6C7CCC(C7)C6C5=O,CYP3A4,
1511,LIverTox,Oxaliplatin,77994,A,1,1,397.29,,132,6,2,15,C1CCC(C(C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+2],.,
1669,LIverTox,Ruxolitinib,25126798,C,1,1,306.4,2.1,83.2,4,1,23,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,CYP3A4,
1553,LIverTox,Phencyclidine,6468,C[HD],1,1,243.4,3.6,3.2,1,0,18,C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3,"Oxidative hydroxylation in liver by CYP450 enzymes, glucuronidation",
157,DILIrank,gabapentin,3446,vLess-DILI-Concern,1,1,171.24,-1.1,63.3,3,2,12,C1CCC(CC1)(CC(=O)O)CN,Not significantly metabolized,
2278,Greene,perhexiline,4746,HH,1,1,277.5,6.8,12,1,1,20,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,	Saturable Liver,
762,DILIrank,procyclidine,207841,vNo-DILI-Concern,0,0,323.9,,23.5,2,2,22,C1CCC(CC1)C(CCN2CCCC2)(C3=CC=CC=C3)O.Cl,.,
4061,Liew,Trihexyphenidyl,5572,negative,0,0,301.5,4.5,23.5,2,1,22,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O,,
1011,LIverTox,Cilostazol,2754,E,0,0,369.5,3.1,81.9,5,1,27,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,"CYP3A4 ,CYP2C19",
3644,Liew,Lomustine,3950,negative,1,1,233.69,2.8,61.8,3,1,15,C1CCC(CC1)NC(=O)N(CCCl)N=O,,
1957,Greene,buspirone,2477,NE,0,0,385.5,2.6,69.6,6,0,28,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,CYP3A4,
956,LIverTox,Butorphanol,5361092,ND,.,0,327.5,3.8,43.7,3,2,24,C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,hydroxylated & glucuronidated,
3568,Liew,Guanadrel,38521,negative,0,0,213.28,0,82.9,3,2,15,C1CCC2(CC1)OCC(O2)CN=C(N)N,,
3225,Liew,Bentazepam,34592,positive,1,1,296.4,3.1,66.8,3,1,21,C1CCC2=C(C1)C3=C(NCC(=O)N=C3S2)C4=CC=CC=C4,,
1733,LIverTox,Tacrine,1935,A,1,1,198.26,2.7,38.9,2,1,15,C1CCC2=NC3=CC=CC=C3C(=C2C1)N,CYP1A2,
3569,Liew,Guanethidine,3518,negative,0,0,198.31,0.5,67.6,2,2,14,C1CCCN(CCC1)CCN=C(N)N,,
3858,Liew,Piretanide,4849,positive,0,0,362.4,2.2,118,7,2,25,C1CCN(C1)C2=C(C(=CC(=C2)C(=O)O)S(=O)(=O)N)OC3=CC=CC=C3,,
3723,Liew,Minoxidil,4201,positive,0,0,209.25,1.2,88.9,3,3,15,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,,
3418,Liew,Dipyridamole,3108,negative,0,0,504.6,0.7,145,12,4,36,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,,
3945,Liew,Roxatidine,91276,positive,0,0,306.4,1.5,61.8,4,2,22,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)CO,Liver,
3240,Liew,Biperiden,2381,negative,0,0,311.5,4.3,23.5,2,1,23,C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O,,
3912,Liew,Raloxifene,5035,positive,0,0,473.6,6.1,98.2,6,2,34,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,Liver,
614,DILIrank,mefloquine,40692,vLess-DILI-Concern,1,1,378.31,3.6,45.2,9,2,26,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,Extensive liver; main metabolite is inactive,
1032,LIverTox,Cobimetinib,16222096,D,1,1,531.3,3.9,64.6,7,3,30,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,Intestinal and low Liver clearance mostly CYP3A4 oxidation and UGT2B7 glucuronidation,
570,DILIrank,flecainide,3356,vLess-DILI-Concern,1,1,414.34,3.8,59.6,10,2,28,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,CYP2D6,
1816,LIverTox,Trospium,107979,E,0,0,428,,46.5,4,1,30,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-],.,
476,DILIrank,darifenacin,444031,vNo-DILI-Concern,0,0,426.5,4.6,55.6,3,1,32,C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5,"CYP2D6,CYP3A4",
2816,Xu,Ticlopidine,5472,Positive,1,1,263.8,3.6,31.5,2,0,17,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,Liver,
3437,Liew,Droperidol,3168,negative,0,0,379.4,3.5,52.6,4,1,28,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,,
3820,Liew,Penfluridol,33630,negative,0,0,524,7.3,23.5,7,1,36,C1CN(CCC1(C2=CC(=C(C=C2)Cl)C(F)(F)F)O)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,,
185,DILIrank,haloperidol,3559,vLess-DILI-Concern,1,1,375.9,3.2,40.5,4,1,26,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,Liver-mediated,
2117,Greene,Fluspirilene,3396,HH,1,1,475.6,5.6,35.6,5,1,35,C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,,
296,DILIrank,pipamazine,6761,vMost-DILI-Concern,1,1,402,4.4,74.9,4,1,27,C1CN(CCC1C(=O)N)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,.,
657,DILIrank,pimozide,16362,vNo-DILI-Concern,0,0,461.5,6.3,35.6,4,1,34,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,"CYP3A4, CYP1A2,CYP2D6",
1362,LIverTox,Lomitapide,9853053,C,1,1,693.7,8.6,61.4,9,2,50,C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F,.,
3831,Liew,Periciazine,4747,positive,0,0,365.5,3.5,75.8,5,1,26,C1CN(CCC1O)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C#N,Liver,
831,LIverTox,Amoxapine,2170,E,0,0,313.8,2.6,36.9,3,1,22,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,Liver cytochrome P450 system,
3854,Liew,Pipobroman,4842,negative,0,0,356.05,0.4,40.6,2,0,16,C1CN(CCN1C(=O)CCBr)C(=O)CCBr,,
567,DILIrank,fipexide,3351,vMost-DILI-Concern,1,1,388.8,3.2,51.2,5,0,27,C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C(=O)COC4=CC=C(C=C4)Cl,.,
3859,Liew,Piribedil,4850,positive,0,0,298.34,1.8,50.7,6,0,22,C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C4=NC=CC=N4,Liver,
3512,Liew,Flunarizine,941361,negative,0,0,404.5,6,6.5,4,0,30,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,,
406,DILIrank,ziprasidone,60854,vLess-DILI-Concern,1,1,412.9,4,76.7,5,1,28,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,Liver aldehyde reductase,
1839,LIverTox,Vilazodone,6918314,E*,0,0,441.5,4,102,5,2,33,C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N,CYP3A4,
944,LIverTox,Brexpiprazole,11978813,E,0,0,433.6,4.7,73,5,1,31,C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4,Liver mainly mediated by CYP3A4 and CYP2D6,
687,DILIrank,trazodone,5533,vLess-DILI-Concern,1,1,371.9,2.8,42.4,4,0,26,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,"CYP3A4, CYP2D6, CYP1A2",
3785,Liew,Opipramol,9417,positive,1,1,363.5,3.6,30,4,1,27,C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO,CYP2D6,
3793,Liew,Oxatomide,4615,positive,0,0,426.6,4.1,38.8,3,1,32,C1CN(CCN1CCCN2C3=CC=CC=C3NC2=O)C(C4=CC=CC=C4)C5=CC=CC=C5,,
3521,Liew,Fluphenazine,3372,positive,1,1,437.5,4.4,55.2,8,1,30,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,,
654,DILIrank,perphenazine,4748,vLess-DILI-Concern,1,1,404,4.2,55.2,5,1,27,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,Liver,
1204,LIverTox,Flibanserin,6918248,E*,0,0,390.4,3.3,38.8,6,1,28,C1CN(CCN1CCN2C3=CC=CC=C3NC2=O)C4=CC=CC(=C4)C(F)(F)F,Extensive by liver mainly by CYP3A4 and CYP2C19,
3299,Liew,Cetirizine,2678,positive,1,1,388.9,1.7,53,5,1,27,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,,
598,DILIrank,hydroxyzine,3658,vNo-DILI-Concern,0,0,374.9,3.7,35.9,4,1,26,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Liver,
145,DILIrank,quetiapine,5002,vLess-DILI-Concern,1,1,383.5,2.1,73.6,5,1,27,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,Liver via CYP3A4-catalysed sulfoxidation to its active metabolite norquetiapine N-desalkylquetiapine,
232,DILIrank,ifosfamide,3690,vLess-DILI-Concern,1,1,261.08,0.9,41.6,4,1,14,C1CN(P(=O)(OC1)NCCCl)CCCl,Liver,
1767,LIverTox,Thiotepa,5453,D,1,1,189.22,0.5,41.1,4,0,11,C1CN1P(=S)(N2CC2)N3CC3,"CYP2B6, CYP3A",
3617,Liew,Ketorolac,3826,positive,1,1,255.27,1.9,59.3,3,1,19,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,,
3660,Liew,Mazindol,4020,negative,0,0,284.74,2.2,35.8,2,1,20,C1CN2C(=N1)C3=CC=CC=C3C2(C4=CC=C(C=C4)Cl)O,,
510,DILIrank,sitagliptin,4369359,vLess-DILI-Concern,1,1,407.31,0.7,77,10,1,28,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N,"CYP3A4,CYP2C8",
1708,LIverTox,Solifenacin,154059,D,1,1,362.5,4,32.8,3,0,27,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5,CYP3A4,
3746,Liew,Naphazoline,4436,negative,0,0,210.27,2.1,24.4,1,1,16,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32,,
4041,Liew,Tolazoline,5504,positive,0,0,160.22,2.6,24.4,1,1,12,C1CN=C(N1)CC2=CC=CC=C2,,
3246,Liew,Brimonidine,2435,negative,0,0,292.13,0.6,62.2,3,2,17,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,,
3196,Liew,Apraclonidine,2216,negative,0,0,245.11,1.3,62.4,2,3,15,C1CN=C(N1)NC2=C(C=C(C=C2Cl)N)Cl,,
1782,LIverTox,Tizanidine,5487,C,1,1,253.71,1.1,90.4,4,2,16,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,"Liver CYP1A2, 95%",
2750,Xu,Paroxetine,43815,Negative,0,1,329.4,3.5,39.7,5,1,24,C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,"Extensive, liver mostly CYP2D6-mediated",
379,DILIrank,fenoldopam,3341,vNo-DILI-Concern,0,0,305.75,2.4,72.7,4,4,21,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,	Liver CYP not involved,
770,DILIrank,plerixafor,65015,vNo-DILI-Concern,0,0,502.8,0,78.7,8,6,36,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,,
6,DILIrank,cyclophosphamide,2907,vLess-DILI-Concern,1,1,261.08,0.6,41.6,4,1,14,C1CNP(=O)(OC1)N(CCCl)CCCl,Liver,
2662,Xu,Furazolidone,3435,Positive,1,1,225.16,-0.1,101,6,0,16,C1COC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],.,
1657,LIverTox,Rivaroxaban,6433119,A,1,1,435.9,2.5,116,6,1,29,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,"CYP3A4, CYP2J2",
3733,Liew,Morniflumate,72106,negative,0,0,395.4,3.7,63.7,9,1,28,C1COCCN1CCOC(=O)C2=C(N=CC=C2)NC3=CC=CC(=C3)C(F)(F)F,,
3631,Liew,Levamisole,26879,positive,0,0,204.29,1.8,40.9,2,0,14,C1CSC2=NC(CN21)C3=CC=CC=C3,,
794,LIverTox,Aclidinium,11519741,E,0,0,564.6,,112,7,1,34,C1C[N+]2(CCC1C(C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5.[Br-],Ester hydrolysis,
2144,Greene,Hydrochlorothiazide,3639,HH,1,1,297.7,-0.1,135,7,3,17,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,	Not significant,
1451,LIverTox,Nalmefene,5284594,E,0,0,339.4,2.7,52.9,4,2,25,C=C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O,Liver,
1861,LIverTox,Zanubrutinib,135565884,E*,0,0,471.5,3.5,103,5,2,35,C=CC(=O)N1CCC(CC1)C2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N,.,
1290,LIverTox,Ibrutinib,24821094,D,1,1,440.5,3.6,99.2,6,1,33,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,"CYP3A,CYP2D6",
4094,Liew,Vigabatrin,5665,positive,1,1,129.16,-2.2,63.3,3,2,9,C=CC(CCC(=O)O)N,,
3278,Liew,Cefdinir,6915944,positive,1,1,395.4,0,212,10,4,26,C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O,,
417,DILIrank,sevelamer,3085017,vNo-DILI-Concern,0,0,149.62,,38.6,2,1,9,C=CCN.C1C(O1)CCl,.,polymer
3744,Liew,Naloxone,5284596,negative,0,0,327.4,2.1,70,5,2,24,C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,,
3157,Liew,Almitrine,33887,positive,0,0,477.6,5.6,69.2,9,2,35,C=CCNC1=NC(=NC(=N1)N2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)NCC=C,,
1895,Greene,Allyl alcohol,7858,HH,1,1,58.08,0.2,20.2,1,1,4,C=CCO,,
291,DILIrank,alclofenac,30951,vMost-DILI-Concern,1,1,226.65,2.5,46.5,3,1,15,C=CCOC1=C(C=C(C=C1)CC(=O)O)Cl,.,
787,LIverTox,Acalabrutinib,71226662,D,1,1,465.5,3,119,6,2,35,CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5,.,
3590,Liew,Iloprost,5311181,positive,0,0,360.5,2.8,77.8,4,3,26,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,,
1356,LIverTox,Linagliptin,10096344,D,1,1,472.5,1.9,114,7,1,35,CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,Minimal ~10% metabolized,
1755,LIverTox,Teriflunomide,54684141,D,1,1,270.21,3.3,73.1,6,2,19,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,.,
3453,Liew,Epalrestat,1549120,positive,1,1,319.4,3.8,115,5,1,21,CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)O,,
1051,LIverTox,Cyproterone,5284537,B,1,1,374.9,3.1,54.4,3,1,26,CC(=O)C1(CCC2C1(CCC3C2C=C(C4=CC(=O)C5CC5C34C)Cl)C)O,.,
1294,LIverTox,Iloperidone,71360,E,0,0,426.5,4.1,64.8,7,0,31,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,Liver CYP2D6-mediated hydroxylation and CYP3A4-mediated O-demethylation,
3141,Liew,Acetophenazine,17676,positive,0,0,411.6,2.6,72.3,6,1,29,CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)CCO,,
1883,Greene,Acetohexamide,1989,HH,1,1,324.4,2.4,101,4,2,22,CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2,.,
115,DILIrank,progesterone,5994,vLess-DILI-Concern,1,1,314.5,3.9,34.1,2,0,23,CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,"	Liver CYP2C19, CYP3A4, CYP2C9, 5??-reductase, 3??-HSDTooltip 3??-hydroxysteroid dehydrogenase, 17??-hydroxylase, 21-hydroxylase, 20??-HSDTooltip 20??-hydroxysteroid dehydrogenase",
943,LIverTox,Brexanolone,92786,E,0,0,318.5,4.9,37.3,2,1,23,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,"Non-CYP450 keto-reduction via aldo-keto reductases AKR, glucuronidation via glucuronosyltransferases UGT, sulfation via sulfotransferases SULT",
1880,Greene,Acenocoumarol,9052,HH,1,1,353.3,2.5,109,6,1,26,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,Liver,
2833,Xu,Warfarin,54678486,Negative,0,1,308.3,2.7,63.6,4,1,23,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,"Liver: CYP2C9, 2C19, 2C8, 2C18, 1A2,3A4",
1447,LIverTox,Nabumetone,4409,E*,0,0,228.29,3.1,26.3,2,0,17,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,"Liver, to active metabolite 6-methoxy-2-naphthylacetic acid; 6-MNA",
3827,Liew,Pentoxifylline,4740,positive,1,1,278.31,0.3,75.5,4,0,20,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,Liver,
1075,LIverTox,Deferoxamine,2973,E,0,1,560.7,-2.1,206,9,6,39,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O,.,
3615,Liew,Ketoconazole,3823,positive,1,1,531.4,4.3,69.1,6,0,36,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,,
619,DILIrank,methazolamide,4100,vLess-DILI-Concern,1,1,236.3,0.1,139,6,1,14,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C,.,
1334,LIverTox,Lacosamide,219078,D,1,1,250.29,0.3,67.4,3,2,18,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,.,
2236,Greene,N-acetyl cysteine,12035,NE,0,0,163.2,0.4,67.4,4,3,10,CC(=O)NC(CS)C(=O)O,Liver,
3395,Liew,Diatrizoate,2140,negative,0,0,613.91,1.8,95.5,4,3,20,CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I,,
1873,Greene,2-acetylaminofluorene (2-AAF),5897,HH,1,1,223.27,3.3,29.1,1,1,17,CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2,.,
3179,Liew,Amithiozone,9568512,positive,0,0,236.3,1,112,3,3,16,CC(=O)NC1=CC=C(C=C1)C=NNC(=S)N,,
3139,Liew,Acetaminophen,1983,positive,1,1,151.16,0.5,49.3,2,2,11,CC(=O)NC1=CC=C(C=C1)O,,
2498,Xu,Acetazolamide,1986,Positive,1,1,222.3,-0.3,152,7,2,13,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,	None,
383,DILIrank,enoxaparin,772,vLess-DILI-Concern,1,1,1134.9,-10.8,652,38,15,70,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,.,
3977,Liew,Sulfacetamide,5320,negative,0,0,214.24,-1,97.6,4,2,14,CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N,,
765,DILIrank,norethindrone acetate,5832,vNo-DILI-Concern,0,0,340.5,3.5,43.4,3,0,25,CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C,.,
278,DILIrank,prasugrel hydrochloride,6918456,vLess-DILI-Concern,1,1,373.4,3.6,74.8,6,0,26,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,.,
509,DILIrank,cyclofenil,2898,vMost-DILI-Concern,1,1,364.4,5.5,52.6,4,0,27,CC(=O)OC1=CC=C(C=C1)C(=C2CCCCC2)C3=CC=C(C=C3)OC(=O)C,.,
932,LIverTox,Bisacodyl,2391,E,0,0,361.4,3.8,65.5,5,0,27,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3,CYP450,
3394,Liew,Diacerein,26248,positive,1,1,368.3,1.9,124,8,1,27,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C2=O)C=C(C=C3OC(=O)C)C(=O)O,,
3766,Liew,Nitazoxanide,41684,positive,0,0,307.28,2,142,7,1,21,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],Liver,
2511,Xu,Aminosalicylic Acid,2244,Positive,1,1,180.16,1.2,63.6,4,1,13,CC(=O)OC1=CC=CC=C1C(=O)O,"	Liver CYP2C19 and possibly CYP3A, some is also hydrolysed to salicylate in the gut wall.",
3938,Liew,Rocuronium,441351,negative,0,0,609.7,,59,6,1,39,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-],,
3411,Liew,Diltiazem,39186,positive,1,1,414.5,3.1,84.4,6,0,29,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,,
1274,LIverTox,Heroin,5462328,"E,E",1,1,369.4,1.5,65.1,6,0,27,CC(=O)OC1C=CC2C3CC4=C5C2(C1OC5=C(C=C4)OC(=O)C)CCN3C,Liver,
1166,LIverTox,Eslicarbazepine,179344,D,1,1,296.32,2,72.6,3,1,22,CC(=O)OC1CC2=CC=CC=C2N(C3=CC=CC=C13)C(=O)N,UGT ,
367,DILIrank,vecuronium,39764,vNo-DILI-Concern,0,0,637.7,,55.8,6,0,41,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-],	liver 30%,
3852,Liew,Pipecuronium,65332,negative,0,0,762.7,,59.1,8,0,45,CC(=O)OC1CC2CCC3C(C2(CC1N4CC[N+](CC4)(C)C)C)CCC5(C3CC(C5OC(=O)C)N6CC[N+](CC6)(C)C)C.[Br-].[Br-],,
352,DILIrank,pancuronium,441289,vNo-DILI-Concern,0,0,572.9,6.6,52.6,4,0,41,CC(=O)OC1CC2CCC3C(C2(CC1[N+]4(CCCCC4)C)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C,Liver,
786,LIverTox,Abiraterone,9821849,C,1,1,391.5,5.2,39.2,3,0,29,CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C,"Esterases, CYP3A4, SULT2A1",
2642,Xu,Ethynodiol Diacetate,9270,Positive,1,1,384.5,3.9,52.6,4,0,28,CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C,.,
311,DILIrank,cortisone acetate,5745,vNo-DILI-Concern,0,0,402.5,2.1,97.7,6,1,29,CC(=O)OCC(=O)C1(CCC2C1(CC(=O)C3C2CCC4=CC(=O)CCC34C)C)O,.,
3515,Liew,Fluocinonide,9642,negative,0,0,494.5,3.2,99.1,9,1,35,CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C,,
3168,Liew,Amcinonide,443958,negative,0,0,502.6,3.6,99.1,8,1,36,CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CCC5=CC(=O)C=CC54C)F)O)C)OC6(O2)CCCC6,,
3487,Liew,Famciclovir,3324,positive,0,0,321.33,0,122,8,1,23,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,,
1987,Greene,Cephapirin Sodium,30699,NE,0,0,423.5,-1.1,177,9,2,28,CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)O,,
2500,Xu,Acetylcholine Chloride,187,Negative,0,0,146.21,0.2,26.3,2,0,10,CC(=O)OCC[N+](C)(C)C,ACH,
1712,LIverTox,Spironolactone,5833,D,1,1,416.6,2.9,85.7,5,0,29,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,"Liver, others: Deacetylation via CESTooltip carboxylesterase  S-Oxygenation via FOMTooltip flavin-containing monooxygenase S-Methylation via TMTTooltip thiol S-methyltransferase Dethioacetylation Hydroxylation via CYP3A4  Lactone hydrolysis via PON3",
380,DILIrank,calcium acetate,6116,vNo-DILI-Concern,0,0,158.17,,80.3,4,0,9,CC(=O)[O-].CC(=O)[O-].[Ca+2],.,
766,DILIrank,exametazime,9552069,vNo-DILI-Concern,0,0,742.6,,179,12,8,40,CC(C(=NO)C)NCC(C)(C)CNC(C)C(=NO)C.CC(C(=NO)C)NCC(C)(C)CNC(C)C(=NO)C.[Tc].[Tc],.,
31,DILIrank,bupropion,444,vLess-DILI-Concern,1,1,239.74,3.2,29.1,2,1,16,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,"Liver, intestines",
1670,LIverTox,Safinamide,131682,E,0,0,302.34,2.2,64.4,4,2,22,CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F,"Amidases, glucuronidation",
1248,LIverTox,Glatiramer Acetate,3081884,B,1,1,623.7,,374,18,12,43,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N,.,
758,DILIrank,alaproclate,2081,vMost-DILI-Concern,1,1,255.74,2.8,52.3,3,1,17,CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N,.,
168,DILIrank,sodium lactate,6286,vNo-DILI-Concern,0,0,112.06,,60.4,3,1,7,CC(C(=O)[O-])O.[Na+],.,
2764,Xu,Pinacidil,4826,Negative,0,0,245.32,2.7,73.1,3,2,18,CC(C(C)(C)C)N=C(NC#N)NC1=CC=NC=C1,.,
2716,Xu,Methoxamine HCl,6082,Negative,0,0,211.26,0.5,64.7,4,2,15,CC(C(C1=C(C=CC(=C1)OC)OC)O)N,.,
3680,Liew,Metaraminol,5906,negative,0,0,167.2,-0.4,66.5,3,3,12,CC(C(C1=CC(=CC=C1)O)O)N,,
3934,Liew,Ritodrine,33572,positive,0,0,287.35,2.3,72.7,4,4,21,CC(C(C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O,Liver,
2370,Greene,Phenylpropanolamine HCl,10297,NE,0,0,151.21,0.8,46.2,2,2,11,CC(C(C1=CC=CC=C1)O)N,CYP2D6,
75,DILIrank,pseudoephedrine,7028,vNo-DILI-Concern,0,0,165.23,0.9,32.3,2,2,12,CC(C(C1=CC=CC=C1)O)NC,	10?30% liver,
3950,Liew,Sapropterin,135398654,negative,0,0,241.25,-1.9,132,6,6,17,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,,
3191,Liew,Anastrozole,2187,positive,1,1,293.4,2.1,78.3,4,0,22,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,,
2901,Liew,Ciprofibrate,2763,positive,.,1,289.15,3.4,46.5,3,1,18,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl,,
1944,Greene,Bezafibrate,39042,NE,0,0,361.8,3.8,75.6,4,2,25,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,.,
1983,Greene,Ceftazidime,5481173,WE,1,1,546.6,0.4,245,12,3,37,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],	negligible,
1534,LIverTox,Penicillamine,5852,A,1,1,149.21,-1.8,64.3,4,3,9,CC(C)(C(C(=O)O)N)S,Liver,
259,DILIrank,terbinafine,1549008,vMost-DILI-Concern,1,1,291.4,5.6,3.2,1,0,22,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,liver,
3417,Liew,Dipivefrin,3105,negative,0,0,351.4,2.9,84.9,6,2,25,CC(C)(C)C(=O)OC1=C(C=C(C=C1)C(CNC)O)OC(=O)C(C)(C)C,,
482,DILIrank,atazanavir,148192,vLess-DILI-Concern,1,1,704.9,5.6,171,9,5,51,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,CYP3A4,
951,LIverTox,Buprenorphine,644073,B[HD],1,1,467.6,5,62.2,5,2,34,CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,"CYP3A4, CYP2C8",
1717,LIverTox,Stiripentol,5311454,E,0,0,234.29,3.6,38.7,3,1,17,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O,.,
3879,Liew,Probucol,4912,positive,0,0,516.8,11.3,91.1,4,2,35,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,,
2443,Greene,terfenadine,5405,NE,0,0,471.7,6.6,43.7,3,2,35,CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O,CYP3A4,
3257,Liew,Butenafine,2484,negative,0,0,317.5,6.3,3.2,1,0,24,CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32,,
3250,Liew,Buclizine,6729,negative,0,0,433,7.1,6.5,2,0,31,CC(C)(C)C1=CC=C(C=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,
454,DILIrank,bosentan,104865,vMost-DILI-Concern,1,1,551.6,3.8,154,11,2,39,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,Liver,
1057,LIverTox,Dabrafenib,44462760,E*,0,0,519.6,4.8,148,11,2,35,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,.,
1499,LIverTox,Omadacycline,54697325,E*,0,0,556.6,3,177,10,6,40,CC(C)(C)CNCC1=CC(=C2CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C,.,
3951,Liew,Saquinavir,441243,positive,1,1,670.8,4.2,167,7,5,49,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,CYP3A4,
1299,LIverTox,Indinavir,5362440,C,1,1,613.8,2.8,118,7,4,45,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,CYP3A4,
3149,Liew,Albuterol,2083,negative,0,0,239.31,0.3,72.7,4,4,17,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,
355,DILIrank,terbutaline,5403,vLess-DILI-Concern,1,1,225.28,0.9,72.7,4,4,16,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O,"	GI tract oral, liver; CYP450: unknown",
2528,Xu,Bambuterol,54766,Negative,0,0,367.4,1.2,91.3,6,2,26,CC(C)(C)NCC(C1=CC(=CC(=C1)OC(=O)N(C)C)OC(=O)N(C)C)O,Extensive Liver.Further metabolized to terbutaline by plasma cholinesterase,
3857,Liew,Pirbuterol,4845,negative,0,0,240.3,-0.1,85.6,5,4,17,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O,,
3990,Liew,Talinolol,68770,positive,0,0,363.5,2.6,82.6,4,4,26,CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O,,
2238,Greene,Nadolol,39147,NE,0,0,309.4,0.7,82,5,4,22,CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O,Not metabolised,
3271,Liew,Carteolol,2583,negative,0,0,292.37,1,70.6,4,3,21,CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O,,
3633,Liew,Levobunolol,39468,negative,0,0,291.4,2.4,58.6,4,2,21,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O,,
4012,Liew,Tertatolol,36920,negative,0,0,295.4,2.7,66.8,4,2,20,CC(C)(C)NCC(COC1=CC=CC2=C1SCCC2)O,,
649,DILIrank,penbutolol,37464,vNo-DILI-Concern,0,0,291.4,4.2,41.5,3,2,21,CC(C)(C)NCC(COC1=CC=CC=C1C2CCCC2)O,.,
353,DILIrank,pentagastrin,9853654,vNo-DILI-Concern,0,0,767.9,1.5,276,10,8,54,CC(C)(C)OC(=O)NCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N,.,
2103,Greene,Fexofenadine,3348,NE,0,0,501.7,3,81,5,3,37,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Liver ???5% of dose,
2726,Xu,montelukast,5281040,Negative,0,1,586.2,7.7,95.7,5,2,41,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,"CYP2C8, CYP3A4, CYP2C9",
345,DILIrank,metyrapone,4174,vNo-DILI-Concern,0,0,226.27,2,42.8,3,0,17,CC(C)(C1=CN=CC=C1)C(=O)C2=CN=CC=C2,.,
1450,LIverTox,Naldemedine,54732242,E,0,0,570.6,3.2,141,9,4,42,CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C(C4C56CCN(C(C5(C3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O,primarily CYP3A4,
1556,LIverTox,Phentermine,4771,E,0,0,149.23,1.9,26,1,1,11,CC(C)(CC1=CC=CC=C1)N,Liver,
1498,LIverTox,Omacetaxine,285033,E,0,0,545.6,0.8,124,10,2,39,CC(C)(CCCC(CC(=O)OC)(C(=O)OC1C2C3=CC4=C(C=C3CCN5C2(CCC5)C=C1OC)OCO4)O)O,Mostly via plasma esterases,
1145,LIverTox,Enasidenib,89683805,E*,0,0,473.4,3.5,109,14,3,33,CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O,.,
2545,Xu,Calcium Pantothenate,988,Negative,0,0,219.23,-1.1,107,5,4,15,CC(C)(CO)C(C(=O)NCCC(=O)O)O,.,
712,DILIrank,dexpanthenol,4678,vNo-DILI-Concern,0,0,205.25,-0.9,89.8,4,4,14,CC(C)(CO)C(C(=O)NCCCO)O,.,
728,DILIrank,pamabrom,11806,vNo-DILI-Concern,0,0,348.2,,116,5,3,20,CC(C)(CO)N.CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Br,.,
1215,LIverTox,Flutamide,3397,A,1,1,276.21,3.3,74.9,6,1,19,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,CYP1A2,
1229,LIverTox,Gabapentin Enacarbil,9883933,E*,0,0,329.39,3.1,102,6,2,23,CC(C)C(=O)OC(C)OC(=O)NCC1(CCCCC1)CC(=O)O,.,
3498,Liew,Fesoterodine,6918558,negative,0,0,411.6,5.5,49.8,4,1,30,CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,,
3318,Liew,Ciclesonide,6918155,negative,0,0,540.7,5.3,99.1,7,1,39,CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6,,
1059,LIverTox,Daclatasvir,25154714,C,1,1,738.9,5.1,175,8,4,54,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,CYP3A,
1862,LIverTox,Zepatier,91669168,C,1,1,1648.9,,388,21,6,119,CC(C)C(C(=O)N1CCCC1C2N=CC(=N2)C3=CC4=C(C=C3)C5=CC6=C(N5C(O4)C7=CC=CC=C7)C=CC(=C6)C8=CN=C(N8)C9CCCN9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC.CC(C)(C)C1C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCCC7CC7OC(=O)N1,.,
3125,Liew,Valganciclovir,135413535,negative,.,1,354.36,-1.5,167,8,4,25,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N,,
1823,LIverTox,Valacyclovir,135398742,D,1,1,324.34,-0.9,147,7,3,23,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,Liver to aciclovir,
116,DILIrank,ergocalciferol,5280793,vNo-DILI-Concern,0,0,396.6,7.4,20.2,1,1,29,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,.,
808,LIverTox,Aliskiren,5493444,C,1,1,551.8,3.5,146,7,4,39,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,CYP3A4,
169,DILIrank,verapamil,2520,vLess-DILI-Concern,1,1,454.6,3.8,64,6,0,33,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,liver,
1139,LIverTox,Elvitegravir,5277135,E*,0,0,447.9,5.3,87.1,7,2,31,CC(C)C(CO)N1C=C(C(=O)C2=C1C=C(C(=C2)CC3=C(C(=CC=C3)Cl)F)OC)C(=O)O,CYP3A,
137,DILIrank,atorvastatin,60823,vMost-DILI-Concern,1,1,558.6,5,112,6,4,41,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,CYP3A4,
3893,Liew,Propofol,4943,positive,1,1,178.27,3.8,20.2,1,1,13,CC(C)C1=C(C(=CC=C1)C(C)C)O,Liver,
3538,Liew,Fospropofol,3038498,negative,1,1,288.28,2.5,76,5,2,19,CC(C)C1=C(C(=CC=C1)C(C)C)OCOP(=O)(O)O,,
1076,LIverTox,Defibrotide,135565962,E,0,0,444.4,1.8,137,7,4,31,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O,.,
3181,Liew,Amlexanox,2161,negative,0,0,298.29,3.1,103,6,2,22,CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N,,
674,DILIrank,ritonavir,392622,vMost-DILI-Concern,1,1,720.9,6,202,9,4,50,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,Liver,
707,DILIrank,rosuvastatin,446157,vLess-DILI-Concern,1,1,481.5,1.6,149,10,3,33,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,Liver: CYP2C9 major and CYP2C19-mediated; ~10% metabolized,
1338,LIverTox,Lanreotide,71349,E*,0,0,1096.3,2.5,406,14,13,77,CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N,In GI tract,
3715,Liew,Mibefradil,60662,negative,0,0,568.5,,67.4,6,3,38,CC(C)C1C2=C(CCC1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F.Cl.Cl,,
3748,Liew,Nateglinide,60026,positive,0,0,317.4,3.2,66.4,3,2,23,CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O,,
1967,Greene,Capsaicin,1548943,NE,0,0,305.4,3.6,58.6,3,2,22,CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,.,
1921,Greene,atractyloside,442005,HH,1,1,726.8,1.2,267,16,5,48,CC(C)CC(=O)OC1C(C(C(OC1OC2CC(C3CCC45CC(CCC4C3(C2)C)C(=C)C5O)C(=O)O)CO)OS(=O)(=O)O)OS(=O)(=O)O,.,
974,LIverTox,Carfilzomib,11556711,D,1,1,719.9,4.7,159,8,4,52,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,Extensive; CYP plays a minor role,
349,DILIrank,cosyntropin,16132265,vNo-DILI-Concern,0,0,4541,-19.7,1860,68,63,322,CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C6CCCN6C(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(C(C)C)NC(=O)C7CCCN7C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC1=CN=CN1)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CO)N,.,peptide
1077,LIverTox,Degarelix,16136245,E,0,0,1632.3,3.5,513,18,17,117,CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C,Subject to common peptidic degradation during passage through the hepato-biliary system; not a substrate for the human CYP450 system,
3740,Liew,Nafarelin,25077649,negative,0,0,1322.5,0.8,475,15,16,96,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,,
201,DILIrank,triptorelin pamoate,25074470,vLess-DILI-Concern,1,0,1311.4,-0.3,490,15,17,95,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,.,oligopeptide
3562,Liew,Gonadorelin,638793,negative,0,0,1182.3,-2.4,475,15,16,85,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,
3563,Liew,Goserelin,5311128,negative,1,1,1269.4,-1.5,496,16,17,91,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,
3659,Liew,Marimastat,119031,positive,0,0,331.41,0.5,128,5,5,23,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C,,
395,DILIrank,sibutramine,5210,vLess-DILI-Concern,1,1,279.8,5.4,3.2,1,0,19,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C,CYP3A4,
460,DILIrank,pregabalin,5486971,vLess-DILI-Concern,1,1,159.23,-1.6,63.3,3,2,11,CC(C)CC(CC(=O)O)CN,.,
117,DILIrank,ibuprofen,3672,vLess-DILI-Concern,1,1,206.28,3.5,37.3,2,1,15,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,	CYP2C9,
3248,Liew,Bromocriptine,31101,negative,1,1,654.6,3.8,118,6,3,43,CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,,
356,DILIrank,calcitonin salmon,16133812,vNo-DILI-Concern,0,0,3431.9,-16.6,1560,55,52,239,CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CNC=N2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO,.,
4015,Liew,Tetrabenazine,6018,negative,0,0,317.4,2.9,38.8,4,0,23,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC,CYP2D6,
505,DILIrank,darunavir,213039,vMost-DILI-Concern,1,1,547.7,2.9,149,9,3,38,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,CYP3A4,
3594,Liew,Imiquimod,57469,positive,0,0,240.3,2.6,56.7,3,1,18,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,,
1563,LIverTox,Pimavanserin,10071196,E,0,0,427.6,4.5,44.8,4,1,31,CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C,"CYP3A4, CYP3A5, CYP2J2",
3232,Liew,Bepridil,2351,positive,0,1,366.5,5.3,15.7,3,0,27,CC(C)COCC(CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3,,
1103,LIverTox,Disopyramide,3114,B,1,1,339.5,3.2,59.2,3,1,25,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C,CYP3A4,
1685,LIverTox,Selexipag,9913767,E,0,0,496.6,3.8,110,7,1,35,CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3,"Activation by carboxylesterases, inactivation by CYP2C8 and others",
2659,Xu,Fluvastatin,446155,Negative,0,1,411.5,3.5,82.7,5,3,30,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,"	Liver: CYP2C9 75%, CYP3A4 20%, CYP2C8 5%",
1146,LIverTox,Encorafenib,50922675,E*,0,0,540,2.7,149,10,3,36,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,.,
4011,Liew,Terconazole,441383,negative,0,0,532.5,4.8,64.9,7,0,36,CC(C)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl,,
1596,LIverTox,Proguanil,4923,E*,0,0,253.73,1.5,88.8,1,3,17,CC(C)N=C(N)N=C(N)NC1=CC=C(C=C1)Cl,CYP2C19,
1022,LIverTox,Clofazimine,2794,E,0,0,473.4,7.1,40,4,1,33,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl,.,
2387,Greene,Procarbazine HCl,4915,HH,1,1,221.3,0.1,53.2,3,3,16,CC(C)NC(=O)C1=CC=C(C=C1)CNNC,"Liver, Kidney",
3375,Liew,Delavirdine,5625,positive,0,0,456.6,2.4,119,7,3,32,CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C,,
295,DILIrank,isaxonine,71169,vMost-DILI-Concern,1,1,137.18,1.3,37.8,3,1,10,CC(C)NC1=NC=CC=N1,.,
118,DILIrank,isoproterenol,3779,vNo-DILI-Concern,0,0,211.26,-0.6,72.7,4,4,15,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,.,
1711,LIverTox,Sotalol,5253,E,0,0,272.37,0.2,86.8,5,3,18,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,Not metabolized,
3204,Liew,Atenolol,2249,negative,1,1,266.34,0.2,84.6,4,3,19,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,,
544,DILIrank,esmolol,59768,vNo-DILI-Concern,0,0,295.37,1.9,67.8,5,2,21,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O,Red blood cell erythrocytic,
3709,Liew,Metoprolol,4171,positive,1,1,267.36,1.9,50.7,4,2,19,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,,
921,LIverTox,Betaxolol,2369,E,0,0,307.4,2.8,50.7,4,2,22,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O,Liver,
3241,Liew,Bisoprolol,2405,positive,0,0,325.4,1.9,60,5,2,23,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,,
658,DILIrank,pindolol,4828,vNo-DILI-Concern,0,0,248.32,1.8,57.3,3,3,18,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O,Liver,
2394,Greene,Propranolol,4946,NE,0,0,259.34,3,41.5,3,2,19,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,"	Liver extensive 1A2, 2D6; minor: 2C19, 3A4",
3797,Liew,Oxprenolol,4631,negative,0,0,265.35,2.1,50.7,4,2,19,CC(C)NCC(COC1=CC=CC=C1OCC=C)O,Liver,
3790,Liew,Oxamniquine,4612,positive,1,1,279.33,2.2,90.1,5,3,20,CC(C)NCC1CCC2=CC(=C(C=C2N1)[N+](=O)[O-])CO,Liver,
3597,Liew,Iproniazid,3748,positive,1,1,179.22,0.4,54,3,2,13,CC(C)NNC(=O)C1=CC=NC=C1,,
2647,Xu,Fenofibrate,3339,Positive,1,1,360.8,5.2,52.6,4,0,25,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,	glucuronidation,
1707,LIverTox,Sofosbuvir,45375808,A,1,1,529.5,1,153,11,3,36,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,"Quickly activated to triphosphate CatA/CES1, HIST1, phosphorylation",
4052,Liew,Travoprost,5282226,negative,0,0,500.5,4.1,96.2,9,3,35,CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O,,
3625,Liew,Latanoprost,5311221,negative,0,0,432.6,4.3,87,5,3,31,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,,
764,DILIrank,tenofovir,5481350,vLess-DILI-Concern,1,1,519.4,1.6,185,14,1,35,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C,Ester hydrolysis,
3604,Liew,Isopropamide,3775,negative,0,0,353.5,4.3,43.1,1,1,26,CC(C)[N+](C)(CCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)N)C(C)C,,
3890,Liew,Propantheline,9279,negative,0,0,448.4,,35.5,4,0,28,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C.[Br-],,
1652,LIverTox,Rimantadine,5071,E,0,0,179.3,2.6,26,1,1,13,CC(C12CC3CC(C1)CC(C3)C2)N,Liver hydroxylation and glucuronidation,
1043,LIverTox,Crizotinib,11626560,C,1,1,450.3,3.7,78,6,2,30,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,"CYP3A4, CYP3A5",
2657,Xu,Flurbiprofen,3394,Positive,1,1,244.26,4.2,37.3,3,1,18,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,	CYP2C9,
3861,Liew,Pirprofen,35935,positive,1,1,251.71,2.9,40.5,3,1,17,CC(C1=CC(=C(C=C1)N2CC=CC2)Cl)C(=O)O,,
3533,Liew,Fosaprepitant,219090,positive,0,0,614.4,1,124,14,3,41,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)N(N3)P(=O)(O)O)C4=CC=C(C=C4)F,,
3197,Liew,Aprepitant,6918365,positive,0,0,534.4,4.2,75.2,11,2,37,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F,,
1661,LIverTox,Rolapitant,10311306,E,0,0,500.5,4.4,50.4,9,2,35,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OCC2(CCC3(CCC(=O)N3)CN2)C4=CC=CC=C4,CYP3A4,
12,DILIrank,ketoprofen,3825,vLess-DILI-Concern,1,1,254.28,3.1,54.4,3,1,19,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,.,
2648,Xu,Fenoprofen Sodium,3342,Positive,1,1,242.27,3.3,46.5,3,1,18,CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)O,,
1127,LIverTox,Duvelisib,50905713,E*,0,0,416.9,4.1,86.8,5,2,30,CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,mainly metabolized by CYP3A4,
3270,Liew,Carprofen,2581,positive,1,1,273.71,4,53.1,2,2,19,CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O,,
2243,Greene,naproxen,156391,WE,1,1,230.26,3.3,46.5,3,1,17,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,	Liver to 6-desmethylnaproxen,
218,DILIrank,benoxaprofen,39941,vMost-DILI-Concern,1,1,301.72,4.1,63.3,4,1,21,CC(C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)Cl)C(=O)O,.,
2113,Greene,flunoxaprofen,68869,WE,1,1,285.27,3.6,63.3,5,1,21,CC(C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)F)C(=O)O,.,
1864,LIverTox,Zileuton,60490,D,1,1,236.29,1.6,94.8,3,2,16,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,"CYP1A2, CYP2C9, CYP3A4",
3988,Liew,Suprofen,5359,positive,0,0,260.31,3.3,82.6,4,1,18,CC(C1=CC=C(C=C1)C(=O)C2=CC=CS2)C(=O)O,,
488,DILIrank,cinacalcet,156419,vNo-DILI-Concern,0,0,357.4,6.1,12,4,1,26,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,"CYP3A4,CYP2D6,CYP1A2",
1018,LIverTox,Clemastine,26987,E,0,0,343.9,5,12.5,2,0,24,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C,Liver,
308,DILIrank,doxylamine,3162,vNo-DILI-Concern,0,0,270.37,2.5,25.4,3,0,20,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C,"CYP2D6,CYP1A2,CYP2C9",
613,DILIrank,mebanazine,6179,vMost-DILI-Concern,1,1,136.19,0.9,38,2,2,10,CC(C1=CC=CC=C1)NN,.,
440,DILIrank,voriconazole,71616,vMost-DILI-Concern,1,1,349.31,1.5,76.7,8,1,25,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,"Liver: CYP2C19 significant involvement, also CYP2C9, CYP3A4",
642,DILIrank,octreotide,448601,vLess-DILI-Concern,1,1,1019.2,1,383,14,13,71,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,Liver,
3737,Liew,Mupirocin,446596,negative,0,0,500.6,3,146,9,4,35,CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,,
1296,LIverTox,Imipenem-Cilastatin,11954222,D,1,1,675.8,,298,14,8,45,CC(C1C2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O.CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)O)C.O,.,
2131,Greene,Gentamycin,3467,NE,0,0,477.6,-4.1,200,12,8,33,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,.,
65,DILIrank,methyldopa,38853,vMost-DILI-Concern,1,1,211.21,-1.9,104,5,4,15,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,Liver,
2549,Xu,Carbidopa,34359,Negative,0,0,226.23,-2.2,116,6,5,16,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,"	7 metabolites known, not metabolized extensively",
3958,Liew,Silodosin,5312125,positive,0,0,495.5,3.6,97,9,3,35,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,,
362,DILIrank,metyrosine,441350,vNo-DILI-Concern,0,0,195.21,-1.6,83.6,4,3,14,CC(CC1=CC=C(C=C1)O)(C(=O)O)N,.,
3532,Liew,Formoterol,3083544,negative,0,0,344.4,1.8,90.8,5,4,25,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,,
2042,Greene,Dextroamphetamine Sulfate,5826,HH,1,0,135.21,1.8,26,1,1,10,CC(CC1=CC=CC=C1)N,"CYP2D6,DBH,FMO3",
676,DILIrank,selegiline,26757,vNo-DILI-Concern,0,0,187.28,2.8,3.2,1,0,14,CC(CC1=CC=CC=C1)N(C)CC#C,Intestines and liver,
343,DILIrank,benzphetamine,5311017,vNo-DILI-Concern,0,0,239.35,4.1,3.2,1,0,18,CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2,.,
3684,Liew,Methamphetamine,1206,negative,0,0,149.23,2.1,12,1,1,11,CC(CC1=CC=CC=C1)NC,,
1009,LIverTox,Cholic Acid,221493,D[HD],1,1,408.6,3.6,98,5,4,29,CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C,.,
1990,Greene,Chenodiol,10133,HH,1,1,392.6,4.9,77.8,4,3,28,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,.,
530,DILIrank,dobutamine,36811,vNo-DILI-Concern,0,0,301.4,3.4,72.7,4,4,22,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,.,
60,DILIrank,labetalol,3869,vMost-DILI-Concern,1,1,328.4,3.1,95.6,4,4,24,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,"Liver pass metabolism,",
255,DILIrank,primaquine,4908,vNo-DILI-Concern,0,0,259.35,2.2,60.2,4,2,19,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2,Liver,
4068,Liew,Trimipramine,5584,positive,1,1,294.4,5.8,6.5,2,0,22,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,Liver,
3693,Liew,Methotrimeprazine,72287,negative,0,0,328.5,4.7,41,4,0,23,CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CN(C)C,,
4063,Liew,Trimeprazine,5574,positive,0,0,298.4,4.7,31.8,3,0,21,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)CN(C)C,Liver,
3888,Liew,Promethazine,4927,positive,1,0,284.4,4.8,31.8,3,0,20,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Liver,
4006,Liew,Tenofovir disoproxil fumarate,464205,positive,1,1,287.21,-1.6,136,8,3,19,CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O,,
3841,Liew,Phenoxybenzamine,4768,negative,0,0,303.8,4.4,12.5,2,0,21,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,,
2684,Xu,Isoxsuprine HCl,3783,Negative,0,0,301.4,2.8,61.7,4,3,22,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O,.,
302,DILIrank,phenoxypropazine,71467,vMost-DILI-Concern,1,1,166.22,1.1,47.3,3,2,12,CC(COC1=CC=CC=C1)NN,.,
3238,Liew,Bicalutamide,2375,positive,1,1,430.4,2.3,116,9,2,29,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,,
3262,Liew,Captopril,44093,positive,1,1,217.29,0.3,58.6,4,2,14,CC(CS)C(=O)N1CCCC1C(=O)O,,
3147,Liew,Alacepril,71992,positive,0,0,406.5,2.1,129,6,2,28,CC(CSC(=O)C)C(=O)N1CCCC1C(=O)NC(CC2=CC=CC=C2)C(=O)O,,
4110,Liew,Zofenopril,92400,positive,0,0,429.6,4.4,125,6,1,29,CC(CSC(=O)C1=CC=CC=C1)C(=O)N2CC(CC2C(=O)O)SC3=CC=CC=C3,,
3683,Liew,Methacholine,6114,negative,0,0,195.69,,26.3,3,0,12,CC(C[N+](C)(C)C)OC(=O)C.[Cl-],,
3234,Liew,Bethanechol,2370,negative,0,0,161.22,0,52.3,2,1,11,CC(C[N+](C)(C)C)OC(=O)N,,
557,DILIrank,etidronic acid,3305,vNo-DILI-Concern,0,0,206.03,-3.7,135,7,5,11,CC(O)(P(=O)(O)O)P(=O)(O)O,	Nil,
636,DILIrank,nilutamide,4493,vMost-DILI-Concern,1,1,317.22,2,95.2,7,1,22,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C,"Liver CYP2C19, FMOTooltip flavin-containing monooxygenase",
2822,Xu,Trimethadione,5576,Positive,1,1,143.14,0.3,46.6,3,0,10,CC1(C(=O)N(C(=O)O1)C)C,	Demethylated to dimethadione,
1152,LIverTox,Enzalutamide,15951529,E,0,0,464.4,3.6,109,8,1,32,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,"CYP2C8,CYP3A4",
1225,LIverTox,Fostamatinib,11671467,E*,0,0,580.5,1.6,187,15,4,40,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,"Gut ALP to tamatinib Liver tamatinib metabolite by CYP3A4, UGT1A9",
3410,Liew,Dihydroergotamine,10531,negative,0,0,583.7,2.4,118,6,3,43,CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C,,
2082,Greene,Ergotamine l-Tartrate,8223,NE,0,0,581.7,2,118,6,3,43,CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C,,
79,DILIrank,indocyanine green,5282412,vNo-DILI-Concern,0,0,775,,137,7,0,54,CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CCCCS(=O)(=O)[O-])C=CC=CC=CC=C4C(C5=C(N4CCCCS(=O)(=O)[O-])C=CC6=CC=CC=C65)(C)C)C.[Na+],.,
3833,Liew,Permethrin,40326,negative,0,0,391.3,6.5,35.5,3,0,26,CC1(C(C1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,,
4001,Liew,Temocillin,171758,negative,0,0,414.5,1.1,187,9,3,27,CC1(C(N2C(S1)C(C2=O)(NC(=O)C(C3=CSC=C3)C(=O)O)OC)C(=O)O)C,,
3169,Liew,Amdinocillin,36273,positive,0,0,325.4,2.1,98.5,5,1,22,CC1(C(N2C(S1)C(C2=O)N=CN3CCCCCC3)C(=O)O)C,,
1910,Greene,Amoxicillin,33613,WE,1,1,365.4,-2,158,7,4,25,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,less than 30% biotransformed in liver,
833,LIverTox,Amoxicillin-Clavulanate,6435924,A,1,1,564.6,,245,12,6,39,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C.C1C2N(C1=O)C(C(=CCO)O2)C(=O)O,.,
836,LIverTox,Ampicillin,6249,C,1,1,349.4,-1.1,138,6,3,24,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C,12 to 50%,
837,LIverTox,Ampicillin-Sulbactam,656676,C,1,1,626.6,,244,11,2,41,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C.CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)[O-])C.[Na+].[Na+],.,
1930,Greene,Azlocillin Sodium,6479523,NE,0,0,461.5,0.1,173,7,4,32,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C,.,
1773,LIverTox,Ticarcillin,36921,D,1,1,384.4,0.8,178,8,3,25,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CSC=C3)C(=O)O)C(=O)O)C,.,
3350,Liew,Cyclacillin,19003,negative,0,0,341.4,1.3,138,6,3,23,CC1(C(N2C(S1)C(C2=O)NC(=O)C3(CCCCC3)N)C(=O)O)C,,
3689,Liew,Methicillin,6087,negative,0,1,380.4,1.2,131,7,2,26,CC1(C(N2C(S1)C(C2=O)NC(=O)C3=C(C=CC=C3OC)OC)C(=O)O)C,,
3822,Liew,Penicillin g benzathine,15232,positive,0,0,909.1,,248,12,6,64,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C.CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C.C1=CC=C(C=C1)CNCCNCC2=CC=CC=C2,,
3823,Liew,Penicillin v,6869,positive,0,0,350.4,2.1,121,6,2,24,CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C,,
938,LIverTox,Boceprevir,10324367,B,1,1,519.7,3.1,151,5,4,37,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,.,
1997,Greene,Chlortetracycline HCl,54675777,HH,1,1,478.9,-1.3,182,9,6,33,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)N)N(C)C)O,.,
18,DILIrank,tetracycline,54685734,vLess-DILI-Concern,1,1,444.4,-2,182,9,6,32,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,Not metabolized,
323,DILIrank,mecamylamine,4032,vNo-DILI-Concern,0,0,167.29,2.6,12,1,1,12,CC1(C2CCC(C2)C1(C)NC)C,.,
1407,LIverTox,Methsuximide,6476,E*,0,0,203.24,1.2,37.4,2,0,15,CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2,Liver (demethylation and glucuronidation),
2153,Greene,indacrinone,42266,HH,1,1,365.2,4.5,63.6,4,1,24,CC1(CC2=CC(=C(C(=C2C1=O)Cl)Cl)OCC(=O)O)C3=CC=CC=C3,.,
1833,LIverTox,Venetoclax,49846579,E,0,0,868.4,8.2,183,11,3,61,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,"CYP3A4, CYP3A5",
3600,Liew,Isepamicin,3037209,positive,0,0,569.6,-6.9,298,16,12,39,CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(C(C(C(O3)CN)O)O)O)N)NC(=O)C(CN)O)O,,
1573,LIverTox,Plazomicin,42613186,E,0,0,592.7,-6.2,269,15,11,41,CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CNCCO)N)N)NC(=O)C(CCN)O)O,.,
3513,Liew,Flunisolide,82153,negative,0,0,434.5,2.5,93.1,7,2,31,CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,,
3522,Liew,Flurandrenolide,15209,negative,0,0,436.5,1.4,93.1,7,2,31,CC1(OC2CC3C4CC(C5=CC(=O)CCC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,,
3382,Liew,Desonide,12536,negative,0,0,416.5,2.7,93.1,6,2,30,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C,,
3573,Liew,Halcinonide,443943,negative,0,0,455,3.6,72.8,6,1,31,CC1(OC2CC3C4CCC5=CC(=O)CCC5(C4(C(CC3(C2(O1)C(=O)CCl)C)O)F)C)C,,
4045,Liew,Topiramate,5284627,positive,1,1,339.36,-0.8,124,9,1,22,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,Liver,
1557,LIverTox,Phentermine-Topiramate,56842108,E*,0,0,488.6,,150,10,2,33,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C.CC(C)(CC1=CC=CC=C1)N,.,
1416,LIverTox,Midostaurin,9829523,E*,0,0,570.6,4.8,77.7,4,1,43,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,.,
107,DILIrank,prednisone,5865,vLess-DILI-Concern,1,1,358.4,1.5,91.7,5,2,26,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,prednisolone liver,
3514,Liew,Fluocinolone,91488,negative,0,0,412.4,1.1,115,8,4,29,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CC(C4=CC(=O)C=CC43C)F)F)O,,
254,DILIrank,prednisolone,5755,vLess-DILI-Concern,1,1,360.4,1.6,94.8,5,3,26,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,.,
3669,Liew,Memantine,4054,positive,1,1,179.3,3.3,26,1,1,13,CC12CC3CC(C1)(CC(C3)(C2)N)C,,
3531,Liew,Formestane,11273,negative,0,0,302.4,2.6,54.4,3,1,22,CC12CCC(=O)C(=C1CCC3C2CCC4(C3CCC4=O)C)O,,
1155,LIverTox,Eplerenone,5282131,E*,0,0,414.5,1.4,82.2,6,0,30,CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC,CYP3A4,
2654,Xu,Fludrocortisone Acetate,31378,Negative,0,0,380.4,1.7,94.8,6,3,27,CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CCC4(C(=O)CO)O)C)O)F,	Liver,
2675,Xu,Hydrocortisone,5754,Negative,0,0,362.5,1.6,94.8,5,3,26,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,"	11??-HSDsTooltip 11??-Hydroxysteroid dehydrogenases, others",
3704,Liew,Methyltestosterone,6010,positive,1,1,302.5,3.4,37.3,2,1,22,CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C,,
4013,Liew,Testolactone,13769,negative,0,0,300.4,3,43.4,3,0,22,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,Liver,
2090,Greene,ethinyl estradiol,5991,HH,1,1,296.4,3.7,40.5,2,2,22,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,	Liver primarily CYP3A4,
2202,Greene,Mestranol,6291,HH,1,1,310.4,4,29.5,2,1,23,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,	Ethinylestradiol,
3908,Liew,Quinestrol,9046,positive,0,0,364.5,5.3,29.5,2,1,27,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC5CCCC5,,
2740,Xu,Norethindrone,6230,Positive,1,1,298.4,3,37.3,2,1,22,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,"	Mainly CYP3A4 liver; also 5??-/5??-reductase, 3??-Tooltip 3??-hydroxysteroid dehydrogenase/3??-HSDTooltip 3??-hydroxysteroid dehydrogenase, and aromatase",
224,DILIrank,danazol,28417,vMost-DILI-Concern,1,1,337.5,3.8,46.3,3,1,25,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5,CYP3A4,
130,DILIrank,oxymetholone,5281034,vMost-DILI-Concern,1,1,332.5,4.4,57.5,3,2,24,CC12CCC3C(C1CCC2(C)O)CCC4C3(CC(=CO)C(=O)C4)C,	Liver,
3969,Liew,Stanozolol,25249,positive,1,1,328.5,4.5,48.9,2,2,24,CC12CCC3C(C1CCC2(C)O)CCC4C3(CC5=C(C4)NN=C5)C,Liver,
3791,Liew,Oxandrolone,5878,positive,1,1,306.4,3.7,46.5,3,1,22,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,Kidney,
181,DILIrank,exemestane,60198,vMost-DILI-Concern,1,1,296.4,3.1,34.1,2,0,22,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,"Liver CYP3A4, aldo-keto reductase",
2088,Greene,Estrone,5870,HH,1,1,270.4,3.1,37.3,2,1,20,CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O,.,
443,DILIrank,dutasteride,6918296,vNo-DILI-Concern,0,0,528.5,5.4,58.2,8,2,37,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,CYP3A4,
3541,Liew,Fulvestrant,104741,negative,0,0,606.8,9.2,76.7,9,2,41,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,,
4062,Liew,Trilostane,656583,negative,0,0,329.4,2.9,76.8,4,2,24,CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C,Liver,
2639,Xu,estradiol,5757,Negative,0,1,272.4,4,40.5,2,2,20,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,"	Liver via hydroxylation, sulfation, glucuronidation",
548,DILIrank,estramustine,259331,vMost-DILI-Concern,1,1,440.4,4,49.8,3,1,29,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl,.,
3745,Liew,Nandrolone,9904,positive,0,0,274.4,2.6,37.3,2,1,20,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34,,
126,DILIrank,testosterone,6013,vMost-DILI-Concern,1,1,288.4,3.3,37.3,2,1,21,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,	Liver mainly reduction and conjugation,
3393,Liew,Dezocine,3033053,negative,0,0,245.36,3.7,46.2,2,2,18,CC12CCCCCC(C1N)CC3=C2C=C(C=C3)O,,
2638,Xu,Eserine,5983,Negative,0,0,275.35,0.7,44.8,4,1,20,CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC)C)C,	Major metabolite: Eseroline,
2704,Xu,Meclofenamate Sodium,4037,Positive,1,1,296.1,5.2,49.3,3,2,19,CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)O)Cl,.,
3917,Liew,Ranolazine,56959,negative,1,1,427.5,2.7,74.3,6,2,31,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,"CYP3A, CYP2D6",
1366,LIverTox,Lopinavir,92727,D,1,1,628.8,5.9,120,5,4,46,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,Liver,
1414,LIverTox,Mexiletine,4178,C,1,1,179.26,2.1,35.2,2,1,13,CC1=C(C(=CC=C1)C)OCC(C)N,"CYP2D6, CYP1A2",
3370,Liew,Dasatinib,3062316,positive,1,1,488,3.6,135,9,3,33,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,,
62,DILIrank,mefenamic acid,4044,vMost-DILI-Concern,1,1,241.28,5.1,49.3,3,2,18,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,CYP2C9,
727,DILIrank,dicloxacillin,18381,vLess-DILI-Concern,1,1,470.3,2.9,138,7,2,30,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,Liver,
3504,Liew,Floxacillin,21319,positive,1,1,453.9,2.6,138,8,2,30,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,,
646,DILIrank,oxacillin,6196,vLess-DILI-Concern,1,1,401.4,2.4,138,7,2,28,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,.,
711,DILIrank,valdecoxib,119607,vLess-DILI-Concern,1,1,314.4,2.6,94.6,5,1,22,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,"CYP3A4,2C9",
500,DILIrank,cloxacillin,6098,vLess-DILI-Concern,1,1,435.9,2.4,138,7,2,29,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,.,
3953,Liew,Seratrodast,2449,positive,1,1,354.4,4.4,71.4,4,1,26,CC1=C(C(=O)C(=C(C1=O)C)C(CCCCCC(=O)O)C2=CC=CC=C2)C,,
3847,Liew,Phytonadione,5284607,positive,0,0,450.7,10.9,34.1,2,0,33,CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C,,
3373,Liew,Deferiprone,2972,positive,0,0,139.15,0.5,40.5,3,1,10,CC1=C(C(=O)C=CN1C)O,,
1135,LIverTox,Elagolix,11250647,E,0,0,631.6,2.6,99.2,11,2,45,CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F,CYP3A,
1520,LIverTox,Palbociclib,5330286,C,1,1,447.5,1.8,103,8,2,33,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,"Liver CYP3A, SULT2A1, glucuronidation",
511,DILIrank,paliperidone,115237,vNo-DILI-Concern,0,0,426.5,2.2,82.2,7,1,31,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,.,
2414,Greene,Risperidone,5073,HH,1,1,410.5,2.7,61.9,6,0,30,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,Liver CYP2D6 mediated to 9-hydroxyrisperidone,
3764,Liew,Nilvadipine,4494,positive,0,0,385.4,2.9,134,8,1,28,CC1=C(C(C(=C(N1)C#N)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC(C)C,,
602,DILIrank,isradipine,3784,vLess-DILI-Concern,1,1,371.4,4.3,104,8,1,27,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,100% Liver,
164,DILIrank,nifedipine,4485,vLess-DILI-Concern,1,1,346.3,2.2,110,7,1,25,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,"Gastrointestinal, Liver",
3047,Liew,Nisoldipine,4499,negative,.,0,388.4,3.3,110,7,1,28,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,CYP3A4,
3321,Liew,Cilnidipine,5282138,positive,0,0,492.5,4.4,120,8,1,36,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC,,
3495,Liew,Fenretinide,5288209,positive,0,0,391.5,7.3,49.3,2,2,29,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C,,
2464,Greene,Tretinoin,444795,HH,1,1,300.4,6.3,37.3,2,1,22,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,.,
1842,LIverTox,Vitamin A,1071,A[HD],1,1,286.5,5.7,20.2,1,1,21,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,.,
3485,Liew,Exisulind,5472495,positive,0,0,372.4,3.5,79.8,5,1,26,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)(=O)C)C=CC(=C2)F)CC(=O)O,,
86,DILIrank,sulindac,1548887,vMost-DILI-Concern,1,1,356.4,3.4,73.6,5,1,25,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,.,
3773,Liew,Nolatrexed,108189,positive,0,0,284.34,1.6,106,3,2,20,CC1=C(C2=C(C=C1)NC(=NC2=O)N)SC3=CC=NC=C3,,
2823,Xu,troglitazone,5591,Positive,1,1,441.5,5.1,110,6,2,31,CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C,.,
1300,LIverTox,Indomethacin,3715,C,1,1,357.8,4.3,68.5,4,1,25,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Liver,
3138,Liew,Acemetacin,1981,positive,0,0,415.8,4.2,94.8,6,1,29,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O,,
497,DILIrank,clometacin,33176,vMost-DILI-Concern,1,1,357.8,4,68.5,4,1,25,CC1=C(C2=C(N1CC(=O)O)C=C(C=C2)OC)C(=O)C3=CC=C(C=C3)Cl,.,
388,DILIrank,porfimer,57166,vNo-DILI-Concern,0,0,1179.4,5.2,314,15,10,87,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)OC(C)C6=C(C7=CC8=C(C(=C(N8)C=C9C(=C(C(=N9)C=C1C(=C(C(=N1)C=C6N7)C)CCC(=O)O)CCC(=O)O)C)C)C(C)O)C)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C(C)O,.,no small molecule
1523,LIverTox,Panobinostat,6918837,E,0,0,349.4,3,77.2,3,4,26,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO,"CYP3A 40%, CYP2D6, CYP2C19",
1578,LIverTox,Ponatinib,24826799,E*,0,0,532.6,4.1,65.8,8,1,39,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,"CYP3A4, 2C8, 2D6, 3A5",
1470,LIverTox,Nilotinib,644241,D,1,1,529.5,4.9,97.6,9,2,39,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,CYP3A4,
276,DILIrank,eltrombopag olamine,9846180,vMost-DILI-Concern,1,1,442.5,4.5,111,7,3,33,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)NN=C3C=CC=C(C3=O)C4=CC(=CC=C4)C(=O)O)C,	extensive liver through CYP1A2 and CYP2C8,
56,DILIrank,imatinib,5291,vMost-DILI-Concern,1,1,493.6,3.5,86.3,7,2,37,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,CYP3A4,
1529,LIverTox,Pazopanib,11525740,C,1,1,474,,127,8,3,32,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl,"Liver: CYP3A4 (major), 1A2 and 2C8 (minor)",
4067,Liew,Trimetrexate,5583,positive,0,0,369.4,2.5,118,8,3,27,CC1=C(C=CC2=C1C(=NC(=N2)N)N)CNC3=CC(=C(C(=C3)OC)OC)OC,,
1699,LIverTox,Simeprevir,24873435,B,1,1,749.9,4.8,194,10,2,52,CC1=C(C=CC2=C1N=C(C=C2OC3CC4C(C3)C(=O)N(CCCCC=CC5CC5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC,"CYP3A, CYP2C8, CYP2C19",
2743,Xu,Novobiocin,9346,Positive,1,1,612.6,3.4,196,11,5,44,CC1=C(C=CC2=C1OC(=C(C2=O)NC(=O)C3=CC(=C(C=C3)O)CC=C(C)C)O)OC4C(C(C(C(O4)(C)C)OC)OC(=O)N)O,	excreted unchanged,
3753,Liew,Nelfinavir,64143,positive,1,1,567.8,5.7,127,6,4,40,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,,
3387,Liew,Dexlansoprazole,9578005,positive,1,1,369.4,2.8,87.1,8,1,25,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,,
142,DILIrank,rabeprazole,5029,vLess-DILI-Concern,1,1,359.4,1.9,96.3,6,1,25,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,"CYP2C19,CYP3A4",
2175,Greene,Leflunomide,3899,HH,1,1,270.21,2.5,55.1,6,1,19,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,GI mucosa and liver,
2494,Greene,Zomepirac,5733,NE,0,0,291.73,2.8,59.3,3,1,20,CC1=C(N(C(=C1)CC(=O)O)C)C(=O)C2=CC=C(C=C2)Cl,.,
3275,Liew,Cefadroxil,47965,positive,0,0,363.4,-2.1,158,7,4,25,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,,
465,DILIrank,cefadroxil,47964,vLess-DILI-Concern,1,1,381.4,,159,8,5,26,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O.O,	unknown,
936,LIverTox,Bleomycin,5460769,D,1,1,1415.6,-7.5,685,31,20,96,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,.,
3323,Liew,Cimetidine,2756,positive,1,1,252.34,0.4,114,4,3,17,CC1=C(N=CN1)CSCCNC(=NC)NC#N,,
3451,Liew,Enoximone,53708,positive,0,0,248.3,1.6,83.5,3,2,17,CC1=C(NC(=O)N1)C(=O)C2=CC=C(C=C2)SC,,
3500,Liew,Flavoxate,3354,negative,0,0,391.5,4.3,55.8,5,0,29,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4,,
3984,Liew,Sulfisoxazole,5344,positive,0,0,267.31,1,107,6,2,18,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,,
228,DILIrank,febuxostat,134018,vMost-DILI-Concern,1,1,316.4,3.9,111,6,1,22,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,"via CYP1A1, 1A2, 2C8, 2C9, UGT1A1, 1A8, 1A9",
3282,Liew,Cefodizime,5361871,positive,0,0,584.7,0.2,305,15,4,37,CC1=C(SC(=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O)CC(=O)O,,
1797,LIverTox,Trametinib,11707110,E*,0,0,615.4,3.4,102,6,2,37,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,.,
139,DILIrank,nevirapine,4463,vMost-DILI-Concern,1,1,266.3,2,58.1,4,1,20,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,Liver,
2267,Greene,Paclitaxel,36314,HH,1,1,853.9,2.5,221,14,4,62,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,"	CYP2C8,CYP3A4",
1106,LIverTox,Docetaxel,148124,C,1,1,807.9,1.6,224,14,5,58,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Liver,
958,LIverTox,Cabazitaxel,9854073,E*,0,0,835.9,2.7,202,14,3,60,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,.,
288,DILIrank,tasosartan,60919,vMost-DILI-Concern,1,1,411.5,3,101,6,1,31,CC1=C2CCC(=O)N(C2=NC(=N1)C)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,.,
1876,Greene,3-Methylcholanthrene,1674,HH,1,1,268.4,6.4,0,0,0,21,CC1=C2CCC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1,.,
3037,Liew,Mycophenolic acid,446541,positive,.,1,320.3,3.2,93.1,6,2,23,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,,
1886,Greene,Acitretin,5284513,HH,1,1,326.4,6.1,46.5,3,1,24,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,Liver,
3800,Liew,Oxymetazoline,4636,negative,0,0,260.37,2.9,44.6,2,2,19,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C,Kidney,
3706,Liew,Metipranolol,31477,negative,0,0,309.4,2.7,67.8,5,2,22,CC1=CC(=C(C(=C1OC(=O)C)C)C)OCC(CNC(C)C)O,,
290,DILIrank,tilbroquinol,65592,vMost-DILI-Concern,1,1,238.08,3.1,33.1,2,1,13,CC1=CC(=C(C2=C1C=CC=N2)O)Br,.,
3555,Liew,Gemfibrozil,3463,positive,1,1,250.33,3.8,46.5,3,1,18,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,,
287,DILIrank,lumiracoxib,151166,vMost-DILI-Concern,1,1,293.72,4.2,49.3,4,2,20,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O,	Predominantly in the liver via oxidation and hydroxylation CYP2C9,
1852,LIverTox,Vortioxetine,9966051,E*,0,0,298.4,4.2,40.6,3,1,21,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,"Liver, primarily CYP2D6-mediated oxidation",
990,LIverTox,Ceritinib,57379345,D,1,1,558.1,6.4,114,8,3,38,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,CYP3A,
630,DILIrank,moxisylyte,4260,vMost-DILI-Concern,1,1,279.37,3.2,38.8,4,0,20,CC1=CC(=C(C=C1OC(=O)C)C(C)C)OCCN(C)C,.,
3903,Liew,Pyrvinium,5281035,negative,0,0,382.5,5.9,12,1,0,29,CC1=CC(=C(N1C2=CC=CC=C2)C)C=CC3=[N+](C4=C(C=C3)C=C(C=C4)N(C)C)C,,
1138,LIverTox,Eluxadoline,11250029,C,1,1,569.6,0.9,165,7,4,42,CC1=CC(=CC(=C1CC(C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)C(C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N,.,
1650,LIverTox,Rilpivirine,6451164,D,1,1,366.4,4.5,97.4,6,2,28,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,CYP3A4,
272,DILIrank,etravirine,193962,vMost-DILI-Concern,1,1,435.3,4.5,121,7,2,28,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,"CYP3A4,CYP2C9,CYP2C19",
327,DILIrank,meclizine,4034,vNo-DILI-Concern,0,0,390.9,5.8,6.5,2,0,28,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,Liver,
1736,LIverTox,Tafenoquine,115358,E,0,0,463.5,5.4,78.6,9,2,33,CC1=CC(=NC2=C1C(=C(C=C2NC(C)CCCN)OC)OC3=CC=CC(=C3)C(F)(F)F)OC,.,
3601,Liew,Isocarboxazid,3759,positive,0,0,231.25,1.5,67.2,4,2,17,CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2,,
2164,Greene,Isoxicam,54677972,NE,0,0,335.34,3,121,7,2,23,CC1=CC(=NO1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,.,
3688,Liew,Methenolone,3037705,positive,1,1,302.5,3.9,37.3,2,1,22,CC1=CC(=O)CC2C1(C3CCC4(C(C3CC2)CCC4O)C)C,,
1999,Greene,Ciclopirox,2749,NE,0,0,207.27,2,40.5,2,1,15,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,.,
4069,Liew,Trioxsalen,5585,negative,0,0,228.24,3,39.4,3,0,17,CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C,,
1794,LIverTox,Trabectedin,108150,C[HD],1,1,761.8,3.4,194,15,4,54,CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O,CYP3A4,
429,DILIrank,bexarotene,82146,vMost-DILI-Concern,1,1,348.5,7.6,37.3,2,1,26,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,CYP3A4,
604,DILIrank,riboflavin,493570,vNo-DILI-Concern,0,0,376.4,-1.5,155,7,5,27,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O,.,
716,DILIrank,cyanocobalamin,16212801,vNo-DILI-Concern,0,0,1355.4,,476,21,9,93,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],.,
779,DILIrank,sitaxsentan,216235,vMost-DILI-Concern,1,1,454.9,3.7,144,9,1,29,CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2,"CYP2C9,CYP3A4",
138,DILIrank,olanzapine,4585,vLess-DILI-Concern,1,1,312.4,2.8,56.2,5,1,22,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Liver (direct glucuronidation and CYP1A2 mediated oxidation),
795,LIverTox,Acrivastine,5284514,E,0,0,348.4,1.6,53.4,4,1,26,CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC(=N3)C=CC(=O)O,.,
4071,Liew,Triprolidine,5282443,negative,0,0,278.4,3.9,16.1,2,0,21,CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3,CYP2D6,
1786,LIverTox,Tolcapone,4659569,C,1,1,273.24,3.3,103,5,2,20,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],Liver mainly glucuronidation,
1787,LIverTox,Tolmetin,5509,D,1,1,257.28,2.8,59.3,3,1,19,CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)O,.,
3242,Liew,Bitolterol,35330,negative,0,0,461.5,5.2,84.9,6,2,34,CC1=CC=C(C=C1)C(=O)OC2=C(C=C(C=C2)C(CNC(C)(C)C)O)OC(=O)C3=CC=C(C=C3)C,,
3294,Liew,Celecoxib,2662,positive,1,1,381.4,3.4,86.4,7,1,26,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,,
3558,Liew,Gliclazide,3475,positive,1,1,323.4,1.5,86.9,4,2,22,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,,
2457,Greene,Tolazamide,5503,HH,1,1,311.4,1.5,86.9,4,2,21,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2,	metabolized in the liver to active metabolites,
275,DILIrank,tolvaptan,216237,vMost-DILI-Concern,1,1,448.9,4.8,69.6,3,2,32,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,CYP3A4,
2261,Greene,Orphenadrine Citrate,4601,NE,0,0,269.4,3.8,12.5,2,0,20,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,	Liver demethylation,
3366,Liew,Dapiprazole,3033538,negative,0,0,325.5,2.4,37.2,4,0,24,CC1=CC=CC=C1N2CCN(CC2)CCC3=NN=C4N3CCCC4,,
453,DILIrank,atomoxetine,54841,vMost-DILI-Concern,1,1,255.35,3.7,21.3,2,1,19,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2,CYP2D6,
4103,Liew,Zafirlukast,5717,positive,1,1,575.7,5.5,124,6,2,41,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,CYP2C9,
3816,Liew,Pemirolast,57697,positive,0,0,228.21,-0.3,87.1,5,1,17,CC1=CC=CN2C1=NC=C(C2=O)C3=NNN=N3,,
1569,LIverTox,Pirfenidone,40632,D,1,1,185.22,1.9,20.3,1,0,14,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,"Liver 70?80% CYP1A2-mediated; minor contributions from CYP2C9, CYP2C19, CYP2D6 and CYP2E1",
1716,LIverTox,Stavudine,18283,A,1,1,224.21,-0.8,78.9,4,2,16,CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,Kidney elimination ~40%,
1863,LIverTox,Zidovudine,35370,B,1,1,267.24,0,93.2,6,2,19,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],Liver,
1745,LIverTox,Telbivudine,159269,E,0,0,242.23,-1.2,99.1,5,3,17,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,Nil,
634,DILIrank,esomeprazole Sodium,9579578,vLess-DILI-Concern,1,1,345.4,2.2,96.3,6,1,24,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,"	Liver CYP2C19, CYP3A4",
132,DILIrank,glipizide,3478,vLess-DILI-Concern,1,1,445.5,1.9,139,6,3,31,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,Liver hydroxylation,
63,DILIrank,meloxicam,54677470,vLess-DILI-Concern,1,1,351.4,3,136,7,2,23,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,"CYP2C9,3A4",
3913,Liew,Raltitrexed,104758,positive,0,0,458.5,1.4,177,8,4,32,CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O,,
489,DILIrank,conivaptan,151171,vNo-DILI-Concern,0,0,498.6,5.7,78.1,3,2,38,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6,.,
714,DILIrank,pyridoxine,1054,vNo-DILI-Concern,0,0,169.18,-0.8,73.6,4,3,12,CC1=NC=C(C(=C1O)CO)CO,.,
1680,LIverTox,Secnidazole,71815,E,0,0,185.18,0.2,83.9,4,1,13,CC1=NC=C(N1CC(C)O)[N+](=O)[O-],.,
1413,LIverTox,Metronidazole,4173,C,1,1,171.15,0,83.9,4,1,12,CC1=NC=C(N1CCO)[N+](=O)[O-],Liver,
625,DILIrank,midazolam,4192,vNo-DILI-Concern,0,0,325.8,2.5,30.2,3,0,23,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,"Liver 3A3, 3A4, 3A5",
3784,Liew,Ondansetron,4595,positive,1,1,293.4,2.3,39.8,2,0,22,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,"CYP3A4, CYP1A2, CYP2D6",
1131,LIverTox,Edaravone,4021,E,0,0,174.2,1.3,32.7,2,0,13,CC1=NN(C(=O)C1)C2=CC=CC=C2,.,
263,DILIrank,maraviroc,3002977,vMost-DILI-Concern,1,1,513.7,5.1,63,6,1,37,CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,"Liver CYP, predominantly CYP3A",
3980,Liew,Sulfamethizole,5328,positive,1,1,270.3,0.5,135,7,2,17,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,,
466,DILIrank,cefazolin,33255,vLess-DILI-Concern,1,1,454.5,-0.4,235,12,2,29,CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O,.,
817,LIverTox,Alprazolam,2118,D,1,1,308.8,2.1,43.1,3,0,22,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,"Liver, via cytochrome P450 3A4",
1804,LIverTox,Triazolam,5556,D,1,1,343.2,2.4,43.1,3,0,23,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,Liver,
966,LIverTox,Capreomycin,3000502,E,0,0,1321.4,,737,23,27,93,CC1C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)NC(C(=O)NCC(C(=O)N1)N)C2CCN=C(N2)N)CNC(=O)CC(CCCN)N.C1CN=C(NC1C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CNC(=O)CC(CCCN)N)CO)N)N,.,
1574,LIverTox,Plecanatide,70693500,E,0,0,1681.9,-8.2,819,31,23,113,CC1C(=O)NC2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC(C)C)C(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C(C)C)CC(=O)N)C(C)C)CC(C)C)CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(=O)N)N,.,
1355,LIverTox,Linaclotide,16158208,E,0,0,1526.8,-6.8,726,28,19,101,CC1C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)O)C(=O)NC(CSSCC(C(=O)N3)N)C(=O)NC(C(=O)N5CCCC5C(=O)N1)CC(=O)N)CC6=CC=C(C=C6)O)CCC(=O)O,.,
2725,Xu,Monocrotaline,9415,Positive,1,1,325.36,-0.7,96.3,7,2,23,CC1C(=O)OC2CCN3C2C(=CC3)COC(=O)C(C1(C)O)(C)O,.,
3215,Liew,Aztreonam,5742832,positive,0,0,435.4,0.3,238,12,4,28,CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N,,
3363,Liew,Dactinomycin,2019,positive,1,1,1255.4,3.8,356,18,5,90,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,,
789,LIverTox,Acarbose,444254,B,1,1,645.6,-8.5,321,19,14,44,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,Gastrointestinal tractglucosidasemaltogenic alpha-amylase and cyclomaltodextrinase from gut microbiome,
83,DILIrank,streptomycin,19649,vNo-DILI-Concern,0,0,581.6,-8,336,15,12,40,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O,.,
4086,Liew,Vancomycin,14969,negative,1,1,1449.2,-2.6,531,26,19,101,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,,
2625,Xu,Digoxin,2724385,Negative,0,0,780.9,1.3,203,14,6,55,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Liver 16%,
3407,Liew,Digitoxin,441207,negative,0,0,764.9,2.3,183,13,5,54,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)O,,
1071,LIverTox,Daunorubicin,30323,E*,0,0,527.5,1.8,186,11,5,38,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,Liver,
2073,Greene,Doxorubicin HCl,443939,HH,1,1,580,,206,12,7,40,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl,Liver,
3856,Liew,Pirarubicin,3033521,positive,0,0,627.6,2.7,204,13,5,45,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)OC6CCCCO6,,
2677,Xu,Idarubicin HCl,42890,Negative,0,0,497.5,1.9,177,10,5,36,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,,
1576,LIverTox,Plicamycin,5284610,A[HD],1,1,1085.1,0.6,358,24,11,76,CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O,.,
3380,Liew,Deslanoside,28620,negative,0,0,943.1,-0.3,282,19,9,66,CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CC(C5(C4(CCC5C6=CC(=O)OC6)O)C)O)C)O)OC7CC(C(C(O7)C)OC8CC(C(C(O8)C)OC9C(C(C(C(O9)CO)O)O)O)O)O,,
3535,Liew,Fosfomycin,446987,positive,1,1,138.06,-1.4,70.1,4,2,8,CC1C(O1)P(=O)(O)O,,
3839,Liew,Phenmetrazine,4762,negative,1,1,177.24,1.4,21.3,2,1,13,CC1C(OCCN1)C2=CC=CC=C2,,
3836,Liew,Phendimetrazine,12460,negative,0,0,191.27,1.9,12.5,2,0,14,CC1C(OCCN1C)C2=CC=CC=C2,Liver,
1370,LIverTox,Lorlatinib,71731823,E*,0,0,406.4,1.5,110,7,1,30,CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,Mainly CYP3A4 and UGT1A4,
1399,LIverTox,Meropenem,441130,D,1,1,383.5,-2.4,136,7,3,26,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O,.,
3459,Liew,Ertapenem,150610,positive,0,0,475.5,-1.5,182,9,5,33,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)C(C)O,,
3427,Liew,Doripenem,73303,positive,0,0,420.5,-3.4,196,10,5,27,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O,,
3434,Liew,Doxycycline,54671203,positive,1,1,444.4,-0.7,182,9,6,32,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,,
3825,Liew,Pentazocine,441278,negative,0,0,285.4,3.3,23.5,2,1,21,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,Liver,
3929,Liew,Rifapentine,135403821,positive,1,1,877,6.7,220,15,6,63,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C6CCCC6)C,,
3928,Liew,Rifampin,5381226,positive,1,1,822.9,4,217,15,6,59,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C,Liver,
1648,LIverTox,Rifaximin,6436173,E,0,0,785.9,6.9,198,12,5,57,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,Liver,
77,DILIrank,rifabutin,6323490,vLess-DILI-Concern,1,1,847,6.3,206,14,5,61,CC1C=CC=C(C(=O)NC2=C3C(=NC4(N3)CCN(CC4)CC(C)C)C5=C(C2=O)C(=C(C6=C5C(=O)C(O6)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)C,liver,
1646,LIverTox,Rifamycin,6324616,E,0,0,697.8,4.9,201,12,6,50,CC1C=CC=C(C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C,.,
25,DILIrank,amphotericin b,14956,vLess-DILI-Concern,1,1,924.1,0,320,18,12,65,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,kidney,
252,DILIrank,nystatin,14960,vNo-DILI-Concern,0,0,926.1,-0.2,320,18,12,65,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,None not extensively absorbed,
1262,LIverTox,Griseofulvin,441140,C,1,1,352.8,2.2,71.1,6,0,24,CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC,Liver demethylation and glucuronidation,
2473,Greene,Troleandomycin,5284630,HH,1,1,814,4.3,184,16,0,57,CC1CC(C(C(O1)OC2C(CC3(CO3)C(=O)C(C(C(C(OC(=O)C(C(C2C)OC4CC(C(C(O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C,.,
1734,LIverTox,Tacrolimus,445643,C,1,1,804,2.7,178,12,3,57,CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,"CYP3A4, CYP3A5",
1246,LIverTox,Givosiran,119058042,E*,0,0,1711,-5.9,597,30,20,119,CC1CC(CN1C(=O)CCCCCCCCCCC(=O)NC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)CO)O)O)NC(=O)C)COCCC(=O)NCCCNC(=O)CCCCOC4C(C(C(C(O4)CO)O)O)NC(=O)C)O,.,
4027,Liew,Tibolone,444008,negative,1,1,312.4,2.4,37.3,2,1,23,CC1CC2=C(CCC(=O)C2)C3C1C4CCC(C4(CC3)C)(C#C)O,"Liver, Intestine",
3150,Liew,Alclometasone,5311000,negative,0,0,408.9,2.2,94.8,5,3,28,CC1CC2C3C(CC4=CC(=O)C=CC4(C3C(CC2(C1(C(=O)CO)O)C)O)C)Cl,,
3574,Liew,Halobetasol,5311167,negative,0,0,428.9,2.7,74.6,6,2,29,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C)F,,
3511,Liew,Flumethasone,16490,negative,0,0,410.5,1.9,94.8,7,3,29,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C)F,,
3526,Liew,Fluticasone,5311101,negative,0,0,444.5,3.2,99.9,8,2,30,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,,
3334,Liew,Clocortolone Pivalate,5282493,negative,0,0,495,4.5,80.7,6,1,34,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)COC(=O)C(C)(C)C)C)O)Cl)C)F,,
3518,Liew,Fluorometholone,9878,negative,0,0,376.5,2,74.6,5,2,27,CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O,,
3703,Liew,Methylprednisolone,6741,positive,1,1,374.5,1.9,94.8,5,3,27,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,,
3664,Liew,Medrysone,247839,negative,0,0,344.5,2.7,54.4,3,1,25,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)CC4)C)O)C)C(=O)C,,
3731,Liew,Mometasone,441335,negative,0,0,427.4,2.7,74.6,4,2,28,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,,
3333,Liew,Clobetasol,5311051,negative,0,0,410.9,2.5,74.6,5,2,28,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,,
2534,Xu,Betamethasone,9782,Negative,0,0,392.5,1.9,94.8,6,3,28,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,CYP3A4,
3383,Liew,Desoximetasone,5311067,negative,0,0,376.5,2.3,74.6,5,2,27,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)CO)C)O)F)C,,
4036,Liew,Tirilazad,104903,positive,0,0,624.9,5.9,72.9,8,0,46,CC1CC2C3CCC4=CC(=O)C=CC4(C3=CCC2(C1C(=O)CN5CCN(CC5)C6=NC(=NC(=C6)N7CCCC7)N8CCCC8)C)C,,
1160,LIverTox,Eribulin,11354606,E*,0,0,729.9,1.1,146,12,2,52,CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O,.,
3612,Liew,Josamycin,5282165,positive,0,0,828,2.9,206,16,3,58,CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)OC(=O)C)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O,,
3925,Liew,Retapamulin,6918462,negative,0,0,517.8,6.1,92.1,6,1,36,CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CC5CCC(C4)N5C)C,CYP3A4,
1343,LIverTox,Lefamulin,25185057,E,0,0,507.7,4.3,135,7,3,35,CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CCC(CC4O)N)C,.,
3510,Liew,Flumequine,3374,positive,1,1,261.25,2.9,57.6,5,1,19,CC1CCC2=C3N1C=C(C(=O)C3=CC(=C2)F)C(=O)O,,
878,LIverTox,Artemisinin,68827,D,1,1,282.33,2.8,54,5,0,20,CC1CCC2C(C(=O)OC3C24C1CCC(O3)(OO4)C)C,.,
195,DILIrank,sirolimus,5284616,vLess-DILI-Concern,1,1,914.2,6,195,13,3,65,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,Liver,
513,DILIrank,temsirolimus,6918289,vNo-DILI-Concern,0,0,1030.3,5.6,242,16,4,73,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,Liver,
1180,LIverTox,Everolimus,6442177,E*,0,0,958.2,5.9,205,14,3,68,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,.,
1322,LIverTox,Ixabepilone,6445540,E*,0,0,506.7,3.6,140,7,3,35,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,CYP3A4,
3200,Liew,Argatroban,440542,positive,0,0,508.6,1.3,189,8,5,35,CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,,
1785,LIverTox,Tofacitinib,9926791,E*,0,0,312.37,1.5,88.9,5,1,23,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,"CYP3A4, CYP2C19",
1732,LIverTox,Suvorexant,24965990,E,0,0,450.9,4.9,80.3,6,0,32,CC1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl,"Liver CYP3A major, CYP2C19 minor",
1109,LIverTox,Dolutegravir,54726191,D,1,1,419.4,2.4,99.2,8,2,30,CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,"UGT1A1, CYP3A",
3967,Liew,Sparfloxacin,60464,positive,0,0,392.4,0.1,98.9,9,3,28,CC1CN(CC(N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F,Liver,
1709,LIverTox,Sonidegib,24775005,E*,0,0,485.5,5.8,63.7,8,1,35,CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,CYP3A,
3164,Liew,Alvimopan,5488548,positive,0,0,424.5,1.7,89.9,5,3,31,CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(=O)O,,
3634,Liew,Levocabastine,54385,negative,0,0,420.5,2.5,64.3,5,1,31,CC1CN(CCC1(C2=CC=CC=C2)C(=O)O)C3CCC(CC3)(C#N)C4=CC=C(C=C4)F,,
3564,Liew,Grepafloxacin,72474,positive,0,0,359.4,-0.2,72.9,7,2,26,CC1CN(CCN1)C2=C(C(=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)C)F,,
2441,Greene,Temafloxacin,60021,HH,1,1,417.4,0.6,72.9,9,2,30,CC1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=C(C=C(C=C4)F)F)F,.,
3552,Liew,Gatifloxacin,5379,positive,0,0,375.4,-0.7,82.1,8,2,27,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,,
1369,LIverTox,Lorcaserin,11658860,E,0,0,195.69,2.7,12,1,1,13,CC1CNCCC2=C1C=C(C=C2)Cl,extensive,
1353,LIverTox,Levofloxacin,149096,A,1,1,361.4,-0.4,73.3,8,1,26,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,<5% desmethyl and N-oxide metabolites,
3022,Liew,Metolazone,4170,positive,.,1,365.8,4.1,101,5,2,24,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,,
3481,Liew,Etoposide,36462,positive,1,1,588.6,0.6,161,13,3,42,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,,
3400,Liew,Dienestrol,667476,negative,0,0,266.3,5.4,40.5,2,2,20,CC=C(C1=CC=C(C=C1)O)C(=CC)C2=CC=C(C=C2)O,,
1662,LIverTox,Romidepsin,	5352062,C,1,1,540.7,2.2,193,8,4,36,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,CYP3A4,
471,DILIrank,cefprozil,9887643,vLess-DILI-Concern,1,1,407.4,,159,8,5,28,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O.O,.,
3436,Liew,Droloxifene,3033767,positive,0,0,387.5,6.8,32.7,3,1,29,CCC(=C(C1=CC=C(C=C1)OCCN(C)C)C2=CC(=CC=C2)O)C3=CC=CC=C3,,
2436,Greene,tamoxifen,2733526,HH,1,1,371.5,7.1,12.5,2,0,28,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,"CYP3A4, CYP2C9, CYP2D6",
3403,Liew,Diethylstilbestrol,448537,positive,0,0,268.3,5.1,40.5,2,2,20,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,,
3470,Liew,Ethacrynic acid,3278,positive,1,1,303.13,3.8,63.6,4,1,19,CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl,,
3932,Liew,Rimexolone,5311412,negative,0,0,370.5,3.5,54.4,3,1,27,CCC(=O)C1(C(CC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C)C,,
3892,Liew,Propiomazine,4940,negative,0,0,340.5,4.8,48.8,4,0,24,CCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CC(C)N(C)C,,
394,DILIrank,remifentanil,60815,vLess-DILI-Concern,1,1,376.4,1.9,76.2,6,0,27,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,	cleaved by non-specific plasma and tissue esterases,
3975,Liew,Sufentanil,41693,negative,0,0,386.6,4,61,4,0,27,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,,
3153,Liew,Alfentanil,51263,negative,0,0,416.5,2.2,81,6,0,30,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,,
3496,Liew,Fentanyl,3345,negative,0,0,336.5,4,23.6,2,0,25,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,,
1741,LIverTox,Tasimelteon,10220503,E,0,0,245.32,2.2,38.3,2,1,18,CCC(=O)NCC1CC1C2=C3CCOC3=CC=C2,"extensive liver, primarily CYP1A2,CYP3A4",
492,DILIrank,ramelteon,208902,vNo-DILI-Concern,0,0,259.34,2.7,38.3,2,1,19,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,"Liver CYP1A2 major, CYP2C,CYP3A4 minor",
583,DILIrank,fosinopril,55891,vLess-DILI-Concern,1,1,563.7,6.2,110,7,1,39,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)O)C3CCCCC3,"liver, GIT mucosa to fosinoprilat",
3894,Liew,Propoxyphene,10100,positive,1,1,339.5,4.2,29.5,3,0,25,CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C,CYP3A4,
3918,Liew,Rapacuronium,5311398,negative,0,0,677.8,,55.8,6,0,44,CCC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)OC(=O)C)N5CCCCC5)C)C)[N+]6(CCCCC6)CC=C.[Br-],,
1936,Greene,Beclomethasone Dipropionate,21700,NE,0,0,521,3,107,7,1,36,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC,	By esterase enzymes found in most tissues,
3873,Liew,Prednicarbate,6714002,negative,0,0,488.6,4.2,116,8,1,35,CCC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)OC(=O)OCC,,
427,DILIrank,levetiracetam,5284583,vLess-DILI-Concern,1,1,170.21,-0.3,63.4,2,1,12,CCC(C(=O)N)N1CCCC1=O,Enzymatic hydrolysis of acetamide group,
1579,LIverTox,Posaconazole,147912,E*,0,0,700.8,4.6,112,11,1,51,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,Liver glucuronidation,
3602,Liew,Isoetharine,3762,negative,0,0,239.31,1.7,72.7,4,4,17,CCC(C(C1=CC(=C(C=C1)O)O)O)NC(C)C,,
1700,LIverTox,Simvastatin,54454,A,1,1,418.6,4.7,72.8,5,1,30,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,.,
112,DILIrank,pravastatin,54687,vLess-DILI-Concern,1,1,424.5,1.6,124,7,4,30,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Liver minimal,
1372,LIverTox,Lovastatin,53232,B,1,1,404.5,4.3,72.8,5,1,29,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Liver CYP3A and CYP2C8 substrate,
193,DILIrank,corticorelin ovine triflutate,16186200,vNo-DILI-Concern,0,0,4757,-14.3,2050,72,67,333,CCC(C)C(C(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CC1=CNC=N1)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC=N2)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)CC)NC(=O)C4CCCN4C(=O)C5CCCN5C(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)N,.,polypeptide
410,DILIrank,bivalirudin,16129704,vNo-DILI-Concern,0,0,2180.3,-7.1,902,35,28,155,CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)C4CCCN4C(=O)C(CCCNC(=N)N)NC(=O)C5CCCN5C(=O)C(CC6=CC=CC=C6)N,	Angiomax is cleared from plasma by a combination of renal mechanisms and proteolytic cleavage,
1686,LIverTox,Semaglutide,56843331,E,0,0,4114,-5.8,1650,63,57,291,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N,Proteolysis,
210,DILIrank,pramlintide,16132446,vNo-DILI-Concern,0,0,3951,-16.7,1690,59,58,277,CCC(C)C(C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC6=CN=CN6)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CS)NC(=O)C(CCCCN)N,Renal,
3101,Liew,Teriparatide,16132393,negative,.,0,4118,-18.7,1800,62,60,289,CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC2=CN=CN2)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC5=CN=CN5)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CO)N,,
1361,LIverTox,Lixisenatide,90472060,E,0,0,4858,-30.8,2090,77,70,342,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC8=CNC=N8)N,.,
1149,LIverTox,Enfuvirtide,16130199,E,0,0,4492,-14.7,1900,67,63,319,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(=O)N)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CC7=CC=CC=C7)C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CC8=CN=CN8)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C,Liver,
204,DILIrank,nesiritide,16134381,vNo-DILI-Concern,0,0,3464,-17.2,1610,55,55,239,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCCN)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C3CCCN3C(=O)C(CO)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC4C=NC=N4)C(=O)O)CC(C)C)CO)CO)CO)CO,.,peptide
1933,Greene,Bacitracin,439542,NE,0,0,1422.7,-4.3,556,21,17,100,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CN=C(S2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,.,
341,DILIrank,oxytocin,439302,vNo-DILI-Concern,0,0,1007.2,-2.6,450,15,12,69,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,Liver and other oxytocinases,
285,DILIrank,ecallantide,118984459,vNo-DILI-Concern,0,0,7054,-27.9,3120,110,100,492,CCC(C)C1C(=O)NC(C(=O)NCC(=O)NCC(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N5CCCC5C(=O)N3)CC(=O)O)CC(=O)O)C)CCCCN)CC6=CC=CC=C6)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CO)NC(=O)C(CC8=CN=CN8)NC(=O)C(CCSC)NC(=O)C(C)NC(=O)C(CCC(=O)O)N)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)O)CCSC)CCCCN)CCCCN)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCC(=O)O)CC(=O)N)CCC(=O)N)CC(=O)N)CCCNC(=N)N)CC9=CC=CC=C9)CCC(=O)O)CO)CC(C)C)CCC(=O)O)CCC(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC1=CC=CC=C1)CCC(=O)O)CCC(=O)O)CCC(=O)N)CCCNC(=N)N)C(C)O)CC1=CC=CC=C1)C(C)CC)CC(=O)N)CC1=CC=CC=C1)CC1=CC=CC=C1)CC1=CNC2=CC=CC=C21)CCCNC(=N)N)CC1=CN=CN1)C)C)CCCNC(=N)N)CC1=CC=C(C=C1)O,.,protein
1320,LIverTox,Ivermectin,6321424,D,1,1,875.1,4.1,170,14,3,62,CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C,CYP450,
3273,Liew,Caspofungin,468682,positive,1,1,1093.3,0.3,412,18,16,77,CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O,,
518,DILIrank,colistimethate,5311054,vNo-DILI-Concern,0,0,1155.4,-3.3,491,18,18,81,CCC(C)CCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)C(C)O,.,
523,DILIrank,polymyxin b sulfate,5702105,vNo-DILI-Concern,0,0,1301.6,,574,22,20,90,CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O,.,
3609,Liew,Itraconazole,55283,positive,1,1,705.6,5.7,101,9,0,49,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,,
277,DILIrank,tapentadol,9838022,vNo-DILI-Concern,0,0,221.34,3.5,23.5,2,1,16,CCC(C1=CC(=CC=C1)O)C(C)CN(C)C,"	Liver mostly via glucuronidation but also by CYP2C9, CYP2C19, CYP2D6",
3842,Liew,Phenprocoumon,9908,negative,0,0,280.3,3.6,46.5,3,1,21,CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,"CYP2C9, CYP3A4",
1292,LIverTox,Idelalisib,11625818,D,1,1,415.4,3.7,99.2,7,2,31,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,"Aldehyde oxidase ~70%, CYP3A4 ~30%; UGT1A4 minor",
3472,Liew,Ethchlorvynol,5281077,positive,0,0,144.6,1.5,20.2,1,1,9,CCC(C=CCl)(C#C)O,,
1545,LIverTox,Peramivir,151164,E,0,0,328.41,0,151,5,5,23,CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C,.,
3788,Liew,Oseltamivir,65028,positive,1,1,312.4,1.1,90.6,5,2,22,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,Liver,
2718,Xu,Methysergide Maleate,9681,Negative,0,0,353.5,2.3,57.5,3,2,26,CCC(CO)NC(=O)C1CN(C2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C,.,
3700,Liew,Methylergonovine,8226,negative,0,0,339.4,2.3,68.4,3,3,25,CCC(CO)NC(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C,,
3471,Liew,Ethambutol,14052,positive,1,1,204.31,-0.1,64.5,4,4,14,CCC(CO)NCCNC(CC)CO,,
3811,Liew,Paramethadione,8280,positive,0,0,157.17,0.8,46.6,3,0,11,CCC1(C(=O)N(C(=O)O1)C)C,,
3673,Liew,Mephobarbital,8271,positive,0,0,246.26,1.8,66.5,3,1,18,CCC1(C(=O)NC(=O)N(C1=O)C)C2=CC=CC=C2,,
1555,LIverTox,Phenobarbital,4763,B,1,1,232.23,1.5,75.3,3,2,17,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,CYP2C19,
140,DILIrank,primidone,4909,vNo-DILI-Concern,0,0,218.25,0.9,58.2,2,2,16,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,Liver,
684,DILIrank,topotecan,60700,vNo-DILI-Concern,0,0,421.4,0.5,103,7,2,31,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O,	Liver,
3475,Liew,Ethosuximide,3291,negative,0,0,141.17,0.4,46.2,2,1,10,CCC1(CC(=O)NC1=O)C,,
1888,Greene,Aclarubicin HCl,42474,WE,1,1,811.9,3.8,217,16,4,58,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O)N(C)C)O,,
2485,Greene,Vinblastine Sulfate,241903,NE,0,0,811,3.7,154,12,3,59,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,CYP3A4,
2486,Greene,Vincristine Sulfate,5978,HH,1,1,825,2.8,171,12,3,60,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,"Liver, mostly via CYP3A4 and CYP3A5",
2510,Xu,Aminoglutethimide,2145,Negative,0,0,232.28,1.2,72.2,3,2,17,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N,	Liver minimal; acetylation,
3559,Liew,Glutethimide,3487,negative,0,0,217.26,1.9,46.2,2,1,16,CCC1(CCC(=O)NC1=O)C2=CC=CC=C2,,
3480,Liew,Etonogestrel,21729469,positive,0,0,324.5,3.3,37.3,2,1,24,CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,,
2741,Xu,Norgestrel,16051930,Positive,1,1,312.4,3.3,37.3,2,1,23,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,.,
2400,Greene,Pyrimethamine,4993,HH,1,1,248.71,2.7,77.8,4,2,17,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,Liver,
147,DILIrank,benzbromarone,2333,vMost-DILI-Concern,1,1,424.1,5.7,50.4,3,1,22,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,.,
448,DILIrank,benziodarone,6237,vMost-DILI-Concern,1,1,518.08,5.6,50.4,3,1,22,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)O)I,.,
3226,Liew,Benzarone,255968,positive,1,1,266.29,4.3,50.4,3,1,20,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC=C(C=C3)O,,
1701,LIverTox,Siponimod,44599207,E*,0,0,516.6,4.8,62.1,8,1,37,CCC1=C(C=CC(=C1)C(=NOCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)C)CN4CC(C4)C(=O)O,.,
1243,LIverTox,Gilteritinib,49803313,E*,0,0,552.7,3.5,121,10,3,40,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,.,
1435,LIverTox,Molindone,23897,D,1,1,276.37,1.7,45.3,3,1,20,CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C,Liver,
1176,LIverTox,Etodolac,3308,C,1,1,287.35,2.8,62.3,3,2,21,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,liver,
600,DILIrank,irinotecan,60838,vLess-DILI-Concern,1,1,586.7,3,113,8,1,43,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,Liver glucuronidation,
803,LIverTox,Alectinib,49806720,D,1,1,482.6,5.2,72.4,5,1,36,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,CYP3A4,
3343,Liew,Clotiazepam,2811,positive,0,0,318.8,3.5,60.9,3,0,21,CCC1=CC2=C(S1)N(C(=O)CN=C2C3=CC=CC=C3Cl)C,,
73,DILIrank,pioglitazone,4829,vLess-DILI-Concern,1,1,356.4,3.8,93.6,5,1,25,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,CYP2C8,
3474,Liew,Ethionamide,2761171,positive,1,1,166.25,1.1,71,2,1,11,CCC1=NC=CC(=C1)C(=S)N,,
2731,Xu,Nefazodone,4449,Positive,1,1,470,4.3,51.6,5,0,33,CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl,"CYP3A4, CYP2D6",
3356,Liew,Cyclosporine,5284373,positive,1,1,1202.6,7.5,279,12,5,85,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,,
1623,LIverTox,Quinupristin-Dalfopristin,23724510,E*,0,0,1713.1,,441,25,6,121,CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CC(C(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CSC6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C.CCN(CC)CCS(=O)(=O)C1CCN2C1C(=O)OC(C(C=CC(=O)NCC=CC(=CC(CC(=O)CC3=NC(=CO3)C2=O)O)C)C)C(C)C,.,
3946,Liew,Roxithromycin,6915744,positive,0,0,837,3.1,217,17,5,58,CCC1C(C(C(C(=NOCOCCOC)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,Liver,
2084,Greene,Erythromycin estolate (1),12560,HH,1,1,733.9,2.7,194,14,5,51,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,.,
3328,Liew,Clarithromycin,84029,positive,1,1,748,3.2,183,14,4,52,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,,
1929,Greene,Azithromycin,55185,WE,1,1,749,4,180,14,5,52,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,LIver,
3419,Liew,Dirithromycin,6917067,positive,0,0,835.1,4.2,196,16,5,58,CCC1C(C2C(C(C(CC(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)C)O)(C)O)C)NC(O2)COCCOC)C)(C)O,,
709,DILIrank,telithromycin,5462516,vMost-DILI-Concern,1,1,812,4.2,172,13,1,58,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,Liver 50% CYP3A4,
1489,LIverTox,Obeticholic Acid,447715,B,1,1,420.6,5.7,77.8,4,3,30,CCC1C2CC(CCC2(C3CCC4(C(C3C1O)CCC4C(C)CCC(=O)O)C)C)O,.,
1198,LIverTox,Fidaxomicin,10034073,E,0,0,1058,6.4,267,18,7,72,CCC1C=C(C(CC=CC=C(C(=O)OC(CC=C(C=C(C1OC2C(C(C(C(O2)(C)C)OC(=O)C(C)C)O)O)C)C)C(C)O)COC3C(C(C(C(O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)C,.,
3848,Liew,Pimecrolimus,16051947,negative,0,0,810.4,3.8,158,11,2,56,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,CYP3A5,
3909,Liew,Quinethazone,6307,positive,0,0,289.74,1.2,110,5,3,18,CCC1NC2=CC(=C(C=C2C(=O)N1)S(=O)(=O)N)Cl,,
1757,LIverTox,Tesamorelin,16137828,E,0,0,5136,-23.3,2360,76,83,361,CCC=CCC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)NC(C(C)CC)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)N,Proteolysis,
415,DILIrank,acebutolol,1978,vLess-DILI-Concern,1,1,336.4,1.7,87.7,5,3,24,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C,LIver,
3406,Liew,Difluprednate,32037,negative,0,0,508.5,3.4,107,9,1,36,CCCC(=O)OC1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C(=O)COC(=O)C,,
265,DILIrank,clevidipine,153994,vNo-DILI-Concern,0,0,456.3,4.3,90.9,7,1,30,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Blood and tissue esterases,
1744,LIverTox,Telaprevir,3010818,B,1,1,679.8,4.2,180,8,4,49,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5,extensive Liver,
3832,Liew,Perindopril,107807,negative,0,0,368.5,0.9,95.9,6,2,26,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Kidney,
617,DILIrank,meprobamate,4064,vNo-DILI-Concern,0,0,218.25,0.7,105,4,2,15,CCCC(C)(COC(=O)N)COC(=O)N,Liver,
3268,Liew,Carisoprodol,2576,negative,0,0,260.33,1.9,90.6,4,2,18,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,,
4024,Liew,Thiopental,3000714,positive,0,0,264.32,,96.6,3,1,17,CCCC(C)C1(C(=O)NC(=S)N=C1[O-])CC.[Na+],Liver,
2066,Greene,Divalproex Sodium,3121,HH,1,1,144.21,2.8,37.3,2,1,10,CCCC(CCC)C(=O)O,"	Liver-glucuronide conjugation 30?50%, mitochondrial ??-oxidation over 40%",
3194,Liew,Anisotropine,6647,negative,0,0,362.3,,26.3,3,0,21,CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[Br-],,
3750,Liew,Nedocromil,50294,negative,0,0,371.3,2.2,121,8,2,27,CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)O)C(=O)C=C(N2CC)C(=O)O,,
1602,LIverTox,Propylthiouracil,657298,A,1,1,170.23,0.8,73.2,2,2,11,CCCC1=CC(=O)NC(=S)N1,.,
1497,LIverTox,Olmesartan,130881,D,1,1,558.6,3.8,154,10,2,41,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,Liver (cannot be removed by hemodialysis),
4087,Liew,Vardenafil,110634,positive,0,0,488.6,2.5,118,7,1,34,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,CYP3A4,
732,DILIrank,telmisartan,65999,vLess-DILI-Concern,1,1,514.6,6.9,72.9,4,1,39,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,Minimal liver glucuronidation,
413,DILIrank,sildenafil,135398744,vLess-DILI-Concern,1,1,474.6,1.5,118,8,1,33,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,"Liver: CYP3A4 major route, CYP2C9 minor route",
946,LIverTox,Brivaracetam,9837243,E,0,0,212.29,1,63.4,2,1,15,CCCC1CC(=O)N(C1)C(CC)C(=O)N,"Hydrolysis by amidase, CYP2C19-mediated hydroxylation",
2014,Greene,Clindamycin HCl,446598,HH,1,1,425,2.2,128,7,4,27,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,Liver,
456,DILIrank,budesonide,40000,vNo-DILI-Concern,0,0,430.5,2.5,93.1,6,2,31,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,CYP3A4,
1826,LIverTox,Valsartan,60846,D,1,1,435.5,4.4,112,6,2,32,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,.,
4084,Liew,Valrubicin,454216,negative,0,0,723.6,4,215,16,5,51,CCCCC(=O)OCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O,,
1375,LIverTox,Lubiprostone,157920,E,0,0,390.5,4,83.8,7,2,27,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,"Extensive, CYP not involved",
2260,Greene,Octyl Methoxycinnamate,5355130,HH,1,1,290.4,5.3,35.5,3,0,21,CCCCC(CC)COC(=O)C=CC1=CC=C(C=C1)OC,.,
1107,LIverTox,Docusate,11339,E,0,0,422.6,5.1,115,7,1,28,CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)O,.,
1119,LIverTox,Dronedarone,208898,C,1,1,556.8,7.2,97.2,7,1,39,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC,Extensive Liver mainly by CYP3A,
1905,Greene,amiodarone,2157,HH,1,1,645.3,7.6,42.7,4,0,31,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,Liver,
2188,Greene,losartan,3961,HH,1,1,422.9,4.3,92.5,5,2,30,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,"	CYP2C9, CYP3A4",
1309,LIverTox,Irbesartan,3749,C,1,1,428.5,4.1,87.1,5,1,32,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,CYP2C9,
1156,LIverTox,Eprosartan,5281037,E*,0,0,424.5,4.5,121,6,2,30,CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O,not metabolized,
2760,Xu,Phenylbutazone,4781,Positive,1,1,308.4,3.2,40.6,2,0,23,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,,
3266,Liew,Carboprost,5281075,negative,0,0,368.5,2.9,98,5,4,26,CCCCCC(C)(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O,,
3414,Liew,Dinoprostone,5280360,positive,0,0,352.5,2.8,94.8,5,3,25,CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,,
3162,Liew,Alprostadil,5280723,positive,0,0,354.5,3.2,94.8,5,3,25,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,,
3413,Liew,Dinoprost,5280363,negative,0,0,354.5,2.7,98,5,4,25,CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O,,
4054,Liew,Treprostinil,6918140,negative,0,0,390.5,4.5,87,5,3,28,CCCCCC(CCC1C(CC2C1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O,Liver,
964,LIverTox,Cannabidiol,644019,E*,0,0,314.5,6.5,40.5,2,2,23,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,.,
1446,LIverTox,Nabilone,5284592,E,0,0,372.5,6.4,46.5,3,1,27,CCCCCCC(C)(C)C1=CC(=C2C3CC(=O)CCC3C(OC2=C1)(C)C)O,.,
4080,Liew,Unoprostone,5311236,negative,0,0,382.5,3.7,94.8,5,3,27,CCCCCCCC(=O)CCC1C(CC(C1CC=CCCCC(=O)O)O)O,,
1136,LIverTox,Eliglustat,23652731,E,0,0,404.5,3.7,71,5,2,29,CCCCCCCC(=O)NC(CN1CCCC1)C(C2=CC3=C(C=C2)OCCO3)O,.,
1200,LIverTox,Fingolimod,107970,C,1,1,307.5,4.2,66.5,3,3,22,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,.,
3368,Liew,Daptomycin,16129629,positive,1,1,1620.7,-5.1,702,28,22,115,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,,
751,DILIrank,nandrolone decanoate,9677,vMost-DILI-Concern,1,1,428.6,7.3,43.4,3,0,31,CCCCCCCCCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C,"	Blood hydrolysis, liver reduction",
759,DILIrank,orlistat,3034010,vMost-DILI-Concern,1,1,495.7,10,81.7,5,1,35,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,In the GI tract,
1036,LIverTox,Colesevelam,160051,E,0,0,618.2,,62.6,5,4,39,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-],Colesevelam is not absorbed and not metabolised.,
681,DILIrank,sulcotidil,5354,vMost-DILI-Concern,1,1,337.6,5.8,57.6,3,2,23,CCCCCCCCNC(C)C(C1=CC=C(C=C1)SC(C)C)O,.,
3587,Liew,Ibutilide,60753,negative,0,0,384.6,4,78,5,2,26,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,,
4101,Liew,Xanomeline,60809,positive,0,0,281.42,3.3,66.5,5,0,19,CCCCCCOC1=NSN=C1C2=CCCN(C2)C,,
3585,Liew,Ibandronate,60852,positive,0,0,319.23,-4.1,139,8,5,19,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,,
3996,Liew,Tegaserod,5362436,positive,0,0,301.39,2.1,84,4,3,22,CCCCCN=C(N)NNC=C1C=NC2=C1C=C(C=C2)OC,"Gastric, Liver",
965,LIverTox,Capecitabine,60953,E*,0,0,359.35,0.6,121,7,3,25,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,"liver, to 5'-DFCR, 5'-DFUR inactive; neoplastic tissue, 5'-DFUR to active fluorouracil",
475,DILIrank,micafungin,477468,vMost-DILI-Concern,1,1,1270.3,-1.6,519,24,16,89,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)C(CC(=O)N)O)C)O)O)O,	Via catechol-O-methyltransferase pathway,
3575,Liew,Halofantrine,37393,positive,0,0,500.4,8.6,23.5,5,1,33,CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O,,
292,DILIrank,aplaviroc,3001322,vMost-DILI-Concern,1,1,577.7,3.1,119,7,3,42,CCCCN1C(=O)C(NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)C(C5CCCCC5)O,.,
3721,Liew,Miglustat,51634,negative,0,0,219.28,-0.6,84.2,5,4,15,CCCCN1CC(C(C(C1CO)O)O)O,,
2540,Xu,Bupivacaine,2474,Negative,0,0,288.4,3.4,32.3,2,1,21,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,	Liver,
3267,Liew,Carbutamide,9564,positive,0,0,271.34,1,110,4,3,18,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)N,,
2539,Xu,Bumetanide,2471,Positive,1,1,364.4,2.8,127,7,3,25,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,	Liver,
329,DILIrank,benzonatate,7699,vLess-DILI-Concern,1,1,603.7,2.4,121,12,1,42,CCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC,.,
3224,Liew,Benoxinate,4633,negative,0,0,308.4,3.1,64.8,5,1,22,CCCCOC1=C(C=CC(=C1)C(=O)OCCN(CC)CC)N,,
3440,Liew,Dyclonine,3180,negative,0,0,289.4,3.6,29.5,3,0,21,CCCCOC1=CC=C(C=C1)C(=O)CCN2CCCCC2,,
3396,Liew,Dibucaine,3025,negative,0,0,343.5,4.4,54.5,4,1,25,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,,
4037,Liew,Tirofiban,60947,negative,0,0,440.6,1.4,113,7,3,30,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O,,
3476,Liew,Etidocaine,37497,negative,0,0,276.4,3.7,32.3,2,1,20,CCCN(CC)C(CC)C(=O)NC1=C(C=CC=C1C)C,,
428,DILIrank,alpidem,54897,vMost-DILI-Concern,1,1,404.3,4.8,37.6,2,0,27,CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl,"	Extensive hydroxylation, dealkylation, conjugation",
3940,Liew,Ropinirole,5095,negative,1,1,260.37,2.7,32.3,2,1,19,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,CYP1A2,
3878,Liew,Probenecid,4911,positive,1,1,285.36,3.2,83.1,5,1,19,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,,
1666,LIverTox,Rotigotine,57537,E,0,0,315.5,4.9,51.7,3,1,22,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O,CYP450,
1547,LIverTox,Pergolide,47811,E*,0,0,314.5,4.2,44.3,2,1,22,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC,Extensively Liver,
3941,Liew,Ropivacaine,175805,negative,0,0,274.4,2.9,32.3,2,1,20,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,CYP1A2,
3314,Liew,Chlorpropamide,2727,positive,1,1,276.74,2.3,83.6,3,2,17,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl,,
3875,Liew,Prilocaine,4906,negative,0,0,220.31,2.1,41.1,2,2,16,CCCNC(C)C(=O)NC1=CC=CC=C1C,"Liver, Kidney",
1581,LIverTox,Pramipexole,119570,E,0,0,211.33,1.9,79.2,4,2,14,CCCNC1CCC2=C(C1)SC(=N2)N,.,
1598,LIverTox,Propafenone,4932,B,1,1,341.4,3.3,58.6,4,2,25,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,.,
1378,LIverTox,Macitentan,16004692,E*,0,0,588.3,3.7,137,10,2,32,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,"Hydrolysis, oxidation CYP3A4",
3896,Liew,Propyliodone,4949,negative,0,0,447.01,2.4,46.6,4,0,16,CCCOC(=O)CN1C=C(C(=O)C(=C1)I)I,,
3891,Liew,Proparacaine,4935,negative,0,0,294.39,2.7,64.8,5,1,21,CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N,,
1832,LIverTox,Vemurafenib,42611257,E*,0,0,489.9,5,100,7,2,33,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,.,
213,DILIrank,albendazole,2082,vMost-DILI-Concern,1,1,265.33,2.9,92.3,4,2,18,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,Liver,
1772,LIverTox,Ticagrelor,9871419,D,1,1,522.6,2,164,12,4,36,CCCSC1=NC(=C2C(=N1)N(N=N2)C3CC(C(C3O)O)OCCO)NC4CC4C5=CC(=C(C=C5)F)F,CYP3A4,
3867,Liew,Prajmaline,37042,positive,0,0,369.5,2.7,43.7,3,2,27,CCC[N+]12C3CC(C(C1O)CC)C4C2CC5(C3N(C6=CC=CC=C65)C)C4O,,
3936,Liew,Rivastigmine,77991,negative,1,1,250.34,2.3,32.8,3,0,18,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,Liver,
269,DILIrank,zaleplon,5719,vNo-DILI-Concern,0,0,305.33,1,74.3,4,0,23,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,"Liver aldehyde oxidase (91%), CYP3A4 (9%)",
3349,Liew,Crotamiton,688020,negative,0,0,203.28,2.8,20.3,1,0,15,CCN(C1=CC=CC=C1C)C(=O)C=CC,,
1150,LIverTox,Entacapone,5281081,D,1,1,305.29,2.1,130,6,2,22,CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N,Liver,
515,DILIrank,milnacipran,65833,vMost-DILI-Concern,1,1,246.35,1.4,46.3,2,1,18,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2,Liver,
3230,Liew,Benzquinamide,2342,negative,0,0,404.5,2.1,68.3,6,0,29,CCN(CC)C(=O)C1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C)OC)OC,,
3401,Liew,Diethylcarbamazine,3052,negative,0,1,199.29,0.3,26.8,2,0,14,CCN(CC)C(=O)N1CCN(CC1)C,,
3421,Liew,Disulfiram,3117,positive,1,1,296.5,3.9,121,4,0,16,CCN(CC)C(=S)SSC(=S)N(CC)CC,,
3402,Liew,Diethylpropion,7029,negative,0,0,205.3,2.8,20.3,2,0,15,CCN(CC)C(C)C(=O)C1=CC=CC=C1,,
741,DILIrank,oxybutynin,4634,vNo-DILI-Concern,0,0,357.5,4.2,49.8,4,1,26,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,.,
2180,Greene,Lidocaine,3676,NE,0,0,234.34,2.3,32.3,2,1,17,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,"	Liver, 90% CYP3A4",
830,LIverTox,Amodiaquine,2165,A,1,1,355.9,2.6,48.4,4,2,25,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O,.,
3906,Liew,Quinacrine,237,positive,0,0,400,6,37.4,4,1,28,CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC,,
3308,Liew,Chloroquine,2719,negative,1,1,319.9,4.6,28.2,3,1,22,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,,
3198,Liew,Aprindine,2218,positive,0,0,322.5,5.2,6.5,2,0,24,CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C3=CC=CC=C3,,
581,DILIrank,flurazepam,3393,vLess-DILI-Concern,1,1,387.9,3,35.9,4,0,27,CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F,Liver,
234,DILIrank,sunitinib,5329102,vMost-DILI-Concern,1,1,398.5,2.6,77.2,4,3,29,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,CYP3A4,
3707,Liew,Metoclopramide,4168,negative,1,1,299.79,2.6,67.6,4,2,20,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,,
3880,Liew,Procainamide,4913,positive,1,1,235.33,0.9,58.4,3,2,17,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N,CYP2D6,
2142,Greene,Hycanthone,3634,HH,1,1,356.5,2.7,77.9,5,2,25,CCN(CC)CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O,,
1090,LIverTox,Dicyclomine,3042,ND,.,0,309.5,5.5,29.5,3,0,22,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,.,
3307,Liew,Chloroprocaine,8612,negative,0,0,270.75,2.9,55.6,4,1,18,CCN(CC)CCOC(=O)C1=C(C=C(C=C1)N)Cl,,
3881,Liew,Procaine,4914,negative,0,0,236.31,1.9,55.6,4,1,17,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N,,
2571,Xu,Clomiphene Citrate,2800,Positive,1,1,406,7.2,12.5,2,0,29,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,"	4-Hydroxyclomiphene 4-OH-CLO, 4-Hydroxy-N-desethylclomiphene 4-OH-DE-CLO",
4075,Liew,Tropicamide,5593,negative,0,0,284.35,1.5,53.4,3,1,21,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2,,
3582,Liew,Hydroxychloroquine,3652,negative,1,1,335.9,3.6,48.4,4,2,23,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,,
3325,Liew,Cinoxacin,2762,positive,0,0,262.22,2.1,88.4,7,1,19,CCN1C2=CC3=C(C=C2C(=O)C(=N1)C(=O)O)OCO3,,
2240,Greene,Nalidixic Acid,4421,HH,1,1,232.23,1.4,70.5,5,1,17,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,	Partially Liver,
3006,Liew,Lomefloxacin,3948,negative,.,1,351.35,-0.8,72.9,8,2,25,CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O,,
3815,Liew,Pefloxacin,51081,positive,0,0,333.36,0.3,64.1,7,1,24,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,Liver,
640,DILIrank,norfloxacin,4539,vLess-DILI-Concern,1,1,319.33,-1,72.9,7,2,23,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,Liver,
3450,Liew,Enoxacin,3229,positive,0,0,320.32,-0.2,85.8,8,2,23,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,,
3978,Liew,Sulfacytine,5322,positive,0,0,294.33,0.1,113,4,2,20,CCN1C=CC(=NC1=O)NS(=O)(=O)C2=CC=C(C=C2)N,,
227,DILIrank,doxapram,3156,vNo-DILI-Concern,0,0,378.5,3.3,32.8,3,0,28,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4,.,
3986,Liew,Sulpiride,5355,positive,0,0,341.4,0.6,110,6,2,23,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,,
1567,LIverTox,Piperacillin,43672,B,1,1,517.6,0.5,182,8,3,36,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,Largely not metabolized,
1568,LIverTox,Piperacillin-Tazobactam,9918881,B,1,1,817.9,,313,15,4,56,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O.CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,.,
785,LIverTox,Abemaciclib,46220502,E*,0,0,506.6,3.8,75,9,1,37,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,.,
205,DILIrank,ganirelix acetate,16186319,vNo-DILI-Concern,0,0,1570.3,5.4,452,16,16,112,CCNC(=NCCCCC(C(=O)NC(CC(C)C)C(=O)NC(CCCCN=C(NCC)NCC)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC=CC6=CC=CC=C65)NC(=O)C)NCC,.,
3577,Liew,Histrelin,25077993,negative,0,0,1323.5,0.7,449,15,15,96,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CN(C=N2)CC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,,
3239,Liew,Bimatoprost,5311027,positive,0,0,415.6,2.8,89.8,4,4,30,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,,
458,DILIrank,cabergoline,54746,vNo-DILI-Concern,0,0,451.6,3.4,71.7,4,2,33,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C,"	Liver, predominately via hydrolysis of the acylurea bond or the urea moiety",
3385,Liew,Dexfenfluramine,66265,positive,0,0,231.26,3.4,12,4,1,16,CCNC(C)CC1=CC(=CC=C1)C(F)(F)F,,
3756,Liew,Netilmicin,41859,positive,0,0,475.6,-4.2,200,12,8,33,CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N,,
3428,Liew,Dorzolamide,5284549,negative,0,0,324.4,0.4,151,7,2,19,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,,
1342,LIverTox,Lavender,	702,E,0,0,46.07,-0.1,20.2,1,1,3,CCO,.,
3337,Liew,Clofibrate,2796,positive,1,1,242.7,3.3,35.5,3,0,16,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,,
1748,LIverTox,Telotristat,25181577,E,0,0,575,5.1,131,11,2,40,CCOC(=O)C(CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)OC(C3=C(C=C(C=C3)Cl)N4C=CC(=N4)C)C(F)(F)F)N,Hydrolysis via carboxylesterases,
3374,Liew,Delapril,5362116,positive,0,0,452.5,1.7,95.9,6,2,33,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N(CC(=O)O)C2CC3=CC=CC=C3C2,,
3592,Liew,Imidapril,5464343,positive,1,1,405.4,-0.7,116,7,2,29,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C(CN(C2=O)C)C(=O)O,,
3915,Liew,Ramipril,5362129,positive,1,1,416.5,1.4,95.9,6,2,30,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Liver,
4049,Liew,Trandolapril,5484727,negative,1,1,430.5,2,95.9,6,2,31,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O,Liver,
1433,LIverTox,Moexipril,91270,E*,0,0,498.6,1.2,114,8,2,36,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC,"active metabolite, moexiprilat",
668,DILIrank,quinapril,54892,vLess-DILI-Concern,1,1,438.5,1.2,95.9,6,2,32,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O,.,
156,DILIrank,enalapril,5388962,vLess-DILI-Concern,1,1,376.4,-0.1,95.9,6,2,27,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Liver to enalaprilat,
2530,Xu,Benazepril,5362124,Negative,0,1,424.5,1.3,95.9,6,2,31,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,Liver glucuronidation,
1395,LIverTox,Meperidine,4058,ND,.,0,247.33,2.5,29.5,3,0,18,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,Liver,
1101,LIverTox,Diphenoxylate,13505,ND,.,0,452.6,5.7,53.3,4,0,34,CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4,.,
1190,LIverTox,Felodipine,3333,E,0,1,384.2,3.9,64.6,5,1,25,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Liver,
3768,Liew,Nitrendipine,4507,positive,0,0,360.4,2.9,110,7,1,26,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,Liver,
3620,Liew,Lacidipine,5311217,positive,0,0,455.5,4.5,90.9,7,1,33,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C,,
829,LIverTox,Amlodipine,2162,C,1,1,408.9,3,99.9,7,2,28,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Liver,
2655,Xu,Flumazenil,3373,Negative,0,0,303.29,1,64.4,5,0,22,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,Liver,
3545,Liew,Gabexate,3447,positive,0,0,321.37,1.4,117,5,2,23,CCOC(=O)C1=CC=C(C=C1)OC(=O)CCCCCN=C(N)N,,
3995,Liew,Tazarotene,5381,negative,0,0,351.5,4.9,64.5,4,0,25,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,,
559,DILIrank,etomidate,36339,vNo-DILI-Concern,0,0,244.29,3,44.1,3,0,18,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2,	Ester hydrolysis in plasma and liver,
3483,Liew,Etretinate,5282375,positive,0,0,354.5,6.8,35.5,3,0,26,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C(=C(C=C1C)OC)C)C,,
3656,Liew,Malathion,4004,negative,0,0,330.4,2.4,128,8,0,19,CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC,,
724,DILIrank,ximelagatran,9574101,vMost-DILI-Concern,1,1,473.6,2.2,146,7,4,34,CCOC(=O)CNC(C1CCCCC1)C(=O)N2CCC2C(=O)NCC3=CC=C(C=C3)C(=NO)N,	to melagatran,
3265,Liew,Carbimazole,31072,positive,1,1,186.23,0.7,64.9,3,0,12,CCOC(=O)N1C=CN(C1=S)C,,
1367,LIverTox,Loratadine,3957,E*,0,0,382.9,5.2,42.4,3,0,27,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,"CYP2D6, CYP3A4",
1185,LIverTox,Ezogabine,121892,E,0,0,303.33,2.8,76.4,5,3,22,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N,Liver glucuronidation and acetylation. CYP not involved,
2233,Greene,Moricizine HCl,34633,HH,1,1,427.5,3,96.4,6,1,30,CCOC(=O)NC1=CC2=C(C=C1)SC3=CC=CC=C3N2C(=O)CCN4CCOCC4,.,
1849,LIverTox,Vorapaxar,10077130,E,0,0,492.6,5.3,77.5,6,1,36,CCOC(=O)NC1CCC2C(C1)CC3C(C2C=CC4=NC=C(C=C4)C5=CC(=CC=C5)F)C(OC3=O)C,"CYP3A4, CYP2J2",
3216,Liew,Bacampicillin,39849,negative,0,0,465.5,2.7,163,9,2,32,CCOC(=O)OC(C)OC(=O)C1C(SC2N1C(=O)C2NC(=O)C(C3=CC=CC=C3)N)(C)C,,
3650,Liew,Loteprednol,444025,negative,0,0,466.9,3.9,99.1,7,1,32,CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl,,
632,DILIrank,nafcillin,8982,vLess-DILI-Concern,1,1,414.5,2.9,121,6,2,29,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,<30% Liver,
1464,LIverTox,Neratinib,9915743,E*,0,0,557,4.9,112,8,2,40,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,.,
873,LIverTox,Apremilast,11561674,E,0,0,460.5,1.8,128,7,1,32,CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,"CYP3A4, with minor contributions from CYP2A6, CYP1A2",
3922,Liew,Repaglinide,65981,negative,1,1,452.6,5.2,78.9,5,2,33,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,CYP3A4,
2755,Xu,Phenacetin,4754,Positive,1,1,179.22,1.6,38.3,2,1,13,CCOC1=CC=C(C=C1)NC(=O)C,,
393,DILIrank,tamsulosin,129211,vLess-DILI-Concern,1,1,408.5,2.7,108,7,2,28,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,Liver,
407,DILIrank,candesartan,2541,vLess-DILI-Concern,1,1,440.5,4.1,119,7,2,33,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Candesartan cilexetil: intestinal wall; candesartan: Hepatic CYP2C9,
897,LIverTox,Azilsartan,135415867,E*,0,1,456.4,4.4,115,7,2,34,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O,CYP2C9,
3539,Liew,Fotemustine,104799,positive,0,0,315.69,0.9,97.3,6,1,19,CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC,,
3443,Liew,Echothiophate,10547,negative,0,0,383.23,,60.8,5,0,16,CCOP(=O)(OCC)SCC[N+](C)(C)C.[I-],,
904,LIverTox,Baricitinib,44205240,E*,0,0,371.4,-0.5,129,7,1,26,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,CYP3A4 <10%,
4022,Liew,Thiethylperazine,5440,positive,0,0,399.6,5.4,60.3,5,0,27,CCSC1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)C,,
2091,Greene,ethionine,6205,HH,1,1,163.24,-1.5,88.6,4,2,10,CCSCCC(C(=O)O)N,.,
3445,Liew,Edrophonium,3202,negative,0,0,166.24,1.8,20.2,1,1,12,CC[N+](C)(C)C1=CC(=CC=C1)O,,
2076,Greene,Edrophonium Chloride,8307,NE,0,0,201.69,,20.2,2,1,13,CC[N+](C)(C)C1=CC(=CC=C1)O.[Cl-],.,
3245,Liew,Bretylium,2431,negative,0,0,243.16,2.8,0,0,0,13,CC[N+](C)(C)CC1=CC=CC=C1Br,,
3685,Liew,Methantheline,4097,negative,0,0,340.4,3.3,35.5,3,0,25,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13,,
4057,Liew,Tridihexethyl chloride,20299,negative,0,0,318.5,4.8,20.2,1,1,23,CC[N+](CC)(CC)CCC(C1CCCCC1)(C2=CC=CC=C2)O,,
2665,Xu,Gallamine Triethiodide,6172,Negative,0,0,891.5,,27.7,6,0,39,CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-],.,
3166,Liew,Ambenonium,2131,negative,0,0,537.6,5.1,58.2,2,2,36,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC2=CC=CC=C2Cl,,
647,DILIrank,ambenonium,8288,vNo-DILI-Concern,0,0,608.5,,58.2,4,2,38,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC2=CC=CC=C2Cl.[Cl-].[Cl-],.,
1922,Greene,Auranofin,6333901,HH,1,1,679.5,,115,10,0,32,CC[PH+](CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+],	Plasma membrane of the cell removes the acetyl groups of the glucose moiety.,
1719,LIverTox,Streptozocin,29327,D,1,1,265.22,-1.4,152,8,5,18,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,"Liver, Kidney",
922,LIverTox,Betrixaban,10275777,E*,0,0,451.9,3.6,107,5,3,32,CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl,.,
1402,LIverTox,Metformin,4091,B,1,1,129.16,-1.3,91.5,1,3,9,CN(C)C(=N)N=C(N)N,Not by liver,
2186,Greene,Loperamide HCl,3955,NE,0,0,477,5,43.8,3,1,34,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,	Liver extensive,
1643,LIverTox,Ribociclib,44631912,C,1,1,434.5,2.2,91.2,7,2,32,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,CYP3A4,
976,LIverTox,Cariprazine,11154555,E*,0,0,427.4,4.3,38.8,3,1,28,CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl,Liver via CYP3A4 and to a lesser extent CYP2D6,
818,LIverTox,Altretamine,2123,E*,0,0,210.28,2.7,48.4,6,0,15,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,Extensive liver,
1157,LIverTox,Eravacycline,54726192,E*,0,0,558.6,1,194,11,6,40,CN(C)C1C2CC3CC4=C(C=C(C(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)NC(=O)CN5CCCC5)F,.,
1674,LIverTox,Sarecycline,54681908,E*,0,0,487.5,1.1,174,10,5,35,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)CN(C)OC,.,
2226,Greene,Minocycline HCl,54675783,HH,1,1,457.5,-0.6,165,9,5,33,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C,.,
3384,Liew,Desvenlafaxine,125017,negative,1,1,263.37,2.6,43.7,3,2,19,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,,
102,DILIrank,venlafaxine,5656,vLess-DILI-Concern,1,1,277.4,2.9,32.7,3,1,20,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,"	Extensively metabolised by the liver, primarily via CYP2D6",
637,DILIrank,niperotidine,3033952,vMost-DILI-Concern,1,1,434.5,2.9,130,9,2,30,CN(C)CC1=CC=C(O1)CSCCNC(=C[N+](=O)[O-])NCC2=CC3=C(C=C2)OCO3,.,
1796,LIverTox,Tramadol,33741,E*,0,0,263.37,2.6,32.7,3,1,19,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,Liver-mediated demethylation and glucuronidation via CYP2D6 & CYP3A4,
702,DILIrank,zimelidine,5365247,vMost-DILI-Concern,1,1,317.22,3.9,16.1,2,0,19,CN(C)CC=C(C1=CC=C(C=C1)Br)C2=CN=CC=C2,.,
799,LIverTox,Afatinib,10184653,D,1,1,485.9,3.6,88.6,8,2,34,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,CYP not involved,
2538,Xu,Brompheniramine Maleate,6834,Negative,0,0,319.24,3.5,16.1,2,0,19,CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2,	Liver,
284,DILIrank,dexchlorpheniramine,33036,vNo-DILI-Concern,0,0,274.79,3.4,16.1,2,0,19,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,.,
906,LIverTox,Bedaquiline,5388906,E*,0,0,555.5,7.2,45.6,4,1,37,CN(C)CCC(C1=CC=CC2=CC=CC=C21)(C(C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O,CYP3A4,
409,DILIrank,rizatriptan,5078,vNo-DILI-Concern,0,0,269.34,1.7,49.7,3,1,20,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,	By monoamine oxidase,
424,DILIrank,almotriptan,123606,vNo-DILI-Concern,0,0,335.5,1.6,64.8,4,1,23,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3,	Liver,
1046,LIverTox,Cyclobenzaprine,2895,E*,0,0,275.4,5.2,3.2,1,0,21,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,"major: CYP3A4, CYP1A2; minor: CYP2D6, N-demethylation",
3180,Liew,Amitriptyline ,2160,positive,1,1,277.4,5,3.2,1,0,21,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,,
3781,Liew,Olopatadine,5281071,negative,0,0,337.4,1.5,49.8,4,1,25,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,,
3432,Liew,Doxepin,3158,positive,1,1,279.4,4.3,12.5,2,0,21,CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31,,
3315,Liew,Chlorprothixene,667467,positive,1,1,315.9,5.2,28.5,2,0,21,CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,,
1015,LIverTox,Citalopram,2771,C,1,1,324.4,3.2,36.3,4,0,24,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,"CYP3A4,CYP2C19",
293,DILIrank,clomacran,21382,vMost-DILI-Concern,1,1,300.8,4.6,15.3,2,1,21,CN(C)CCCC1C2=CC=CC=C2NC3=C1C=C(C=C3)Cl,.,
3339,Liew,Clomipramine,2801,positive,1,1,314.9,5.2,6.5,2,0,22,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,,
2679,Xu,Imipramine HCl,3696,Positive,1,1,280.4,4.8,6.5,2,0,21,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,"CYP1A2, CYP2C19, CYP2D6",
4059,Liew,Triflupromazine,5568,positive,0,0,352.4,5.2,31.8,6,0,24,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F,,
2555,Xu,chlorpromazine,2726,Positive,1,1,318.9,5.2,31.8,3,0,21,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,CYP2D6,
3887,Liew,Promazine,4926,positive,0,0,284.4,4.5,31.8,3,0,20,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31,,
4070,Liew,Tripelennamine,5587,negative,0,0,255.36,3.3,19.4,3,0,19,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2,Liver,
2206,Greene,Methapyrilene,4098,HH,1,1,261.39,2.6,47.6,4,0,18,CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2,,
3287,Liew,Cefotiam,43708,positive,1,1,525.6,-2.4,251,13,3,34,CN(C)CCN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)CC4=CSC(=N4)N)SC2)C(=O)O,,
3183,Liew,Amonafide,50515,positive,0,0,283.32,1.5,66.6,4,1,21,CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)N,,
3354,Liew,Cyclopentolate,2905,negative,0,0,291.4,2.7,49.8,4,1,21,CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O,,
2883,Liew,Carbinoxamine,2564,negative,.,0,290.79,2.9,25.4,3,0,20,CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,,
2627,Xu,Diphenhydramine HCl,3100,Negative,0,0,255.35,3.3,12.5,2,0,19,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,"	CYP2D6, others",
4047,Liew,Toremifene,3005573,positive,1,1,406,7.2,12.5,2,0,29,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,
4065,Liew,Trimethobenzamide,5577,positive,1,1,388.5,2.3,69.3,6,1,28,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC,,
1559,LIverTox,Phenyltoloxamine,7077,E,0,0,255.35,3.9,12.5,2,0,19,CN(C)CCOC1=CC=CC=C1CC2=CC=CC=C2,.,
152,DILIrank,dacarbazine,2942,vMost-DILI-Concern,1,1,182.18,-0.6,99.7,5,2,13,CN(C)N=NC1=C(NC=N1)C(=O)N,Extensive,
3855,Liew,Pipotiazine,62867,positive,0,0,475.7,3.5,97.8,7,1,32,CN(C)S(=O)(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCC(CC4)CCO,,
2270,Greene,Pargyline,4688,NE,0,0,159.23,2.1,3.2,1,0,12,CN(CC#C)CC1=CC=CC=C1,.,
4044,Liew,Tolrestat,53359,positive,1,1,357.3,3.7,81.9,7,1,24,CN(CC(=O)O)C(=S)C1=CC=CC2=C1C=CC(=C2C(F)(F)F)OC,,
2209,Greene,Methotrexate,126941,HH,1,1,454.4,-1.8,211,12,5,33,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,	Liver and intracellular,
3742,Liew,Naftifine,47641,negative,0,0,287.4,5.1,3.2,1,0,22,CN(CC=CC1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32,,
3424,Liew,Dofetilide,71329,negative,0,0,441.6,1.8,122,8,2,29,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,,
3376,Liew,Demecarium,5966,negative,0,0,556.8,6.6,59.1,4,0,40,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC2=CC=CC(=C2)[N+](C)(C)C,,
2038,Greene,Demecarium Bromide,5965,HH,1,1,716.6,,59.1,6,0,42,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC2=CC=CC(=C2)[N+](C)(C)C.[Br-].[Br-],,
3643,Liew,Lofepramine,3947,positive,1,1,419,6.8,23.6,3,0,30,CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl,,
1319,LIverTox,Ivabradine,132999,E,0,0,468.6,2.4,60.5,6,0,34,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC,"Liver first-pass >50%, CYP3A4",
806,LIverTox,Alfuzosin,2092,C,1,1,389.4,1.7,112,8,2,28,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,CYP3A4,
1641,LIverTox,Revefenacin,11753673,E,0,0,597.7,4.1,108,6,2,44,CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(C=C4)CN5CCC(CC5)C(=O)N,.,
2416,Greene,Rosiglitazone,77999,WE,1,1,357.4,3.1,96.8,6,1,25,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,CYP2C8,
3860,Liew,Piroxicam,54676228,positive,1,1,331.3,3.1,108,6,2,23,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,Liver,
4007,Liew,Tenoxicam,5282194,positive,0,0,337.4,2.2,136,8,2,22,CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=C(S1(=O)=O)C=CS3,,
473,DILIrank,ceftriaxone,5479530,vLess-DILI-Concern,1,1,554.6,-1.3,288,13,4,36,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,Negligible,
3734,Liew,Moxalactam,47499,positive,0,0,520.5,-0.6,232,13,4,36,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C(C4=CC=C(C=C4)O)C(=O)O)OC)OC2)C(=O)O,,
3281,Liew,Cefmetazole,42008,positive,0,0,471.5,-0.6,239,12,2,30,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O,,
3280,Liew,Cefmenoxime,9570757,positive,0,0,511.6,0,270,14,3,33,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,,
3276,Liew,Cefamandole,456255,positive,0,0,462.5,-0.9,201,10,3,31,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(C4=CC=CC=C4)O)SC2)C(=O)O,,
2916,Liew,Diazepam,3016,positive,1,1,284.74,3,32.7,2,0,20,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,,
1750,LIverTox,Temozolomide,5394,B,1,1,194.15,-1.1,106,5,1,14,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,hydrolysis,
778,DILIrank,levomefolate calcium,444412,vNo-DILI-Concern,0,0,459.5,-0.5,199,9,7,33,CN1C(CNC2=C1C(=O)N=C(N2)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,.,
3306,Liew,Chlormezanone,2717,positive,1,1,273.74,1.1,62.8,3,0,17,CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl,,
314,DILIrank,dyphylline,3182,vNo-DILI-Concern,0,0,254.24,-1.8,98.9,5,2,18,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O,.,
226,DILIrank,dimenhydrinate,10660,vNo-DILI-Concern,0,0,470,,81.8,5,1,33,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,Liver,
4019,Liew,Theophylline,2153,negative,0,0,180.16,0,69.3,3,1,13,CN1C2=C(C(=O)N(C1=O)C)NC=N2,hepatic,
304,DILIrank,aminophylline,9433,vNo-DILI-Concern,0,0,420.43,,191,8,4,30,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,.,
537,DILIrank,droxicam,65679,vMost-DILI-Concern,1,1,357.3,1.2,105,7,0,25,CN1C2=C(C3=CC=CC=C3S1(=O)=O)OC(=O)N(C2=O)C4=CC=CC=N4,.,
1056,LIverTox,Dabigatran,216210,D,1,1,471.5,1.7,150,7,4,35,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,.,
1749,LIverTox,Temazepam,5391,E,0,0,300.74,2.2,52.9,3,1,21,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Liver,
3221,Liew,Bendamustine,65628,negative,0,0,358.3,2.9,58.4,4,1,23,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,,
2452,Greene,tianeptine,68870,HH,1,1,437,1.2,95.1,6,2,29,CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O,Liver by ??-oxidation,
1033,LIverTox,Cocaine,446220,A[HD],1,1,303.35,2.3,55.8,5,0,22,CN1C2CCC1C(C(C2)OC(=O)C3=CC=CC=C3)C(=O)OC,CYP3A4,
3578,Liew,Homatropine,6321423,negative,0,0,275.34,1.9,49.8,4,1,20,CN1C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O,,
217,DILIrank,atropine,174174,vNo-DILI-Concern,0,0,289.4,1.8,49.8,4,1,21,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,???50% hydrolysed to tropine and tropic acid,
4076,Liew,Tropisetron,72165,positive,0,0,284.35,3.8,45.3,3,1,21,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43,"CYP3A4, CYP1A2, CYP2D6",
449,DILIrank,benztropine,1201549,vNo-DILI-Concern,0,0,307.4,4.5,12.5,2,0,23,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4,Liver,
1509,LIverTox,Osimertinib,71496458,E*,0,0,499.6,3.7,87.6,7,2,37,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,Oxidation CYP3A,
242,DILIrank,methimazole,1349907,vMost-DILI-Concern,1,1,114.17,-0.3,47.4,1,1,7,CN1C=CNC1=S,Liver,
1928,Greene,Azathioprine,2265,HH,1,1,277.27,0.1,143,7,1,19,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],"	Activated non-enzymatically, deactivated mainly by xanthine oxidase",
703,DILIrank,caffeine,2519,vNo-DILI-Concern,0,0,194.19,-0.1,58.4,3,0,14,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,"	Primary: CYP1A2 inor: CYP2E1,CYP3A4,
CYP2C8,CYP2C9",
1735,LIverTox,Tadalafil,110635,D,1,1,389.4,2.3,74.9,4,1,29,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,Liver predominantly CYP3A4,
2739,Xu,nomifensine,4528,Positive,1,1,238.33,2.6,29.3,2,1,18,CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3,.,
3681,Liew,Metergoline,28693,positive,0,0,403.5,3.8,46.5,3,1,30,CN1CC(CC2C1CC3=CN(C4=CC=CC2=C34)C)CNC(=O)OCC5=CC=CC=C5,,
879,LIverTox,Asenapine,163091,D,1,1,285.8,3.8,12.5,2,0,20,CN1CC2C(C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24,Liver glucurinodation by UGT1A4 and oxidative metabolism by CYP1A2,
2687,Xu,Ketotifen,3827,Negative,0,0,309.4,3.2,48.6,3,0,22,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,Liver,
1050,LIverTox,Cyproheptadine,2913,C,1,1,287.4,4.7,3.2,1,0,22,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,CYP3A4,
3210,Liew,Azatadine,19861,negative,0,0,290.4,3.6,16.1,2,0,22,CN1CCC(=C2C3=CC=CC=C3CCC4=C2N=CC=C4)CC1,,
3687,Liew,Methdilazine,14677,positive,0,0,296.4,5.2,31.8,3,0,21,CN1CCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42,,
1828,LIverTox,Vandetanib,3081361,E*,0,0,475.4,4.9,59.5,7,1,30,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,"CYP3A4, FMO1, FMO3",
1247,LIverTox,Glasdegib,25166913,E*,0,0,374.4,2.4,96.8,4,3,28,CN1CCC(CC1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,.,
3802,Liew,Oxymorphone,5284604,negative,0,0,301.34,0.8,70,5,2,22,CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,CYP3A4,
1518,LIverTox,Oxycodone,5284603,E,0,0,315.4,1.2,59,5,1,23,CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O,"Liver: mainly CYP3A, and, to a much lesser extent, CYP2D6 ~5%; 95% metabolized i.e., 5% excreted unchanged",
3036,Liew,Morphine,5288826,positive,.,0,285.34,0.8,52.9,4,2,21,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,,
1034,LIverTox,Codeine,5284371,E,0,0,299.4,1.1,41.9,4,1,22,CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O,"Liver: CYP2D6 to morphine, CYP3A4 to norcodeine, UGT2B7 to 3- and 6-glucuronides of codeine, norcodeine, and morphine",
1230,LIverTox,Galantamine,9651,E,0,0,287.35,1.8,41.9,4,1,21,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,Liver partially CYP450:CYP2D6/3A4,
3637,Liew,Levorphanol,5359272,negative,0,0,257.37,3.1,23.5,2,1,19,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O,,
2619,Xu,Dextromethorphan HBr,5360696,Negative,0,0,271.4,3.4,12.5,2,0,20,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC,"	Liver enzymes: major CYP2D6, minor CYP3A4, and minor CYP3A5",
1132,LIverTox,Edoxaban,10280735,D,1,1,548.1,1.4,165,8,3,37,CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,"minimal CES1, CYP3A4/5, hydrolysis, glucuronidation",
760,DILIrank,apomorphine,6005,vNo-DILI-Concern,0,0,267.32,2.3,43.7,3,2,20,CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O,"Liver, phase II",
4079,Liew,Tubocurarine,6000,negative,0,0,609.7,6,80.6,7,2,45,CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)O)O3)[N+](CCC6=CC(=C5O)OC)(C)C)OC,,
750,DILIrank,mepazine,6075,vMost-DILI-Concern,1,1,310.5,5.6,31.8,3,0,22,CN1CCCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42,.,
3212,Liew,Azelastine,2267,negative,0,0,381.9,4.4,35.9,3,0,27,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,,
3761,Liew,Nicotine,89594,negative,0,0,162.23,1.2,16.1,2,0,12,CN1CCCC1C2=CN=CC=C2,,
2201,Greene,Mesoridazine Besylate,4078,HH,1,1,386.6,4.5,68.1,5,0,26,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)C,	Liver/renal,
4025,Liew,Thioridazine,5452,positive,1,1,370.6,5.9,57.1,4,0,25,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC,CYP2D6,
1614,LIverTox,Pyrantel,708857,E,0,0,206.31,1.6,43.8,2,0,14,CN1CCCN=C1C=CC2=CC=CS2,.,
3803,Liew,Oxyphencyclimine,4642,negative,0,0,344.4,2.9,62.1,4,1,25,CN1CCCN=C1COC(=O)C(C2CCCCC2)(C3=CC=CC=C3)O,,
3468,Liew,Eszopiclone,969472,negative,0,0,388.8,0.5,91.8,7,0,27,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,,
36,DILIrank,chlorcyclizine,2710,vLess-DILI-Concern,1,1,300.8,4.5,6.5,2,0,21,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,.,
1045,LIverTox,Cyclizine,6726,E,0,0,266.4,3.6,6.5,2,0,20,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3,N-demethylated to inactive norcyclizine,
3502,Liew,Fleroxacin,3357,positive,0,0,369.34,-0.1,64.1,9,1,26,CN1CCN(CC1)C2=C(C=C3C(=C2F)N(C=C(C3=O)C(=O)O)CCF)F,,
2021,Greene,Clozapine,2818,HH,1,1,326.8,3.2,30.9,4,1,23,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,"	Liver, by several CYP isozymes",
1374,LIverTox,Loxapine,3964,D,1,1,327.8,3.1,28.1,3,0,23,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,"Extensive Liver; active metabolites include amoxapine and 8-hydroxyloxapine. Inhibits P-gp and is a substrate of CYP1A2, CYP3A4 and CYP2D6",
945,LIverTox,Brigatinib,68165256,E*,0,0,584.1,4.6,85.9,9,2,40,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,.,
1474,LIverTox,Nintedanib,9809715,E*,0,0,539.6,3.3,94.2,7,2,40,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)NC(=C3C4=C(C=C(C=C4)C(=O)OC)NC3=O)C5=CC=CC=C5,"Esterases, glucuronidation",
4058,Liew,Trifluoperazine,5566,positive,1,1,407.5,5,35,7,0,28,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F,Liver,
3883,Liew,Prochlorperazine,4917,positive,1,1,373.9,4.9,35,4,0,25,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,"CYP2D6, CYP3A4",
3828,Liew,Perazine,4744,positive,0,0,339.5,4.1,35,4,0,24,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=CC=CC=C42,,
941,LIverTox,Bosutinib,5328940,D,1,1,530.4,5.4,82.9,8,1,36,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,"By CYP3A4, to inactive metabolites",
1428,LIverTox,Mirtazapine,4205,C,1,1,265.35,3.3,19.4,3,0,20,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,"CYP1A2, CYP2D6, CYP3A4",
2222,Greene,mianserin,4184,HH,1,1,264.4,3.4,6.5,2,0,20,CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42,"	Liver CYP2D6; via aromatic hydroxylation, N-oxidation, N-demethylation",
1743,LIverTox,Tedizolid,11234049,E*,0,0,370.3,1.4,106,8,1,27,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)CO)F,.,
481,DILIrank,chlordiazepoxide,2712,vLess-DILI-Concern,1,1,299.75,2.4,48.2,3,1,21,CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O,Liver,
76,DILIrank,ranitidine,3001055,vLess-DILI-Concern,1,1,314.41,0.3,112,7,2,21,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,"Liver: FMOs, including FMO3; other enzymes",
1482,LIverTox,Nizatidine,3033637,D,1,1,331.5,1.6,140,8,2,21,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,Liver,
3235,Liew,Bethanidine,2368,negative,0,0,177.25,0.9,36.4,1,2,13,CNC(=NC)NCC1=CC=CC=C1,,
869,LIverTox,Apalutamide,24872560,E,0,0,477.4,3,121,9,1,33,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F,"CYP2C8, CYP3A4",
894,LIverTox,Axitinib,6450551,E*,0,0,386.5,4.2,96,4,2,28,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,"Liver mostly CYP3A4/CYP3A5-mediated but with some contributions from CYP1A2, CYP2C19, UGT1A1",
267,DILIrank,regadenoson,219024,vNo-DILI-Concern,0,0,390.35,-1.5,187,10,5,28,CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N,.,
1635,LIverTox,Regorafenib,11167602,B,1,1,482.8,4.2,92.4,8,3,33,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,Hepatic UGT1A9-mediated,
1710,LIverTox,Sorafenib,216239,B,1,1,464.8,4.1,92.4,7,3,32,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,Liver oxidation and glucuronidation CYP3A4 & UGT1A9-mediated,
3546,Liew,Gadodiamide,153921,negative,0,0,573.7,,188,11,2,30,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],,
1327,LIverTox,Ketamine,3821,B,1,1,237.72,2.2,29.1,2,1,16,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,"Liver, intestine oral:",
3955,Liew,Sertraline,68617,positive,1,1,306.2,4.8,12,1,1,20,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,"CYP2B6(major), CYP2C19",
425,DILIrank,frovatriptan,77992,vNo-DILI-Concern,0,0,243.3,1.2,70.9,2,3,18,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N,	Liver,
1667,LIverTox,Rucaparib,9931954,E*,0,0,323.4,2.5,56.9,3,3,24,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,Liver primarily CYP2D6; 1A2 and 3A4 to a lesser extent,
1211,LIverTox,Fluoxetine,3386,C,1,1,309.33,4,21.3,5,1,22,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CYP2D6,
1123,LIverTox,Duloxetine,60835,B,1,1,297.4,4.3,49.5,3,1,21,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,"Liver, two P450 isozymes, CYP2D6 and CYP1A2",
2742,Xu,Nortriptyline HCl,4543,Positive,1,1,263.4,4.5,12,1,1,20,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,Liver,
2190,Greene,Maprotiline,4011,WE,1,1,277.4,4.6,12,1,1,21,CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24,Liver,
1608,LIverTox,Protriptyline,4976,E*,0,0,263.4,4.4,12,1,1,20,CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13,Liver,
3379,Liew,Desipramine,2995,positive,1,1,266.4,4.9,15.3,2,1,20,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,,
3098,Liew,Sumatriptan,5358,negative,.,0,295.4,0.9,73.6,4,2,20,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,MAO,
1028,LIverTox,Clopidogrel,60606,B,1,1,321.8,3.8,57.8,4,0,21,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Liver,
1409,LIverTox,Methylphenidate,4158,C[H],1,1,233.31,0.2,38.3,3,1,17,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Liver 80% mostly CES1A1-mediated,
1857,LIverTox,Yohimbine,8969,E,0,0,354.4,2.9,65.6,4,2,26,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O,.,
1097,LIverTox,Dimethyl Fumarate,637568,"C,E*,E*",1,1,144.12,0.7,52.6,4,0,10,COC(=O)C=CC(=O)OC,.,
1384,LIverTox,Mebendazole,4030,D,1,1,295.29,2.8,84.1,4,2,22,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,Extensive liver,
2253,Greene,Nocodazole,4122,NE,0,0,301.32,2.8,112,5,2,21,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CS3,.,
902,LIverTox,Baloxavir,124081896,E,0,0,571.6,3.8,123,12,0,40,COC(=O)OCOC1=C2C(=O)N3CCOCC3N(N2C=CC1=O)C4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F,.,
3696,Liew,Methoxyflurane,4116,positive,1,1,164.96,2.2,9.2,3,0,8,COC(C(Cl)Cl)(F)F,,
3503,Liew,Flomoxef,65864,positive,0,0,496.5,-1.3,220,14,3,32,COC1(C2N(C1=O)C(=C(CO2)CSC3=NN=NN3CCO)C(=O)O)NC(=O)CSC(F)F,,
3809,Liew,Pantoprazole,4679,positive,1,1,383.4,2.4,106,9,1,26,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,"CYP2C19, CYP3A4",
4092,Liew,Vesnarinone,5663,positive,0,0,395.5,2.1,71.1,5,1,29,COC1=C(C=C(C=C1)C(=O)N2CCN(CC2)C3=CC4=C(C=C3)NC(=O)CC4)OC,,
1347,LIverTox,Letermovir,45138674,E,0,0,572.5,4.6,77.8,10,1,41,COC1=C(C=C(C=C1)C(F)(F)F)N2C(C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O,glucuronidation UGT1A1/1A3 to a minor extent,
3145,Liew,Adapalene,60164,negative,0,0,412.5,7.7,46.5,3,1,31,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,,
4050,Liew,Tranilast,5282230,positive,1,1,327.3,3.2,84.9,5,2,24,COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC,,
3810,Liew,Papaverine,4680,positive,1,1,339.4,3.9,49.8,5,0,25,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC,Liver,
892,LIverTox,Avanafil,9869929,E*,0,0,483.9,2.6,125,9,3,34,COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCCC4CO)Cl,.,
158,DILIrank,glibenclamide,3488,vLess-DILI-Concern,1,1,494,4.8,122,5,3,33,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,	Liver hydroxylation CYP2C9,
3872,Liew,Prazosin,4893,positive,0,0,383.4,2,107,8,1,28,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,,
679,DILIrank,terazosin,5401,vNo-DILI-Concern,0,0,387.4,1.4,103,8,1,28,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,.,
1113,LIverTox,Doxazosin,3157,E*,0,0,451.5,2.5,112,9,1,33,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Liver,
2630,Xu,Donepezil,3152,Negative,0,1,379.5,4.3,38.8,4,0,28,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,"	CYP2D6, CYP3A4, and glucuronidation.Four major metabolites, two of which are active.",
1061,LIverTox,Dacomitinib,11511120,E*,0,0,469.9,4.4,79.4,7,2,33,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,"CYP2D6, CYP3A4",
3553,Liew,Gefitinib,123631,positive,1,1,446.9,4.1,68.7,8,1,31,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,,
2517,Xu,Amsacrine HCl,2179,Positive,1,1,393.5,4,88.7,6,2,28,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,
1040,LIverTox,Copanlisib,24989044,E*,0,0,480.5,-0.3,140,10,2,35,COC1=C(C=CC2=C1N=C(N3C2=NCC3)NC(=O)C4=CN=C(N=C4)N)OCCCN5CCOCC5,"CYP3A4/5 (?90%), CYP1A1 (?10%)",
3735,Liew,Moxifloxacin,152946,positive,1,1,401.4,0.6,82.1,8,2,29,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,,
3695,Liew,Methoxsalen,4114,positive,1,1,216.19,1.9,48.7,4,0,16,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,,
1891,Greene,aflatoxin B1,14403,HH,1,1,312.27,1.6,71.1,6,0,23,COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4C5C=COC5OC4=C1,.,
690,DILIrank,trimethoprim,5578,vLess-DILI-Concern,1,1,290.32,0.9,106,7,2,21,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,Liver,
1622,LIverTox,Quinine,8549,B,1,1,324.4,2.9,45.6,4,1,24,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,"CYP3A4, CYP2C19",
959,LIverTox,Cabozantinib,25102847,E*,0,0,501.5,5.4,98.8,7,2,37,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,CYP3A4,
1345,LIverTox,Lenvatinib,9823820,D,1,1,426.9,2.8,116,5,3,30,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,"CYP3A4, aldehyde oxidase, non-enzymatic",
3309,Liew,Chlorotrianisene,11289,negative,0,0,380.9,6.4,27.7,3,0,27,COC1=CC=C(C=C1)C(=C(C2=CC=C(C=C2)OC)Cl)C3=CC=C(C=C3)OC,,
3192,Liew,Aniracetam,2196,negative,0,0,219.24,1.6,46.6,3,0,16,COC1=CC=C(C=C1)C(=O)N2CCCC2=O,,
3193,Liew,Anisindione,2197,negative,0,0,252.26,2.9,43.4,3,0,19,COC1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O,,
1918,Greene,Astemizole,2247,NE,0,0,458.6,6,42.3,5,1,34,COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F,CYP3A4,
870,LIverTox,Apixaban,10182969,B,1,1,459.5,2.2,111,5,1,34,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,"CYP3A4, CYP3A5, CYP1A2 and others",
441,DILIrank,guaifenesin,3516,vNo-DILI-Concern,0,0,198.22,1.4,58.9,4,2,14,COC1=CC=CC=C1OCC(CO)O,	Kidney,
1405,LIverTox,Methocarbamol,4107,E,0,0,241.24,0.6,91,5,2,17,COC1=CC=CC=C1OCC(COC(=O)N)O,Liver,
3272,Liew,Carvedilol,2585,positive,1,1,406.5,4.2,75.7,5,3,30,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,,
499,DILIrank,nelarabine,3011155,vLess-DILI-Concern,1,1,297.27,-0.7,149,9,4,21,COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N,"By adenosine deaminase, to 9-??-D-arabinofuranosylguanine",
1219,LIverTox,Fondaparinux,636380,E,0,1,1728.1,,901,52,9,101,COC1C(C(C(C(O1)COS(=O)(=O)[O-])OC2C(C(C(C(O2)C(=O)[O-])OC3C(C(C(C(O3)COS(=O)(=O)[O-])OC4C(C(C(C(O4)C(=O)[O-])OC5C(C(C(C(O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],renally excreted unchanged,
1637,LIverTox,Reserpine,5770,E,0,0,608.7,4,118,10,1,44,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,"Liver, Gut",
3923,Liew,Rescinnamine,5280954,negative,0,0,634.7,4.5,118,10,1,46,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C=CC6=CC(=C(C(=C6)OC)OC)OC,,
3378,Liew,Deserpidine,8550,negative,0,0,578.7,4.1,109,9,1,42,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=CC=CC=C45)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,,
2563,Xu,Cisapride,2769,Negative,0,0,465.9,3.4,86,7,2,32,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F,"	liver CYP3A4, intestinal",
2119,Greene,fluvoxamine,5324346,HH,1,1,318.33,2.6,56.8,7,1,22,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,Liver primarily O-demethylation Major: CYP1A2 Minor: CYP3A4 Minor: CYP2C19,
3345,Liew,Clovoxamine,6335903,positive,0,0,284.78,2.4,56.8,4,1,19,COCCCCC(=NOCCN)C1=CC=C(C=C1)Cl,,
1609,LIverTox,Prucalopride,3052762,E,0,0,367.9,2,76.8,5,2,25,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,.,
3458,Liew,Erlotinib,176870,positive,1,1,393.4,3.3,74.7,7,1,29,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,,
1452,LIverTox,Naloxegol,56959087,E,0,0,651.8,-1,127,12,2,46,COCCOCCOCCOCCOCCOCCOCCOC1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC=C)O,CYP3A,
3288,Liew,Cefpirome,6917674,positive,0,0,514.6,0.9,208,10,2,35,CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC5=C4CCC5)C(=O)[O-],,
437,DILIrank,gemifloxacin,9571107,vLess-DILI-Concern,1,1,389.4,-0.7,121,10,2,28,CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F,Limited metabolism by the liver to minor metabolites,
753,DILIrank,simethicone,6433516,vNo-DILI-Concern,0,0,238.46,,52.6,4,0,13,CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O,	Not metabolized,
1841,LIverTox,Vismodegib,24776445,C,1,1,421.3,3.8,84.5,4,1,27,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,"<2% metabolised by CYP2C9, CYP3A4, CYP3A5",
3939,Liew,Rofecoxib,5090,positive,1,1,314.4,2.3,68.8,4,0,22,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Liver,
3624,Liew,Lapatinib,208908,positive,1,1,581.1,5.1,115,9,2,40,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,,
3765,Liew,Nimesulide,4495,positive,1,1,308.31,2.6,110,6,1,21,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,Liver,
149,DILIrank,busulfan,2478,vMost-DILI-Concern,1,1,246.3,-0.5,104,6,0,14,CS(=O)(=O)OCCCCOS(=O)(=O)C,Liver,
172,DILIrank,sincalide,32800,vNo-DILI-Concern,0,0,1143.3,-2.6,486,19,13,78,CSCCC(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CC(=O)O)N,.,
601,DILIrank,l-methionine,6137,vNo-DILI-Concern,0,0,149.21,-1.9,88.6,4,2,9,CSCCC(C(=O)O)N,.,
963,LIverTox,Cangrelor,9854012,E,0,0,776.4,-1,307,21,7,44,CSCCNC1=C2C(=NC(=N1)SCCC(F)(F)F)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O,Rapid deactivation in the circulation independent of CYP system,
1942,Greene,Betaine HCl,247,NE,0,0,117.15,0.5,40.1,2,0,8,C[N+](C)(C)CC(=O)[O-],,
606,DILIrank,l-carnitine,288,vNo-DILI-Concern,0,0,161.2,-0.2,60.4,3,1,11,C[N+](C)(C)CC(CC(=O)[O-])O,slightly,
3973,Liew,Succinylcholine,22475,negative,0,0,361.3,,52.6,6,0,22,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-],,
3263,Liew,Carbachol,5831,negative,0,0,182.65,,52.3,3,1,11,C[N+](C)(C)CCOC(=O)N.[Cl-],,
2009,Greene,Citicoline,11583971,NE,0,0,488.32,-4,214,11,4,31,C[N+](C)(C)CCOP(=O)(O)OP(=O)([O-])OCC1C(C(C(O1)N2C=CC(=NC2=O)N)O)O,.,
3576,Liew,Hexafluorenium,9434,negative,0,0,662.5,,0,2,0,40,C[N+](C)(CCCCCC[N+](C)(C)C1C2=CC=CC=C2C3=CC=CC=C13)C4C5=CC=CC=C5C6=CC=CC=C46.[Br-].[Br-],,
4035,Liew,Tiotropium,5487427,negative,0,0,392.5,2.3,116,6,1,26,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,"CYP2D6, CYP3A4",
3697,Liew,Methscopolamine,441342,negative,0,0,398.3,,59.1,5,1,24,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C.[Br-],,
344,DILIrank,glycopyrrolate,3494,vNo-DILI-Concern,0,0,318.4,3.1,46.5,3,1,23,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C,.,
237,DILIrank,methylnaltrexone bromide,5361918,vNo-DILI-Concern,0,0,356.4,1.6,66.8,4,2,26,C[N+]1(CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6,	Liver,
3429,Liew,Doxacurium,60169,negative,0,0,1035.2,7.4,163,16,0,74,C[N+]1(CCC2=CC(=C(C(=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)OC)CCCOC(=O)CCC(=O)OCCC[N+]4(CCC5=CC(=C(C(=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)OC)C,,
3727,Liew,Mivacurium,71316,negative,0,0,1029.3,8.7,145,14,0,74,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C,,
368,DILIrank,atracurium,47320,vNo-DILI-Concern,0,0,1243.5,,258,18,0,87,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],	Hofmann elimination retro-Michael addition and ester hydrolysis by nonspecific esterases,
3708,Liew,Metocurine,21233,negative,0,0,652.8,6.7,55.4,6,0,48,C[N+]1(CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)OC)O3)[N+](CCC6=CC(=C5OC)OC)(C)C)OC)C,,
3670,Liew,Mepenzolate,4057,negative,0,0,340.4,3.2,46.5,3,1,25,C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C,,
3279,Liew,Cefepime,5479537,positive,1,1,480.6,-0.1,204,10,2,32,C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],,
3331,Liew,Clidinium,2784,negative,0,0,352.4,3.3,46.5,3,1,26,C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O,,
739,DILIrank,pyridostigmine,4991,vNo-DILI-Concern,0,0,181.21,0.7,33.4,2,0,13,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,.,
175,DILIrank,cupric chloride,24014,vNo-DILI-Concern,0,0,134.45,,0,0,0,3,Cl[Cu]Cl,.,
1916,Greene,Arsenic Trioxide,261004,HH,1,1,197.841,,43.4,3,0,5,O=[As]O[As]=O,.,
358,DILIrank,nitroprusside,11953895,vNo-DILI-Concern,0,0,297.95,,139,14,2,17,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.O.O.[Na+].[Na+].[Fe+4],,complex
373,DILIrank,rubidium chloride rb-82,71357,vNo-DILI-Concern,0,0,117.37,,0,1,0,2,[Cl-].[Rb+],.,
452,DILIrank,gadobenate dimeglumine,105124,vNo-DILI-Concern,0,0,667.7,,220,14,2,37,[H+].[H+].C1=CC=C(C=C1)COCC(C(=O)[O-])N(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],.,
1014,LIverTox,Cisplatin,2767,C,1,1,298.03,,2,2,2,5,[NH2-].[NH2-].Cl[Pt+2]Cl,.,
1907,Greene,ammonium chloride,25517,NE,0,0,53.49,,1,1,1,2,[NH4+].[Cl-],.,
2237,Greene,NaCl,5234,NE,0,0,58.44,,0,1,0,2,[Na+].[Cl-],.,
194,DILIrank,sodium thiosulfate,24477,vNo-DILI-Concern,0,0,158.11,,104,4,0,7,[O-]S(=O)(=S)[O-].[Na+].[Na+],.,
>>>>>>> 772863a274eb6a0a836c8f6db049ba9b99d86e02
